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Abstract 
 
Acute Coronary Syndrome (ACS) is common and associated with high 
mortality. Effective treatments are available but require prompt administration. 
Studies have consistently demonstrated that delays to treatment are common, 
with patient decision time accounting for most delay. Interventions aimed at 
reducing delay have had little success.  
Evidence suggests that psychological factors, in particular illness 
representations (Leventhal’s Commonsense Model of Self-Regulation (CS-
SRM)) might be important in relation to patient decision time. This thesis 
describes a two-stage investigation, undertaken within NHS 24, exploring the 
content and timing of people’s initial presentations with possible symptoms of 
ACS. 
The first stage comprised a CS-SRM-guided content analysis of peoples’ initial 
symptom presentations. The second stage utilised the Illness Perception 
Questionnaire-revised (IPQ-R) to explore how illness representations relate to 
patient decision time.  
Results show that the components of illness representations accounted for 
95% of participants’ initial presentations. The components most related to 
behaviour and outcome were volunteered least (cause, consequences, 
cure/control and coherence). Decision time for most participants (89%) was 
out-with the ideal and appraisal time accounted for most of the delay.  
Appraisal delay was shorter for those with fewer symptoms and high emotion. 
 ii 
Illness delay was longer where the person making the call reported high 
treatment control.  
Interventions may need to raise awareness of the range of possible 
presentations and of the consequences associated with delay.  Interventions 
should also provide guidance as to an appropriate time-limit for self-care. 
Individuals may benefit from being informed about how to respond to strong 
emotional responses. Interventions aimed at bystanders may need to differ 
from those for patients. People at high risk of ACS should be informed about 
how and when to access healthcare out-of-hours. 
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Chapter 1. Introduction  
Coronary heart disease (CHD) is the leading cause of death worldwide 
(World Health Organization, 2007). Most CHD-related deaths are due to 
Acute Coronary Syndrome (ACS) and most occur before the patient even 
reaches hospital (World Health Organization, 2007). Early access to 
advanced life support and to treatments for ACS can significantly reduce 
mortality and morbidity. However, there is evidence that delay to receipt of 
treatment is common (Dracup and Moser, 1997; Dracup and Moser, 1997; 
Canto et al.  2000; Goldberg et al.  2002b). It has been demonstrated that 
the interval which contributes most to pre-hospital time is patient decision 
time (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI), 
1995). Reductions in patient decision time could lead to a reduction in 
mortality for ACS. However, to date interventions aimed at reducing patient 
delay have met with little success (Meischke et al.  1997; Luepker et al.  
2000; Kainth et al.  2004). The aim of the thesis is to contribute to the body 
of knowledge regarding patient decision time in order to inform future, more 
successful, interventions. 
1.1 Plan of thesis 
In the following chapter of the thesis, the existing evidence relating to 
patient decision time and ACS is reviewed. Critical analysis of the literature 
reveals a number of important limitations and gaps in knowledge and 
highlights the likely importance of psychological factors in relation to patient 
decision time. In particular, the likely utility of Leventhal’s Commonsense 
Model of Self-Regulation (CS-SRM) as a theoretical framework for the 
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study is explored.  
Chapter 3 describes the aims of a two-stage investigation which was 
undertaken to explore both the presentation of symptoms, and patient 
decision time, in relation to ACS, using the CS-SRM. The study was 
conducted within NHS 24, a telephone-based health advice service in 
Scotland. A rationale for the choice of setting is provided.   
The first stage of the investigation explored how the CS-SRM related to 
peoples’ initial symptom presentations to health services and comprised a 
theory-guided content analysis of transcriptions of calls to NHS 24. The 
methodology, including the preliminary pilot work which was undertaken is 
described in detail in Chapter 4. Results are presented and discussed in 
Chapter 5.  
The second stage of the investigation explored whether components of the 
CS-SRM were useful in explaining patient decision time. A cross-sectional 
survey of people who called NHS 24 with possible symptoms of ACS was 
conducted using a specifically adapted Illness Perception Questionnaire 
(IPQ-R). Details of the methodology and of further pilot work are described 
in Chapter 6. The results are presented and discussed in Chapter 7. 
Finally, the overall conclusions from both stages of the investigation are 
discussed in Chapter 8. Implications for practice, theory and future 
research are identified. 
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Chapter 2. Literature review 
2.1 Background 
2.1.1 Coronary Heart Disease 
Worldwide, Coronary Heart Disease (CHD) is the single most common 
cause of death (World Health Organization, 2007). Within the UK, death 
rates are highest in Scotland (Petersen et al.  2005). CHD refers to 
narrowing of the coronary arteries, usually due to atheroma. The term 
atheroma is used to describe a build up of ‘fatty plaques’ which develop 
within the inner lining of the artery. A number of factors (e.g. smoking, high 
blood pressure, high blood cholesterol and diabetes mellitus) are 
associated with an increased risk of developing atheroma and therefore 
CHD (Anderson et al.  1991). CHD usually develops over many years 
before symptoms emerge and is characterised by phases of stability and 
instability (Bertrand et al.  2002). The onset of an acute coronary syndrome 
(ACS) is frequently the first presentation of CHD.  
Acute coronary syndromes 
Atheromatous plaques can rupture, releasing the thrombogenic material 
they contain into the lumen of the coronary artery.  The term ‘acute 
coronary syndromes’ (ACS) is used to refer to the spectrum of clinical 
manifestations of CHD which share this common underlying pathology 
(Davies, 1995; Davies, 1997). The term ACS encompasses myocardial 
infarction (MI), non-ST elevation MI (NSTEMI) and unstable angina (UA) 
 4 
which are described in more detail below1.  
Myocardial Infarction 
Rupture of atheromatous plaque may result in complete occlusion of the 
coronary artery by thrombus or other aggregates. This leads to necrosis2 of 
the area of myocardium subtended by the affected artery and is labelled as 
myocardial infarction (MI). MI is typically associated with ST segment 
elevation on the electrocardiograph (ECG) and the release of biochemical 
markers of necrosis (Fox, 2000). 
Unstable angina 
Where less obstructive thrombi exist or, where spontaneous dissolution of 
the thrombus occurs and flow within the artery is restored within 20 
minutes, persistent changes on the ECG or release of biochemical markers 
do not usually occur. Clinically, this is described as unstable angina.   
Non- ST elevation MI 
Episodes of occlusion may occur where release of biochemical markers of 
necrosis occurs but where ST elevation is not evident on the ECG. This is 
termed non-ST elevation MI (NSTEMI) (Fox, 2000). 
Mortality risks vary between the syndromes and the treatment indicated for 
each is different. In particular, emergency reperfusion treatment is indicated 
for acute MI but not for the remainder of the syndromes (Van de Werf et al.  
2003). Early management of ACS is discussed further on page 8. 
                                               
1
 ST-elevation refers to a particular abnormality of a waveform observed on the 
Electrocardiograph (ECG) 
2
 necrosis refers to death of cells or tissue. 
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However, the symptoms associated with each ACS are similar and these 
are discussed below. 
Symptoms associated with acute coronary syndromes 
Chest pain is the classic symptom associated with ACS (Lee and Cannon, 
2005). The particular type of chest pain associated with ACS is known as 
angina pectoris. The nature of angina pectoris is particular in terms of 
quality, location and duration.  
Quality 
Angina pectoris is typically described as a ‘tightening’ sensation by patients 
and often not described as a pain at all. Words commonly used by patients 
to describe the discomfort include “pressing”, “squeezing” or “burning”. The 
sensation of a heavy weight on the chest or of a tight band around the 
chest are also frequently described (Lee and Cannon, 2005). 
Location 
Angina is typically experienced below the sternum or across the chest. 
Often the discomfort is restricted to the left of the chest and less commonly 
to the right. It is ‘visceral’ in nature and therefore diffuse and difficult to 
localise (Lee and Cannon, 2005). 
Duration 
Stable angina is usually of brief duration (lasting less than a few minutes) 
and predictably associated with exertion (Gibbons et al.  2003). However, 
the symptoms of unstable angina tend to be of longer duration (>10 mins.). 
Pain which is prolonged (>30 mins.) and associated with other symptoms, 
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such as sweating or nausea and vomiting, is commonly associated with MI. 
The pain of a myocardial infarction may last for several hours. Onset of 
discomfort whilst resting is also highly suggestive of ACS (Braunwald et al.  
2002). 
Identifying symptoms of ACS 
The symptoms of ACS share many common features and are therefore 
very difficult to distinguish from each other. The features of ACS, described 
above, could be considered ‘typical’. However, there is evidence to suggest 
that a substantial proportion of patients with ACS experience atypical chest 
pain (e.g. sharp pain or pain induced by palpation) (Bertrand et al.  2002) or 
indeed other ‘atypical’ symptoms such as dyspnoea, nausea and vomiting 
or palpitations (Canto et al.  2000; Gupta et al.  2002). Furthermore, there is 
evidence that in patients with objective pathological evidence of MI, a 
proportion are unable to recall any symptom episode they could associate 
with MI (Kannel and Abbott, 1984).  
Particular groups appear to be most likely to present with atypical 
symptoms or silent ischaemia. These include women, the elderly and 
people with diabetes (Gupta et al.  2002; Bertrand et al.  2002).  The 
implications of this in relation to help-seeking are discussed in more detail 
on page 28. 
However, it is important to note that the symptoms described above as 
typical of ACS may also be present in a range of other conditions. These 
conditions may be related to the cardio-vascular system (e.g. pericarditis; 
pulmonary embolism; tachyarrhythmia) or to other body systems (e.g. 
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gastro-oesophageal reflux disorder, musculoskeletal pain or panic disorder) 
(Goldberg et al.  2002b). The proportion of patients presenting with chest 
pain who receive a cardiac-related diagnosis varies between clinical 
settings (Erhardt et al.  2002). A Canadian study of family doctors found 
that 18% of patients consulting about chest pain received a cardiac 
diagnosis with the largest proportion (49%) being diagnosed as 
musculoskeletal in origin (Svavarsdóttir et al.  1996). However, a Swedish 
study of people transported by ambulance found that for 69% of patients 
with chest pain a cardiac cause was considered most likely (Herlitz et al.  
1995). 
Furthermore, symptoms of ACS can also be misdiagnosed. A large study of 
participants who presented to emergency departments with symptoms 
suggestive of ischaemia in the USA  found that 2.1% of patients with MI 
and 2.3% of patients with UA were mistakenly discharged (Pope et al.  
2000). 
Therefore a significant challenge exists for healthcare providers in the 
evaluation of the complex symptoms of ACS.  Large numbers of people 
present with chest symptoms, most of which are benign (Erhardt et al.  
2002). Conversely, a proportion of patients who do have ACS will present 
with atypical or absent symptoms. Acute hospital care for people with ACS 
is specialised, intensive and costly whilst the consequences of not 
providing such care, due to a missed diagnosis, are potentially fatal (Lee et 
al.  1987).  
Thus a number of strategies, additional to clinical history and examination, 
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have been developed to improve the triage of patients with ACS. These 
include ECG, biochemical assays, and decision algorithms (Selker et al.  
1997). Until recently the focus has been on either making or excluding the 
diagnosis of MI. However, research over the last two decades has 
improved understanding of the underlying pathological processes and their 
importance in the evolution of ACS. It is now recognised that a continuum 
of risk exists in ACS and therefore evaluation now includes assessment of 
this risk and treatment is tailored accordingly. The treatment of ACS is 
described below, highlighting in particular the time-dependent nature of the 
most effective therapies. 
2.2 Early management of the acute coronary syndromes 
2.2.1 Myocardial Infarction 
MI is associated with a very high mortality rate. The Multinational 
Monitoring of Trends and Determinants in Cardiovascular Disease 
(MONICA) project found that approximately a third of all cases are fatal 
before hospitalisation, most of these within an hour of symptom onset 
(Chambless et al.  1997). The project was a large epidemiological study 
conducted on behalf of the World Health Organisation to monitor trends in 
CHD over 10 years across 37 populations in 21 countries. Median 28-day 
mortality rates of 49% for men and 51% for women were documented. 
Importantly, two-thirds of these deaths (most due to cardiac arrest) 
occurred before reaching hospital.  Survival following cardiac arrest is more 
likely if the event occurs in the presence of paramedical staff equipped with 
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defibrillators (Norris, 1998). 
Furthermore, a number of medical interventions, particularly thrombolysis 
(Fibrinolytic Therapy Trialists' (FTT) Collaborative Group, 1994; GISSI, 
1995) and percutaneous transluminal coronary angioplasty (PTCA) (Zijlstra 
et al.  1999; De Luca et al.  2004) have been demonstrated as effective in 
reducing mortality. However the benefits of such reperfusion treatments are 
dependent upon prompt administration (Boersma et al.  1996). Greatest 
benefit is achieved if treatment is administered within an hour of the onset 
of symptoms. With each minute that passes benefit is reduced, until 
ultimately a time point is reached where the risks associated with treatment 
are judged to outweigh any likely benefit. Thrombolysis is usually not given 
where the onset of symptoms occurred more than 12 hours previously (Van 
de Werf et al.  2003).  
In 1996 Boersma and colleagues conducted a meta-analysis of 22 trials of 
thrombolytic therapy with data from a total of 50,246 patients being 
included. They estimated that treatment with thrombolysis saved 65 lives 
per thousand treated if given within 1 hour of the onset of symptoms; 37 
lives per thousand if given 1-2 hours after the onset of symptoms; reducing 
to 26 and 29 lives per thousand if given 2-3 hours and 3-6 hours 
respectively after the onset of symptoms. They found evidence of benefit 
until at least 12 hours after the onset of symptoms, although this was of 
significantly lower magnitude. They found insufficient evidence to assess 
benefit after this time point. This meta-analysis was well-conducted and 
included data from over 50,000 patients. Additionally, recent authors have 
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suggested that, due to an issue relating to how times were measured in 
certain trials included within the meta-analysis, results from this analysis 
might even underestimate the favourable effects of early thrombolysis 
(Terkelsen et al.  2003).  
In summary, there are compelling reasons why patients who are 
experiencing MI should come under the care of appropriately equipped 
medical or paramedical staff as soon as possible: Firstly to allow the 
prompt identification and treatment of arrhythmias including cardiac arrest 
and secondly to facilitate the early administration of beneficial treatments 
such as thrombolysis or PTCA. 
2.2.2 Unstable angina / Non-ST elevation MI 
Patients with UA/NSTEMI are at a lower, but still significant, risk of death. 
The large, multinational, observational Global Registry of Acute Coronary 
Events (GRACE) has been used to derive regression models to predict 
death from an unbiased population of patients with ACS. Data were 
collected from 26,267 patients with the full spectrum of ACS. A 30-day 
mortality rate of 3% was documented for patients with UA, almost 6% for 
patients with NSTEMI and 9% for patients with ST elevation MI (Fox et al.  
2006).   
However, data also demonstrate that risks for individual patients are not 
equal. Patients with high risk features such as pulmonary oedema or 
ongoing rest pain are at higher risk of death and MI (Braunwald et al.  
2002). Methods for stratifying patients into high, intermediate and low risk 
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categories and tailoring their management accordingly have been proposed 
in recent practice guidelines jointly published by the American College of 
Cardiology and the American Heart Association (Braunwald et al.  2002). 
These guidelines suggest that all except the lowest risk group (who 
comprise approx 6% of patients with UA or NSTEMI) require urgent 
hospital care.  
A number of treatments including aspirin (Antiplatelet Trialists' 
Collaboration, 1994), other anti-platelet drugs (Balsano et al.  1990; Yusuf 
et al.  2001) and anti-thrombin treatments (Eikelboom et al.  2000; Direct 
Thrombin Inhibitor Trialists' Collaborative Group, 2002) have been shown to 
be effective in reducing the risk of death and myocardial infarction in this 
group of patients. Thus prompt medical assessment is warranted for all 
patients with symptoms suggestive of an acute coronary syndrome, to 
identify both those with MI and those with other ACS, associated with high 
risk features, requiring hospital care. 
2.3 Time from onset of symptoms to treatment 
Despite the clear benefits of prompt medical care, studies have consistently 
demonstrated that the time between the onset of symptoms and hospital 
treatment (pre-hospital time) is longer than optimal for many patients with 
ACS. Table 1, below contains a summary of studies where pre-hospital 
time has been investigated amongst patients with MI3. Reports of median 
pre-hospital time vary between 30 mins (Bleeker et al.  1995) and 474 
minutes (Canto et al.  2000). Direct comparisons between studies are 
                                               
3
 1987-2007, median pre-hospital time reported 
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difficult due to important differences in methodology which are likely to 
influence the results obtained. Firstly, there are differences in the 
population being studied. Some studies have been conducted amongst 
participants in randomised controlled trials (RCTs) of thrombolytic drugs 
(GISSI, 1995; Gibler et al.  2002),  a group that is likely to represent a 
highly selected sample of the overall population of patients with MI. Some 
investigators have selected patients on the basis of age, either excluding 
those aged >75 years (Bleeker et al.  1995) or only studying those aged 
>65 years (Sheifer et al.  2000). Others report less restrictive inclusion 
criteria (Horne et al.  2000; O'Carroll et al.  2001; Goldberg et al.  2002b).  
Secondly, studies have differed with regards to the method of data 
collection. Some have abstracted data from medical notes or patient 
registries whilst others have used patient interviews. Previous work in 
relation to pre-hospital time has demonstrated that data obtained by 
interview can differ significantly from that recorded within medical notes 
with people tending to report longer pre-hospital times during interview than 
those recorded in their medical notes (Goldberg et al.  1998; Goldberg et al.  
2002a).  
Finally, there are differences in how pre-hospital time is defined. For 
example, whether the onset of prodromal symptoms is included in the 
definition of the onset of symptoms is likely to affect calculations of pre-
hospital time.  
   
Table 1: Summary of studies examining pre-hospital delay - MI 
  
n  Country Data source Median time 
symptom onset - 
hospital 
presentation 
(mins) 
Notes 
Rawles, J & Haites, N (1988) 450 U.K Medical records 120  
Rawles, J et al (1990) 250 U.K Patient interview 90  
Goldberg, R et al (1992) 800 USA Medical records 120  
Yarzebski, J et al (1994) 1279 USA Medical records 120  
Bleeker, J et al (1995) 300 Netherlands Patient interview 30  
GISSI group (1995) 5301 Italy Patient interview 230  
Dracup et al (1997) 317 Australia Patient interview 384  
Rawles, J et al (1998) 1046 UK Medical records 45 GP  
   Medical records 150 Hospital  
Goldberg, R et al (2000) 3837 USA Medical records 132 1986 
   Medical records 120 1997 
Canto et al, (2000) 434877 USA Registry 474 no chest pain 
   Registry 318 chest pain 
Horne, R et al (2000) 88 UK Patient interview 132  
O'Carroll, R et al (2001) 72 UK Patient interview 167  
Gibler, W et al (2002) 27849 USA Thrombolytic trial 84 GUSTO I 
   Thrombolytic trial 84 GUSTO II 
Goldberg, R et al (2002) 3693 International  Registry 138  
Dracup, K et al (2003) 192 USA Patient interview 198  
 127 S. Korea Patient interview 264  
 136 Japan Patient interview 270  
 141 England Patient interview 150  
  317 Australia Patient interview 384   
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Despite these problems, it is clear that most studies suggest median pre-
hospital times of >2 hours. The consequence of this is that many patients 
with MI may not receive maximal benefit from the treatments available 
(described on page 8).  
Fewer studies have been conducted amongst patients with ACS other than 
MI. Table 2, below, summarises those identified which reported median 
pre-hospital times.  The same issues with comparison apply to these 
studies. In fact, the issue regarding different populations is even more 
evident. Participants might include those with chest pain (Goff et al.  1999), 
those with possible symptoms of ACS (Grossman et al.  2003) or those with 
a final diagnosis of UA or NSTEMI (Goldberg et al.  2002b).  However, 
consistent with the studies of patients with MI, most report pre-hospital 
times >2 hours.  
 The GRACE project provides useful data comparing pre-hospital times 
amongst a large group of patients with ACS (Goldberg et al.  2002b). 
Eighteen countries participated in the GRACE project, collecting 
demographic and detailed clinical data on patients hospitalised with ACS. 
Data from 10,582 patients was used to explore the extent of, and factors 
associated with, delay to hospital presentation. This sample included 3693 
patients with ST elevation MI; 2935 with NSTEMI and 3954 with unstable 
angina. Delay time was defined as the time interval between the onset of 
symptoms suggestive of ACS and arrival in the Emergency Department 
(ED). Average delay times were highest in patients with NSTEMI (mean 6.1 
hours, median 3.0 hours) followed by patients with unstable angina (mean 
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5.6 hours, median 3.0 hours) and were shortest in those with ST elevation 
MI (mean 4.7, median 2.3 hours). A significant proportion (23% – 32%) of 
all patient groups arrived in the emergency department more than 6 hours 
after symptom onset. These data confirm that prolonged times from 
symptom onset to hospital arrival remain an issue for patients with MI and 
are also associated with the other ACS, possibly to an even greater degree. 
In summary, ACS is common and potentially life-threatening. Interventions 
are most effective when administered early. However, there is substantial 
evidence that delays occur between the onset of symptom and receipt of 
treatment and thus this period of delay is an important focus for research.
  
 
 
 
 
 
 
 
 
Table 2: Summary of studies examining pre-hospital delay - ACS 
  
n  Country Median time symptom 
onset - hospital 
presentation (mins) 
Data source Participants 
Goff, D et al (1999) 3783 USA 120 Medical records Chest pain or discomfort at ED 
Goldberg, R et al (2002) 2935 International  180 Registry NSTEMI 
 3954 International  180 Registry UA 
Rasmussen, C et al (2003) 337 Denmark 233 Interviews Chest pain, suspicion of ACS 
Grossman, S et al (2003) 374 USA 240 Questionnaire Symptoms suggestive of ACS 
Ottesen, M et al (2004) 250 Denmark 107 Interviews Admitted with ACS 
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2.4 Factors associated with longer pre-hospital times 
Many studies have been conducted with the aim of identifying factors 
associated with longer pre-hospital times in patients with ACS. Although 
there have been some conflicting results, a number of factors have been 
identified as being associated with longer pre-hospital delay, these are 
described below. 
2.4.1 Demographic factors 
Age 
A number of studies have found a relationship between age and pre-hospital 
time. The Worcester Heart Attack Study group in the USA conducted a 
retrospective chart review of 3837 patients who had been hospitalised and 
received a discharge diagnosis of MI in seven, one-year periods between 
1986 and 1997 (Goldberg et al.  2000). They found that when those who 
arrived <2 hours after symptom onset were compared with those who arrived 
>2hours, there were significantly more patients aged over 75 years in the 
latter group. Multiple regression analysis confirmed age was associated with 
an increased risk of delay. Similarly, in a study of patients with ACS the 
GRACE investigators found that 32% of patients aged under 55 years 
presented within 2 hours whereas only 17% of those aged over 75 years did 
so (Goldberg et al.  2002b). Similar patterns have been identified in other 
studies although different time points and age ranges have been used 
(GISSI, 1995; Gurwitz et al.  1997; Goff et al.  1999). 
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Dracup et al (1997) compared mean pre-hospital times between patients of 
different age ranges. The authors found that patients aged 61-86 years had 
significantly longer pre-hospital times (mean=122 mins.) than those aged 41-
60 years (105 mins) or 29-40 years (66 mins.).  Investigators using data from 
Global Utilization of Streptokinase and Tissue Plasminogen Activator for 
Occluded Coronary Arteries (GUSTO)-I and GUSTO-III found that patients 
with a pre-hospital time of less than 2 hours tended to be younger (median 
age = 60 years) than those who arrived at hospital later than 2 hours after 
symptom onset (64 years, p=0.001) (Gibler et al.  2002). 
However, a few studies have failed to find an association between age and 
pre-hospital time.  Burnett and colleagues (1995) studied 501 patients who 
formed a subgroup of participants in the Thrombolysis and Angioplasty in 
Myocardial Infarction (TAMI) trials (Burnett et al.  1995). Those who 
requested medical assistance within 60 minutes of the onset of symptoms 
(early responders) were compared with those who requested assistance later 
than 60 minutes (late responders). No significant differences in age or other 
demographic characteristics were found between the two groups. The mean 
age of the early responders was 57.6 years vs. 57.7 years in the late 
responder group (ns). Similarly, in a study of 88 patients with MI conducted in 
the UK, Horne et al (2000) found no relationship between age and pre-
hospital time. 
Possible reasons for the conflicting findings are difficult to identify. Patients 
aged over 76 years were excluded from participation in the TAMI trial; the 
absence of this much older group might have reduced the potential for this 
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study to identify an association.  This study also used patient decision time 
as an outcome measure rather than total pre-hospital time.  It is possible that 
whilst patients take similar times to request medical attention that their 
subsequent management differs systematically, on the basis of their age, so 
that older patients ultimately arrive later at hospital.  
The different components of pre-hospital time were examined in a Danish 
study of 250 patients with ACS and thus provide an opportunity to address 
this hypothesis (Ottesen et al.  2004). However, in this study too, age was not 
found to be associated with any of the components of pre-hospital delay 
(time from onset of symptoms until hospital presentation; time from the onset 
of symptoms until seeking medical attention; time from seeking medical 
attention until arrival and time from arrival of ambulance to hospital). 
However, the authors did conclude that the different components of pre-
hospital delay were not influenced by identical factors. Further research 
which differentiates the pre-hospital components of delay would be helpful.  
A number of possible reasons for longer delays amongst older people have 
been suggested. There is evidence to suggest that as people get older, they 
are more likely  to attribute many symptoms to ‘normal’ ageing (Leventhal 
and Prochaska, 1986). Older people are more likely to have existing co-
morbid conditions, and this may complicate recognition of cardiac symptoms 
(Ryan and Zerwic, 2003). They are also likely to experience a greater 
number of symptoms in general, and thus have established patterns of 
coping which may not be desirable in the context of ACS (Stoller and Forster, 
1994). Additionally, older people are more likely to live alone - this may 
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influence how and when they seek help (Gibler et al.  2002). The importance 
of the context of the event is discussed further on page 32. 
Female gender 
It is widely reported that women are likely to have longer pre-hospital times 
than men. Several very large investigations provide evidence of this. Data 
from 364,131 patients included in the US National Registry of Myocardial 
Infarction (NRMI-2) between 1994 and 1997 showed  median pre-hospital 
times to be longer for women (Mdn=2.4 hours) than for men (2.0 hours) 
(Goldberg et al.  1999). Analysis of data from the GUSTO trials by Gibler et al 
(2002) also demonstrated that 35% women versus 27% men arrived more 
than 4 hours after the onset of symptoms (p=0.001).  
In relation to ACS, data from The GRACE project have been reported. This 
project was described earlier (page 14). Data from 3693 patients with STEMI, 
2935 patients with NSTEMI and 3954 with UA were used to explore factors 
associated with delay to hospital presentation (Goldberg et al.  2002b). 
Multivariate analysis demonstrated that, for each of the ACS, men were 
significantly more likely to present within 2 hours of symptoms onset than 
women. Other studies have found similar results (Gurwitz et al.  1997; 
Sheifer et al.  2000). However, the evidence is not consistent. Some 
investigators have found that relationships identified between female gender 
and pre-hospital time lose their significance when other factors (e.g. age) are 
controlled for in multivariate analysis (GISSI, 1995; Goff et al.  1999; 
Goldberg et al.  2000). Furthermore, a Danish study which analysed the 
various components of pre-hospital time (previously described on page 19) 
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found that total pre-hospital time was longer for women but, importantly, this 
was accounted for by physician and transport delays. Patient decision time 
was not related to gender. Other studies have not found gender differences 
in pre-hospital time amongst patients with MI (Burnett et al.  1995; Bleeker et 
al.  1995; Dracup et al.  1997; Dracup and Moser, 1997; Mumford et al.  
1999; Horne et al.  2000; Schoenberg et al.  2003; Dracup et al.  2003; 
Zerwic et al.  2003) or other ACS (Grossman et al.  2003; Rasmussen et al.  
2003). 
A number of reasons why pre-hospital times might be longer for women than 
for men are suggested in the literature. There is evidence to suggest that 
women may be more likely to present with atypical symptoms (Meischke et 
al.  1998; Canto et al.  2000). This is a factor which has also been associated 
with increased pre-hospital delay (Dracup et al.  1997; Canto et al.  2000; 
Grossman et al.  2003).  
Women tend to be older than men when they receive a diagnosis of CHD 
(Lerner and Kannel, 1986).  The association between increased age and 
delayed presentation has already been discussed (see page 17). In each of 
the studies where the relationship between gender and pre-hospital time did 
not remain significant in multivariate analysis, age was identified as a 
significant factor. 
It has been suggested that women may perceive their personal risk of CHD 
to be low and that this might influence what they do in the event of 
experiencing symptoms (van Tiel et al.  1998; Wilcox and Stefanick, 1999).  
Martin and colleagues have provided evidence that there are gender biases 
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in the attribution of cardiac symptoms. In one study, undergraduate 
participants were presented with vignettes where gender, symptoms and life 
events were manipulated (Martin et al.  1998).  Participants were significantly 
less likely to attribute symptoms to possible cardiac causes for female victims 
reporting stressful life events than for females without such stressors or for 
male victims with or without concurrent stressors. Similarly, in a subsequent 
study of 157 patients who had experienced MI, women were found to be 
significantly less likely than men to attribute their pre-hospital symptoms to MI 
(Martin et al.  2004).   
Ethnicity 
Evidence regarding an association between ethnicity and time to 
presentation is mixed. The NRMI-2 investigators in a study of 346,131 
patients with MI found that African Americans , Hispanics, Asians and 
American Indians (NRMI-2 authors’ terminology) all had significantly longer 
pre-hospital times (Mdn=2.4 hours, 2.3 hours, 2.2 hours, 3.0 hours 
respectively)  than white people (2.1 hours).  Even within this very large 
registry the proportion of patients of non-white ethnic origin was small, an 
issue common to all the studies identified.  
The GUSTO investigations also found that longer times from symptom onset 
to hospital arrival were associated with those of non-white race (6% >4 hrs) 
than those of white race (4% >4 hrs; p= 0.02) (Gibler et al.  2002).  
Similarly, in a study of time to presentation in elderly patients with MI, Sheifer 
et al (2000) found that individuals arriving more than 6 hours after the onset 
of symptoms were significantly more likely to be non-white (p=0.001) . 
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A study which specifically compared the presentation and management of 
African American and white patients presenting to the ED found similar 
results (Johnson et al.  1993). After adjustment for presenting symptoms, 
African Americans were found to be significantly more likely to present at the 
ED more than 6 hours after the onset of symptoms (OR 1.3; 95% CI 1.1-1.5). 
The REACT group also found longer pre-hospital times amongst non-
Hispanic blacks (Mdn = 3.26 hours) than non-Hispanic whites (2.0 hours) 
(Goff et al.  1999). 
Conversely, a study conducted in the USA amongst 215 patients admitted to 
a Chest Pain Unit did not find any significant association between race and 
the timing of symptoms (Klinger et al.  2002). Studies of patients awaiting 
PTCA (Conigliaro et al.  2002), patients who have died from CHD (Frayne et 
al.  2002) and of Bangladeshi patients with MI in the UK (Barakat et al.  2003) 
have also failed to find an association between race and time to presentation.  
The weight of available evidence, particularly in the context of MI would 
appear to suggest an association. The reasons why this would be the case 
are unclear. In a vignette study conducted in the UK, black respondents were 
at least as likely as white respondents to seek immediate health care in 
response to 2 scenarios, one of which was ‘chest pain’ (Adamson et al.  
2003). The authors concluded that any barriers to care related to ethnicity 
must occur at the level of healthcare provision. Other studies have found 
differences in the management of patients with ACS and chest pain to be 
related to ethnicity (Johnson et al.  1993; Pope et al.  2000). Future research 
relating to pre-hospital time and ACS should consider the role of ethnicity and 
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more actively seek participation of people from various ethnic backgrounds. 
Evidence about how ethnicity relates to the various stages of pre-hospital 
time would be particularly useful in order to identify any patient or provider-
related issues which might be amenable to intervention.  
Socio-economic factors 
Fewer studies have examined the impact of socio-economic factors in 
relation to time to treatment in patients with MI. Variations in how socio-
economic status was assessed further hampers comparisons between the 
studies that have been conducted.  
Gurwitz et al (1997) studied 2409 people in Minnesota with confirmed MI. 
Socioeconomic status was determined on the basis of zip code and was not 
found to be associated with delayed presentation (i.e. time from symptom 
onset to hospital arrival > 6 hours). Two smaller studies (<100 participants) 
conducted in the UK amongst patients with MI also found no association 
between socio-economic status and pre-hospital delay (assessed using the 
Registrar General’s classification of occupation as a measure of socio-
economic status) (Mumford et al.  1999; Horne et al.  2000).  
However, Dracup et al (1997) studied a subset of 277 patients enrolled in a 
thrombolytic trial (GUSTO-I) and found that people with an income of more 
than $20,000 had significantly lower mean time from symptom onset to 
hospital admission than those with a yearly income of less than $20,000 (103 
minutes vs. 136 minutes; p=0.01).  
Sheifer et al (2000) in their study of over 100,000 older adults with MI also 
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found an association between residence in an impoverished area and time to 
presentation. Impoverished areas were identified by zip code. Sixteen 
percent of those who presented more than 12 hours after onset of symptoms 
lived in an impoverished area versus 14% of those who presented less than 
6 hours after the onset of symptoms (p=0.001). It has previously been 
suggested that the effect of race might be confounded by socioeconomic 
factors. Interestingly, in this study, poverty and race were demonstrated to be 
independently associated with time to presentation. However, significant 
interaction effects were also identified, suggesting that individuals with 
multiple racial, economic and gender characteristics are at particular risk of 
delayed presentation.  
The GUSTO investigators (2002) evaluated occupation, years of education, 
type of insurance and living alone as socioeconomic measures. People with 
higher educational levels (30% vs. 26%; p=0.001), management or 
professional occupations (28% vs. 21%; p=0.001), private health insurance 
(64% vs. 56%; p=0.003) or who did not live alone (23% vs. 18%; p=0.006) 
were found to present more quickly to hospital. Again, this sample was 
selected for a thrombolytic trial and was again conducted in the US so there 
are limits to the generalisability of the findings.  
As mentioned previously, a number of measures of socio-economic status 
were used in this context. Each has its own advantages and limitations. The 
use of zip code data as a measure of socioeconomic status can be criticised– 
all residents of impoverished regions are not poor (Piantadosi et al.  1988). 
However such data are often used as a proxy when individual data are not 
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available and has the advantage of being easily replicated, facilitating 
comparison between studies.  
The use of income level alone as a measure of socio-economic status can 
also be problematic, particularly amongst older people. Older persons’ 
income may be low but they may be wealthy or of high social status. Income 
may also come from a number of different and possibly indirect sources e.g. 
tax exemption (Grundy and Holt, 2001). 
Classifications based on occupation also have inherent difficulties. No 
adequate way has been found to classify those who are not in paid 
employment such as retired people or those caring for young children at 
home. Furthermore there may be wide differences in income, prestige and 
education within classes of one occupational group. 
A recent qualitative study conducted in Glasgow provides insights into 
possible reasons why pre-hospital time might be related to socio-economic 
status (Richards et al.  2002). Data from interviews with 30 participants (15 
affluent; 15 deprived) suggested that people from socio-economically 
deprived areas report higher perceived vulnerability to CHD, probably 
deriving from their increased exposure to affected family or friends and 
identification with a high risk stereotype. However, the authors suggested 
that increased awareness led to normalisation of symptoms such as chest 
pain. This, coupled with confusion with other conditions and concerns about 
over-using services, led to a tendency not to present to healthcare providers 
with chest pain.  
The relationship between social deprivation and delayed presentation with 
  27 
ACS is clearly an area which requires further investigation. Future research 
should aim to include standard measures of socio-economic status and to 
better represent people from poorer social backgrounds. 
2.4.2 Clinical characteristics 
A number of clinical characteristics, such as symptoms and past medical 
history have been evaluated in relation to time to presentation in ACS. These 
factors are discussed in more detail below. 
Symptoms 
Many of the largest studies of pre-hospital time in ACS have not examined 
the influence of the symptoms experienced by patients (Goldberg et al.  
1999; Goldberg et al.  2000; Sheifer et al.  2000; Gibler et al.  2002). This is 
probably due to the reliance of these larger studies on registries and 
database data. However, other studies have explored the severity, type and 
number of symptoms in relation to pre-hospital time, these are described 
below. 
Severity 
An association between the severity of presenting symptoms and the time to 
hospital arrival was reported by the GISSI group (1995). They found that 
compared with patients who reported strong pain; those with mild / moderate 
pain were significantly more likely to present more than 6 hours after 
symptom onset (OR: 1.86, 95% CI: 1.28-2.72).  
Similarly, Horne and colleagues (2000) examined symptom severity in 
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relation to pre-hospital time. A visual analogue scale was used to assess 
symptom severity.  They reported a weak negative correlation between 
symptom severity and pre-hospital time (r= -0.24; p<0.05). A qualitative 
investigation has also suggested that the presence of less severe symptoms 
may influence decision making processes, leading individuals to doubt that 
their symptoms could be those of a heart attack (Pattenden et al.  2002). 
However, other studies have found no association between pain scores 
(Walsh J C et al.  2004) or other assessments of pain severity (Dracup and 
Moser, 1997) suggesting that factors other than the severity of symptoms are 
important (Dracup et al.  1997; Mumford et al.  1999). 
Type 
The type of symptoms associated with extended pre-hospital time has also 
been examined in some studies. Following their examination of the NRMI-2 
database, Canto and colleagues (2000) concluded that the presence or 
absence of chest pain was an important factor. They found that patients 
without chest pain had significantly longer pre-hospital time (mean = 7.9 
hours) than those with chest pain (5.3 hours). Similar results were found in 
the UK where the mean delay of patients who did not experience chest pain 
was 11.5 hours compared with 4.8 hours amongst those who did (Horne et 
al.  2000). Gurwitz et al (1997) found the presence of chest discomfort to 
significantly reduce the risk of delay. 
The presence of diaphoresis or extreme sweating has been associated with 
reduced pre-hospital time (Dracup et al.  1997; Bunde and Martin, 2006) 
whereas the presence of heartburn or other gastro-intestinal symptoms has 
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been associated with longer delay (Dracup et al.  1997; Dracup and Moser, 
1997; Bunde and Martin, 2006). 
Amongst patients with ACS, the GRACE investigators found that a higher 
proportion of those who arrived at hospital within 2 hours had diaphoresis 
(28%) than did those who arrived > 6hours after symptom onset (20%; 
p<.001) (The GRACE Investigators, 2001). 
Number of symptoms 
The influence of the number of symptoms experienced by patients on pre-
hospital time has been explored by a number of authors but no association 
has been found (Mumford et al.  1999; Horne et al.  2000; Walsh J C et al.  
2004). 
Diabetes mellitus 
People with a history of diabetes mellitus are a group who have consistently 
been shown to have longer pre-hospital times. The studies of patients with MI 
already described above by the GISSI (1995), NRMI-2 (Goldberg et al.  
1999) and Worcester groups (Goldberg et al.  2000) have all found a history 
of diabetes to be associated with longer pre-hospital times in multivariate 
analysis (OR (95% CI) = 1.36 (1.09-1.70); 1.20 (1.18-1.22); 1.27 (1.09-1.48) 
respectively).  Similarly, Shiefer et al (2000) found that the presence of 
diabetes was a significant predictor of hospital arrival >6 hours after symptom 
onset in their study of patients aged >65 (OR: 1.11, 95% CI: 1.07-1.14).  
With regard to ACS, data from the GRACE registry showed that patients with 
diabetes were significantly less likely to present within 2 hours of symptom 
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onset than those without (OR: 1.84, 95% CI: 1.14 - 2.95) (The GRACE 
Investigators, 2001). 
Reasons why patients with diabetes might experience longer pre-hospital 
times have been suggested. Research has demonstrated that people with 
diabetes who are experiencing MI are significantly more likely to present 
without chest pain (Canto et al.  2000). The absence of this ‘classic’ symptom 
may lead to difficulties in symptom interpretation both for patients and 
bystanders, as well as for clinicians. Diabetes is often associated with 
neuropathy and it is hypothesised that this results in altered symptom 
perception in this patient group (Ambepityia et al.  1990; Umachandran et al.  
1991), with the result that symptoms are more difficult to interpret. The 
pathology of CHD in diabetics is also different and associated with extensive 
and diffuse disease (Morgan et al.  2004). This may influence how individuals 
experience acute events. 
 Diabetes is an established risk factor for coronary disease (Garcia et al.  
1974), thus people with diabetes are at higher risk of experiencing ACS. 
Furthermore, outcomes for diabetic patients who experience ACS are poorer 
than those for patients without diabetes (Franklin et al.  2004).  Thus the 
reduction of pre-hospital times for this group is a particularly important goal 
for future research.   
Previous history of CHD 
The evidence regarding the importance of patients’ previous cardiac history 
in relation to pre-hospital times is conflicting and difficult to interpret. 
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The Worcester Heart Attack study group (Goldberg et al.  2000) and Sheifer 
et al (2000) found that longer pre-hospital times were associated with 
patients who had a past medical history of angina.  However, two studies by 
Dracup et al found no association (Dracup et al.  1997; Dracup and Moser, 
1997). Furthermore, neither of the these studies identified a relationship 
between a previous history of MI and pre-hospital time, a finding consistent 
with those of the GISSI investigators (1995).  However, studies of elderly 
patients post- MI (Sheifer et al.  2000) and patients with ACS (Ottesen et al.  
2004) have found that a history of MI is associated with reduced delay. More 
consistently, investigators have found patients with a history of coronary 
intervention (i.e. PTCA or coronary artery bypass graft surgery (CABG)) to be 
less likely to have prolonged pre-hospital times with subsequent MI (Gurwitz 
et al.  1997; Sheifer et al.  2000) or ACS episodes (Goldberg et al.  2002b).  
However, Ottesen et al (2004) found a history of PTCA to be associated with 
longer pre-hospital delay in patients with ACS.   
Data from qualitative studies provide insights into possible mechanisms. In a 
study of patients with confirmed second, third or fourth MI, 20 of the 22 
patients studied reported that the symptoms of their recent event were not 
similar to those of any previous MI. This was found to have led to confusion 
and slow the decision-making process (Pattenden et al.  2002).  
Another study suggests that people may find it hard to distinguish the 
symptoms of MI from those of other pre-existing conditions such as stomach 
ulcers (Scherk, 1997). This might be especially true for people with an 
existing diagnosis of angina where the nature of the symptoms may be very 
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similar. Given that people with existing angina have established CHD and are 
therefore at increased risk for MI this is of particular importance.  
2.4.3 Context 
The context in which the acute coronary event takes place has also been the 
subject of investigation. The time of day, location and presence or absence of 
others have been examined and are discussed below. 
Time of day 
Conflicting results regarding the significance of time of day have been 
reported. Gurwitz et al (1997) found that patients with symptom onset 
between midnight and 5:59 hrs were more likely than those with symptom 
onset between 06:00 and 11:59 hrs to have a pre-hospital time >6 hrs. 
Similarly the GRACE investigators found that daytime symptom onset (noon-
17:59 hrs)  was associated with shortest pre-hospital times (Goldberg et al.  
2002b).  
The GISSI group found that those experiencing symptoms at night or when 
asleep were significantly more likely to have increased times from symptom 
onset to admission than those who experienced symptoms at other times. 
Seventy-one percent  of patients who presented in less than 6 hours did so 
during the day, whereas only 29% did so at night (GISSI, 1995).  However 
the Worcester group found the occurrence of symptoms between noon and 
midnight to be significantly associated with pre-hospital times of >2 hours and 
> 6 hours (Goldberg et al.  2000).  
Reasons for these conflicting results are not clear. Evidence from a 
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qualitative study suggests that people might be reluctant to seek help during 
the night and weekends (Pattenden et al.  2002).  The findings of the first 
three studies are consistent with this hypothesis.  
Location and presence of others 
 A number of studies have found that people tend to delay longer if they are 
at home when symptoms arise (GISSI, 1995; Dracup and Moser, 1997) 
whilst others have not (Dracup et al.  1997; Mumford et al.  1999). The GISSI 
investigators (1995) found that the presence of others at the time of onset of 
symptoms was associated with reduced delay but that the relationship of a 
bystander to the person with symptoms was an important moderator. 
Spouses and relatives were less successful in reducing delay than friends or 
strangers (GISSI, 1995). Living alone was also found to be an independent 
predictor of pre-hospital delay (OR: 2.11 95% CI: 1.57-2.83), possibly 
highlighting the importance of others in facilitating help-seeking. Others have 
not found a relationship between pre-hospital times and the presence of 
others in the context of MI (Dracup and Moser, 1997; Mumford et al.  1999). 
Horne et al (2000) found that others were influential in the decision to call for 
help but only if the patient’s experience of their symptoms did not match their 
prior expectations of a heart attack. This highlights the possible importance of 
psychological factors in the context of ACS, these are discussed further 
below. 
2.5 Patient decision time 
The pre-hospital phase of MI can be conceptualised in 3 phases: appraisal 
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delay – the time someone takes to identify a symptom as an indication that 
they are ill; illness delay- the time between someone recognising that they 
are ill and deciding to seek medical attention; and utilisation delay- the time 
taken between seeking medical care and actually receiving it (Safer et al.  
1979).  
There are data to suggest that the interval which contributes most to pre-
hospital time is the patients’ decision time, defined as the interval between 
the onset of symptoms and the decision to seek help (or appraisal and illness 
delay combined, using Safer et al’s definition above). The GISSI group 
(1995) calculated that patient decision time accounted for approximately 80% 
of the overall delay in those who delayed over 12 hours and for 23% among 
those who presented earliest (i.e. within 2 hours).  
Data from the Worcester Heart Attack Study (1986 -1997) (Goldberg et al.  
2000) and from a pair of thrombolytic trials conducted 1990-1997 (Gibler et 
al.  2002) suggest that patient decision time has remained unchanged during 
the respective study periods. The second study (Gibler et al.  2002) found 
that time from arrival at hospital to administration of treatment had improved 
significantly due to the introduction of new procedures aimed at facilitating 
rapid assessment and treatment of this group of patients. However during the 
same period, the time from onset of symptoms to arrival at hospital had 
remained unchanged.  
Interventions aimed at reducing pre-hospital delay have met with little 
success. Two RCTs, including the large scale Rapid Early Action for 
Coronary Treatment (REACT) trial, reported no statistical effect of the 
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intervention (Meischke et al.  1997; Luepker et al.  2000).     
A systematic review of interventions to reduce delay in patients with 
suspected heart attack identified one controlled trial and three ‘before and 
after’ studies which specifically examined patient delay (Kainth et al.  2004). 
A Swiss before and after study reported a significant reduction in median 
delay during a 12 month multimedia public campaign (180 mins. vs. 155 
mins., p<.001) (Gaspoz et al.  1996). The multi-media campaign was 
intensive and data regarding the long term effect of the campaign could not 
be identified within the literature.   
However, the other before and after studies reported no differences in delay 
(Ho et al.  1989; Bett et al.  1993). The controlled trial reported an increase in 
the percentage of patients in the intervention group calling their GP after the 
intervention (compared with before) but this was not compared with the 
control group (Rowley et al.  1982).   
The content of interventions has varied but most include information about 
the importance of prompt action when symptoms occur. Given the substantial 
complexities involved in recognising and attending to symptoms, identifying 
the likely cause and identifying the appropriate avenue for healthcare such 
messages may be over-simplistic. Psychological factors are likely to be of 
key importance in this context. These are discussed in further detail in the 
following section. 
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2.5.1 Psychological factors 
Attributions 
Whether or not an individual attributes the symptoms they are experiencing 
to the heart has consistently been shown to relate to pre-hospital times in 
ACS. Data from 501 patients enrolled in a clinical trial of revascularisation 
procedures showed that patients who arrived at hospital <60 mins after the 
onset of symptoms were more likely to believe their symptoms were cardiac 
in nature than those who arrived later (Burnett et al.  1995). A large number 
of demographic, contextual and clinical factors were considered in this study 
but attribution of symptoms to the heart emerged as one of the two most 
significant predictors of pre-hospital time. The authors calculate that  
attributing symptoms to the heart resulted in patients reaching hospital 26 
minutes earlier than if symptoms were attributed to any other body system.  
Other studies of patients with MI have found similar results (Dracup and 
Moser, 1997; O'Carroll et al.  2001; Carney et al.  2002; Bunde and Martin, 
2006). However, a number of these studies also demonstrate that the 
majority of patients do not usually attribute their symptoms to the heart and 
are more likely to attribute symptoms to indigestion (Burnett et al.  1995; 
O'Carroll et al.  2001; Carney et al.  2002). O’Carroll and colleagues found 
that 42% of patients with MI attributed their initial symptoms to heartburn or 
indigestion whilst only 17% believed it was a heart attack. Thus the data 
provide evidence that patients’ cognitions about their symptoms and the 
meanings they ascribe to them influence when they seek medical help in the 
context of ACS.  
  37 
Expectations 
Whether or not people perceive their symptoms as related to their heart may 
be influenced by their expectations of what the symptoms of MI might be. It 
has been reported that many people share an expectation that a heart attack 
will be a sudden and dramatic event – the so-called ‘Hollywood’ portrayal 
(Finnegan et al.  2000). However, evidence suggests that many patients do 
not experience sudden or dramatic symptoms. Following interviews with 
hundreds of patients with MI, Dracup et al (1995) reported that approximately 
a third did not report abrupt onset of symptoms and consequently found it 
difficult to specify the time of onset. Similarly, after conducting 34 focus 
groups amongst people who had experienced or witnessed an MI, Finnegan 
et al (2000) reported that even classic symptoms were often of gradual onset 
or preceded by vague or mild symptoms which made them difficult to 
interpret. 
Johnson and King (1995) first highlighted the importance of expectations in 
relation to help-seeking in their study of 65 patients with MI. They found that 
only 26% of patients experienced symptoms that matched their expectations. 
Furthermore, they found that patients, whose experience of MI did not match 
their expectations, were likely to delay significantly longer than those whose 
expectations matched their symptoms. A similar pattern was reported by 
Horne et al (2000) in a study of 88 patients with MI. These authors found that 
58% of patients reported a mismatch between the symptoms they expected 
and those they experienced as part of the MI. They reported an association 
between patients’ expectations and help-seeking too. The decision to call for 
help was more likely to be made by a third party if the patients’ experience of 
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symptoms did not match their prior expectations (p<0.05). Waiting for 
symptoms to match expectations may explain why many patients, despite 
realising that something is wrong, describe a ‘wait and see’ approach 
(Finnegan et al.  2000). Certainly, in the qualitative study involving patients 
who had experienced their second, third or fourth MI, many reported waiting 
until their symptoms resembled those of the previous MI before seeking help 
(Pattenden et al.  2002). Alternatively, it may be that people choose to ‘wait 
and see’ as they expect the symptoms to go away (Leslie et al.  2000). 
Deciding not to ‘wait and see’ was identified as a predictor of early help-
seeking by Dracup et al (1997).  
Together, these studies highlight the importance of expectations about 
symptoms in relation to help-seeking and time to treatment. This is an 
essential focus for future research as the potential may exist to modify 
expectations about the symptoms of MI amongst the general population and 
thus impact on help-seeking and pre-hospital time. 
Influence of others 
The study by Horne et al also highlights that people other than the patient 
may be important in the decision to seek medical help.  It is common for 
people experiencing possible symptoms of ACS to discuss their symptoms 
with others e.g. spouse, family member, friend (Brink et al.  2002; 
Rasmussen et al.  2003; Johansson et al.  2004; Bunde and Martin, 2006). It 
has been identified within the literature that the responses of others may be 
either instrumental in facilitating prompt medical help or otherwise (Burnett et 
al.  1995; Dracup and Moser, 1997). The GISSI investigators found that 
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patients who experienced symptoms in the presence of others were more 
likely to have shorter pre-hospital times than those who were alone (GISSI, 
1995). Similarly ‘seeking social support’ was found to be associated with 
reduced pre-hospital time in patients with MI in a Dutch study by Bleeker et al 
(1995). An American study of 2316 survivors of MI found that, of those who 
had contacted ‘911’, only 21% did so themselves. In 40% of cases the call 
was made by a spouse or significant other; 16% by another family member; 
23% by other people (Meischke et al.  1995)  
However, in studies where the nature of the responses provided by 
bystanders has been examined, no differences have been found in the pre-
hospital times of patients who received advice to seek medical help and 
those who did not (Burnett et al.  1995; Dracup and Moser, 1997). 
Furthermore, results where patients who informed a relative were more likely 
to have pre-hospital time >2 hours have been reported (Rasmussen et al.  
2003). Similarly, qualitative work has identified the positive influence of 
others in the decision to seek medical help (Brink et al.  2002; Lockyer, 2005) 
but also highlighted important examples where this was not the case 
(Lockyer, 2005).   
There is evidence to suggest that the decision to seek medical help may be 
more likely to be made by a bystander if the patient is older (Schoenberg et 
al.  2003) or male (Martin and Lemos, 2002)  Others have found that a third 
party is more likely to intervene if the symptoms the patient is experiencing 
do not match their expectations of MI (Horne et al.  2000).  
Understanding of the role of others in facilitating patients with possible 
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symptoms of ACS towards prompt medical attention is incomplete and an 
important area for future research.  
Perceptions of symptoms 
Individuals’ perceptions of the symptoms they experience have also been 
found to be related to pre-hospital times. The perceived seriousness of the 
symptoms has been investigated most often. Consistently, studies have 
found that those who perceive their symptoms to be serious have shorter 
pre-hospital times than those who do not (Burnett et al.  1995; Dracup and 
Moser, 1997; Rasmussen et al.  2003; McKinley et al.  2004; Bunde and 
Martin, 2006). Indeed in the relatively large (n=501) study by Burnett and 
colleagues (1995) the most significant predictor of pre-hospital time was the 
perceived seriousness of symptoms. 
A study conducted in Scotland  amongst survivors of MI reported that ‘not 
thinking it was serious’ was the second most common reason offered by 
participants who called for help more than 1 hour after the onset of symptoms 
(‘thinking the problem would go away’ being the most common) (Leslie et al.  
2000).  The same study found that thinking that symptoms were ‘not 
important enough for 999’ was the most common reason for choosing the GP 
as the first point of contact.  
Perceptions of control have also been explored. Burnett et al (1995) found 
that early responders (pre-hospital time <60 mins.) reported less perceived 
control over their symptoms than late responders (pre-hospital time >60 
mins.). 
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In an international comparison of data on delay in presentation in the context 
of MI, McKinley et al (2004) report that those with high perceived ability to 
control symptoms have significantly higher median delay times than those 
with low perceived ability to control (p<0.05) .  
O’Carroll et al (2001) used the validated Multidimensional Health Locus of 
Control scale (Norman and Bennett, 1995), amongst 72 patients 3-5 days 
post-MI. They found that the belief ‘health is largely due to chance factors’ 
was the best predictor of extended time to presentation. This suggests that 
those who believe there is little they can do to control their health are most 
likely to delay and is therefore consistent with the findings of the previous 
studies. 
Thus there is evidence that the beliefs people have about the likely cause 
and seriousness of their symptoms, and the degree to which they believe 
they have control over symptoms, may influence how quickly they seek 
medical help in the context of MI.  
The premise that people hold beliefs about illness which guide their coping is 
a key component of Leventhal’s commonsense model of self-regulation (CS-
SRM). The CS-SRM has been selected to provide the theoretical framework 
for the study. The model and the empirical evidence for it’s application in this 
context are described in detail in the following section.  
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2.6 Leventhal’s commonsense model of self-regulation 
 
2.6.1 General overview 
The CS-SRM posits that individuals actively develop representations of 
illness based upon (1) a general pool of knowledge of illness current in 
culture, (2) social communication with individuals such as health 
professionals or family and (3) personal experience of illness. It is 
hypothesised that a change in somatic activity, such as a symptom, 
stimulates a self-regulatory process whereby individuals integrate such pre-
existing ideas about illness with current bodily experiences. The processing 
system can be viewed as consisting of 2 parallel pathways. One involves the 
creation of a cognitive representation or ‘mental picture’ of a health threat 
and the development of a coping plan. The other pathway involves the 
creation of an emotional representation of the health threat and an 
associated plan for coping with the emotional response. The 2 pathways are 
proposed to interact, as the threat develops, via feedback loops and 
appraisal of coping strategies. Therefore, failure of coping mechanisms to 
control emotion may result in a change in the cognitive representation (e.g. 
intensify or diminish symptoms). Similarly, failure of coping mechanisms to 
ameliorate symptoms may result in alteration to emotional representations 
e.g. causing distress (Leventhal et al.  1984).  
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Figure 1: Leventhal’s commonsense model of self-regulation (CS-SRM). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reproduced with permission from Leventhal et al (2007). 
 
 
Thus, the processing system can be conceptualised as operating in three 
stages. The first involves the creation of cognitive and emotional 
representations and thus goals for coping; the second stage refers to the 
development and execution of plans for coping directed towards those goals; 
the third stage of appraisal involves evaluating whether the coping response 
has moved the individual closer to, or further from, the goals specified by the 
representation. Each stage involves both concrete (e.g. chest pains) and 
abstract features (the idea that one is having a heart attack). It is suggested 
by Leventhal et al (1984) that cognitive representations might be influenced 
most by abstract information, whilst emotional representations might depend 
to a greater degree on concrete processing. 
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2.6.2 Illness representations 
Early work by Leventhal and colleagues involved using open-ended 
interviews to elicit the illness representations of  patients with hypertension 
and cancer (Leventhal et al.  1980). They identified that the content of 
representations was elaborated around 4 main components, namely identity, 
timeline, cause and consequences. Identity refers to the label a person uses 
or to the symptoms that they view as being part of their illness. Timeline 
refers to an individual's beliefs about how long the illness will last. Cause 
describes an individual’s personal ideas about the cause of the health 
problem. Consequences relate to an individual's beliefs about the likely 
impact of the illness on quality of life or functional ability. Both abstract and 
concrete information might contribute to an individual’s illness representation. 
In studies where undergraduate students were asked to describe the last 
time they were sick, Lau and Hartman (1983) provided evidence that people 
also have ideas about how one might recover from a disease and the fifth 
component of cure/control was added to the model. However, in Lau and 
Hartman’s study, the questions were framed in terms of the model, e.g. ‘why 
do you think you got sick?’ (cause), ‘why do you think you got better?’ 
(cure/control) which would clearly have influenced the type of response 
obtained.  However, evidence of the five components of illness perception 
was confirmed in subsequent studies using different methodologies. Bishop 
et al (1987) provided participants (undergraduate students) with scenarios of 
symptoms which varied in their seriousness and typicality .  Participants were 
asked to describe other details that might be associated with the symptoms. 
The responses were coded according to the components of illness 
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perception or to a residual ‘other’ category (identity was split into symptoms 
and labels due to the nature of the study). Results showed that 91% of 
responses were coded to the 5 components of illness perception.  
Similarly, in a later study of students and their parents, Lau and colleagues 
(1989) asked participants to describe everything they remembered about a 
recent illness. Responses were divided into distinct thoughts and then coded 
according to the same categories as Bishop and colleagues (1987). Almost 
all respondents (99.5%) identified symptoms or labels (identity); 72% gave 
responses relating to timeline; 51.8% to cause; 45% to consequences; 53.1% 
to cure/control. Just over 40% of responses were coded as other. These 
were reported as being idiosyncratic and that they could not be placed in 
categories that included more than 2% of the population.  
Acknowledging that the main limitation of this study was that the coding was 
performed by the authors, a validation study was also conducted. A random 
sample of example statements from the original study were selected and 
given to 20 naïve participants who were asked to sort them into groups that 
made sense to them. The authors reported high correspondence between 
the observed groupings of the naïve participants and the a priori, theory-
driven categorisations. Together, the results of these studies provide strong 
support for the existence of the components of illness representations. 
The CS-SRM proposes that as an illness unfolds, coping procedures are 
executed and appraised, and illness representations become increasingly 
elaborated. It is suggested that the more complex the representations, the 
more likely that active coping mechanisms will be adopted (Cameron et al.  
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1993). When this process results in a judgement by an individual that a 
symptom(s) is (are) serious, disruptive of ongoing activities and difficult to 
control, it is hypothesised that a person is more likely to seek help.  
The Illness Perception Questionnaire (IPQ) was designed to provide a 
quantitative method of assessing the components of illness representation 
present in Leventhal’s CS-SRM (Weinman et al.  1996). This was revised 
(IPQ-R) to improve internal consistency of some subscales and to include 
assessment of emotional representations which were not assessed in the 
original IPQ (Moss-Morris et al.  2002). In addition, the revised measure 
includes an assessment of the degree to which a person’s representation of 
illness provides a coherent understanding. Subsequent empirical work by 
Hall et al (2004) has confirmed coherence to be an important factor in 
predicting health behaviour. 
The CS-SRM has been used in a large number of studies amongst different 
populations including diabetes (Griva et al.  2000), chronic fatigue syndrome 
(Heijmans, 1998) and coronary heart disease (Petrie et al.  1996).  A meta-
analysis of 45 studies found evidence of theoretically predictable 
relationships between illness cognitions, coping and outcome but also 
highlighted the need for further longitudinal data (Hagger and Orbell, 2003).  
2.6.3 Illness representations and seeking medical help 
The hypothesis that illness representations guide help-seeking, as described 
above, is supported by empirical evidence. In a longitudinal field study, 
Cameron et al conducted 111 interviews amongst people spontaneously 
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seeking medical care from their physician (Cameron et al.  1993). They 
compared the illness representations of care-seekers with 111 matched 
controls. The authors found that care seekers were more likely than controls 
to have identified their symptom problems with a disease label (p<0.02). 
Symptoms were rated as more serious by care-seekers than by controls 
(p<0.001) and ratings of symptom disruption of daily activities were higher for 
care-seekers compared to controls (p<0.01). The data from this study 
support the hypothesis that symptoms play a key role in the initiation of help-
seeking. In addition, they suggest that the presence of symptoms alone is not 
sufficient to motivate a decision to seek care. Controls who experienced 
comparable symptoms (but who did not seek help) gave their symptoms 
significantly lower seriousness ratings and were less likely to identify possible 
consequences. The study reinforces the importance of interpretive processes 
in prompting care-seeking. However, it should be borne in mind that these 
data were obtained retrospectively. This introduces the possibility that people 
who sought care might represent their symptoms in a way which justifies their 
decision to attend a physician. The authors assert that this is unlikely, as the 
use of healthcare services as a focus for the study was not apparent to the 
participants.  
2.6.4 Illness representations and pre-hospital time 
The usefulness of the model as a framework for explaining pre-hospital 
delay, amongst people with MI, was recently examined by Walsh et al (2004). 
Sixty-one consecutive patients admitted to a coronary care unit (CCU) were 
interviewed by a health psychologist 2-4 days post MI. The IPQ (Weinman et 
  48 
al.  1996) was used to assess illness representations. Data from measures 
such as the McGill Pain Questionnaire (Melzack, 1975) and the Coping 
Response Inventory (Billings and Moos, 1981) were also analysed, as were 
demographic, clinical and social variables.  The consequences scale of the 
IPQ was found to be significantly related to delay (r=-.50, p<0.01). Those 
who perceived their MI to have serious consequences had shorter delay 
times. Coping style was also found to be significantly associated with delay. 
Those with strong active-cognitive coping style or strong problem-focused 
coping style had shorter delay times (r=-.46, p<0.01; r=-.43; p<0.01). 
Hierarchical multiple regression was then used to evaluate the components 
of CS-SRM. Demographic variables were controlled for in step1; symptom 
identity and pain index were entered next; step 3 comprised cognitive and 
emotional representations; coping response was entered in step 4 and 
appraisal in step 5. Cognitive and emotional representations explained an 
additional 13% of variance to that explained by demographic, symptom and 
pain variables. Coping explained a further 16% of variance in stage 4. The 
overall model was significant, explaining 37% of the variance in patient delay.  
These data suggest that self-regulation theory is a useful guiding framework 
for research, and possibly intervention, related to time to treatment for 
possible symptoms of ACS. However, the sample of patients in this study 
was relatively small (n=61) and composed only of those who received a 
diagnosis of MI. The participants were not randomly selected and may not be 
representative of all patients with MI.  The methodology relied upon patients’ 
recall of their thoughts and emotions a number of days after the event, and it 
may be that their scores were affected by their subsequent experience of MI 
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and hospital care. It would be useful to further evaluate the explanatory 
power of the model in the context of a larger, randomly selected group of 
patients. Ideally this would be conducted at the onset of symptoms. However, 
given the significant practical difficulties involved in identifying individuals at 
this time, an alternative would be to identify people at the time they seek 
help. This would allow the CS-SRM to be evaluated without reliance on 
recall. This would also allow the opportunity to study the components of 
illness representation amongst a group of people who have not yet received 
a diagnosis. Such a study could explore whether the model accounts for how 
people represent their symptoms to health professionals before diagnostic 
labels are applied,  whether components of the model help to differentiate 
those who seek help soonest from those who present later and whether the 
model adds to the medical model in identifying those at highest risk of a poor 
outcome.  Exploration of such questions has the potential to both inform 
future interventions aimed at reducing treatment delay for people with 
symptoms of ACS and to contribute to the body of evidence around self-
regulation theory and help-seeking.  
 
2.7 Conclusion 
ACS is a common cause of death and morbidity. Pre-hospital delay in the 
context of ACS is an important issue. Further reductions in pre-hospital delay 
could reduce the high mortality associated with ACS.  
The evidence regarding time to presentation to healthcare services with 
symptoms of ACS is inconsistent. Variations in definitions of time periods 
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being measured and of the patient groups being studied make it difficult to 
compare and contrast studies. As a consequence, conflicting results are 
difficult to interpret. Much of the evidence derives from studies which were 
conducted amongst those with MI, with its application to those with other 
ACS unknown. Most studies have identified and studied patients 
retrospectively. Thus, the experiences of those who die very soon after the 
onset of symptoms, or are too ill to participate, are excluded. Sample bias, 
problems with recall or with inaccurate and incomplete medical records may 
also hamper retrospective methods.  
Despite these limitations, the studies discussed above highlight a number of 
factors which appear to be associated with longer pre-hospital times. Older 
people, women and those with a history of diabetes seem likely to present 
later. Non-white ethnic group; socio-economic disadvantage; previous history 
of angina; or living alone may also be associated with longer times from 
symptom onset to treatment. This provides useful information about particular 
groups at risk of late presentation who might be targeted in an intervention. 
However, this type of knowledge does not inform how an intervention should 
be developed.  The factors identified are generally not amenable to change 
and much of the evidence is atheoretical.   
Psychological factors have been identified as areas of key importance: how 
people come to recognise that symptoms may be related to their heart and of 
a serious nature, peoples’ expectations about what a heart attack might be 
like and the influence of others have been demonstrated as important factors 
in pre-hospital time for people with confirmed ACS. In particular, research 
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suggests that individuals’ representations of illness are likely to influence how 
and when people seek help with symptoms. In contrast to demographic, 
clinical and socio-economic factors; psychological factors may be amenable 
to change and thus offer a possible route for intervention.  
Evidence has also been presented which suggests that Leventhal’s CS-SRM 
could be a useful theoretical framework in which to explore these issues and 
guide intervention. To date the CS-SRM has not been evaluated in the 
context of people experiencing possible symptoms of ACS. Studies have 
identified participants after diagnosis and evaluated factors retrospectively. 
Narrowing the focus of research only to those who ultimately receive a 
diagnosis has not allowed comparison with the larger group of people who 
may have experienced similar symptoms but not been found to have ACS.  It 
would be extremely useful to study a representative sample of this larger 
group in order to evaluate the predictive abilities of the model in relation to 
patient decision time and outcome.   
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Chapter 3. Aims and rationale  
The overall aim of the investigation is to explore how illness representations 
relate to presentation to health services amongst patients with possible 
symptoms of ACS and thus to inform future interventions aimed at reducing 
delay. As described in Chapter 1, the relationship between the CS-SRM 
constructs and both (a) the content, and (b) the timing, of initial presentation 
to health services are of particular interest and thus a two-stage research 
design was adopted. NHS 24 (a national service in Scotland which provides 
health related advice and information via the telephone) was selected as the 
setting for the research. The rationale for this decision is discussed below. 
There then follows a description of NHS 24, an outline of the aims of the 
study and finally a brief recap of the rationale for the choice of theoretical 
framework. 
3.1 Setting - NHS 24 
NHS 24 was selected as the setting for the research for a number of reasons. 
Firstly, all calls to Scottish General Practitioners (GPs) in the out-of-hours 
period4 were dealt with by NHS 24. Thus, during the out-of-hours period a 
sample could be obtained from the entire population of people seeking help 
from their GP in Scotland. Such a sample could be considered more 
representative than one obtained in a particular region. 
Secondly, a dialogue about the nature of the patient’s symptoms occurred 
between the caller and the member of staff at NHS 24.  This would not have 
                                               
4
 Out-of-hours period usually 6pm-8am weekdays, all day and night weekends and public holidays. 
Varies slightly in different localities. 
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been possible within the alternative setting of the Scottish Ambulance 
Service (SAS) where the focus on the immediate need to despatch an 
ambulance limits the dialogue.  
Furthermore, all calls to NHS 24 are automatically recorded and stored in a 
format where they can be retrieved electronically. Thus there was a rare 
opportunity to study what people said at the time of seeking help with no 
impact on the delivery of care. Rather than having to interrupt a consultation 
to request consent (which would clearly be impossible in such an emergency 
situation), consent to use the existing recording for the purposes of research 
was sought at a later date. It would have been very difficult to achieve this in 
other potential settings (e.g. Accident & Emergency Departments (A&E)) due 
to the unpredictability of patient presentations and the need to obtain consent 
before data collection could take place.  
Detailed electronic records for each call were stored within a central 
database. This made it possible to identify all individuals presenting with 
particular symptoms and then to select a random sample to invite to 
participate. The ability to identify people before diagnostic labels were 
applied was important in two ways.  
Firstly, it allowed people’s accounts of their symptoms at the time of seeking 
help to be studied without reliance on recall. In contrast to retrospective 
reports, people’s experiences subsequent to the call (such as hospitalisation 
or receipt of a diagnosis) could not influence this data – a criticism that could 
be made of previous work in this area. However, the method was not without 
its own limitations. It was possible that there were important elements of the 
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patient's experience that they did not share with NHS 24 staff and which 
would therefore not be identified using this method alone.  However, 
comparison of call-data with subsequent retrospective report (IPQ-R) was 
possible in a small number of cases (n=35) which allowed the possible 
impact of this issue to be explored (see page 124).  
It was also possible that the degree to which an individual communicated 
their illness representations was influenced by the consulting style of the 
NHS 24 staff member, a factor difficult to control for in an organisation with 
hundreds of staff. Analysis was restricted to only participants’ responses to 
an initial open question from NHS 24 staff in an attempt to limit the impact of 
this issue.   
Secondly, the method allowed a sample to be identified from a population 
which was more representative of those experiencing possible symptoms of 
ACS than a sample comprised only of those with a diagnosis of ACS. As a 
diagnosis of ACS cannot be made solely on the basis of symptoms all those 
with possible symptoms are advised to seek urgent medical help. Thus the 
research which informs interventions aimed at facilitating prompt help-
seeking should be conducted amongst this wider group. Restriction of 
research to only those who receive an ACS diagnosis excludes from 
consideration the experiences of people who may have experienced identical 
symptoms as those with ACS but did not receive a diagnosis. Furthermore, 
research restricted to only those with ACS would be unable to identify 
features which might help to distinguish those with ACS from those with other 
problems. This is an important issue as this is a task which remains 
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challenging for clinicians. 
In summary NHS 24 offered a number of unique opportunities. However the 
unique context of the clinical and research environment meant that specific 
methods of identifying, approaching and obtaining consent from participants 
needed to be developed. A substantial level of detail about the setting is 
necessary in order to justify the choice of these methods. This detail is 
provided below and summarised in a diagram within Appendix 1. 
3.1.1 NHS 24 
NHS 24 was established in 2003 and provides telephone health advice and 
information for people in Scotland. It receives on average 30,000 calls each 
week. Calls are received about an enormous variety of symptoms in both 
adults and children e.g. fever; headache; backache; depression; chest pain. 
The process of how calls are dealt with by the service will be described 
below. However, it should be noted that whilst this was the process at the 
time the study was planned and conducted, some processes have since 
changed.  
Call process 
At times when GP surgeries were closed, if someone called their GP’s 
number, their call was automatically re-routed to NHS 24. In addition, at any 
time, people could reach the service by dialling a dedicated 0845 number. 
The call was answered by a call-handler who would briefly establish the 
reason for the call and record demographic details in a computerised patient 
record. The call-handler summarised in less than 10 words, within this 
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record, the reason the caller has given for contacting the service, where 
possible using the patients own words (this is known as the call reason).  
In all circumstances where the patient had symptoms (except if they were 
unconscious or not breathing, in which case an ambulance would be 
requested immediately), the call (and the associated electronic record) were 
then passed to a nurse advisor. The nurse advisor assessed the patient’s 
symptoms in order to advise the most appropriate course of action.  
The consultation consisted of an initial assessment which allowed the nurse 
to assess the needs of the patient, followed by further detailed questioning 
supported by specially designed, decision-making software. The software 
provided a selection of symptom-related algorithms from which the nurse 
could choose the most appropriate. The algorithms prompt the nurse to 
consider a series of relevant questions. These were designed to guide 
nurses’ assessments and ensure the most high-risk clinical scenarios were 
quickly identified. Where there were multiple symptoms the nurse would 
choose the algorithm relating to the most serious symptom. Where no 
algorithm exactly matched the symptom the patient described (e.g. facial 
drooping) the nurse would either select one which was similar (e.g. 
weakness) or proceed without one, documenting why an algorithm had not 
been used.  
Where a nurse suspected that symptoms may be related to ACS it was usual 
practice to select a ‘chest pain’ algorithm. However, occasionally it was 
expected that an algorithm might not be used. This would occur where the 
nurse became aware after their initial questioning that the situation was 
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immediately life-threatening and would take appropriate action without delay. 
The use of a specific algorithm was recorded on the electronic record, as 
were any reasons for not doing so.   
After completing an assessment of the patient’s symptoms, either with or 
without an algorithm, the nurse would decide on an appropriate course of 
action and advise the patient what to do next. The nurse would record this 
outcome within the record along with an appropriate time-frame (e.g. as soon 
as possible; within 4 hours). This is known as the ‘disposition’ and examples 
include 999 ambulance; a GP home visit; a Primary Care Emergency Centre 
(PCEC) appointment or self-care. 
In summary, the procedures described above meant that NHS 24 could 
facilitate the identification of a large, representative sample of people with 
possible symptoms of ACS and provide a recording of their initial symptom 
presentation. Data relating to a number of demographic and clinical variables 
(including contact details) were also readily available. It was therefore 
considered an appropriate and feasible setting for the planned investigation, 
the aims of which are described in detail, below.  
 
3.2 Aims 
3.2.1 The content of initial presentations 
The aim of the first stage of the investigation was to explore how the CS-
SRM relates to peoples’ initial symptom presentations to health services. The 
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study comprised a CS-SRM-guided content analysis of the initial 
presentations of NHS 24 callers (including a proportion with possible 
symptoms of ACS). This allowed the utility of the model as a theoretical 
framework for the overall study to be explored. It also provided an opportunity 
to develop and pilot a specifically adapted version of the IPQ-R to be used in 
the second stage of the investigation. Furthermore, it allowed methods of 
identifying and approaching participants to be piloted. This was important for 
a number of reasons 
1. There were no precedents for using the NHS 24 database to identify a 
particular clinical group as a population for research and thus new 
methods had to be developed. 
2. The target group were, by their very nature, a challenging group to 
approach. The definition of ‘possible symptoms of ACS’ was broad 
and potentially ambiguous. People with these types of symptoms 
might have been in circumstances that would make contact very 
difficult (e.g. still in hospital) and there was also the possibility that 
some may even have died soon after their call. Thus there were 
significant ethical issues related to contacting people with these types 
of symptoms.  
3. NHS 24 is a large, national service based in a number of contact 
centre environments. As such the nature of the relationship between 
users of this service and those providing care might be expected to 
differ from other clinical settings. It was not clear how this might affect 
participation.  
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3.2.2 The timing of initial presentations 
The aim of the second stage of the investigation was to explore how illness 
representations relate to patient decision time amongst patients with 
possible symptoms of ACS. This study comprised a larger-scale survey of 
people with possible symptoms of ACS. The IPQ-R was utilised to explore 
how illness representations related to a number of measures of patient 
decision time.  
3.3 Rationale for theoretical framework 
As was discussed in Chapter 2, a common problem with much of the 
literature with regard to ACS and delay is that much research has been 
conducted in the absence of an explicit theoretical framework. The 
consequence being that relationships between empirically derived factors, 
causal mechanisms and targets for intervention have been poorly defined 
and do not readily inform an intervention.  
The CS-SRM was selected as the theoretical framework for this study for the 
following reasons: 
1. The theory provided a plausible explanation for the patterns of behaviour 
observed in previous studies. The link between symptoms and help-
seeking was made but not assumed to be inevitable. 
 
2. The model conceptualises individuals as rational, problem-solving 
individuals but does not exclude the influence of other social factors. The 
role of emotion in affecting health behaviour is acknowledged, an area 
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neglected by other social cognition models (Fishbein and Azjen, 1974; 
Becker, 1974). 
 
3. A large body of evidence exists to support the illness representation 
dimensions and their relationships with coping behaviours and clinical 
outcomes (Hagger and Orbell, 2003). 
 
4. The framework had been used successfully with people with CHD and 
found to be predictive of outcome (Petrie et al.  1996). The model was 
found to explain variance in pre-hospital time additional to that explained 
by demographic and clinical factors, amongst patients with MI, (Walsh J 
C et al.  2004). 
 
5. The IPQ-R was a tool which could easily be adapted for use with 
patients with possible symptoms of ACS.  (Moss-Morris et al.  2002).  
The overall design of the study is summarised in Figure 2, below and 
described in the following chapters.  
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Figure 2: Overall study design 
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Chapter 4. Content of initial presentations: Methods 
4.1 Introduction 
The following chapter describes the methods used in the first stage of the 
investigation, exploring the content of participants’ initial presentations to 
NHS 24.  The two pilot studies which were undertaken prior to the main 
investigation are described first. Methods of identifying patients with possible 
symptoms of ACS and inviting their participation in research were the focus 
of these pilot studies and informed the methods ultimately employed in this 
stage of the investigation. These methods are then described in detail.  
4.2 Pilot work 
4.2.1 Background 
As has already been discussed in Chapter 3, NHS 24 was chosen as the 
setting for the research. Previous Scottish research indicated that people with 
possible symptoms of ACS seek help via 3 main routes –via their GP, the 
SAS or Accident & Emergency (A&E) departments (Leslie et al.  2000).  Any 
one of these settings could potentially have provided access to the 
population of interest. However, the recently conceived NHS 24 possessed a 
number of key advantages which led to it being selected as the setting for 
this research (these were described earlier on page 52). However, the unique 
nature of the setting meant that appropriate methods of identifying, 
approaching and achieving the participation of patients required to be 
developed. Pilot work around the invitation of patients; the identification of the 
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clinical population and the administration of the IPQ-R was therefore 
conducted. This work is described below and served to define the methods 
used in the main study, exploring the content of initial presentations which 
are subsequently described on page 90.  
4.2.2 Pilot study 1: Inviting patients of NHS 24 to participate in 
research5 
Background 
Due to the urgent and remote nature of patients’ contact with NHS 24, the 
usual methods of recruitment employed in general practice or a hospital/clinic 
environment were not feasible (e.g. invitation by clinician, approach in person 
by researcher).  Furthermore, there were no precedents for using the NHS 24 
database to identify a particular clinical group as a population for research 
and the target group were, by their very nature, a challenging group to 
approach. It was therefore necessary to develop sensitive, but effective, 
ways to approach patients and achieve their participation in the research. 
As it was neither practical, nor ethical, to approach people at the time of their 
call about research it was, instead, necessary to make contact with people at 
a later time. Contact could potentially have been achieved in person, by letter 
or by telephone. However, the geographical spread of potential participants 
and the ethical difficulties involved in finding out their whereabouts, before 
they had given consent, meant that direct personal contact was not 
considered feasible.  
                                               
5
 This was not originally designed as pilot work but as a result of the issues encountered, ultimately 
acted as such. 
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The choice of approach between telephone and letter was driven by both 
methodological and pragmatic considerations. Methodologically, in order to 
be able to generalise results it was important to achieve as high a 
participation rate as possible (Buckingham and Saunders, 2004b). In 
addition, as patients were being asked to recall their thoughts about their 
symptoms, it was necessary for this to be done as soon as possible after the 
call to minimise any problems with recall (Bowling, 2002).  
However, a number of pragmatic issues also had to be considered. Given the 
nature of the symptoms they contacted NHS 24 with, it was possible that 
some potential participants might be unwell, in hospital or may even have 
died at the time of contact. The ethical issues regarding the approach to 
patients were therefore of primary importance. It was essential that the 
wording of invitation letters was sensitive to the possible circumstances of 
recipients (who might even be very recently bereaved relatives). It was 
considered very important that those invited to participate in the research 
(simply as a result of accessing their GP via the only route available to them 
at that time) should not feel coerced into taking part. Furthermore the 
research was being conducted at a time when NHS 24 was subject to high 
levels of critical media attention (Harper, 2005; Rodrick and Bruce, 2005; 
Musson, 2005a; Musson, 2005b) also see Appendix 2.   It was considered 
important that the approach to patients did not stimulate any additional 
negative feedback for the organisation.  
In view of these issues the decision was made to invite people to take part in 
the research by letter rather than by telephone. This allowed potential 
  65 
participants the freedom to read the information if, and when, it was 
convenient. The decision about whether or not to take part could be made in 
their own time and the information could be discussed with others. 
Furthermore, as returned written consent was a requirement of inclusion, a 
decision not to take part required no effort on the part of the participant. The 
approach was also consistent with NHS 24 policy whereby, in order to avoid 
the negative connotations associated with some contact-centre 
environments, the organisation did not make unsolicited calls to individuals.  
The approach also allowed large numbers of participants to be contacted 
relatively easily.  In addition it provided an opportunity to make contact with 
those who made calls on behalf of identified patients by asking patients to 
pass on the relevant information to the appropriate third party.  
However it was recognised at the time that the method had a number of 
limitations. Firstly, the requirement to be able to read written English may 
have limited certain individuals from participating.  It was considered that this 
could reduce response rates and possibly bias the sample, limiting the 
generalisability of findings. Low response rate is a well recognised and 
common problem associated with postal surveys (Buckingham and 
Saunders, 2004b). However, it was considered that given the nature of the 
symptoms and the recentness of patients’ experiences, that potential 
participants might be more positively disposed to taking part. In any case, 
given the lack of previous work with this group; the patients’ clinical 
circumstances and the sensitivities around approaching them at this time it 
was considered that results from this study would nevertheless be valuable 
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and worthwhile pursuing despite this limitation. NHS 24 records contained 
numerous data regarding the characteristics of individual patients and 
consultations. This allowed checks for non-responder bias in a number of key 
areas to be made. These included age, gender, social deprivation, whether 
or not someone made the call themselves, nurse outcome and whether the 
patient had a recorded history of CHD.  It was considered that, in the event of 
a low response rate, this would allow any potential bias in the sample to be 
identified and taken into account during the interpretation of results.  
Staff members involved in the calls of participating patients were also 
approached and invited to participate by letter. The same standards of 
informed consent applied to patients were applied to the staff members. It 
was not anticipated that staff would be unduly concerned about their calls 
being utilised for research. All calls to NHS 24 are recorded and regular 
reviews conducted in order to monitor performance, thus staff were 
accustomed to this type of surveillance. The decision was therefore made to 
approach patients and callers in the first instance and then only the staff 
involved in the calls of participating patients were approached. This avoided 
the need to approach and inconvenience all 500 staff at NHS 24, when the 
participation of only a very small number was required. 
The approach was piloted in May 2005 and is described below. 
Aim  
To pilot an opt-in, postal invitation to participate in research amongst people 
who had been in contact with NHS 24.  
  67 
Research Questions 
1. How acceptable is an opt-in postal invitation to participate in research to 
people who have contacted NHS 24?  
2. What participation rate can be achieved by this method of approach?  
Method 
Design 
A postal survey of people who had sought medical help from the national 
telephone out-of-hours service (NHS 24), within 10 days of their call. 
Setting and participants 
NHS 24 was the setting for the research.  
A random sample of 75 calls were identified where either the chest pain 
algorithm had been used or no algorithm was used as the call was deemed 
‘immediately life-threatening’ and possible symptoms of ACS were identified 
within the call reason or clinical summary (see Appendix 1 for details of NHS 
24 call process).  
A further 75 calls where either an algorithm other than ‘chest pain’ had been 
used or an algorithm was not used for reasons other than that the symptoms 
were immediately life-threatening were identified.  
The patients involved in these calls (and if applicable anyone who called on 
their behalf) were invited to take part. Where patients agreed to participate 
the NHS 24 staff members involved were also asked to participate. 
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 Inclusion Criteria 
A call had been received and recorded by NHS 24 within the previous 3 
days. 
Exclusion Criteria 
It was planned that any patients who stated or documented that they did not 
wish their data to be used for research were not to be approached. However, 
this assumed that a recorded message informing callers that their data may 
be used for research would be active at the time of recruitment. However, for 
organisational reasons this was not implemented as planned and no 
mechanism existed for patients to record their wishes.  
Any calls involving children aged 16 or under were excluded as ACS in 
someone of this age would be exceptionally rare (Petersen et al.  2005).  
Procedures 
Ethical and NHS management approval were obtained (see page 96 for 
details). The sample was identified as described above.  The corresponding 
150 patient records were then accessed in May 2005. It was identified from 
the record whether the patient called themselves or if someone else called on 
their behalf.  
The patient called about themselves 
Where the patient called about themselves (63 cases) a letter and 
information leaflet was sent to the patient explaining the purpose and nature 
of the study and inviting their participation in it (Appendix 3 and Appendix 4). 
They were asked to sign and return a consent form (Appendix 5) if they 
  69 
wished to take part.  
On receipt of the patient’s written consent, letters were then sent to the call-
handler and nurse who handled the call explaining the purpose of the study 
and requesting their consent to use their voice recordings (Appendix 6, 
Appendix 7 and Appendix 8). 
Someone else called on behalf of the patient 
Where someone else called on behalf of the patient (87 cases) an alternative 
letter (Appendix 9) and information leaflet (Appendix 4) was sent to the 
patient which included a request to pass ‘caller information’ to the person 
who called on their behalf. A second set of information directed towards the 
person who called, (Appendix 10, Appendix 11 and Appendix 13) was 
enclosed and the patient requested to pass it to them. Again, staff members 
were contacted following receipt of the patient’s written consent. 
Where any party declined to give their consent the call was excluded from 
the study.  
Voice recordings of calls exclusively involving consenting patients, staff (and 
where appropriate callers) were then retrieved and transcribed verbatim.  
Patients and callers were also asked to complete and return the adapted 
IPQ-R and Caller Illness Perception Questionnaire (CIPQ-R) respectively, 
(see Appendix 12 and Appendix 13) as part of the piloting process for the 
questionnaire (this is described in more detail in on page 157). The 
questionnaire also included items (PF1-4) designed to obtain feedback on 
the acceptability and timing of the approach and on the ease of completion of 
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the questionnaire.  
Analysis 
Patient and staff response and participation rates were explored.  
Feedback from participants regarding the acceptability of the approach was 
examined.   
Results 
Of the 150 calls identified, 63 were made by the patient themselves and 87 
were made by a caller on behalf of the patient.  Forty-four of the 150 patients 
contacted (29%) responded to the letter of invitation.  A total of 26 (17%) 
patients agreed to take part in the study. Eighteen of the 87 callers 
approached responded, 12 agreed to take part.  
Nineteen call-handlers and 20 nurse advisers involved in consenting patients 
calls were approached (some were involved in more than one of the 
identified calls). Consent was received from 9 call handlers and 6 nurse 
advisors to access their calls.   
Overall the consent of all parties to access the recording of calls was only 
available for a total of 2 calls (see Figure 3 on page 71). 
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Figure 3. Effect of patient, caller and staff response on access to calls. 
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Discussion 
Low response rate from patients 
The response rate of 29% and participation rate of 17% were low. However, 
given the challenging population being targeted it was difficult to estimate 
what could realistically be achieved. Higher rates would have been preferable 
from a methodological point of view.  If the majority of people invited to 
participate did not respond, the generalisability of the results obtained from 
those who did, was questionable.  It was possible that those who chose to 
respond differed from those who did not in important ways e.g. in age, clinical 
condition and level of literacy (unfortunately there were insufficient data to 
assess whether or not this was the case at this time). There were also 
practical implications of a low response rate. Higher numbers of invitations 
would be required to achieve the necessary sample and therefore be more 
costly, take longer and risk causing distress to the increased number of 
individuals being contacted. These issues were likely to be most significant in 
the second stage of the project, during which it was planned to recruit larger 
numbers of patients.   
The opportunity for patients to ‘opt-out’ by simply returning the information 
was provided and, if patients did not respond to the letter, no further action 
was taken and it was assumed they had declined. Importantly, this meant 
that information about why people did not respond was not available. This 
was problematic. Potential reasons were numerous – the patient may have 
died, be too unwell, not interested in research, not like the questionnaire, 
have trouble reading etc. Clearly, non-participation for one reason may have 
had very different implications for the study than for other reasons.  
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It was possible that the reasons for non-response were amenable to change 
and that such change would allow more people to participate and improve 
the acceptability of the approach for them. It was considered unethical to 
continue to recruit patients without trying to identify any areas for 
improvement. The method ultimately adopted for the main study included the 
opportunity to elicit reasons for non-participation from patients. The results 
are reported on page 107. 
More encouragingly, the experience of approaching these first 150 patients 
did not produce any particularly negative feedback regarding the 
appropriateness of the approach to participants. Feedback was only available 
from those who did agree to participate, but suggested that most considered 
the approach soon after their call to be appropriate.  
It was also considered necessary to take steps to establish if improvement to 
response rates could be achieved. It was recognised that the relatively 
impersonal contact of a letter might have been less engaging than other 
methods of approach and may have contributed to the poor response rate. 
When people are busy and, perhaps, in the midst of a serious illness 
episode, such a letter might be easily overlooked. Also, even where people 
were motivated to take part, difficulties encountered in understanding the 
information or in completing a questionnaire may have led to non-response 
or to incomplete responses. Whilst a sincere offer was made to answer any 
questions or queries, people may have felt reluctant to ask. It was considered 
that it would be easier to detect and discuss such difficulties in a 
conversation or one to one situation. Such an approach had the added 
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advantage of being less likely to result in incomplete data being gathered 
(Bryman, 2004).  
Low response rate from staff 
The staff participation rate of 38% was also much lower than anticipated. All 
staff at NHS 24 were aware that all their consultations were recorded and 
each staff member had at least 2 calls reviewed each month by their team 
leader. Calls were also reviewed whenever negative feedback was received 
from patients or from colleagues in partner organisations. Given this level of 
ongoing surveillance it was not expected that access to calls for the purposes 
of this research would be problematic.  
However, as seen in Figure 3, low staff participation further compounded the 
problem of the low response from patients. It meant that even larger numbers 
of potential participants would require to be contacted in order to ultimately 
achieve the planned number of calls for transcription.  Therefore the 
methodological limitations associated with a postal survey were likely to be 
further magnified. 
It was considered that the response rates achieved might not be a true 
reflection of NHS 24 staffs’ inclination to be part of research. A member of 
staff, who declined to participate, stated that she was disappointed as she 
was delighted to hear that a nurse colleague was undertaking research and 
would have liked to be a part of it. It appeared that concern over potential 
negative implications had deterred staff who might otherwise have been keen 
to participate.  It was considered essential that steps were taken to ensure 
that staff felt safe and free to participate in research.  
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Feedback was received from 2 members of staff indicating that they had 
concerns about potential negative consequences for them, as a result of 
taking part.  In particular, the information provided in the staff information 
sheet which stated that  
“ in the unlikely event that serious misconduct was identified during 
the course of the study, the researcher would be professionally 
obliged to take action and would bring the matter to the attention of 
your Team Leader.” 
seems likely to have caused particular concern. The statement was included 
in an attempt to delineate and clarify the boundaries of the chief investigator’s 
role as a clinician whilst functioning as a researcher. It was intended to 
communicate honestly that there were limits to the confidentiality that could 
be assured and that in extreme circumstances action might need to be taken. 
However, it became clear that the term ‘serious misconduct’ was open to a 
number of interpretations. It was extremely difficult to define exactly what it 
referred to. Thus, the mere suggestion that there may be circumstances 
whereby staff members participation in this research could have negative 
consequences for them, may have led to a significant number choosing not 
to participate.  This had a number of implications. Firstly, it unintentionally 
caused anxiety and worry for NHS 24 staff which was regrettable. Secondly, 
it resulted in a lower than anticipated level of participation. This seriously 
impacted on the conduct of the research. There were 18 circumstances 
where the patients (and caller if applicable) had agreed to participate in the 
research and given their consent for their call to be analysed. However, their 
data could not be accessed as at least one member of staff involved in the 
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call did not give their consent (the consent of both the call handler and the 
nurse advisor were required). To request data from patients, at such a 
sensitive time, but not actually use it was considered unacceptable.  
As a result the method was adapted to avoid this situation.  NHS 24 staff 
were contacted in the first instance and asked to give their consent for their 
consultations to be used in the research. Subsequently, potential participants 
were identified only from calls involving staff who had agreed to participate. 
The information leaflet for staff was also revised to assure participating staff 
of absolute confidentiality. 
This element of the pilot work also informed the scale of the remainder of the 
project. Challenges were encountered with obtaining consent to access calls 
as discussed above. However, unanticipated problems with retrieval of calls 
were also encountered. This was because there was a time lapse (often a 
few weeks) before all the relevant consents were obtained. This meant that 
the call recordings could no longer be accessed from the easily accessible 
web-based application as planned. Instead they were stored on back-up 
tapes. Consequently, the team responsible within NHS 24 for these tapes 
were required to individually retrieve each call.  This was inconvenient and 
extremely time-consuming. Furthermore, as approximately half of the calls 
were essentially a random selection, many were not urgent and as such 
tended to be longer in length than those identified as possibly cardiac (some 
up to 20 minutes long). Thus transcription also took much longer than had 
been estimated (based on an average 6 minute call). In view of these issues 
a decision was made to reduce the scale of the main study from a planned 
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sample of 100, to a quota sample of 60 patients, 30 from each group. It was 
considered that this would remain sufficient to address the research 
questions whilst avoiding additional delay to the remainder of the project.  
 
Conclusions 
1. The opt-in, postal invitation to participate in research did not result in 
adequate participation rates by patients. This was compounded by 
inadequate participation amongst staff. An alternative method of 
achieving participation was required.  
 
2. The lack of information about peoples’ reasons for non-participation was 
problematic, particularly in view of the low response rates achieved. A 
method of obtaining this information was required. 
 
3. The approach to potential participants was considered acceptable by 
those who participated. However, additional efforts to improve response 
rate were required. 
 
4. The situation during the pilot where consenting patients’ data could not 
be used as one of the staff involved in their call had not provided consent 
was considered unacceptable. All staff of NHS 24 should be approached 
in the first instance and asked to participate in the study.  Then only 
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potential participants who had consulted with consenting staff be 
approached for consent.  
 
5. In view of the practical difficulties encountered in accessing and 
transcribing the calls the planned quota sample was reduced from 100 to 
60 calls. 
 
4.2.3 Pilot study 2: Identifying people with possible symptoms of 
ACS 
Background 
The population of interest for the study as a whole were people seeking help 
with possible symptoms of ACS. As was discussed earlier in the literature 
review, the identification of the symptoms of a cardiac event is generally 
problematic. There is considerable variation in presentation. ‘Typical’ 
symptoms have been described as chest pain; radiating pain or numbness in 
the arm, neck, jaw or shoulder and collapse (Horne et al.  2000). However, 
other presentations might include shortness of breath; nausea and/or 
vomiting; feeling faint and sweating. None of these symptoms are specific to 
cardiac events and may be associated with a large number of other 
conditions (e.g. viral illness) making the identification of the symptoms of 
ACS exclusively and reliably extremely challenging. 
It has also been demonstrated that patients without chest pain tend to 
present later than those who experience this symptom (Canto et al.  2000). 
Therefore it was considered inappropriate to exclude patients with ‘atypical’ 
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presentations from the investigation. A sampling strategy which reliably 
identified patients with possible symptoms of ACS with as high a degree of 
sensitivity and specificity as possible was the best that could be achieved.  
Two possible methods were identified. The first based upon the nurses use 
of algorithms (algorithm strategy) and the second based upon the call reason 
provided by the patient and documented by the call handler (call reason 
strategy), these are described below. 
Algorithm strategy 
Calls where the nurse’s assessment included the use of the chest pain 
algorithm could be identified from the electronic database. In addition calls 
where the nurse did not use an algorithm but where the symptoms were 
considered immediately life threatening could also be easily identified 
(although given that there could be many reasons a call was considered 
immediately life threatening, aside from ACS, each call identified by this 
method required to be screened for other symptoms). 
Call reason strategy 
The initial call reasons given by callers and recorded by the call handlers 
could be examined and those which included specified symptoms identified 
for inclusion.  
A pilot study compared the 2 possible methods and is described in further 
detail below. 
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Aim  
To evaluate the relative merits of 2 possible sampling strategies in identifying 
potential participants at NHS 24.  
Research Question 
How effective are the algorithm and call-reason sampling methods in reliably 
identifying patients with possible cardiac symptoms?  
Method 
Design 
A comparison of the effectiveness of 2 sampling strategies in identifying 
patients with possible symptoms of ACS from NHS 24 records, utilising a 
panel of 3 clinical experts.  
Setting and participants 
A random sample of 75 calls to NHS 24 were identified where either the 
chest pain algorithm had been used or no algorithm was used as the call was 
deemed ‘immediately life-threatening’ and possible symptoms of ACS were 
identified within the call reason or clinical summary.  
A further 75 calls where either an algorithm other than ‘chest pain’ had been 
used or an algorithm was not used for reasons other than that the symptoms 
were immediately life-threatening were identified.  
The patients involved in these calls (and if applicable anyone who called on 
their behalf) were invited to take part. This was designed to achieve a quota 
sample of 30 patients in each group.  
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Inclusion Criteria 
A call had been received and recorded by NHS 24 
The patient (and if applicable anyone who called on their behalf) and NHS 24 
staff members had given consent for their voice recording to be used for the 
purposes of this study. (If the patient had died, the next of kin had given their 
consent to the recording being used).  
Group 1: The nurse used a chest pain algorithm or did not use an algorithm 
as the call was deemed ‘immediately life-threatening’ and possible symptoms 
of ACS were identified within the call reason or clinical summary.  
Group 2: The nurse used an algorithm other than 'chest pain' or did not use 
an algorithm for reasons other than that the symptoms were considered 
immediately life-threatening. 
Exclusion Criteria 
Any calls involving children aged 16 or under were excluded. 
Procedures 
Approaching  staff 
All call handlers, nurse advisors and team leaders employed by NHS 24 as of 
8th November 2005 (total n= 880) were invited by letter (Appendix 14, 
Appendix 15 and Appendix 16) to give their permission for consultations they 
were involved in to be used in the project. In order to protect the 
confidentiality of staff, letters were issued by the Human Resources (HR) 
department at NHS 24 Headquarters, Glasgow. A list of the names of those 
invited was provided so that a record could be kept about how many 
  82 
responses were received and from which staff groups (i.e. call handlers, 
nurse advisors, team leaders). As the list comprised all current employees, a 
number of those invited were on maternity leave, long-term sick leave or had 
already tendered their resignation. HR advised that this was the case for 114 
of those invited but were obviously unable to identify which staff this related 
to, for reasons of confidentiality. It is reasonable to conclude that people in 
these situations would not be able to participate. Therefore the participation 
rate has been calculated from the total number invited minus those in 
identified as absent by HR (n=766). A total of 324 (43%) consented to take 
part.  
On 30th November 2005 the database was searched to identify all calls which 
fulfilled the inclusion criteria within the previous 3 days. A total of 12 597 
were identified. Those handled exclusively by consenting staff was 963. This 
number is a small proportion because calls were only eligible if both the call 
handler and the nurse advisor involved had given consent. Staff follow a 
variety of different shift rotas and number of hours per week. Therefore if a 
high volume of staff who work fewer hours a week have consented to take 
part then the total number of calls eligible would be reduced. Similarly, staff 
who work more nightshifts or other less busy times or who are on holiday 
would be expected to deal with less calls. This may explain the low 
proportion. 
The subset of consultations undertaken only by staff that had consented to 
participate in the research was identified. This generated a list of unique call 
identifiers (Patient Relationship Management (PRM) numbers) relating to 
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eligible calls. The PRM numbers were entered into the Statistical Package for 
the Social Sciences 14.0 (SPSS) and a random selection of 75 were selected 
to be approached. The corresponding patient records were then accessed by 
the investigator. It was identified from the record whether the patient called 
themselves or if someone called on their behalf. Subsequent to Pilot Study 1 
an alternative process of approaching potential participants was developed. 
This is described below.  
Approaching patients 
The patient called about themselves 
Where the patient called about themselves a letter (Appendix 3) and 
information leaflet (either Appendix 17 or Appendix 18), depending upon 
randomisation) was sent to the patient explaining the purpose and nature of 
the study and inviting their participation in it. Permission to telephone them to 
discuss it further was requested. It was made clear that there was no 
obligation to receive this call or to take part in the research. If the patient did 
not wish to be contacted they were asked to notify the researcher, by either 
returning a postcard (Appendix 19) or by telephoning a dedicated telephone 
number. Patients who took either of these actions were not contacted further. 
Those who did not decline were telephoned and the research discussed 
further with them as detailed in the schedule for invitation by telephone 
(Appendix 20). This call was recorded (patients were informed of this at the 
earliest reasonable opportunity). 
It was ascertained whether the patient had received and read the information 
posted to them. If they had not, they were given the opportunity to do so (if 
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they wished). Once the investigator was satisfied that the patient had read 
and understood the nature of the research and had the opportunity to ask 
questions they then requested the patient’s consent to take part. It was made 
clear that participants were free to withdraw their consent at any time. 
Arrangements were made for either a telephone interview or for self-
completion and return of the questionnaire  
The original telephone call of those who consented was accessed, 
transcribed and analysed at a later date. 
Where the patient declined to take part, they were asked sensitively to 
provide a reason for this which was recorded.  
Someone else called on behalf of the patient 
Where someone else called on behalf of the patient, an alternative letter 
(Appendix 9) and the information leaflet (Appendix 17 or Appendix 18) were 
sent to the patient including a request to pass ‘caller information’ to the 
person who called on their behalf. A second set of information directed 
towards the person who called (Appendix 10 and Appendix 22 or Appendix 
23) was enclosed and the patient was requested to pass it to the person who 
called on their behalf.  
Patients who consented to take part, and who had a contact number for the 
caller, were asked permission to contact that person by telephone (frequently 
they were a family member). 
The caller was invited to give consent and participate in the same manner as 
the patient (see Appendix 20). Similarly, callers were asked to provide a 
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reason if they declined to take part. 
Where any party declined consent the call was excluded from the study. 
Where a third party was not available to respond regarding the request for 
consent, but consent was given by the patient and the NHS 24 staff involved, 
then the call was included but any personal details regarding the third party 
omitted from transcripts.  
All patients and callers who were invited to participate were also sent the 
specially adapted IPQ-R (or CIPQ-R) (Appendix 12 and Appendix 13) in 
order to further pilot the questionnaire – this is described in more detail on 
page 157. A subgroup of 20 of these participants was asked to take part in a 
telephone interview in order to share their experiences of completing the 
questionnaire (see page 162 for more detail). 
Voice recordings of calls involving only consenting patients and staff were 
then retrieved and transcribed verbatim. All personally identifiable information 
was omitted during transcription.  A quota sample of 60 transcriptions was 
produced, including 30 from the algorithm strategy designed to identify 
patients with possible symptoms of ACS.  
Each transcript was presented to an expert panel of 3 clinical raters (2 
registered general nurses and 1 GP). They were each asked independently 
to assess the degree to which they considered the symptoms described to be 
‘possible symptoms of ACS’. After reading each transcript, raters were asked 
to indicate on a 4 point scale (Appendix 24) how likely the symptoms 
described were to be possible symptoms of ACS.  
  86 
In addition the call reason, provided by the patient and stored on the 
electronic record (see Appendix 1 for more detail) was obtained for both 
groups.  Thus 60 call reasons were available. These call reasons were 
assessed by the chief investigator and those which included either a ‘typical 
symptom’ (as defined in Figure 4, below) or at least 2 ‘atypical’ symptoms 
(also defined below) were identified and classified as possible cases of ACS. 
Figure 4: Criteria for possible symptoms of ACS 
Includes any one of the following ‘typical’ symptoms: collapse; chest pain; 
radiating pain in the arm, jaw, back, neck or shoulder  
 
Or 
 
any two of the following ‘atypical’ symptoms: shortness of breath; 
nausea/vomiting; feeling faint or sweating 
Horne R, James D, Petrie K et al. (2000) 
 
Analysis 
Experts’ ratings of ‘definitely not’ and ‘probably not’ symptoms of ACS were 
combined as ‘unlikely to be symptoms of ACS’. Likewise ratings of ‘definitely’ 
and ‘probably’ symptoms of ACS were combined as ‘likely to be symptoms of 
ACS’. The 3 ratings for each transcription were compared and the majority 
opinion accepted as the standard for comparison. 
The sensitivity and specificity of the algorithm and call-reason sampling 
methods for identifying patients with ‘possible symptoms of ACS’ were then 
evaluated against the standard generated by the expert panel. 
Results 
Of the 60 transcripts, 35 were rated by the panel as likely to be symptoms of 
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ACS and 25 were rated unlikely to be symptoms of ACS. The transcriptions 
rated as likely to contain the symptoms of ACS were compared with those 
identified by each of the sampling strategies.  The results are presented in 
Table 3 below. The specificity of both methods was identical. Both methods 
correctly excluded 27 of the 35 transcriptions assessed as unlikely to include 
symptoms of ACS (although it is important to clarify that the 27 calls excluded 
by each strategy were not the same calls).   
However, the algorithm strategy correctly identified 24 of the 25 calls 
identified as possibly symptoms of ACS by the expert panel.  Only 18 of 
these were identified by the call reason strategy. 
Table 3. Cases identified by sampling strategies against the opinion of the expert panel 
 
    
Expert 
panel Sensitivity Specificity 
   yes no 
% correctly  
identified 
% correctly  
excluded 
Algorithm strategy Yes 24 8 
  No 1 27 
96% 77% 
Call reason strategy Yes 18 8 
  No 7 27 
77% 77% 
Discussion 
The two sampling strategies performed equally well in excluding cases 
assessed as unlikely to be symptoms of ACS by the expert panel. However, 
the algorithm strategy proved more sensitive, identifying a larger proportion 
of the cases assessed as including possible symptoms of ACS by the expert 
panel. This informed the second stage of the study where the algorithm 
strategy was selected to identify the larger number of patients required.     
However, two other significant issues related to the selection of eligible 
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patients were identified during the course of this pilot work. These are 
discussed below and the subsequent modifications to the protocol required 
described thereafter.  
Identification of suicidal patients in Group 2 
During the collection of ‘general characteristics’ data, it became apparent that 
there were a number of instances (n=2) where the ‘call reason’ recorded 
within the clinical record was that the patient was suicidal. This raised the 
issue of how appropriate it was to contact people in such a critical situation. It 
was feared that to contact people in this situation and ask them to recall their 
reasons for seeking help may be, not only insensitive, but could potentially 
pose a clinical risk. However, as this situation was not anticipated, there were 
not provisions made within the protocol to deal with it. It was also considered 
important to ensure that decisions taken to exclude certain groups of callers 
were clinically justified and would not adversely affect the representativeness 
of the sample and bias results.  
At the time the issue arose, advice was sought from the supervisory team 
and from a senior clinician within NHS 24. It was decided not to approach 
people in this situation, given the appreciable risk of causing harm balanced 
against the minimal risk of their exclusion causing bias in the results. 
Thereafter, people contacting NHS 24 for reasons of this nature were 
explicitly excluded from the study. 
Identification of patients for whom no algorithm was used as the situation 
was deemed as immediately life threatening. 
In a substantial proportion of cases where a patient with symptoms of ACS 
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called NHS 24, an algorithm was not used. This occurred when the nurse 
quickly recognised that the situation may be immediately life-threatening and 
thus immediately contacted the SAS to request an ambulance. It was 
considered essential that patients in this situation were identified for inclusion 
as they were likely to be a group for whom a diagnosis of ACS was most 
probable. Thus patients for whom no algorithm was used, and for whom the 
outcome was a 999 ambulance, were identified for inclusion in the population 
from which the random sample is drawn. 
It was identified in the original protocol that some of the calls which fell into 
this category would not be related to ACS.  Provision was made to exclude 
those if, after listening to the call, symptoms of ACS were not identified.  
However, the need to listen to the call necessitated approaching the patient 
to invite their participation and request consent. It became apparent that most 
of these exclusions could be made by simply examining the ‘call reason’ and 
‘clinical summary’ of the electronic record (accessed whilst collecting ‘general 
characteristics’ data). If no possible symptoms of ACS were identified within 
these fields, the call could be excluded. This avoided the need to contact 
patients (who were possibly extremely ill) to request their consent, only to 
ultimately have to exclude the call as it did not relate to symptoms which 
were eligible for inclusion. This approach was adopted in subsequent 
protocols. 
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Conclusions 
1. Given that the specificity of both methods of identifying potential 
participants was equal and that the algorithm method was more sensitive 
than the call reason strategy, the algorithm method was adopted for the 
main study. 
 
2. Call-reasons which suggest that a patient is suicidal should be 
considered criteria for exclusion during future studies. 
 
3. The call reason and clinical summary should be utilised to exclude calls 
where no algorithm was used and no possible symptoms of ACS were 
identified.  
4.3  Content of initial presentations: Methods for main study 
4.3.1 Aim  
To explore the utility of Leventhal’s model of Self Regulation (CS-SRM) as a 
theoretical framework for the study. 
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4.3.2 Research questions. 
1. How do callers verbal presentations to NHS 24 relate to Leventhal’s CS-
SRM? 
 
4.3.3 Method 
Research design 
The study comprised a CS-SRM guided content analysis of recordings of 
calls to NHS 24 combined with a postal survey designed to further pilot and 
validate the specially adapted IPQ-R.   
Setting and participants 
As in the pilot work, NHS 24 provided the setting. Participants comprised 
• those involved in the 2 calls from Pilot Study 1 where all relevant 
parties had given their consent (see page 71)  
and  
a. Are the components of illness perception evident in callers’ accounts 
of their symptoms?  
b. Are there further components evident in presentations unaccounted 
for by the model?  
c.  How do illness perceptions expressed at time of seeking help relate 
to those measured by the IPQ-R up to 14 days later? 
  92 
• those who participated in Pilot Study 2 (see page 80 for details) 
Thus a quota sample of 30 calls was achieved where either the ‘chest pain’ 
algorithm had been used or no algorithm was used as the call was deemed 
‘immediately life-threatening’ and possible symptoms of ACS were identified 
within the call reason or clinical summary 
plus 
another quota sample of 30 calls where either an algorithm other than ‘chest 
pain’ had been used or an algorithm was not used for reasons other than that 
the symptoms were immediately life-threatening were identified.  
Thus data obtained from participants recruited during the pilot studies was 
used in the main study. This has the potential to be problematic as it may not 
be valid to compare data obtained under differing circumstances. However, 
the methods for identifying participants and obtaining transcribed data were 
consistent throughout the respective studies and thus it was considered 
appropriate to utilise the accumulated call transcriptions in the main study. 
 
Inclusion Criteria 
A call had been handled and recorded by NHS 24 
The patient and NHS 24 staff members had given consent for their voice 
recording to be used for the purposes of the study. (If the patient had died, 
the next of kin had given their consent for the recording to be used). Any third 
party had not declined consent. 
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Exclusion Criteria 
Any calls involving children aged 16 or under. 
Any calls where the call-reason stated that the patient was suicidal or where 
the clinical summary revealed that this was the case. 
Procedures 
The transcriptions generated in Pilot Studies 1 and 2 provided the data for 
this study (see page 81 for details of how the transcriptions were obtained). 
These were imported into N-VIVO 7©, a software package designed to assist 
with the management and analysis of qualitative data.  
Each transcript began with a call handler’s opening statement, usually in the 
form of an open question. An example from the transcript data being  
“Hi you are through to [call handler’s name], one of the call handlers. 
Can you tell me briefly why you are calling?”. 
Participants’ responses to this first open question (and if applicable to any 
subsequent non-directive prompts e.g. “yes?”, “uh-huh”) were identified for 
analysis. These responses were considered of particular interest as the 
content was determined freely by participants and not prompted by NHS 24 
staff questions. Thus it was considered that these data reflected how people 
articulate their reasons for seeking medical help in the context of a real-life 
health threat without any clinician or researcher contamination (Webb et al.  
1999).   
The responses identified for analysis were then divided into distinct thoughts 
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in common with the method described by Lau and colleagues (Lau et al.  
1989). Distinct thoughts constituted either whole sentences or portions of 
sentences where individual thoughts were delimited by pauses, commas, 
‘but’ or hesitations. These constituted the coding units and each unit was 
annotated with a unique identifying number to facilitate later inter-rater 
reliability checks (inter-rater reliability is discussed further on page 112).  
Each coding unit was then coded in relation to the components of illness 
representation by the author. Definitions provided by Howard Leventhal and 
colleagues in a recent publication were used to code identity, timeline, cause 
consequences, and cure/control (Leventhal et al.  2007).  Definitions of 
coherence and emotional representations was obtained from the paper 
describing the IPQ-R (Moss-Morris et al.  2002). A residual ‘other’ category 
was used to code units which did not relate to any of the pre-defined codes 
relating to CS-SRM.  The definitions used are summarised in Figure 5, 
below. 
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Figure 5: Definitions of CS-SRM constructs 
 
Identity 
 
Refers to the category, name or label, and the experience of 
symptoms, changes in function and visible signs. The 
combination of abstract and concrete experiential features 
‘define’ or identify the disease. 
 
Timeline The duration that is expected and/or perceived with respect to 
the onset and duration of an illness both with and without 
effective treatment. 
Time-lines are represented abstractly as clock and calendar 
time and concretely as experienced or felt time. 
 
Cause  
 
Reflects the perception of the single or complex set of events 
that are perceived responsible for disease onset. 
 
Consequences 
 
The set of expected and perceived physical/functional, 
personal and social and economic factors that are impacted 
by the illness. 
 
Cure/control 
 
Refers to the expectation that a specific disease can be cured 
or controlled by the body’s own defences and/or in 
conjunction with expert intervention, and the actual 
experience of the effects of these interventions on specific 
features (symptoms and/or test results) of disease. 
 
Coherence Whether or not people understand or have a clear picture of 
their illness. 
 
Emotion An emotional representation generated by the illness. 
 
 
In order to evaluate the reliability of coding, the responses of a random 
sample of 30 participants were coded independently by Liz Glidewell, a 
colleague familiar with CS-SRM from the University of Aberdeen. Thus for 
each of the coding units generated by these 30 participants, the 2 
independent ratings for the presence or absence of each construct were 
compared. 
Analysis 
The frequency of occurrence of each component within the coding units was 
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calculated. 
Similarly, the frequency of occurrence of each component within individual 
participants was calculated.   
Krippendorff’s alpha was used to assess the degree of inter-rater reliability 
(Krippendorff, 2004; Hayes and Krippendorff, 2007).    
 
4.4 Ethical issues 
The following section outlines the ethical issues relating to the study 
described. The process of ethical review undertaken in relation to Pilot Study 
1 is described first. This is followed by a discussion of the additional ethical 
issues associated with the revised method of approach and the subsequent 
additional ethical review required. 
4.4.1 Process of ethical review – Pilot study 1. 
The study was conducted amongst NHS patients and staff in an NHS 
organisation. The Research Governance Framework for Health and Social 
Care published in 2001 specified that  all research involving patients, service 
users, care professionals or their data should be reviewed independently to 
ensure it met ethical standards (Department of Health, 2001). 
In line with local guidelines, an application was first made to the 
Departmental Research Ethics Committee (REC) in the Department of 
Nursing & Midwifery, University of Stirling on 18th October 2004. This 
provided an opportunity to receive feedback on the 
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submission to the Central Office for Research Ethics Committees (COREC). 
The submission was approved. In addition the proposal was discussed with 
patient representatives at a Local Health Council (LHC). They kindly read 
and discussed the proposal and the patient information. Feedback from the 
LHC and departmental REC was incorporated into the proposal which was 
then submitted to COREC.  Advice was sought prior to submission about 
whether it should be considered by a Local (LREC) or Main (MREC) 
Research Ethics Committee as it was not clear which was most appropriate. 
Access to records was taking place in one location (NHS 24, South 
Queensferry). However, the data being accessed was stored electronically 
on computer servers in 3 separate locations (Aberdeen, South Queensferry 
and Clydebank). The patients to whom the data pertained could be located 
anywhere in Scotland. In view of the complexities it was advised that 
submission to a MREC would be most appropriate and the submission was 
referred to Fife and Forth Valley MREC. A number of ethical issues 
associated with the study were highlighted to the committee, along with the 
proposed measures for addressing them. These are discussed below.   
Potential for distress to patients / relatives at a difficult time 
It was recognised that the sampling strategy risked contacting people who 
were very ill or who may even have died. The invitation letter and information 
sheets were carefully worded with these particular groups in mind. However, 
at the same time it was also considered necessary to avoid causing alarm to 
the majority of participants, who were likely to have called regarding only 
minor symptoms. 
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Approaching participants who may no longer be alive 
The approach to patients who might no longer be alive was particularly 
problematic but considered necessary as this group were important. The 
inclusion of transcripts from people who may have recently died was 
important for a number of reasons which are discussed below. Although 
there was the potential to cause distress to some families, it was argued that 
this was outweighed by the potential gains from improved understanding of 
this group of patients.  However, given the difficulties associated with 
approaching this group, options to exclude them were considered. This would 
have necessitated making enquiries as to the status of all potential 
participants. This raised serious ethical issues around the probity of seeking 
to acquire such confidential information about patients prior to obtaining their 
consent. Even if it were possible to obtain this information it was recognised it 
was only reliable at that time. A letter could be posted to an apparently well 
individual who might subsequently die before the letter arrives. The 
practicalities of excluding these patients were therefore problematic. 
Furthermore, from a methodological point of view, it was considered 
important to at least offer the opportunity for relatives of recently deceased 
patients to participate. Patients who die soon after symptom onset have 
tended to be excluded from previous research because research has largely 
relied upon retrospective methodologies which identify people once they 
have received a diagnosis of MI and asks people to recall events. It was 
hoped that the approach taken in this study would allow the recordings of 
peoples’ actual words at the time of seeking help to be utilised.  
In actual fact, 2 patients were identified in Stage 1 as having died subsequent 
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to their call. However, next-of-kin were not available to provide consent in 
either case. Consequently, no data about this group was collected. It is 
recognised that even if next-of-kin were available it would be extremely 
difficult to broach such a subject with them so soon after the death of their 
relative, especially given the lack of any personal relationship. However, 
knowledge of these poorest outcomes would still be extremely useful. It 
would appear feasible to design alternative methodologies specifically 
designed to explore further the experiences of this group. This is considered 
worthy of further exploration. 
Approach adopted 
Within this study, it was considered that the most appropriate way to proceed 
was to send letters of invitation to all potential participants and to word this 
sensitively in the knowledge that perhaps a small number would reach 
recently bereaved relatives. Within this information it was made very clear 
that there was no necessity to take part.  The acceptability of this was 
assessed in this relatively small group and informed the larger scale survey 
undertaken in the study relating to the timing of presentations. It was also 
identified at the time that it was possible that some relatives might actually 
take some comfort from participating in research which aimed to better 
understand the experiences of people in a similar situation to that of the 
deceased.  
Informed consent 
In recognition of individuals rights to voluntarily participate in research and to 
freely consent or decline for their information to be used it was essential that 
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all participants gave their informed consent.  However, the context of the 
study meant there were a number of complexities around this subject. NHS 
24 medical records (of which the voice-recording forms a part) pertained to 
the patient so undoubtedly their consent was required. However the voice 
and words which were being analysed often belonged to someone else, a 
third party who called on behalf of the patient. Where possible it was 
considered desirable to obtain the consent of the third party as well as that of 
the patient. However, there were specific circumstances where it was clear 
this would not be possible. Where someone called on behalf of the patient, a 
record was created for the patient (not the caller).  Contact details of the 
caller were not routinely collected (only the telephone number they were 
calling from (not necessarily their own number), their name and their 
relationship to the patient (e.g. spouse/carer). Where a stranger or carer 
called on behalf of the patient it was not always possible for the patient to 
contact the relevant person.  
It was undesirable to exclude all patients who did not call on their own behalf 
as it would bias the results. Instead it was proposed that where a decision 
about consent could not be obtained from the third party, that the callers 
words would be transcribed and analysed anonymously. However, the 
difficulties with the implementation of the welcome message discussed 
earlier (see page 68) meant that this too had to be revisited. As callers were 
not being automatically informed at the beginning of their call that their data 
might be used in research, it was not considered ethical to use their data 
without explicit consent. Therefore, ethical approval was obtained to adjust 
the protocol such that only calls where all parties
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accessed.  
Researcher’s role 
Another issue that was identified was the position of the chief investigator as 
a member of staff within NHS 24. This raised the possibility that misconduct 
on their behalf might be easily disguised. The following structures were put in 
place to ensure the protocol was adhered to and that the investigator’s 
conduct was subject to scrutiny. 
Prior to receipt of consent, patients’ details were accessed in a limited way 
only, and in the presence of another member of clinical staff. This was to 
ensure that no personal data about patients were recorded or stored at this 
stage. (It was necessary to access records at this point in order to obtain the 
name and address for invitation correspondence and to record anonymous 
characteristics of all those invited as discussed on page 66.) 
Once consent had been obtained from the appropriate parties, records were 
accessed only for the purposes outlined in the protocol and it was recorded 
when this took place (all records were electronically ‘foot printed’ and so it is 
documented whenever anyone accesses a patient record). No further contact 
was made with patients after the initial letter. 
The process of identifying the sample and selecting a random sample was 
documented and is available for audit and scrutiny. 10% of transcriptions 
were randomly selected by Carol Bugge (supervisor) on the 5th April 2006 
and the relevant calls accessed to check transcription accuracy and thus 
confirm authenticity and accuracy. 
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Furthermore, as a Registered General Nurse with expertise in the area of 
clinical practice being observed, it was identified that a professional conflict of 
interest could arise in the unlikely event that serious misconduct by NHS 24 
staff was observed during the course of the research. The actions the author 
would take might be different from those that would normally be taken by a 
researcher observing practice. The professional guidance issued by the 
Nursing and Midwifery Council (Nursing & Midwifery Council, 2004) states 
that 
“As a registered nurse…you must act quickly to protect patients and clients 
from risk if you have good reason to believe that you or a colleague, from 
your own or another profession, may not be fit to practise for reasons of 
conduct, health or competence.” 
This was understood to mean that the investigator was duty-bound to take 
action in circumstances where they observed an act or omission that put a 
patient at risk. It was therefore documented in the protocol that if such an 
issue was discovered that the investigator would find and note the name of 
the member of staff and bring it to the attention of their line manager. This 
process was agreed with Gill Stillie (Associate Director of Nursing NHS 24) 
and NHS 24 staff partnership forum (staff representatives). The monitoring of 
calls was routine practice within NHS 24 and staff were familiar with this type 
of surveillance therefore it was not anticipated that this would cause a 
difficulty. However, as discussed on page 74, feedback from staff during the 
pilot of the recruitment process suggested some may have been uneasy 
about the potential implications of this additional scrutiny.  Revisions were 
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made to the protocol and it was re-submitted for ethical approval on 16th 
August 2005. The additional ethical issues associated with the resubmission 
are discussed on page 104.  
Data handling 
The research involved access to confidential patient information and it was 
therefore essential that steps were taken to ensure these data were 
protected. It was also vital that data from the study were safely stored and 
made available for external scrutiny (Department of Health, 2001). 
Voice recordings remained within secure storage at NHS 24. Calls were only 
accessed in order to transcribe. Personal identifiable information was stored 
separately from the transcripts and questionnaires. These were linked by a 
unique study identification number. Transcripts were stored on a lap-top 
computer until transferred to a secure hard drive in Stirling University where 
they were backed-up. All electronic data was password protected. Only the 
supervisory team (Dr Carol Bugge and Prof Marie Johnston) and the 
investigator had access.  
Voice recordings are routinely stored on tape within NHS 24 for 10 years. 
Data from the research was stored in a locked filing cabinet for the duration 
of the study and will be archived within the University. A permanent member 
of University staff will act as custodian. 
Outcome of ethical review 
The issues above were considered by Fife and Forth Valley REC at a 
meeting on 7th December 2004.  The written response from the committee 
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gave a favourable ethical opinion subject to some minor alterations. Formal 
management approval was granted by NHS 24 on 22nd February 2005 and 
recruitment commenced for pilot work on 5th May 2004.  
 
4.4.2 Additional ethical issues- Pilot Study 2 and main study  
The revisions required following Pilot Study 1 meant that resubmission for 
ethical approval was necessary. Ethical review was again performed by Fife 
and Forth Valley MREC on 6th September 2005 and approval given on 2nd 
November 2005. The delay was incurred due the committee having some 
concerns re the processes for obtaining consent and the action to be taken in 
the event of staff misconduct which required further discussion at a second 
meeting.  An administrative mix-up resulted in the application not being 
considered at the meeting planned and instead being delayed until the 
following meeting.  
The ethical issues identified were similar to the initial submission but with the 
following key differences.  
Opt-out invitation process 
The revised process required that those who did not want to receive a 
telephone call of invitation were required to take action rather than those who 
wished to take part. It was made easy for those who did not wish to receive 
this call to decline by either postcard or telephone. However, the remainder 
would receive a phone call of invitation which offered them the opportunity to 
ask questions, discuss the research or highlight difficulties with participation 
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(e.g. with eyesight). Thus, it was considered this enhanced the informed 
consent process. It was also emphasised to the committee that it was not 
assumed that those who did not decline, wished to take part. This would be 
established during the telephone call once it had been confirmed that the 
patient had read and understood the information.  As before, patients’ 
records would only be accessed with their full and informed consent. 
Informed consent 
The revised process involved inviting potential participants by telephone. 
Thus consent was obtained verbally rather than in writing. In order to ensure 
a record of consent was obtained, the phone calls were conducted at NHS 24 
where the technology existed to easily record calls and later access them via 
a secure web-application (patients were informed that the calls were 
recorded). It was also highlighted that this method had the additional 
advantage of making the process of obtaining consent available for external 
scrutiny. This is something which would be unavailable in most situations and 
was considered to further enhance the rigour of the consent process.  
Researcher’s role. 
The role of the chief investigator was explicitly stated to be primarily that of 
researcher, and not clinician.  In order to make staff feel safe to participate, 
absolute confidentiality for staff was assured and they were reassured that no 
action would be taken as a result of their taking part in this research.  It was 
emphasised that other mechanisms exist within NHS 24 to ensure the quality 
of consultations and that it was not within the remit of this study to perform 
that function.  
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Data handling 
Telephone interviews were recorded digitally utilising existing technology for 
call recording within NHS 24. These were ‘tagged’ to the chief investigator to 
facilitate easy identification.  
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Chapter 5. Content of initial presentations: Results  
5.1 Introduction 
The following chapter begins by reporting rates of participation and 
assessment for non-responder bias. The characteristics of the sample are 
then described.  
The results of the CS-SRM guided analysis of all the coding units derived 
from the transcription excerpts are then reported, in particular describing the 
content of coding units which could not be coded to a component of illness 
representation. 
Next, the content of illness representations expressed within the initial 
presentations of individual participants are described.  Participant quotations 
are provided to facilitate scrutiny of how coding was applied. 
Then, amongst participants for whom both IPQ-R data and a coded 
transcription are available, a comparison of the two assessments of illness 
representation is reported. The coding units of participants scoring above and 
below the mean for each subscale were compared. Implications of the results 
are then discussed. 
5.2 Participation 
Overall, during the two pilot studies already described, 315 patients were 
invited to participate.  Of these, 93 (29.5%) consented to participate in some 
way with 64 (20%) giving consent for the recording of their call to be 
transcribed (others participated by completing the IPQ-R but did not wish the 
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recordings of their call to be accessed). The first 60 to be transcribed 
constituted the quota sample. For clarity, only those whose calls were 
transcribed are referred to as participants in the following chapter. 
5.3 Participants compared with non-participants 
In order to assess if participants differed in significant ways from non-
participants, tests for difference across a number of key variables were 
conducted. The results are reported below and summarised in Table 4, 
below. 
5.3.1 Demographics 
No significant difference in age was identified between participants (mean 
age=50 years, SD=17.1) and non-participants (mean=55 years, SD=21.0;  
p=0.107).  
More women (n=191) than men (n=124) were identified by random selection, 
reflecting the pattern observed overall in NHS 24, where approximately 60% 
of calls received relate to female patients (see Appendix 25). The proportion 
of women who agreed to participate was 19% (n=37) compared with 18% 
(n=22) of men. The difference was not statistically significant (χ2 (df=1) = 
0.131, p = 0.717).  
Participants with higher DEPCAT classification (i.e. living in more deprived 
areas) were less likely to participate than those with lower DEPCAT 
classifications (F (6, 306) =2.641, p=.008). 
  109 
Table 4: Comparison of participants and non-participants 
  Participants Non-participants Difference   
p -
value 
  n=59 n=256 (95% C.I)   
 
Mean (SD) 
 
 
Age in years 50.54 (17.00) 54.74 (21.05) (-0.91,  9.30) 0.107 
No of previous calls  4.00 ( 5.12) 7.84 (51.20) (-9.30, 16.99) 0.566 
 
   
 
n (%) df  
Male gender 22 (37%) 102 (40%) 1 0.717 
Documented history CHD  11 (18%) 47 (19%) 1 0.999 
Emergency response 21 (36%) 88 (34%) 1 0.859 
Caller involved 16 (27%) 161 (63%) 1 <0.001* 
  
   
  
F df p 
DEPCAT score   2.978 6, 306 0.008* 
 
 
 
5.3.2 Clinical characteristics 
There were no significant differences between participants and non-
participants in either their number of previous calls to NHS 24 (t=0.575, 
p=0.566); whether or not they had a history of CHD documented within NHS 
24 (χ2 (df=1) = 0, p = 0.999) or whether or not the nurse treated them as an 
emergency (χ2 (df=1) = 0.031, p = 0.859). 
However, patients for whom the original call to NHS 24 was made by 
someone other than themselves were significantly less likely to participate 
than patients who called themselves (χ2 (df=1) = 25.63, p <0.001).  
 
5.4  Characteristics of the sample 
The mean age of participants was 55 years (SD 21.05). People with a range 
of socio-economic classifications participated in the study (see Figure 6).  
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Figure 6: Participants’ DEPCAT classification  
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In terms of their previous use of the service, 95% (n=61) of participants had 
called 12 times or less, for 32% (n=19) it was their first call (see Figure 7). 
Just under a fifth (19%) of participants had a documented previous history of 
CHD. Calls with a range of outcomes were represented (see Figure 8). In 
70% of cases (n=45) the participant called on their own behalf. However, in 
the remaining 30% of cases (n=19) someone else called NHS 24 on behalf of 
the patient. 
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Figure 7: Number of previous calls to NHS 24 
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Figure 8: Outcome of participants’ calls 
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5.5 Illness representations during initial presentation of 
symptoms 
One transcription was excluded from the analysis as the initial question by 
the call handler was not an open question. Thus 59 transcriptions were 
analysed. 
The excerpts from the 59 eligible transcriptions contained between 1 and 13 
individual coding units, (mean = 3.89, SD=2.78). Thus a total of 230 coding 
units were available for coding. Overall, 202 (88%) of coding units were 
coded to at least one component of illness representation.  
Analysis of the 230 coding units and of the 59 participants was undertaken 
and is reported below. However, before presenting these results, data 
relating to the reliability of coding is provided.  
5.5.1 Reliability of coding 
Coding was performed by the author. Additional coding of 50% (n=30) cases 
was performed by a colleague who was unconnected with the project but 
familiar with CS-SRM. The 30 cases yielded 109 coding units which were 
coded independently by the two coders. Krippendorff’s alpha (α) was used to 
assess inter-rater reliability. Results are summarised in Table 5, below. 
Adequate reliability (α ≥ 0.7) was achieved for all constructs with the 
exception of coherence. The results reported are based only on the authors 
original coding.  
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Table 5: Inter-rater reliability 
  No of units 
Krippendorff's 
alpha 95% C.I 
Identity 109 0.865 (0.770, 0.962) 
Timeline 109 0.865 (0.730, 0.973) 
Cause 109 0.696 (0.392, 0.924) 
Consequences 109 0.791 (0.478, 1.000) 
Cure/control 109 0.840 (0.707, 0.946) 
Coherence 109 0.593 (0.186, 0.919) 
Emotion 109 1.000 (0.000, 1.000) 
Other 109 0.809 (0.555, 1.000) 
 
5.5.2 Components of illness representation within all 230 coding 
units 
Identity was by far the most frequently coded component with 131 (56%) 
coding units containing references to the experience of symptoms, visible 
signs or labels. There were 48 (21%) coding units containing reference to 
timeline. Ten (4%) coding units contained references to possible causes of 
the symptoms. Participants expressed possible consequences of their 
symptoms in 9 coding units (4%). References to cure/control were identified 
within 46 (20%) coding units. Thirteen (6%) coding units contained 
expressions of the degree of coherence the participant was experiencing. 
Emotional responses to the symptoms were expressed in 8 (3%) coding 
units. There were 28 (12%) coding units which could not be allocated to any 
of the pre-defined codes.  
Inductive analysis of the units which could not be allocated to the CS-SRM 
codes revealed that most (n=16) consisted of a statement in which 
participants introduced either themselves or the person they were calling 
about, for example: 
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“Good evening, my name is XXXXX XXXXXXXXX” (Coding unit 
4060-1)  
 “Hi there. Its em..it’s actually my grandfather.” (Coding unit 1050-1) 
A further 7 coding units composed of odd words or phrases, usually 
hesitations within the dialogue, for example:  
“And it was em,.. “ (Coding unit 4020-2) 
“I’ll tell you what it is.” (Coding unit 5033-1) 
A further 4 coding units appeared to relate to the context in which the 
symptoms were occurring: 
“I’ve just come in and my Mum has just phoned me.” (Coding unit 
4055-3) 
 “She is just sitting beside me just now.” (Coding unit 4068-2) 
“She lives on her own, right.” (Coding unit 5014-4) 
“and its closed [diabetic unit] and I can’t get in touch with someone.” 
(Coding unit 5031-2) 
One coding unit composed of a statement in which the participant appeared 
to compare the patient’s situation with previous episodes:  
“I’ve never seen him as bad as this.” (Coding unit 4075-4) 
This statement is entirely consistent with the hypothesis of the CS-SRM that 
people develop representations based upon their previous experience of 
illness but could not be allocated to any of the definitions of the components 
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of illness representation. 
 
5.5.3 Illness representations expressed by individual participants 
The responses relating to individual participants were analysed and reported 
below. Each participant volunteered between 1 and 6 components of illness 
representation at least once within their initial response to the open question 
relating to the reason for their call (mean = 2.24, SD = 1.18) (see Figure 9).  
Figure 9: Number CS-SRM components volunteered at least once by participants 
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Figure 10, below, illustrates the number of participants who made reference 
to each component of illness representation. All 59 (100%) participants made 
reference to identity within their response. The second most commonly 
identified component was timeline with 26 (44%) participants referring to this. 
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Cause was referred to by 9 (15%) of participants. Consequences were 
referred to by 8 (14%) of participants. References to cure/control were made 
by 22 (37%) participants. References to the degree of coherence were made 
by 11 (19%) participants and an emotional response to the symptoms was 
evident for 6 (10%) participants. 
 
Figure 10: Components of illness representation volunteered by participants 
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Identity 
All 59 (100%) participants made reference to identity within their response. 
Most (n=44) described their experience of symptoms. Some examples are: 
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“I’ve been getting pains across my chest”. (Participant 4009) 
“He is having trouble with his breathing something, you know” 
(Participant 4019) 
“Yeah. I’ve eh I’ve got a bad head” (Participant 4012) 
“..and eh I feel sicky with it but I’m no being sick.” (Participant 5017) 
Labels were also mentioned frequently (by n=22 participants), sometimes in 
relation to the current symptoms and sometimes when referring to previous 
or ongoing illnesses:  
 “Yes, I’ve got really bad cystitis.” (Participant 4076) 
“..and he’s also had a chest infection” (Participant 5024) 
“I’m asthmatic and I’ve went doon with this temp” (Participant 4070) 
Visible signs were described by 15 participants (9 of whom were callers), for 
example: 
“em and to be honest er there’s a little bit of blood coming from the 
tear duct.” (Participant 4024) 
“but she is very pale” (Participant 5014) 
Timeline 
Most of the 26 participants who referred to timeline, referred to the duration 
of symptoms, for example:  
“He’s been up the whole night” (Participant 4040) 
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“And it’s been there since over a week, well over a week now” 
(Participant 5017)  
Others indicated that the duration of symptoms was longer than they would 
have expected: 
“I thought it would go away but eh, this morning it seems to be 
worse” (Participant 4027) 
Some indicated precise times of the onset of symptoms: 
“It started actually at 8 o’clock this morning I had shooting pains 
down my left hand” (Participant 4045) 
“Maybe it is nothing but she wakened up with a pain down her left 
arm at 4 o’clock this morning”. (Participant 5014) 
whilst others indicated the duration of symptoms less precisely:  
“em, I had a really bad headache all weekend” (Participant 5027) 
“Em, it’s like the last couple of days I’ve got like, it’s like pins and 
needles” (Participant 5033). 
One participant volunteered that their symptoms were cyclical in nature:  
“..and it seems to come maybe every 4 or 5 weeks” (Participant 
5017) 
Cause 
Few participants (n=9) mentioned cause in their responses as to why they 
were calling. Of those who did, a few clearly articulated possible causes for 
the symptoms: 
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“I’m phoning up em cos I’ve got like a bad inner ear infection, I 
think.”    (Participant 5030) 
“I’m calling because em my husband is experiencing symptoms 
which almost certainly are from his heart” (Participant 5010) 
 “I think it is either a muscle spasm or a trapped nerve in her back?”        
(Participant 5022) 
In some cases it appeared that pre-existing knowledge or experience led 
participants to suspect a particular cause: 
“See as soon as I hear about chest pains I think of course about the 
heart and everything like that, you know.” (Participant 5014). 
In another case, the cause the participant suspected was implied through the 
type of self-care they described having already tried (although clearly this 
also relates to cure/control):  
“I’ve tried to take em stuff for the stomach and I’ve tried to take em 
like rennies and things like that but I don’t, nothing seems to be 
helping.” (Participant 5017) 
In one case, the participant mentioned a possible contributing factor 
(regarding his eye problem) but it was not possible to be sure how much he 
believed this to be the cause of his symptoms: 
“Um, now I have just been going on and off planes all day” 
(Participant 4024) 
Consequences 
Again, few (n=8) participants referred to the likely consequences of their 
symptoms. Where consequences were mentioned they tended to relate to 
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physical functioning:  
“I was in bed and I couldn’t get up to open the doors and that” 
(Participant 4015) 
“She just collapsed on the stairs and cant move”. (Participant 4077) 
“She can’t actually walk forwards”. (Participant 5022) 
Three references to personal and social consequences were identified but 
instances relating to economic consequences were not: 
 “Um I’ve injured my left hand and um unfortunately I am flying out at 
3 o’clock in the morning… ” (Participant 4006) 
“He’s been up the whole night.” (Participant 4040) 
 “I had a really bad headache all weekend, been in bed” (Participant 
5027) 
Cure / control 
Twenty-two participants made reference to cure/control. Some related to the 
request for medical assistance, some stating what they thought was required: 
“Em I was wondering if I could em be seen by a doctor. So I really 
need to see if..I think what I might need is a hand-brace?” 
(Participant 4006) 
“Hello, eh I am looking for a doctor but obviously eh the doctor is not 
in at the moment. I’m looking for the doctor eh she is being sick.” 
(Participant 4037)  
Others sought advice as to what would be an appropriate course of action: 
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“I just wanted to see if I should go to the hospital or not as I have 
just been feeling a wee bit sick.” (Participant 4020)  
 “and I was just wondering if what we can do about it”. (Participant 
4019) 
 “..and I think she’d quite like to get it checked out.” (Participant 
4068) 
A number mentioned attempts they had already made to control the 
symptoms, either during the acute episode: 
“Yeah, em I’ve had a constant headache for 2 days and 
paracetamol is, paracetamol is just not shifting it and my usual 
migraine tablets that I take aren’t shifting it either.” (Participant 5063) 
“And em, she she she got up and made a cup of tea and took two 
paracetamol.” (Participant 5014) 
Or in the past: 
“Well, she has been having blackouts now for oh, about well a year. 
Just blackouts, we’ve been back and forward to hospital but she 
was taken in by ambulance 2 weeks ago and got back. Digoxin was 
low level and we were on double digoxin she was getting. But she’s 
had, just had 4 or 5 since 7, 5 o’clock this afternoon.” (Participant 
5004) 
“I’m on painkillers at the moment for a pain in my lower abdomen 
and em I’ve just waiting for a laparoscopy “ (Participant 5060) 
Others stated current treatments, possibly by way of introducing relevant past 
medical history: 
“Eh, I’m asthmatic and on inhalers as well.” (Participant 4009)  
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“Eh I’ve been taking warfarin for about the past 6 years” (Participant 
4030)  
The examples demonstrate patients describing their ideas about what would 
control symptoms (see Participant 4006), callers describing patients ideas 
about cure/control (see Participant 5014) and callers describing their 
attempts to control the patients symptoms (see Participant 4037). 
Coherence 
A number of participants made statements which suggested that they had a 
clear understanding of their symptoms (the examples have been highlighted 
before as they include ideas about other constructs): 
“I’m calling because em my husband is experiencing symptoms 
which almost certainly are from his heart” (Participant 5010) 
“I’m phoning up em cos I’ve got like a bad inner ear infection, I 
think.”    (Participant 5030) 
However, other participants’ statements suggested less coherence in relation 
to their symptoms as in the example of the following 3 statements from a 
single participant:  
“But she says she wakened up with chest pains at 6 o’clock but we 
don’t know if she has maybe pulled a muscle or if its flu I don’t 
know...   
..maybe it is nothing but she wakened up with a pain down her left 
arm at 4 o’clock this morning... 
..she says her gums have been bleeding but I don’t know if that’s 
anything to do with it.” (Participant 5014) 
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The examples above demonstrate that patients expressed coherence about 
their symptoms and that callers expressed their own level of coherence (see 
Participant 5014). Examples of callers expressing the patient’s level of 
coherence were not identified.  
Emotion 
Emotional responses to symptoms were evident in a small number of 
participants (n=6) responses to the initial open questions. These ranged from 
mild concern to high distress. The following examples demonstrate patients 
expressing emotion about their symptoms and also show that callers 
expressed both their interpretation of the patients’ emotion (see Participant 
4052) and their own (see Participant 4075).  
“I was just a little concerned” (Participant 4024) 
“now what it is, I’m just a wee bit worried” (Participant 5014) 
“She has actually lost a baby before um due to this and obviously 
she is very concerned” (Participant 4068) 
“Obviously he is very anxious because the symptoms appear to be 
similar.” (Participant 4052) 
“I’m extremely worried about him.” (Participant 4075) 
“Em, well he has been in the hospital with em...eh oh dear, oh god  
...angina attack” (Participant 5024) 
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5.6 Comparison of IPQ-R data with initial presentation of 
symptoms 
A total of 46 participants provided IPQ-R during the data collection period 
described in Pilot studies 1 and 2. A coded transcription and IPQ-R data 
were available for 35 participants and thus able to be compared. As this 
further reduced the sample, further tests were conducted to assess whether 
the 35 participants for whom both types of data were available differed 
across key variables from the overall population. 
The results are reported below and summarised in Table 6, below. 
5.6.1 Demographics 
No significant difference in age was identified between participants (mean 
age=50 years, SD=15.7) and non-participants (mean=54 years, SD=21.0; 
p=0.169).  
The proportion of women for whom both types of data were available was 
10% (n=20) compared with 12% (n=15) of men. The difference was not 
statistically significant: χ2 (df=1) = 2.01, p = 0.654.  
Participants with higher DEPCAT classification (i.e. living in more deprived 
areas) were less likely to participate than those with lower DEPCAT 
classifications (F (6, 306) =3.069, p=.006). 
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Table 6: Comparison of participants (both IPQ-R and transcription data) and non-participants 
  Participants Non-participants Difference   
p -
value 
  n=35 n=280 (95% C.I)   
 
Mean (SD) 
 
 
Age in years 50.3 (25.7) 54.4 (20.9) (-1.79, 9.97) 0.169 
No of previous calls  4.3   (5.6) 7.5 (49.0) (-13.13, 19.5) 0.701 
 
   
 
n (%) df  
Male gender 15 (42%) 124 (39%) 1 0.654 
Documented history CHD  8 (23%) 50 (18%) 1 0.498 
Emergency response 12 (34%) 97 (35%) 1 0.967 
Caller involved 9 (26%) 168 (60%) 1 <0.001* 
  
   
  
F df p 
DEPCAT score   3.069 6, 306 0.006* 
 
 
 
5.6.2 Clinical characteristics 
There were no significant differences between participants (for whom both 
types of data were available) and non-participants in either their number of 
previous calls to NHS 24 (t=0.385, p=.701); whether or not they had a history 
of CHD documented within NHS 24 (χ2 (df=1) =0.46, p = 0.498) or whether 
or not the nurse treated them as an emergency (χ2 (df=1) = 0.002, p = 
0.967). 
However, patients for whom the original call to NHS 24 was made by 
someone other than themselves were significantly less likely to provide both 
types of data than patients who called themselves (χ2 (df=1) = 15.25, p 
<0.001).  
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5.6.3 Characteristics of the sample 
The mean age of participants was 50 years (SD 15.67). People with a range 
of socio-economic classifications participated in the study (see Figure 11, 
below).  
  
Figure 11: Participants’ DEPCAT classification 
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In terms of their previous use of the service, participants had called on 
average 4 times, for n=10 (29%) it was their first call. Just under a quarter 
(n= 8, 23%) of participants had a documented previous history of CHD. Calls 
with a range of outcomes were represented (see Figure 12, below). In 74% of 
cases (n=26) the participant called on their own behalf. However, in the 
remaining 26% of cases (n=9) someone else made the call to NHS 24 on 
behalf of the patient. 
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Figure 12: Outcome of participants’ calls 
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The two sources of data (coded transcriptions of initial presentations and 
IPQ-R scores) were compared for each of the components of illness 
representation and are reported below. Some IPQ-Rs were returned 
incomplete and thus the number of eligible questionnaires for each construct 
varied slightly where the number of items completed was inadequate to 
calculate some subscales. 
5.6.4 Identity 
Symptoms were identified within 44 of the 59 participants’ initial 
presentations. An IPQ-R identity score was available for 23 of these 44 
participants.  
The 23 participants identified 26 unique symptoms (e.g. ‘pain’ is a unique 
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symptom, even if participant refers to it twice) within their initial presentations. 
Twenty participants reported 1 symptom and 3 participants reported 2 
symptoms. Of the 26 symptoms, 17 were captured (65%) by the identity 
measure of the IPQ-R. Five symptoms were described in a vague way during 
the initial presentation (e.g. “not feeling well” or “took a turn”) and although 
participants had checked items on the identity scale it was impossible to be 
sure about whether the items checked related to their presentations. One 
symptom (headache) was mentioned by a participant in their presentation but 
not identified on the IPQ-R despite the symptom being listed. A remaining 3 
symptoms were mentioned in presentations but not available on the IPQ-R, 
namely palpitations, being sick and a hurt foot.  
5.6.5 Timeline 
An IPQ-R timeline score and coded transcription were available for a total of 
34 participants. The transcriptions of 17 participants with timeline scores 
greater than the mean (mean=15) (i.e. those who believed their symptoms 
were of more chronic duration) were compared with 16 participants with 
timeline scores lower than the mean (those who believed symptoms were of 
acute nature). The data of the one participant who scored the mean was 
excluded from this analysis. 
Despite their being approximately equal number in both groups (17 and 16), 
significantly fewer participants (n=3) with below-average timeline scores 
made references to timeline within the coded transcripts than participants 
with above-average timeline scores (n=12) (χ2 (df=1) =10.935, p=.001). 
There were also qualitative differences between the two groups. Eight of the 
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12 with above-average timeline scores made reference to timeline in terms of 
durations of days or longer: 
“yeah well I’ve got a chest pain and eh I’ve had it for a few days now 
and I thought it would go away but eh this morning it seems to be 
worse.” (Participant 4027) 
“He has a drink problem and he’s been drinking since Christmas.” 
(Participant 4075) 
“Well, she has been having blackouts now for oh, about well a year. 
Just blackouts, we’ve been back and forward to hospital but she 
was taken in by ambulance 2 weeks ago and got back. Digoxin was 
low level and we were on double digoxin she was getting. But she’s 
had, just had 4 or 5 since 7, 5 o’clock this afternoon. Every day, I’ve 
got them all day to you my dear, she just blacks out and within 10 to 
15 seconds she’s she is all right.” (Participant 5004). 
Whilst all 3 participants with below-average timeline scores referred to 
timelines of less than 24 hours (although Participant 4052 also compared the 
acute episode to one 2 years previous): 
“Well, I took a turn last night.” (Participant 4015) 
 “Eh yes. Em, my partner is em extremely unwell. Has had sickness 
and diarrhoea since em 5 o’clock this morning. Em, made worse by 
the fact that em he had this same problem just before a heart attack 
2 years, a year and a half ago.” (Participant 4052) 
“And have been in pain for the last 4 hours.” (Participant 5061) 
However, 3 of those with above-average timelines also referred to symptoms 
of recent onset although for Participant 5024 this was within the context of an 
ongoing illness of longer duration: 
“It’s been going on for the last 4 hours.” (Participant 4035) 
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“It started actually at 8 o’clock this morning I had shooting pains 
down my left hand” (Participant 4045)  
“Eh well I had my wife up at the hospital last night? Em, she’s been 
sick all night. Em, we seen the doctor last night and eh the doctor 
had said she has got a lung infection. She’s got tablets for it …but 
the thing is...she’s no eh holding her food down at all.” (Participant 
5024) 
Unfortunately, IPQ-R data was not available for the one participant who 
referred to a cyclical pattern in their presentation of symptoms at the time of 
the call. 
 
5.6.6 Cause 
The IPQ-R is designed to collect data regarding participants’ ideas about the 
cause of their symptoms differently from other constructs in the IPQ-R. 
Rather than a scoring responses on a scale, participants are asked to rank in 
order what they consider to be the 3 most likely causes of their symptoms.  
Eight participants suggested possible causes for their symptoms in their 
original call. IPQ-R data relating to cause were available for 5 of these 
participants. These were compared with the possible causes subsequently 
reported on the IPQ-R. In 3 of the 5 cases the most important cause 
identified by the participant on the IPQ-R was identical to the cause 
suggested during their initial presentation (heart, ear infection, sinus 
infection). In one case the participant had suggested the heart as a possible 
cause during their initial presentation but ranked a “bug” as the most likely 
cause on the IPQ-R, with heart attack being second. The remaining 
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participant had mentioned going on and off planes in relation to his 
symptoms, a statement subsequently coded as ‘cause’. However within the 
IPQ-R this participant did not mention plane travel as a possible cause and 
identified being rundown as the most likely cause of his symptoms. 
5.6.7 Consequences 
An IPQ-R consequences score and a coded transcription were available for a 
total of 33 participants. The transcriptions of the 14 participants with 
consequences scores greater than the mean (mean=16) were compared with 
15 participants with consequences scores lower than the mean (the data of 4 
participants who scored the mean were excluded from this analysis). Only 3 
of the 31 participants made reference to consequences during their original 
call. Two participants with above-average consequences scores highlighted 
potentially serious consequences within their original call:  
“She has actually lost a baby before um due to this and obviously 
she is very concerned” (Participant 4068) 
“My Mum is actually, she just collapsed on the stairs and can’t 
move.” (Participant 4077) 
Whilst the only reference to consequences identified amongst those with 
below-average consequences scores related to disruption of travel plans: 
“Um I’ve injured my left hand and um unfortunately I am flying out at 
3 o’clock in the morning…” (Participant 4006). 
5.6.8 Cure / control 
The IPQ-R measured 2 aspects of cure/control – personal control and 
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treatment control. The results for each are reported separately below. 
Personal control 
A personal control score and coded transcription were available for 33 
participants. The transcriptions of the 14 participants with personal control 
scores greater than the mean (mean=18) were compared with 18 participants 
with personal control scores lower than the mean (the data of 1 participant 
who scored the mean was excluded from this analysis). 
Overall, there were few references (n=2) to personal control within the coded 
transcripts (most cure/control references related to treatment, see below). 
One participant with a below-average personal control score made a 
statement which suggested low personal control: 
“Yeah, I had an operation on Thursday and em I need cleaning up.” 
(Participant 5071) 
Similarly, the transcript of a participant with an above average personal-
control score was suggestive of high personal control: 
“He is struggling and I was just wondering if, what we can do about 
it.” (Participant 4019) 
Treatment control 
A treatment control score and coded transcription were available for 32 
participants. The transcriptions of the 19 participants with treatment control 
scores greater than the mean (mean=17) were compared with 10 participants 
with treatment control scores lower than the mean (data for 3 participants 
who scored the mean were excluded from this analysis). One participant with 
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an above-average treatment control score referred to treatment control by 
discussing treatment she had recently commenced. In this case, symptoms 
possibly associated with the treatment appeared to constitute the reason for 
seeking advice: 
“Em, actually I’ve had 2 , 2 different new tablets from my doctor 
yesterday, right dear, cos you see about 3 weeks ago I had a mini-
stroke, right. And a doctor prescribed me tablets, brand new tablets 
yesterday and I started taking them today. I don’t know which ones 
is giving me a terrible headache and palpitations.”  (Participant 
4041) 
Eight participants with below-average treatment control scores made 
statements relating to treatment control. Most (n=5) related to previous 
attempts to control symptoms and all suggested that treatment had been 
inadequate in controlling symptoms (or had led to new symptoms):  
“Eh, went to the chemist yesterday and got a sort of over the 
counter prescription em which hasn’t done any good” (Participant 
4076) 
“We’ve been back and forward to hospital but she was taken in by 
ambulance 2 weeks ago and got back. Digoxin was low level and 
we were on double digoxin she was getting. But she’s had, just had 
4 or 5 [blackouts] since 7, 5 o’clock this afternoon.” (Participant 
5004) 
“Hi, em I’m on painkillers at the moment for a pain in my lower 
abdomen and em I’ve just waiting for a laparoscopy but the 
painkillers I have are em just aren’t helping me” (Participant 5060)  
“Em, we seen the doctor last night and eh the doctor had said she 
has got a lung infection…she’s got tablets for it …but the thing 
is...she’s no eh holding her food down at all.” (Participant 4059) 
Other references related to access to expert intervention: 
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“Em I was wondering if I could em be seen by a doctor” (Participant 
4006).  
“Hello, eh I am looking for a doctor but obviously eh the doctor is not 
in at the moment.” (Participant 4037) 
“I was told if I took a turn like that to get down to A&E “(Participant 
4015) 
People with below-average treatment control scores were significantly more 
likely to mention treatment control during their initial presentation than those 
with above-average scores (χ2 (df=1) =22.737, p<.001). 
5.6.9 Coherence 
An IPQ-R coherence score and coded transcription were available for a total 
of 35 participants. The transcriptions of the 19 participants with coherence 
scores greater than the mean (mean=15) were compared with 15 participants 
with coherence scores less than the mean (data relating to one participant 
who scored the mean was excluded from this analysis).  
None of the participants with above-average coherence scores (i.e. who 
reported a good understanding of the symptoms) made reference to 
coherence within the coded transcripts. However, 6 participants with below-
average coherence scores referred to coherence. In two cases, the 
statements were considered to represent a coherent understanding and were 
therefore inconsistent with the IPQ-R score. However, in both these cases, 
the participants did also express a suggestion of doubt. This is emphasised 
by underlining in the following quotations: 
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“I’m calling because em my husband is experiencing symptoms 
which almost certainly are from his heart” (Participant 5010) 
“I’m phoning up em cos I’ve got like a bad inner ear infection, I 
think.”(Participant 5030) 
The remaining 4 participants made statements that suggested a lack of 
understanding and which were therefore consistent with the IPQ-R score: 
“I don’t know whether it was a heart attack or no.” (Participant 4015) 
“I don’t know which ones is giving me a terrible headache” 
(Participant 4041) 
“Eh, I’m nae actually sure.” (Participant 4073) 
“Em, just  ...well I’ve, I don’t know if I’ve got some kind of infection in 
the sinuses” (Participant 5028) 
Participants with below-average coherence scores were significantly more 
likely to refer to their level of coherence within their initial consultation than 
participants with above-average scores (χ2 (df=1) =9.229, p=.004) 
5.6.10 Emotion  
An IPQ-R emotion score and coded transcription were available for a total of 
33 participants. The transcriptions of the 17 participants with emotion scores 
greater than the mean6 (mean=18) were compared with 16 participants with 
emotion scores less than the mean. 
None of the participants with below-average emotion scores (i.e. who 
                                               
6
 The functionality within N-Vivo that allows participants to be grouped by attributes scores uses 
actual values within those attributes as filters. As no participants scored the mean for this construct, it 
was not possible to select scores above and below 19 and therefore 18 was the cut-off instead. 
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reported lower emotional response to symptoms) made reference to emotion 
within the coded transcripts. However, 5 participants with above-average 
emotion scores were found to have made reference to emotion within the 
coded transcript. References were made to concern, anxiety and worry: 
“She is 4 and a half months pregnant and she has had a nasty fall 
and obviously gotten a bit of a scare. She has actually lost a baby 
before um due to this and obviously she is very concerned” 
(Participant 4068) 
“but I was just a little concerned” (Participant 4024) 
“Obviously he is very anxious because the symptoms appear to be 
similar” (Participant 4052) 
“I’m extremely worried about him.”(Participant 4075) 
“Em, well he has been in the hospital with em...eh oh dear, oh god… 
angina attack …and he’s also had a chest infection, now he’s taken, 
I’m a bit concerned just now” (Participant 5024) 
Participants with above-average emotion scores were significantly more likely 
to mention emotion within their initial presentation than participants with 
below-average emotion scores (χ2 (df=1) =6.261, p=.018). 
5.7 Discussion 
5.7.1 Components of illness representation within initial 
presentations. 
The CS-SRM accounted for a large proportion of the content of participants’ 
presentations to NHS 24. A large proportion (88%) of coding units were 
related to components of illness representation. If coding units where the 
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participant simply introduced themselves (or the patient) were excluded, the 
proportion was even higher (95%).  Thus the model successfully accounts for 
the content of participants initial symptom presentations. 
Most of the remaining 5% coding units which could not be coded to a 
component of illness representation tended to relate to the context in which 
the symptoms occurred (e.g. was the person alone). Within the CS-SRM it is 
identified that social and environmental factors are an important influence on 
illness representations and thus coping procedures. Indeed Leventhal states 
that  
“problem-solving occurs in context” (Leventhal et al.  1998) 
Thus, it may be that people include context as a component when articulating 
their representation of illness to health services. Another possibility is that 
people rehearse the context in order to aid their recall of the events 
surrounding the onset of symptoms (Smith, 1994), i.e. that context is not part 
of the illness representation but rather a cue to recalling illness 
representations.  
The context of the event emerged as an important theme in a qualitative 
study where people who had recently experienced an MI recounted their 
symptoms (Pattenden et al.  2002) confirming ‘context’ as a key element in 
illness representations. Furthermore, previous studies have found contextual 
factors (e.g. whether or not the person was alone [see Participant 5014, page 
114]) to be important, both in relation to pre-hospital decision time for people 
with MI (GISSI, 1995; Dracup and Moser, 1997) and to whether or not an 
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ambulance was called (Ruston, 2001). The relevance of context in the 
elaboration and recollection of illness representations is therefore considered 
worthy of further exploration.  
Participants were not comprehensive in their expression of the various 
components of illness representation within their initial presentations. 
Eighteen participants (30%) referred only to identity and a further 15 (25%) to 
only 2 components (one of which was identity as all participants referred to 
identity). Thus 55% of the sample referred to 1 or 2 components of illness 
representation. Less than a quarter of participants referred to each of the 
components: cause, consequences, coherence and emotion.  
The results of this study are compared with those of previous work relating to 
the prevalence of the components of illness representation within peoples’ 
descriptions of illness in Table 7, below. Two studies by Lau and colleagues 
inspired the methodology for the current investigation (Lau and Hartman, 
1983; Lau et al.  1989). The authors asked participants, on a number of 
occasions, to describe everything they remembered about a recent illness. 
The results they obtained on first administration are presented for 
comparison.  
Table 7: Prevalence of components of illness representation. Comparison with Lau, Bernard & 
Hartman (1989) 
 Lau et al (1989)  Current study 
Identity 96% 100% 
Timeline 49% 44% 
Cause 28% 15% 
Consequences 33% 14% 
Cure control 32% 37% 
Coherence ~  19% 
Emotion  ~  10% 
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It can be seen that similar proportions of participants referred to identity and 
timeline. However, a much smaller percentage of participants in the current 
study made reference to both consequences and cause than in the study by 
Lau and colleagues. Results regarding cure/control were similar in the two 
studies whilst coherence and emotion were not reported by Lau and 
colleagues.  
The difference in prevalence of consequence and cause statements may be 
related to the difference in context and methodology. Participants recalling a 
previous, resolved illness may be more likely to consider aspects such as 
consequences and cause than those experiencing current symptoms. 
Alternatively it might be the case that people are particularly reluctant to 
reveal their ideas about cause or consequence to health services. This could 
be through fear of appearing ignorant (Weinman and Petrie, 1997) or 
because they believe that it is the role of health professionals to establish 
such matters (Participant 4040). It might also be that people present what 
they consider is expected when they call to seek medical advice (e.g. social 
and economic consequences were referred to less frequently than physical 
or functional consequences). Leventhal has suggested that the way 
healthcare is organised and delivered can influence illness representations 
(Leventhal et al.  1991). Thus it is plausible that the procedure of presenting 
symptoms to health services is “socially defined” and that experience (direct 
or vicarious) of previous consultations with health services influences the 
illness representations people present on subsequent occasions. 
Furthermore, people in the process of seeking medical help may be more 
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likely to be seeking information about the cause of their symptoms and 
possible consequences rather than supplying them (Wong and Weiner, 
1981).   
However, it must also be borne in mind that only participants’ responses to 
the initial open question constituted the subject of this analysis. Whilst this 
data is particularly valuable as it is largely uncontaminated by either the 
researcher’s or professionals’ questions, it represents a small proportion of 
the overall clinical presentation. It is possible that participants may be more 
likely to discuss their ideas about cause and consequences later in the 
consultation. Analysis of the remainder of the transcripts is required (and 
indeed planned) in order to establish if this is the case.  
The transcriptions of participants’ initial presentations included 16 where a 
caller made the call on behalf of the patient.  Thus the current study has 
demonstrated that those calling for medical help on behalf of others also 
present the same components of illness representation. Interestingly, callers 
presented either their perception of the patient’s illness representation (e.g. 
“Obviously he is very anxious because the symptoms appear to be similar”, 
Participant 4052) or their own representation of the patient’s illness (e.g. “I’m 
extremely worried about him” Participant 4075). The relationships between 
these perspectives are important to investigate further. Previous authors 
have highlighted the lack of research amongst significant others and their 
role in medical consultations (Roter, 2003). Specifically, in relation to patient 
decision time in ACS, the evidence relating to the influence of others is 
sparse and results are mixed (see page 38).  Previous work has identified 
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that the degree of concordance between spouses illness representations was 
related to recovery after MI (Figueiras and Weinman, 2003).  
Good inter-rater reliability was achieved for all constructs except coherence. 
It is considered that this may reflect a degree of ambiguity surrounding this 
construct. The definitions used were obtained from the IPQ-R (Moss-Morris 
et al.  2002) and measured the degree to which an individual’s illness (or 
symptoms) make(s) sense to them. However, coherence has also been 
characterised as the degree to which the other components of illness 
representation ‘hang together’ to form a logical model of illness (Leventhal et 
al. 1992; Leventhal et al. 2005). This ambiguity may have been reflected in 
the raters’ coding. Furthermore, there were differences between raters as to 
whether or not they coded statements suggesting a lack of coherence as 
coherence. It is considered further refinement of coding rules would likely 
overcome these difficulties and improve inter-rater reliability. 
 
 
5.7.2 Illness representations: Initial presentations compared with 
IPQ-R 
The relationship between illness representations expressed at the time of 
seeking help and the associated IPQ-R measure differed amongst the 
components. The patterns observed in relation to each component of illness 
representation are discussed below.  
Identity  
Most (65%) symptoms mentioned by participants during their initial 
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presentations to NHS 24 were captured accurately by the identity measure of 
the IPQ-R administered up to 14 days later. However, the measure failed to 
capture 4 symptoms, relating to 3 participants which is clearly of concern. 
Two of these symptoms, namely “being sick” and “palpitations” could be 
associated with ACS and so are considered important to include in future 
versions of the IPQ-R (i.e. in the second stage). For 2 participants this meant 
that the IPQ-R failed to capture any of the symptoms they reported during 
their call ((i) a hurt foot (ii) headache and palpitations). The symptom of 
‘headache’ in fact appeared as an option on the identity scale. This suggests 
that occasionally participants may experience difficulty in recalling the 
symptoms they associated with their call to NHS 24 or that their 
representations may change in the period between their call and 
administration of the questionnaire (which was up to 10 days later). 
The wide variety of language used by participants to describe symptoms in 
contrast to the limited options on the IPQ-R meant it was often difficult to 
compare the two measures of identity. This was particularly problematic 
where people used vague descriptions of their illness statements such as 
“not feeling well”. Such statements could relate to a number of symptoms 
subsequently identified by participants on the IPQ-R (e.g. nausea) but were 
too ambiguous to be confidently considered consistent. However, that 
participants who had not identified specific symptoms during their initial 
presentations to NHS 24 were subsequently able to identify symptoms that 
they associated with their call on the IPQ-R suggests that for some the list 
format may be useful in helping them to articulate their illness 
representations.   
  143 
Timeline 
Participants who reported longer timelines on the IPQ-R were significantly 
more likely to have made reference to timeline during their initial consultation. 
This is consistent with the hypothesis that duration is a heuristic used by 
individuals to evaluate somatic change (Leventhal et al.  2007). Previous 
work has found that increased duration of symptoms is related to a greater 
likelihood that older people will seek care for symptoms (Mora et al.  2002). 
Participants in the current study were more likely to present information about 
symptoms of longer duration than short during their initial presentations. This 
provides further evidence that the duration of symptoms is an important 
factor for individuals which is obviously of particular concern in the context of 
ACS.  
IPQ-R reports of timeline were generally consistent with what people said at 
the time of their call. The few participants with below-average timeline 
scores, who made reference to timeline during their presentations, all 
presented symptoms of less than 24 hour duration. Similarly, most of those 
with above-average timeline scores reported timelines of days or longer 
durations. However, there were 2 participants who reported a chronic 
timeline on the IPQ-R but presented acute symptoms during their initial 
presentation.  
The tendency for people not to present information regarding shorter 
timelines has important implications. The symptoms of ACS become 
potentially life-threatening immediately following onset and the aim is for 
people to seek help within an hour of onset.  The current data appear to 
suggest that the heuristic relating to duration operates over much longer time 
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periods - people made reference to timelines of > 24 hours early in their 
presentations to health services but mentioned shorter durations less often. 
This may be an important element to highlight in interventions aimed at 
reducing delay. It might be useful to provide precise information about the 
durations that health professionals consider delay in the context of ACS as 
these may be at variance with the time frames people would ordinarily 
consider cause for concern.  
The tendency for people not to volunteer information about acute timelines 
has implications for health professionals involved in evaluating symptoms, 
particularly the symptoms of ACS. These data emphasise the key importance 
of questioning regarding the onset of symptoms as this information may not 
always be volunteered. In addition these results suggest that clinicians 
should be alert to the tendency for patients to present chronic timelines. 
Patient emphasis on symptoms of long duration could lead to clinicians failing 
to identify salient, acute symptoms and thus potentially adversely affect their 
clinical judgement.  
In terms of methodology, the examples where participants reported chronic 
timeline on the IPQ-R although they had presented acute symptoms 
demonstrate that some caution is required in interpreting the results of a 
retrospective report of timeline – patient reports may not accurately describe 
the content of presentations. 
Cause 
As already discussed, few participants made reference to cause during their 
initial presentations and thus there were only a small number of cases (n=5) 
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where IPQ-R reports could be compared. Most participants were consistent 
between the two reports. The example, where Participant 4024 mentioned 
“going on and off planes all day” but did not report this as a possible cause 
on the IPQ-R, illustrated another difficulty in comparing the two sources of 
data. The example may constitute further evidence that participants find it 
hard to recall their illness representations or that change over time affects 
retrospective accounts. However, it is also possible that this participant did 
not consider his plane travel as a possible cause and referred to it for another 
reason (possibly providing context as discussed earlier). There are inherent 
difficulties in trying to interpret what people think from what they say (Halldén 
et al.  2007). This is particularly true in the context of the current study where 
there was no opportunity to clarify interpretations with participants. A 
methodology where participants are given the opportunity to review the 
recording of their own call might help to overcome this difficulty and provide 
additional opportunities to elaborate people’s representations at the time of 
seeking help. However, it is recognised there might be a number of practical 
and ethical difficulties associated with such a method.  
Consequences 
There were few references to consequences within the coded transcriptions 
and it is therefore difficult to draw firm conclusions about their relationship to 
participants’ IPQ-R scores. However, both participants who identified 
potential serious consequences during their initial presentations did report 
above-average consequences scores, providing some support for the validity 
of the measure.  
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It is important to observe that a large proportion of participants who later 
reported that they believed their symptoms to have severe consequences did 
not share those beliefs with NHS 24 staff when presenting their symptoms 
(only 2 of 15 participants with above average consequences scores on IPQ-R 
mentioned possible consequences when presenting their symptoms). This 
would appear to have important clinical implications, particularly in the 
context of a telephone triage situation. Information that an individual believes 
their symptoms to have serious consequences might help the clinician 
identify urgent clinical situations. Thus it may be important for clinicians to 
ask questions relating to potential consequences as it appears unlikely to be 
volunteered. Furthermore, irrespective of the actual urgency of the clinical 
situation , knowledge that the caller believes their symptoms to have serious 
consequences would be helpful information for the clinician in their 
negotiation of an appropriate outcome with the caller and might aid 
adherence with their advice (Leventhal et al.  1992; Petrie et al.  1996; Horne 
and Weinman, 2002). 
Cure/control 
There were few references to personal control within the transcripts, with 
most participants referring to treatment. This is not unexpected. Given that 
the study involved people who were seeking medical help, it could be 
anticipated that people would identify the type of help they were seeking. 
However, it is interesting that when people did make reference to attempts to 
control symptoms they referred only to treatment and in particular to using 
medicines. Previous research amongst patients with possible symptoms of 
MI found that resting and increasing activity were common first responses to 
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symptoms (Meischke et al.  1995) and yet were not mentioned by any of the 
participants in this study. This suggests that people might consider non-
medical attempts to control symptoms un-important or not valid to discuss in 
clinical consultations. Again, this has implications for clinicians who need to 
ensure they ask questions in order to elicit important information about what 
self-care measures people have tried. 
Most references to treatment control related to the failure of medicines to 
control symptoms or having led to new symptoms. This is a pattern 
consistent with what the CS-SRM would predict. The model proposes that 
people implement coping procedures, based upon their illness 
representations. When an individual appraises the coping procedures as 
having failed to move them towards the goals specified by their illness 
representations, help-seeking is more likely to occur (Leventhal et al.  1984; 
Mora et al.  2002; Martin and Leventhal, 2004). The data presented here 
illustrate this pattern. Furthermore, most (5/6) of the participants who 
described the failure of treatment to control symptoms reported below-
average scores on the IPQ-R.  Other participants who reported below-
average scores sought expert advice (e.g. from a doctor). Again, it appears 
consistent that people who did not believe that treatment (in particular, 
people referred to medicines) would control their symptoms would look to 
experts for alternative solutions.  Indeed, those with below-average 
treatment-control scores were significantly more likely to make reference to 
treatment control than those with high scores.  
The IPQ-R scores associated with the 2 references to personal control 
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identified within the transcripts appeared to reflect the degree of control 
suggested in the participants’ statements. However, clearly additional data 
would be helpful in drawing firmer conclusions about how accurately the IPQ-
R subscale reflects individuals’ personal control. The IPQ-R items appear 
useful in eliciting the personal control component of illness representation, 
which people tend not to reveal during their initial presentations. 
The treatment control subscale appears consistent with representations 
expressed during initial presentation. 
Coherence 
None of the 20 participants who reported above average coherence scores 
discussed their understanding of their symptoms at the time of presentation. 
This suggests that those who had a good understanding of their symptoms 
did not feel it necessary to discuss their level of understanding and instead 
talked about other components of illness representation.   
Furthermore, most statements made by participants with below-average 
coherence scores suggested a poor understanding of their symptoms. 
Together these findings suggest the IPQ-R measure of coherence is 
consistent with the illness representations expressed during initial 
presentations and support the validity of the measure. 
However, there were 2 exceptions where people presented what appeared to 
be a good understanding at the time of the call but subsequently reported 
below-average coherence scores. A number of interpretations are possible.  
These exceptions may simply reflect isolated difficulties with recall. Equally, 
  149 
within the two examples there were indications of uncertainty (see page 135) 
and so they may actually be consistent with the IPQ-R measure. 
Alternatively, the two participants may have articulated coherent explanations 
whilst remaining uncertain about the symptoms. Within an early reference to 
the CS-SRM, Leventhal and colleagues postulated that what people say is 
not necessarily always consistent with their underlying beliefs (Leventhal et 
al.  1980).  On the other hand, what was a coherent explanation at the time of 
the call may have become less so during the interval between the call and 
completion of the questionnaire, a period during which participants may have 
received an alternative diagnosis. Subsequently, participants may have 
reported lower coherence than was apparent at the time of the call. 
Emotion 
None of the 16 participants with below-average emotion scores made 
statements relating to emotion during their presentation of symptoms. 
However, 6 of the 17 with higher than average scores did. Participants with 
above-average emotion scores on the IPQ-R were significantly more likely to 
express emotion during their initial presentation (χ2 (df=1) =6.902, p=0.018). 
This suggests that those who express emotion about symptoms at the time of 
seeking medical help tend to report higher emotion on questionnaire up to 14 
days later and those who report below-average emotion scores on IPQ-R 
were unlikely to have expressed an emotional reaction at the time of 
presentation. These data provide support for the validity of the IPQ-R 
measure of emotion. 
Overall, the data suggest the IPQ-R is a valid, although possibly incomplete, 
  150 
retrospective measure of people’s illness representations at the time of 
seeking help. Thus the IPQ-R is considered suitable for use in the second 
stage of the investigation.   
 
5.7.3 Strengths and limitations 
The major strength of the methodology was that participants’ transcription 
data were provided at the actual time of seeking help and thus were not 
reliant on recall. Previous examples of a similar methodology being used 
amongst people seeking urgent medical help were not identified in the 
literature.  
Further, as responses to an initial open question were isolated, the data 
could be considered ‘uncontaminated’ by either the researcher or NHS 24 
staff. Furthermore, these data were obtained before diagnostic labels had 
been applied and thus responses could not have been influenced by whether 
or not particular diagnoses were made. This has not been possible in prior 
studies of decision time relating to this patient group and is an important 
limitation of existing evidence. However, it is recognised that the IPQ-R 
measure was reliant on recall and may have been influenced by events that 
occurred between the time of the call and completion of the questionnaire. 
The main limitation of the study was the low participation rate (20%) which is 
likely to have resulted in some bias in the sample. Furthermore, reasons for 
non-participation were not systematically collected which limits the ability to 
assess further the likely impact of the low participation rate. However, 
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patients for whom the call to NHS 24 was made by someone else were 
significantly less likely to take part. It is possible that patients in this situation 
are most unwell or less confident communicators and thus that the resultant 
sample under-represents these groups. However, it is also possible that it 
was simply the additional burden and complexity of achieving the 
participation of two people that led to less people in this situation taking part. 
Secondly people from areas of high social deprivation were significantly less 
likely to take part than people from low. It is not clear why this was the case 
although the requirement to complete a questionnaire may have deterred 
people with literacy problems from taking part, a common issue in areas of 
deprivation (Organisation for Economic Co-operation and Development, 
1997). However, people from socially deprived areas have poorer health 
outcomes (Townsend et al 1992; Davey Smith et al.  1997) and are at 
increased risk of CHD (Kaplan and Keil, 1993; Scottish Executive, 2004). It 
was therefore considered important to achieve the participation of people 
from these areas and to understand their illness representations. It was 
considered that the inclusion of telephone interview as an alternative to self-
completion (only adopted during Pilot Study 2 of this study) might help to 
improve the representation of this group in the second stage of the 
investigation. 
The sample is considered representative in other important ways. A variety of 
information about potential participants was available at NHS 24 which 
allowed an assessment of non-responder bias to be made. Participants did 
not differ from non-participants with regard to age, gender, number of 
previous calls to NHS 24 or previous history of CHD. Importantly, the sample 
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was selected from the entire total of people trying to reach their GP in out-of-
hours period and was randomly selected.  
Coding was undertaken by the investigator and thus it was possible that the 
results could be subject to bias in relation to the investigator’s interpretation. 
However, the data were independently coded by a second investigator and 
coding was found to be highly reliable between the two coders, even after 
correcting for chance agreement. Furthermore, the use of N-Vivo software 
ensured that the coding of data is readily available for further scrutiny and 
independent replication of analysis.  
 
5.8 Conclusion 
This study confirmed that the components of CS-SRM were evident within 
peoples’ verbal presentations of their symptoms at the time of seeking 
medical help. The components of illness representation accounted for a high 
proportion of the content of people’s initial presentations. Illness 
representations were volunteered spontaneously by participants, without 
prompting, providing important evidence of the existence of the components. 
However, a number of participants also made reference to the context in 
which the symptoms were occurring and these statements could not be 
assigned to any of the components of illness representation. The relevance 
of context in the elaboration and recollection of illness representations is 
therefore considered worthy of further exploration.  
Mixed results were obtained when retrospective reports of illness perception 
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as measured by the modified IPQ-R were compared with those expressed 
during initial presentation. The identity subscale captured the majority of 
symptoms identified from participants’ initial presentations but importantly not 
all. The IPQ-R failed to capture any of the symptoms from the initial 
presentations of 2 participants which was of concern. This finding led to the 
addition of ‘vomiting’ to the next version of the IPQ-R (Appendix 3 and 29) in 
order to ensure better identification of these particular symptoms. However, it 
is also recognised that the number of symptoms people might identify as 
related to their call is without limit and thus that a checklist will always be 
inadequate. Additional methods of eliciting information about identity might 
be useful to add to the IPQ-R. In particular, given that all participants made 
spontaneous reference to identity in their initial presentations, an open 
question about the reason for their call might be a useful method of eliciting 
additional information about identity (and possibly other components of 
illness representation). 
Similarly, although most references to timeline within initial presentations 
were consistent with IPQ-R scores there were 2 instances where the two 
measures were inconsistent with each other. Furthermore, participants who 
reported acute timelines on the IPQ-R were significantly less likely to refer to 
timeline within their initial presentation. Thus high and low timeline scores do 
not necessarily reflect what people declare during initial presentations. 
References to cause, consequences and personal control within initial 
presentations were rare but the limited examples appeared consistent with 
the related IPQ-scores. The apparent tendency for these components not to 
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be discussed has implications for clinical practice and is therefore an 
important area for further investigation. In particular, it is important to 
examine the content of consultations beyond only the initial presentation to 
explore whether further components of illness representation are revealed by 
patients or indeed elicited by health professionals. However, the comparison 
between the two types of data also demonstrates the usefulness of a tool like 
the IPQ-R in eliciting components of illness representation that might 
otherwise not be expressed. IPQ-R type questions might be usefully 
incorporated into clinical consultations to improve practitioners’ 
understanding of patients’ understanding of their symptoms or illness. This 
might increase patient satisfaction (Cooper et al.  2007) and adherence with 
advice (Lang et al.  2002; Horne and Weinman, 2002), lead to improved 
communication (de Ridder et al.  2007) and possibly improve clinical 
decisions.  
Treatment control scores were generally consistent with illness 
representations expressed during initial presentations although again, those 
with above-average treatment-control scores were less likely to refer to 
treatment control than those with higher scores. 
Coherence and emotion scores also appeared consistent with the IPQ-R 
measure. None of the participants with above-average coherence scores 
discussed their understanding of their symptoms at the time of presentation 
whilst most statements made by participants with below-average scores 
suggested low coherence. Similarly, those reporting high emotional 
representations tended to express emotion within their presentations 
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whereas those reporting low emotional representations on IPQ-R did not.   
This suggests that those with poor understanding of their symptoms and 
strong emotional representations will tend to reveal this within their initial 
presentation. These may be useful cues for clinicians who may need to 
provide more coherent explanations for patients and to take into account 
patients’ emotional representations when providing treatment or advice. The 
findings support the validity of the coherence and emotion measures within 
the IPQ-R. 
The possibility that subsequent events might distort the subsequent 
retrospective reporting of illness representations has been a major limitation 
of prior studies which have used the IPQ-R retrospectively. The results 
obtained in this study provide additional support for the validity of results 
previously obtained in such studies although also highlight a number of 
limitations with the approach.  
Overall the CS-SRM is considered a valid and useful theoretical framework 
for the investigation of patient decision time with possible symptoms of ACS. 
The IPQ-R appears a valid, although possibly incomplete, retrospective 
measure of people’s illness representations at the time of seeking help and 
suitable to be utilised within the second stage of the investigation. 
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Chapter 6.  Timing of initial presentations: Methods 
6.1 Introduction 
The following chapter describes the methods used in the second stage of the 
investigation, exploring decision time amongst participants with symptoms of 
ACS.  Firstly, the aims and research questions are described. This is 
followed by a description of two pilot studies which were undertaken to pilot 
the content and mode of administration of the IPQ-R, prior to the main 
investigation. The methods adopted in the main study are then described in 
detail.  
6.2 Aim 
The aim was to  
1. Learn how the illness perceptions, symptoms and demographic 
characteristics of patients (who have possible symptoms of ACS) relate 
to how and when they present to healthcare services and to clinical 
outcome.   
 
6.3 Research Questions 
1. Do patients’ or callers’(if applicable)  illness perceptions explain variance 
in decision time additional to that explained by demographic factors (age, 
gender, social deprivation score, ethnic group) and clinical factors 
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(presence or absence of pain, previous history of CHD, number of 
previous calls to NHS 24, presence or absence of diabetes)? 
 
2. How do patients’ illness perceptions relate to patient decision time? 
 
3. Do patients’ or callers’ (if applicable) perceptions of illness predict ACS 
or other clinical outcomes?  
 
4. What is the relationship between patients’ (and callers’ if applicable) 
illness perceptions and outcome at 3 months? 
 
6.4 Pilot work 
Before these research questions could be addressed, it was necessary to 
pilot the adapted IPQ-R and to establish the most appropriate mode of 
completion for participants recruited from NHS 24. Pilot work relating to both 
these issues (Pilot Study 3 and Pilot Study 4) was undertaken and is 
described below. This is followed by a description of the methods ultimately 
adopted for this study. 
6.4.1 Pilot study 3: Administering the IPQ-R 
Background 
The IPQ-R(Moss-Morris et al.  2002) was developed to assess illness 
perception and has been used with a wide variety of clinical groups e.g. 
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asthma (Horne and Weinman, 2002), chronic fatigue syndrome and 
rheumatoid arthritis (Moss-Morris and Chalder T, 2003) and CHD (Petrie et 
al.  1996). However, in the context of this study people were identified at the 
time they sought help with symptoms. They may or may not have received a 
diagnostic label in relation to those symptoms and in any case it was 
unknown to the investigator. It was therefore necessary to adapt the 
questionnaire to assess peoples’ perceptions of their symptoms rather than a 
specific illness. Thus it was necessary to reassess reliability and validity. 
In addition, the literature review had not identified any previous examples of 
the questionnaire being used in a similar context to NHS 24 and so it was 
considered useful to explore how acceptable it would be to patients. 
Acceptability was considered especially important given the potential for 
distress that was identified in relation to contacting this group within the 
proposed timeframe. The IPQ-R was included within the information sent in 
Pilot Study 1 (see page 68). However, given the difficulties experienced with 
recruitment (described on page 72 ) insufficient numbers were completed 
which meant that validation was not possible at this time. However, feedback 
from people who did complete the IPQ-R, and from a number of enquiries, 
indicated that there might be ways in which the questionnaire could be made 
more manageable for participants.  
In an attempt to reduce difficulties with the questionnaire semi-structured 
interviews were conducted with 20 participants. It was planned that feedback 
from patients could be used to improve the questionnaire prior to further pilot 
work.   
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Aim 
To explore participants experiences of completing the IPQ-R.  
Research question 
1. What aspects of IPQ-R completion are problematic?  
Method 
Design 
Semi-structured interviews designed to elicit participant feedback on the 
adapted IPQ-R and CIPQ-R. 
Setting 
The 24-hour telephone health advice line (NHS 24) provided the setting for 
the research. 
Participants 
A subset (n=20) of the sample identified for Pilot Study 2 (see page 80 for 
details) participated in this pilot.  
Inclusion Criteria 
A call had been received and recorded by NHS 24. 
Exclusion Criteria 
Any calls involving children aged 16 or under were excluded. Calls where the 
call-reason stated that the patient was suicidal were also excluded. 
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Procedures 
Fifty-nine NHS 24 callers were approached by letter, to ask if they would be 
willing to participate in a telephone interview. A quota sample of 20 was 
recruited.  
20 telephone interviews were conducted with participants using the interview 
schedule in Appendix 26. This included additional questions regarding the 
content and acceptability of the questionnaire. All interviews were recorded 
and the recording subsequently reviewed.  
Analysis 
Areas of difficulty, confusion or which required clarification were identified 
(see Appendix 27 for summary).  
Results 
Five symptoms were volunteered by participants which could relate to ACS 
but which were not included on the questionnaire – vomiting, shaking, pins 
and needles, sweating and collapse. 
Respondents referred to symptoms and time points which did not relate to 
the NHS 24 call on more than one occasion. 
Most participants (17 out of 20) reported the timing of the questionnaire to be 
acceptable. 
Participants consistently found negatively phrased questions such as “my 
symptoms would not have much effect on my life”  problematic, requiring 
clarification and causing frustration. 
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A number of participants indicated that they would prefer to answer in their 
own way and disliked too many tick-boxes. 
Discussion 
The symptoms suggested by participants, but which were not listed in the 
questionnaire, included a number of possible symptoms of ACS (Canto et al.  
2000; Gupta et al.  2002). These symptoms were therefore added to the IPQ-
R used in the main study (Appendix 28 and Appendix 29). 
The interviews highlighted that patients encountered difficulties in identifying 
which symptoms were being referred to and at which time-point. However, it 
was difficult to improve the instructions in this regard without priming patients’ 
responses to identity and timeline items. It was considered that such 
problems might be obscured by self-administration and thus that telephone 
administration would be preferable.   
It was considered that inclusion of an open question might overcome the 
limiting nature of tick-boxes identified by some participants by providing an 
opportunity to freely respond. 
Minor alterations were made to 17 questions where a number of participants 
highlighted difficulty (see Appendix 27). The modified questionnaires were 
resubmitted for ethical review (Appendix 28 and Appendix 29). Data collected 
in the study exploring the content of initial presentations provided a further 
opportunity to compare self-completion of the questionnaire with completion 
via telephone interview. This is discussed below. 
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Conclusions. 
The symptom list was changed to include the symptoms noted above and a 
number of questions were reworded where a number of participants 
highlighted difficulty.  
Completion of the IPQ-R by telephone interview may be preferable to self-
completion by providing an opportunity to clarify symptoms and time-points 
referred to.   
An open question was introduced to allow participants the opportunity to 
freely respond. 
 
6.4.2 Pilot study 4: Comparison of self-completion with telephone 
interview completion of the IPQ-R 
Rationale 
Following the results of Pilot Study 3, the alternative option of administering 
the questionnaire via telephone interview was considered worthy of 
exploration. The purpose being to investigate whether this might overcome 
some of the difficulties identified on page 66 and be perceived as more 
meaningful by potential participants. Pilot study 4 was also designed to 
investigate whether interviews might attract a higher response rate and be 
more likely to obtain complete and timely data. Furthermore interviews offer a 
more conducive environment for people to ask questions or express 
concerns and are helpful for people with difficulties in reading or writing. 
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Aim 
To compare self-completion with telephone interview completion of the 
adapted IPQ-R on response rate, timeliness of response and acceptability to 
participants. 
Research questions 
1. What effect does the method of administration (telephone interview or 
self-completion) of the IPQ-R have on (i) response rate, (ii) response 
delay, and (iii) acceptability to participants? 
 
Method 
Design 
A randomised comparison of the effects of postal self-administration versus 
telephone interview completion of the IPQ-R on response rate and 
completeness of questionnaire responses. 
Sample 
Participants (n=86) invited to participate in Pilot Study 2 and in the study 
relating to the content of initial presentations (see pages 80 and 91 for more 
details) were also asked to complete the second version of the IPQ-R.  
Inclusion Criteria 
A call had been received and recorded by NHS 24 
The patient (and if applicable anyone who called on their behalf) and NHS 24 
staff members consented to take part.   
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Exclusion Criteria 
Any calls involving children aged 16 or under were excluded. Calls where the 
call-reason stated that the patient was suicidal were also excluded. 
Procedures 
Patients identified as eligible for the study were randomised to either an 
invitation to take part in a telephone interview or an invitation to self-complete 
the revised IPQ-R. Letters were sent to potential participants 1-3 days after 
their call, inviting them to take part in the research using the approach 
described in Pilot Study 2 (see page 81). The questionnaire (Appendix 28 
and Appendix 29) was sent to participants allocated to both groups. This 
allowed participants who completed the questionnaire via telephone interview 
to comment on visual aspects such as layout and also acted as a guide for 
interviews.  
Those who were randomised to self-completion were asked to complete the 
questionnaire within a week and return in the postage-paid envelope 
provided. 
Participants randomised to interview were asked for a convenient time to 
conduct the interview. All interviews were audio-recorded using NHS 24 
technology (participants were informed this would be the case). An interview 
schedule (Appendix 26) provided the structure for the interview. The duration 
of interviews was approximately 20 minutes.  
Where patients were unable to complete a questionnaire then the alternative 
of a telephone interview was offered. Similarly, if a telephone interview was 
not feasible (e.g. the patient was in hospital) then self-completion of the 
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questionnaire was offered.  
Analysis 
It was planned that the two approaches would be compared in terms of 
positive responses obtained, completeness of data achieved and in terms of 
acceptability to participants.  
Reliability 
Analysis of the responses was used to assess internal reliability using 
Cronbach’s Alpha, a method of checking that items within the questionnaire 
designed to assess specific concepts do so consistently. It would be usual to 
also assess stability over time using the test-retest method where little 
variability in responses confirms the reliability of the test. However in the 
context of this study where patients were experiencing acute and evolving 
symptoms it was probable that illness perceptions would be changing 
significantly and it was therefore considered inappropriate to use stability as 
a criterion of reliability in this context. 
Validity 
The original IPQ-R has been extensively validated and adapted specifically 
for use with patients with a range of clinical conditions. The adapted 
questionnaire devised for this study was reviewed by an experienced health 
psychology researcher familiar with the theoretical and methodological 
aspects of the IPQ-R (MJ) and considered a logical, balanced and 
comprehensive measure of the concept of illness perception.  
Additionally, the components of illness perception identified in the transcripts 
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were compared with those assessed by the adapted IPQ-R to establish how 
the assessment of illness perception compares between the two in this 
population (convergent validity). The results of this analysis were presented 
on page 124. 
Acceptability 
Respondents were invited to provide feedback on how acceptable they found 
both the approach and the questionnaire. These results are presented below 
and were used to inform the second stage of the study. 
Readability 
The readability of the questionnaire (and indeed of all written material sent to 
patients) was assessed using the Flesch Reading Ease measure (Flesch, 
1948) within Microsoft® Word 2002.  
Results 
Of 80 participants invited to participate, 15 (19%) provided IPQ-R data 
(Figure 13 summarises how participation was achieved for each of the pilot 
studies and the main study exploring the content of initial presentations).   
Of the 41 patients allocated to telephone interview, 7 participated (although 5 
of these by self-completion). Of the 39 allocated to self-administration, 8 
participated.  
Therefore there were insufficient data from the telephone interview group to 
perform a statistical analysis. However data were also available from Pilot 
study 2. When the two were combined a greater proportion (31%) of those 
who had been offered telephone interview completed the IPQ-R (although 
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not necessarily via telephone interview) than those who were invited to self-
complete (18%) (χ2 (df=1) = 2.42, p=0.119).  
Figure 13: Participation achieved for pilot studies and Stage 1 
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Reliability 
Table 8, below shows the Cronbach’s alpha scores for the various subscales 
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of the IPQ-R. All subscales were found to have acceptable internal reliability 
(α > 0.7) with the exception of the treatment control subscale. Due to an 
administrative error, timeline-cyclic items were omitted from the questionnaire 
and thus the internal reliability of this subscale could not be assessed. 
Table 8: Internal reliability of modified IPQ-R 
  
N responses N items α 
Timeline (acute/chronic) 14 6 0.717 
Timeline (cyclical) ~ ~  
Consequences 13 6 0.887 
Personal control 12 6 0.746 
Treatment control 14 5 0.405 
Coherence 14 5 0.799 
Emotion 14 6 0.848 
Acceptability 
Fourteen participants provided data on the acceptability of the questionnaire 
and approach. Responses are summarised in Table 9, below. Most 
participants reported finding the questionnaire easy to complete, that the 
timescale was appropriate and that they remembered clearly the reason they 
contacted NHS 24. However, 2 participants did not find the questions 
relevant to them. 
    
 
 
 
 
 
 
Table 9: Participants’ responses to acceptability items 
 
n 
Strongly 
disagree Disagree 
Neither 
agree or 
disagree Agree 
Strongly 
agree 
The questionnaire was easy to complete  14 0 1 2 9 2 
I was contacted at an appropriate time  14 0 0 3 9 2 
The questions were relevant to me  14 0 2 4 6 2 
I remember reason I contacted NHS 24 14 0 0 0 10 4 
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Readability 
The readability of the patient information is presented in Table 10 below. 
Despite substantial effort to limit the complexity of information, the reading 
ease of patient information ranged between standard and fairly difficult 
(equivalent to requiring some secondary school education).  
Table 10: Flesch Reading Ease Scores for patient information 
 
Flesch reading ease  
Invitation letter 52% 
Information sheet 61% 
IPQ-R 65% 
 
Discussion 
The problems encountered with administering the IPQ-R highlighted the 
challenge of developing a method suitable for all. People with different 
circumstances had different preferences for the mode of completion. 
Interviews had the disadvantage of being time-consuming to conduct. Simply 
achieving contact with potential participants took many attempts and was 
very time-consuming. Additionally, the requirement for the interviewee and 
the researcher to be available at the same time to conduct the interview was 
problematic. The method also has the potential to be susceptible to 
interviewer bias (Buckingham and Saunders, 2004a).  
Telephone interview did have the advantage of ensuring timely data and 
allowed responses to be clarified. It also allowed participants to ask 
questions as they occurred. Invitation to take part in a telephone interview 
tended to be associated with higher participation rates (although participants 
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did not necessarily take part via the mode offered).  
Conclusion 
On balance, telephone interview was considered the preferable method for 
the remainder of the study as it offered an opportunity to clarify responses, 
particularly those relating to the timings of symptoms. However, in view of the 
difficulties experienced in achieving participation, it was also considered 
important to continue to offer the alternative of self-completion. This would 
ensure that all those who wished to take part could do so, even where a 
telephone interview was not possible.  
 
6.5 Timing of initial presentations: Methods for main study 
6.5.1 Research design 
The study comprised a survey of patients with possible symptoms of ACS 
who were in contact with NHS 24 (and callers where the call was made by 
someone other than the patient). Participants were asked to complete the 
IPQ-R questionnaire, piloted in Pilot Studies 3 and 4, within 2 weeks of 
contacting NHS 24. Data regarding demographic details, decision time and 
clinical outcomes at 3 months were also collected.  
6.5.2 Setting 
NHS 24 provided the setting for the research.  
The rationale for the choice of NHS 24 as a setting for the earlier part of the 
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investigation was provided in Chapter 3. Likewise, for this part of the 
investigation, NHS 24 offered the opportunity to sample from a large 
population of patients seeking help with symptoms from all over Scotland. 
Furthermore, pilot work had confirmed that it was possible to reliably identify 
patients with possible symptoms of ACS from NHS 24 records. Thus it was 
relatively easy to identify a large, diverse random sample of patients with 
these types of symptoms. 
 
6.5.3 Participants 
The aim was to recruit 200 patients who presented to NHS 24 with possible 
symptoms of ACS. Statistical advice was sought from KH (Statistician, 
University of Stirling) and the number of participants informed by the 
following power calculation. Based on testing whether there was a significant 
correlation between decision time and illness perception then assuming 
Pearson's product moment correlation was appropriate (i.e. assuming 
normality), and for a significance level of 5% then using 200 subjects gave an 
80% power of finding a correlation of at least 0.2. 
During the recruitment period all calls to NHS 24 where either the chest pain 
algorithm had been used or no algorithm was used as the call was deemed 
‘immediately life-threatening’ and possible symptoms of ACS were identified 
within the call reason or clinical summary were identified.   
Twice weekly, a random sample of 60 patients were identified and the 
patients involved in these calls (and if applicable anyone who called on their 
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behalf) invited to take part. 
Inclusion Criteria 
A call had been received and recorded by NHS 24. 
The nurse had used either the chest pain algorithm or no algorithm 
had been used but the outcome was 999 ambulance and possible 
cardiac symptoms were identified within the ‘call reason’ or ‘clinical 
summary’ (as outlined on page 86.) 
The patient had consented to participate. 
Exclusion Criteria 
Any calls involving children aged 16 or under. 
Any calls where the call was made by a health professional (as the 
aim was to investigate lay perceptions of illness) 
Any calls where the call-reason stated that the patient was suicidal 
or where the clinical summary revealed that this was the case. 
6.5.4 Procedures 
Recruitment and consent 
The recruitment and consent procedures developed in the study relating to 
the content of initial presentations were used again in this study.  Twice 
weekly, all calls to NHS 24 which fulfilled the inclusion criteria were identified. 
This generated a list of unique call numbers which were entered into SPSS 
and a random sample of 60 selected to be approached on each occasion. 
Based on the levels of non-response experienced in the previous study it was 
estimated that approximately 600 patients would need to be contacted to 
yield 200 participants. It was considered that this could realistically be 
achieved within approximately 7-8 weeks. As before, information about the 
general characteristics of all patients approached was collected from the 
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patient record at the time the patient was identified (age, gender, geographic 
location etc.)  in order to assess if the group who responded differed in any 
significant way from those who did not.  
The corresponding records were then accessed by the chief investigator. It 
was identified from the record whether the patient called themselves or if 
someone called on their behalf.  
Where the patient called about themselves 
A letter and information leaflet was sent to the patient explaining the purpose 
and nature of the study and inviting their participation in it (Appendix 30 and 
Appendix 31). Permission to telephone them to discuss it further was 
requested. It was made clear that there was no obligation to receive this call 
or to take part in the research. If the patient did not wish to be contacted they 
were able to notify the researcher, by either returning a postcard (Appendix 
32) or by telephoning a dedicated telephone number. Patients who took 
either of these actions were not contacted further. 
Those who did not decline were telephoned no less than 5 days after the 
letter was sent, and the research discussed further with them as detailed in 
the schedule for invitation by telephone (Appendix 33). This call was 
recorded (patients were informed of this in the patient information leaflet).  
It was ascertained whether the patient had received and read the information 
posted to them. If not, they were given the opportunity to do so (if they 
wished). 
Once the investigator was satisfied that the patient had read and understood 
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the nature of the research and had the opportunity to ask questions, they 
requested the patient’s consent to take part. It was made clear that 
participants were free to withdraw this consent at any time. A letter 
summarising what the participant had consented to was sent to each 
individual (Appendix 34) providing a further opportunity for participants to 
change their mind.  Arrangements were made for a telephone interview. If it 
was not possible to conduct a telephone interview participants were offered 
the opportunity to self-complete and return the questionnaire by post. The 
interview schedule (Appendix 35) outlined the planned content of the 
interviews. 
The recordings of consenting patients’ original telephone calls were 
accessed and symptoms identified. All participants were also asked if it 
would be acceptable to approach them again at some time in the future with 
regard to future projects7.  
If the patient declined to take part, they were asked sensitively if they would 
be able to provide a reason and this was recorded.  
Someone else called on behalf of the patient 
A letter (Appendix 36) and information leaflet (Appendix 31) were sent to the 
patient and a request to pass ‘caller information’ to the person who called on 
their behalf was included. This comprised a second set of information 
directed towards the person who called (Appendix 37 and Appendix 38). 
Patients who consented to take part, and who had a contact number for the 
                                               
7
 It was considered that particular patients (e.g. those with long decision times but high consequence 
scores on IPQ-R) might be of particular interest and it was anticipated that data collected in this 
study could be used in future research. 
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caller, were asked for permission to contact that person by telephone. The 
caller was invited to give consent and participate in the same manner as the 
patient. 
All patients and callers who were invited to participate were sent a 
specifically adapted IPQ-R questionnaire (Appendix 39 and Appendix 40) as 
an example of the type of questions to be asked in the interview. This also 
provided an opportunity for self-completion in the event that a telephone 
interview was not possible. 
Interviews were conducted at a mutually convenient time. An interview 
schedule (Appendix 41) provided the structure for the interview. SPSS Data 
Entry 4.0, an add-on for SPSS 14.0 was used to produce an electronic 
version of the IPQ-R with an associated SPSS file. This allowed participants’ 
responses to be entered directly into SPSS, thus minimising the potential for 
data entry error. All interviews were audio-recorded using NHS 24 technology 
(participants were informed this would be the case) and are thus available for 
external scrutiny. The recordings of interviews were also used to transcribe 
longer responses to the first open question. The average duration of 
interviews was approximately 20 minutes.  
Each patient who agreed to take part was asked permission for their GP to 
be notified of their participation and contacted in 3 months time to obtain 
details of their diagnosis. Where participants gave consent, their GP was 
informed by letter (Appendix 42) of their participation in the study and of the 
intention to request data regarding the patient’s diagnosis at 3 months. The 
GP was contacted again at 3 months by letter (Appendix 43) to request brief 
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information regarding each of their patients who had consented to be 
involved. Where a reply was not received, a telephone approach to the 
practice manager was undertaken to obtain the required information. Where 
it was still not possible to obtain the information the researcher contacted the 
practice again and attempted to negotiate access to the practice to obtain the 
data in person. To avoid over-burdening practices, the number of cases from 
each practice was collated and each practice approached only once 
regarding data for all participating patients. 
Data collection 
Measures 
Patient decision time  
As originally described by Safer and colleagues, the pre-hospital phase of MI 
can be conceptualised in 3 phases: appraisal delay – the time someone 
takes to identify a symptom as an indication that they are ill; illness delay- the 
time between someone recognising that they are ill and deciding to seek 
medical attention; and utilisation delay- the time taken between seeking 
medical care and actually receiving it (Safer et al.  1979).  Frequently this is 
collapsed into one measure of pre-hospital delay. However, the time period 
between seeking medical care and receiving it is largely out with the control 
of an individual and influenced most by the healthcare staff and systems they 
encounter. Therefore within this study it was planned to measure appraisal 
delay (by measuring the time between when participants first began to 
experience the symptoms that led to them calling and when they began to 
cause them real concern) and utilisation delay (by measuring the time that 
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their symptoms began to cause them real concern and when the call was 
received). This is an area previous research has identified as challenging. 
The measure obviously relies on patient recall which can be problematic. It 
also assumes that the time of onset of symptoms of ACS can be readily 
identified whereas there is evidence to suggest otherwise.  Previous research 
has identified many patients with MI do not report abrupt onset of symptoms 
(Dracup et al.  1995) and thus may find it difficult to specify a time of onset.  
However, telephone interview provides the opportunity to ask probing and 
clarifying questions in order to obtain as accurate timings as possible. In 
addition, where the patient gave their consent, it was possible to access the 
voice-recording of the original call and obtain any references to the timing of 
symptoms. This provided an opportunity to compare these to the data 
obtained from participants retrospectively.  
The IPQ-R contained the following questions about timing. Patients who were 
interviewed were read the same information.  
“We are interested in how long you experienced your symptoms 
before you decided to contact health services. It is really important 
that this is as accurate as possible, so we ask that you think 
carefully and double-check your dates and times”.  
Questions T1, T2 and T3 from the IPQ-R and CIPQ-R (Appendix 39 and 
Appendix 40) were used to obtain detailed information about when the 
participant first noticed the symptoms, when the symptoms began to cause 
real concern and when they first made contact with medical services. A date 
and time was recorded for each question. 
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T1: When did you first notice the symptoms you spoke to NHS 24 
about?  
T2: When did you your symptoms begin to cause you real concern?  
T3: Did you contact any other health professional before you spoke 
to NHS 24? If yes, who and at what time? 
The time the call was received is electronically recorded at NHS 24 providing 
a reliable measure (T4).  Where NHS 24 was not the first point of contact 
with health services the patient was asked who they first made contact with 
and at what time.  
Appraisal delay was calculated as the time elapsed between T1 and T2, 
illness delay between T2 and T3 (if applicable, otherwise T4).  
In addition, data re timing were available from the recording of the call. It is 
common during consultation for clinical staff to enquire about the duration of 
symptoms. Participants’ calls were reviewed by the investigator and all 
references to timing of symptoms recorded. Where available within the call 
the duration of symptoms was calculated and is referred to as decision time 
from call.  
 
Illness perceptions 
The specifically adapted questionnaires (IPQ-R and CIPQ-R) developed 
following Pilot Studies 3 and 4 were utilised to assess the illness perceptions 
of the patient and, if relevant those of a caller (Appendix 39 and Appendix 40) 
within 2 weeks of seeking help.  
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Scores for each subscale were generated for each participant, as described 
by the authors of the scale (http://www.uib.no/ipq ).  
Symptoms 
Two measures of symptoms at presentation were obtained. One from the 
original voice recording of the call received by NHS 24 and the other from the 
IPQ-R or CIPQ-R. 
Clinical Outcome 
Data about clinical outcome was collected from the patient’s GP at 3 months 
(see Appendix 43). It was established whether the patient was alive or dead, 
whether or not they received a diagnosis of ACS relating to the symptoms 
within the call and whether they received any medical diagnosis in the 
following 3 months. It was also established if the patient was diabetic as this 
clinical factor is known to be associated with longer pre-hospital time (see 
page 29). 
Analysis 
The characteristics of patients who responded were compared with those 
who did not in order to assess non-responder bias. Independent t-tests (or, 
where applicable, non-parametric equivalents) and chi squared tests were 
used to test for differences in age, gender, known past medical history of 
CHD, number of calls to NHS 24, NHS 24 nurse outcome and social 
deprivation scores. 
The internal reliability of IPQ-R and CIPQ-R subscales was checked using 
Cronbach’s alpha.  
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Amongst those participants who gave permission for their call-recording to be 
accessed, scores for identity and timeline were obtained from the recording. 
This allowed individual scores on the IPQ-R to be compared with their 
references to the components of illness perception at the time of the call. 
Correlations were used to explore the relationship between (a) illness 
perceptions, (b) demographic factors and (c) clinical factors and (i) patient 
decision time (ii) appraisal time (iii) diagnosis of ACS and (iv) outcome at 3 
months.  
Furthermore, to facilitate  comparison with previous studies amongst people 
with ACS (Goldberg et al.  2000; Goldberg et al.  2002b), two groups were 
created on the basis of delay time – those who delayed < 2 hours and those 
who delayed >2 hours. Mann-Whitney tests were used to explore differences 
between the two groups. In addition, comparisons of illness representations 
within sub-groups were performed where significant relationships with 
decision time were identified.  
Where relevant, logistic regression analyses were performed to assess 
whether illness perceptions explained variance in delay category.  
It was recognised that in circumstances where a third party makes a call on 
behalf of a patient that their illness perceptions may differ and that either 
might relate to decision time. Analyses were performed using the patients 
IPQ-R and then repeated using the IPQ-R scores and reported decision time 
of the person who made the call (PWMC) (whether this was the patient or 
caller (CIPQ-R)).  
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Thus the analytic strategy involved conducting multiple statistical tests. This 
could potentially increase the likelihood that significant results might be 
obtained due to chance.  Given the exploratory nature of the study, and thus 
the need to balance the risk of Type I and Type II errors, the conventional 
significance (p) level of <0.05 is applied throughout. However, during the 
discussion of the results, the pattern of results which would have been 
obtained using a more cautionary significance level (<0.02) is considered. 
6.6 Ethical issues 
6.6.1 Potential for distress to patients / relatives at a difficult time 
As in the previous study, it was recognised that the proposed sampling 
strategy risked contacting people who were very ill or who may even have 
died. The invitation letter and information sheets were, again, carefully 
worded with these particular groups in mind. The opportunity to decline to 
participate was offered to all and efforts made to ensure this was as easy as 
possible. Two alternative means of notifying the researcher were offered 
(postcard and telephone). Participants were not required to speak directly 
with the investigator and needed only to state their study number.  
Where people did not decline, subsequent telephone contact was sensitive to 
their potential circumstances. It was not assumed that they wished to take 
part. Rather, the phone call provided an opportunity to answer any questions, 
discuss the research and establish if they required any further information in 
order to make a decision about participation.  
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6.6.2 Informed consent 
In recognition of individuals’ rights to voluntarily participate in research and to 
freely consent or decline for their information to be used, the consent of all 
participants was sought. As before, this was requested verbally during the 
invitation phone call which was recorded at NHS 24. Thus a record that 
consent had been given was available. A written record of what the patient 
had consented to was kept by the investigator and a copy sent to the patient 
(Appendix 34).  It was made clear that individuals could withdraw this 
consent at any time.  
6.6.3 Researcher’s role 
The position of the chief investigator as a member of staff within NHS 24 
continued to be an important issue, as was the case in the earlier study and 
the structures put in place at that time were continued, as detailed on page 
101.  
6.6.4 Sensitive topics 
By nature of the topic of study some patients were in emergency situations 
i.e. seeking medical help with possible symptoms of ACS. However, they 
were not approached at that time, but rather a few days later. This approach 
was found to be acceptable to the majority of respondents in the study 
relating to the content of presentations, see page 166. 
6.6.5 Data handling 
Personal identifiable information was stored separately from the 
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questionnaires. These were linked by a unique study identification number.  
All electronic data was password protected. Only the chief investigator and 
supervisory team had access. Voice recordings are routinely stored on tape 
within NHS 24 for 10 years and will not be removed from their secure 
storage. Call details were only accessed once the patient had given consent 
for the researcher to do so. No copies or transcriptions of the call were made. 
Instead, the call was accessed by the investigator and references to 
symptoms and the timing of those symptoms documented.  
Data from the research was stored in a locked filing cabinet for the duration 
of the study and will then be archived within the University of Stirling. A 
permanent member of University staff will act as custodian after the chief 
investigator has completed the current studentship. 
6.6.6 Confidentiality 
The chief investigator had access to confidential personal and health related 
data. However they endeavoured to only access this data with the explicit 
permission of all those involved. Where it was necessary to access records 
without consent (to send invitation letters and to record anonymous data), 
this was done in the presence of another member of clinical staff to ensure 
no personal identifiable data was recorded. As a registered nurse, the chief 
investigator was bound by their professional code of conduct regarding the 
disclosure of such information at all times. The minimum data required for the 
purposes of the investigation was accessed and used only as described in 
the protocol. 
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Chapter 7. Timing of initial presentations: Results 
7.1 Participation 
A total of 710 eligible patients were invited by letter to take part. However, 
during telephone follow-up 51 (7%) patients stated that they had not received 
the information sent about the study.  As these individuals did not have an 
opportunity to make a decision regarding participation, calculations of 
participation rates have been calculated from the remaining 659 who 
received the relevant information.  
A decline to any further contact was received from 121 (17%) of patients. 
Follow-up telephone calls were made to the remaining 589.  
Overall 262 (40%) patients agreed to participate during the follow-up 
telephone call. However, actual participation was achieved for 182 (28%). 
Reasons for non-participation are highlighted in Figure 14 and discussed 
further on page 281. Those who declined were offered the opportunity to give 
their reasons. More than half did so and these are also summarised in Figure 
14, below. 
 
7.2 Participants compared with non-participants 
In order to assess if participants differed in significant ways from non-
participants, tests for difference across a number of key variables were 
conducted. Results are summarised in Table 11.  
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Figure 14: Participant invitation process 
 
 
 
 
7.2.1 Demographics 
Participants were found to be significantly younger than non-participants 
(mean age=53 (SD=15.78) versus 57 (SD=20.60), difference 3.5 (95% C.I: 
0.6, 6.4), p=0.018).  
More women (n=386) than men (n=324) were identified by random selection, 
reflecting the pattern observed overall in NHS 24, where approximately 60% 
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of calls received relate to female patients (see Appendix 25). The proportion 
of women who agreed to participate was 24% (n=94) compared with 27% 
(n=88) of men. The difference was not statistically significant: χ2 (df=1) = 
0.729, p = 0.393.  
There were no significant differences between participants and non-
participants in DEPCAT scores F (6, 656) =1.394, p=.214. 
Table 11: Comparison of participants and non-participants 
  Participants Non-participants Difference   p -value 
  n=182 n=477 (95% C.I)   
 
Mean (SD) 
 
 
Age in years 53 (16) 57 (21) (0.60, 6.4) 0.018* 
No of previous calls  5 (13) 5 (12) (-2.02, 2.1)   0.970 
 
   
 
n (%) df  
Male gender 88 (48%) 236 (45%) 1   0.393 
Documented history CHD  47 (26%) 158 (30%) 1   0.316 
Emergency response 156 (86%) 458 (87%) 1   0.684 
Caller involved 84 (46%) 321 (61%) 1 0.001* 
  
   
  
F df p 
DEPCAT score   1.394 6, 656   0.214 
 
 
 
7.2.2 Clinical characteristics 
There were no significant differences between participants and non-
participants in either their number of previous calls to NHS 24 (t=0.037, 
df=707, p=0.97); whether or not they had a history of CHD documented 
within NHS 24 (χ2 (df=1) = 1.004, p = 0.316) or whether or not the nurse 
treated them as an emergency (χ2 (df=1) = 0.166, p = 0.684). 
However, patients where someone made a call on their behalf were 
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significantly less likely to participate than those who called about themselves 
(χ2 (df=1) = 11.841, p = .001).  
7.3 Characteristics of the sample. 
The mean age of participants was 53 years (SD=15.78).  Figure 15, below, 
illustrates the distribution of participants’ ages. As already reported, 94 
participants were female and 88 participants were male. 
Figure 15: Age distribution of participants 
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People with a range of social deprivation classifications (DEPCAT) 
participated in the study (see Figure 16, below). 
Figure 17 illustrates the geographical location of participants in relation to 
population density. Rates of participation were considered approximately 
proportionate to the density of population. 
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Figure 16: DEPCAT classifications of participants 
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Figure 17: Geographical spread of participants 
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As can be seen in Figure 18, below, 135 (74.2%) participants described their 
ethnic group as Scottish; 21 (11.5%) British; 1 (0.5%) Irish and 2 (1.1%) other 
white background. Two participants (1.1%) described their ethnic group as 
Indian; 1 (0.5%) mixed race and 2 (1.1%) described other ethnic 
backgrounds. A response to the item was not provided by 18 (9.9%) of 
participants.  
Figure 18: Ethnic background of participants 
MissingAny otherMixedIndianOther whiteIrishBritishScottish
140
120
100
80
60
40
20
0
 
Just over a quarter (26%, n=47) of participants had a previous history of CHD 
documented at NHS 24 at the time of the call. 
In terms of their previous use of NHS 24, 95% (n=173) of participants had 
called 15 times or less. For 42% (n=76) it was their first call (see Figure 19, 
below).  
  191 
Figure 19: Participants’ number of previous calls to NHS 248 
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The outcome for most calls (86%) was 999 ambulance with less urgent 
outcomes being less frequent (see Figure 20, below). 
In 54% of cases (n=98) the participant called on their own behalf. However, 
in the remaining 46% of cases (n=84) someone else called NHS 24 on behalf 
of the participant. 
 
                                               
8
 In order to improve clarity, the data of the 3 participants with the highest number of calls (121, 119 
and 42) are not displayed on this graph 
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Figure 20: Outcome of patients’ calls 
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7.4 IPQ-R measurement 
  
7.4.1 Administration of IPQ-R 
Questionnaires were administered between 2 and 15 days after the patients 
call to NHS 24 (Mean =8, SD =3). In contrast to what was planned, 70% of 
patients (n=116) elected to self-complete the IPQ whilst the remaining 30% 
(n=50) participated in a telephone interview. 
In addition, 59 Caller IPQs were completed by people who made calls on 
behalf of participants. In 45 cases both IPQ and C-IPQ data was collected 
and in 14 cases, C-IPQ data only. Most callers (n=54) self-completed the 
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questionnaire whilst 5 took part in a telephone interview. 
Patient IPQ-R 
As is standard procedure (http://www.uib.no/ipq), patient responses to IPQ-R 
items were scored across the 8 subscales: identity, timeline acute/chronic; 
timeline cyclical; consequences, personal control; treatment control; 
coherence and emotion. It is important to note that a minimum number of 
items are required to be completed for each subscale in order to calculate 
this score. Therefore, the data of participants who did not complete the 
required number of items is missing.  
Also, as recommended by the authors, participants’ beliefs about cause were 
not measured by a subscale. Instead participants were asked to rank, in 
order of importance, the 3 most likely causes of their symptoms. These data 
were used to compare those who identified the heart as the most important 
likely cause of their symptoms with those who identified other most likely 
causes.  
Cronbach’s alpha was used to assess internal reliability of the subscales, 
with the exception of the identity subscale9. In Table 12, below, it can be 
seen that all subscales were found to have acceptable internal reliability 
(α > 0.7)  with the exception of the personal control items (α = 0.642). 
Reliability of the subscales was found to be good regardless of the mode of 
administration, with the exception of the personal control subscale. This 
subscale had good internal reliability when the IPQ-R was self-completed 
                                               
9
 Scores for the identity subscale on both IPQ-R and CIPQ-R compose the sum of a list of disparate 
symptoms; therefore internal reliability is not relevant.   
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(n=96; α = 0.706) but was poor when telephone administered (n=44; 
α = 0.405).This could not be improved by removal of items. 
Table 12: Distribution of scores and internal reliability of patient IPQ-R. 
  
N responses N items α mean SD min max 
Timeline (acute/chronic) 143 5 0.823 13.78 4.04 5 24 
Timeline (cyclical) 147 4 0.794 12.18 3.46 4 20 
Consequences 149 6 0.753 18.67 4.43 6 30 
Personal control 143 5 0.642 13.14 3.29 5 24 
Treatment control 146 4 0.714 15.10 2.34 5 20 
Coherence 153 4 0.925 10.86 4.19 4 20 
Emotion 152 6 0.716 21.52 3.77 12 30 
 
Caller IPQ-R 
The C-IPQ assessed the caller’s perception of the patient’s representations 
across the same 8 subscales. As can be seen in Table 13, all but 2 
subscales were found to have acceptable internal reliability. Cronbach’s alpha 
was 0.647 for the treatment control items and 0.627 for the emotion items.  
The treatment control subscale alpha could be improved to 0.855 with the 
removal of item CIP23 “There was nothing which could help their condition”. 
This item was therefore removed. However, there were no items within the 
emotion subscale where removal improved the internal reliability of the 
subscale and therefore all items were retained.   
It was not possible to assess for the effects of mode of administration 
amongst C-IPQ items as there were too few callers who participated in 
telephone interview (n=4). 
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Table 13: Distribution of scores and internal reliability of caller IPQ-R. 
  N responses N items α mean SD min max 
Timeline (acute/chronic) 49 5 0.811 14.96 4.05 5 25 
Timeline (cyclical) 48 4 0.743 11.00 3.13 4 19 
Consequences 49 6 0.822 19.24 4.57 6 30 
Personal control 52 5 0.767 12.46 3.92 5 25 
Treatment control 55 3 0.855 11.96 1.89 5 15 
Coherence 53 4 0.895 11.40 3.62 4 19 
Emotion 51 6 0.627 21.96 3.32 14 29 
 
Finally, items within the caller IPQ designed to assess callers’ perceptions of 
the patient’s illness gave scores on 3 subscales (see Table 14, below). The 
coherence and emotion subscales had acceptable internal reliability but the 
personal control items were problematic (α=0.526).  This was improved 
slightly to α=0.626 when item CIP42, “There was nothing I could do to affect 
their symptoms”, was removed but was still lower than 0.7. 
Table 14: Distribution of scores and internal reliability of caller items on caller IPQ-R. 
  N responses N items α mean SD min max 
Personal control 54 4 0.626 12.39 3.12 4 17 
Coherence 54 4 0.951 13.11 4.37 4 20 
Emotion 53 6 0.729 20.73 3.84 11 30 
 
7.5 Mode of administration 
Patients who participated in a telephone interview were compared with those 
who self-completed the IPQ-R with regards to demographic and clinical data 
and IPQ-R scores. Results are summarised in Table 15 and Table 16, below. 
Those who participated in telephone interview were significantly less likely to 
have had a caller involved in the original call (χ2 (df=1) = 3.956, p = 0.047) 
and had significantly higher scores for personal control (Mean =13.91, 
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SD=2.79) than those who self-completed (Mean = 12.67, SD=3.52), 
difference 1.24 (95% C.I: 0.11 – 2.38), p=0.032). This is discussed further on 
page 289. No other significant differences between the two groups were 
identified. 
 Table 15:  Differences relating to mode of IPQ-R administration:  t-tests 
  Telephone interview   Self-completion   Difference     
  n mean SD   n mean SD t (95% C.I) p  
Age 50 49.02 14.25  116 53.52 15.73 -1.74 (-9.61,  0.62) 0.084 
Previous calls to NHS 24 50 7.16 17.46  116 4.53 12.12 1.11 (-2.03, 7.28) 0.267 
Identity† 50 5.00 5.00  107 4.00 3.00 2440.0    0.374 
Timeline- acute/chronic 50 13.90 3.82  101 13.77 4.17 0.18 (-1.26, 1.52) 0.856 
Timeline - cyclical 49 12.55 3.26  104 12.23 3.45 0.54 (-0.84, 1.48) 0.590 
Consequences 50 19.44 4.08  104 18.42 4.54 1.36 (-0.47, 2.52) 0.177 
Personal Control 49 13.91 2.79  103 12.67 3.52 2.17 (0.11, 2.38)  0.032* 
Treatment control† 49 16.00 1.00  104 15.00 2.00 2113.0  0.080 
Coherence 50 10.9 3.41  106 10.83 4.47 0.06 (-1.21, 1.35) 0.918 
Emotion 50 21.62 3.42   107 21.55 3.97 0.1 (-1.22, 1.35) 0.919 
      †
 
Mann-Whitney U, Median and IQR 
Table 16: Differences relating to mode of IPQ-R administration: χ2 tests and ANOVA 
 Telephone interview Self-completion χ2 df p 
Male 23 (46%) 59 (51%) 0.33 1     0.565 
Documented history CHD 15 (31%) 27 (23%) 0.92 1     0.338 
Emergency response 40 (80%) 101 (87%) 1.37 1     0.243 
Caller 16 (33%) 56 (50%) 3.96 1 0.047* 
   
F df p 
DEPCAT classification   0.204 6, 148   0.975 
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7.6 Illness representations 
In order to select appropriate statistical tests, the distributions of scores 
across each subscale were checked for normality (Appendix 44). All except 
the identity and treatment control subscales (for both patients and callers) 
were normally distributed (i.e. absolute value of z-scores for kurtosis and 
skewness were both <2.58 (Field, 2005) ). The distributions for each 
subscale for both patients and callers are described below. The scores of 
patients and callers were also compared; the results of this analysis are 
reported on page 232. 
7.6.1 Identity 
The range of possible identity scores was 0-17, with the score reflecting the 
number of symptoms an individual viewed as relating to the reason for their 
call to NHS 24.  
Scores were available for 161 patients and 50 callers and were not normally 
distributed. Patients reported a median of 5 symptoms (IQR=4) as being 
“related to why I was in contact with NHS 24”.  The number reported ranged 
from 0 to 17. Callers reported a median of 4 symptoms (IQR=3) as being 
“related to why I contacted NHS 24 on their (the patients) behalf”.  
 
7.6.2 Timeline-acute/chronic 
The range of possible timeline-acute/chronic scores was between 4 and 25, 
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with higher scores reflecting beliefs that symptoms were of a longer, more 
chronic duration. 
Timeline-acute/chronic scores were available for 154 patients and for 53 
callers and were normally distributed. Patients’ mean timeline score was 
13.78 (SD 4.04) and callers’ mean was 14.96 (SD 4.05).  
 
7.6.3 Timeline –cyclical 
The range of possible timeline-cyclical scores was between 3 and 20, with 
higher scores reflecting beliefs that symptoms were cyclical in nature.  
Scores for cyclical timeline were available for 156 patients and 54 callers and 
were normally distributed. Patients’ mean score was 12.28 (SD=3.42). The 
callers’ mean was 11.38 (SD=3.24). 
 
7.6.4 Cause 
Participants were asked to identify (in order of importance) what they 
considered were the 3 most likely causes of their symptoms. 163 participants 
identified at least one likely cause of their symptoms. These responses were 
reviewed by the investigator and those causes which related to the heart 
identified (n=39). The decision times of this group were compared with the 
remaining participants who had not identified the heart as the most likely 
cause of their symptoms. 
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7.6.5 Consequences 
The range of possible consequences scores was between 4 and 30, with 
higher scores reflecting beliefs that symptoms had more serious 
consequences.  
A score on the consequences subscale was available for 157 patients and 55 
callers and were normally distributed. The mean score for patients was 18.67 
(SD 4.43). The callers’ mean was 19.57 (SD 4.63).  
 
7.6.6 Personal control 
The range of possible personal control scores was between 4 and 25, with 
higher scores reflecting beliefs that individuals had high personal control over 
their symptoms.  
As already discussed, the internal reliability of personal control items was 
less than optimal (α=.642). However, as the reliability could not be improved, 
the scores available were analysed.  Scores were normally distributed. 
Scores of personal control were available for 155 patients, mean score was 
13.11 (SD=3.33). Callers reported their assessment of patients’ degree of 
personal control. A mean score of 12.62 (SD=3.94) was reported by 55 
callers. Callers (n=56) also reported their own sense of personal control, the 
mean score was 9.58 (SD=2.97).  
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7.6.7 Treatment control 
The range of possible treatment control scores was between 3 and 20, with 
higher scores reflecting confidence that treatment could control symptoms.  
Treatment control scores were available for 156 patients and 56 callers but 
were not normally distributed. Patients’ median score was 16.00 (IQR=2.00). 
Callers median score was 12.00 (IQR=0.00).  
 
7.6.8 Coherence 
The range of possible coherence scores was between 3 and 20, with higher 
scores reflecting a clear understanding of symptoms. 
Coherence scores were available for 159 patients and were normally 
distributed (as were callers’ scores). The mean score was 10.86 (SD=4.13). 
Callers report of patient coherence were available from 54 callers 
(Mean=11.33, SD=3.62). In addition scores relating to the coherence of the 
caller were available for 55 callers (Mean=13.02, SD=4.38).  
 
7.6.9 Emotion 
The range of possible emotion scores was between 4 and 30, with higher 
scores reflecting stronger emotions in relation to symptoms.  
Scores for the emotion subscale were available for 160 patients 
(mean=21.58, SD=3.77). Callers report of patient emotion were available 
from 54 callers (mean=22.12, SD=3.30). In addition scores relating to the 
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emotion of the caller were available for 55 callers (Mean=20.79, SD=3.87). 
All were normally distributed. 
 
7.7 Decision time 
The timings provided by patients (and where relevant callers) in response to 
questions T1, T2 and T3 were used to calculate total patient (or caller) 
decision time (T3-T1); appraisal delay (T2-T1) and illness delay (T3-T2). 
Graphs of the raw distributions are shown in Figure 21, below. 
Initial exploratory analysis revealed a number of participants’ decision times 
to be negative (i.e. participants reported symptoms starting after they had 
sought help for those symptoms). Examination of the individual cases 
suggested that this was most probably due to errors by participants in 
recording dates. These cases were therefore excluded from each calculation 
of decision time. Results of the comparison of questionnaire data with the 
real-time call data are reported on page 248. 
Furthermore initial analysis showed that results for decision time were not 
normally distributed; being skewed towards shorter times and with a small 
number of extreme scores affecting the mean (see Figure 21, below). Thus 
median and Inter-Quartile Range (IQR) have been used to describe central 
tendency and dispersion of decision times and non-parametric statistics have 
been used to explore the relationship between the patients’ illness 
representations and decision time. 
Spearman’s correlations (rs) were used to explore relationships between 
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continuous variables
. 
Mann-Whitney tests (U) were used to test for 
differences in binary variables. The Kruskal-Wallis test (K-W, H ) was used to 
explore whether decision times varied in relation to DEPCAT classification. 
Mann-Whitney was also used to test for differences in illness representations 
between those who delayed <2 hours with those who delayed >2 hours.  
However, as previously discussed, in a number of circumstances calls were 
not made by the patient, but instead by a caller. The measures of decision 
time have been calculated using the time the call was made, and therefore 
were possibly defined most by the person making the call. Therefore, the 
relationship between the illness representations of the person who made the 
call (be that the patient or a caller) and each measure of decision time were 
also explored.   
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Figure 21: Distributions of measures of delay 
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7.7.1 Total delay 
Median total delay reported by patients was  4 hours 26 mins., range 0 
minutes to 104 weeks  , IQR = 13.89 hours. Median total delay reported by 
callers was 3 hours 48 mins., range 19 mins. – 89 weeks, IQR = 18.58 hours. 
Callers’ reports of total delay were highly correlated with those of the 
corresponding patient (rs =0.736, p<.001) and there were no significant 
differences between the two reports (z=-0.805, p=.421). 
When the total delay time reported by the PWMC (whether that be a caller or 
patient) was calculated for each call, median total delay was 4 hours 42 
minutes, range 0 minutes – 104 weeks, IQR = 18.5 hours. 
Relationship between study variables and total delay time 
Patients 
Demographic and clinical factors 
No significant relationships were observed between patient delay time and 
the patients age (rs =-.057, p=.507). No significant difference was found 
between men and women (U= 2106, p= .373) or DEPCAT classifications (H 
(6) = 6.535, p=.366, see Table 17 page 206) or between people of white and 
non-white ethnic group (U= 27, p= .315).  
Patients who reported pain did not report significantly different total delay 
times than those who did not (U= 512.5, p= .831). Total patient delay times 
for those with a documented history of CHD (Mdn = 4 hours 22 mins.) were 
not significantly different from those without (Mdn = 4 hours 35 mins.; U= 
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1778.5, p= .987). Nor was total delay time significantly different between 
participants with diabetes and those without (U=377.5, p=0.783).There was 
no significant correlation between the number of previous calls to NHS 24 
and total patient delay time (rs =-.017, p=.846) nor was a significant 
difference found between those who were calling for the first time and those 
who had called before (U= 2203, p= .831) or between those who received an 
ambulance as a result of their call and those who did not (U= 769, p= .197).  
Table 17: DEPCAT classification and patient decision time: Kruskal-Wallis test 
  
H  df p  
Total patient delay 6.535 6 0.366 
Appraisal delay 5.515 6 0.480 
Illness delay 10.604 6 0.101 
Delay reported during call 8.239 6 0.221 
Table 18 shows the results obtained when participants who had total patient 
delay of < 2 hours were compared with those >2 hours. There were no 
significant differences between the two groups in terms of age (U=2280, 
p=0.760) or gender. A larger proportion of people with high DEPCAT 
classifications (i.e. living in more deprived areas) were found in the delay 
group (42%) than the non-delay group (26%), χ2 (df=1) = 3.750, p=0.053).  
There were no significant differences between the two groups regarding 
experience of pain, previous history of CHD, presence of diabetes, whether 
or not it was the patient’s first call to NHS 24, the frequency of receiving an 
ambulance response or caller involvement in the call.  
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Table 18: Total patient delay:  χ2 test comparing delayers and non-delayers 
 
No delay 
(< 2 hours) 
(n=50) 
Delay 
(> 2 hours) 
(n=92) χ2 df p 
Male 54% 46% 0.335 1 0.563 
High deprivation 26% 42% 3.750 1 0.053 
Reported pain 89% 88% 0.034 1 1.000 
Documented history CHD 22% 28% 0.558 1 0.455 
First call 44% 40% 0.191 1 0.662 
Emergency response 90% 88% 0.124 1 0.789 
Caller 42% 43% 0.029 1 0.865 
Diabetes 9% 9% 0.000 1 1.000 
 
Illness representations 
No significant correlations were found between total patient delay and 
patients’ scores on the identity, timeline- acute/chronic, timeline-cyclical, 
consequences, personal control, treatment control, coherence or emotion 
subscales. (see Table 19, below).  
Table 19. Spearman’s correlations between IPQ-R subscales and total patient delay (patients) 
 
N rs p 
Age 136 -.057 0.507 
Identity 131 .055 0.533 
Timeline- acute/chronic 125 .050 0.582 
Timeline - cyclic 126 .053 0.556 
Consequences 127 -.029 0.749 
Personal Control 126 -.002 0.981 
Treatment control 127 -.056 0.532 
Coherence 129 .063 0.477 
Emotion 129 -.129 0.145 
Nor were significant differences in scores on these subscales found between 
delayers and non-delayers (see Table 20, below). 
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Table 20: Total patient delay: Comparison of delayers with non-delayers (Mann-Whitney tests) 
 Delay < 2 hours  Delay > 2 hours   
 mdn IQR  mdn IQR U p 
Age 54.0 24.0  54.0 21.0 2228.0 0.760 
Previous calls to NHS 24 2.0 3.0  2.0 2.0 2265.0 0.877 
Identity 4.0 3.0  5.0 4.0 2011.0 0.572 
Timeline- acute/chronic 14.00 7.13  14.00 6.50 1772.0 0.345 
Timeline - cyclical 12.00 5.00  12.00 5.00 1597.0 0.099 
Consequences 19.25 5.35  20.00 6.00 2012.5 0.988 
Personal Control 13.37 5.00  13.00 5.00 1930.0 0.905 
Treatment control 16.00 4.00  16.00 2.00 1874.0 0.547 
Coherence 8.00 5.25  10.00 6.25 1672.0 0.064 
Emotion 22.00 4.50  22.00 4.25 1754.5 0.175 
 
Participants who identified the most important likely cause of their symptoms 
as relating to the heart did not have significantly different total delay time than 
those who identified other causes as most important (U= 1640, p= .528, see 
Table 21). 
Table 21: Differences in delay times between those who identified heart as most likely cause 
and those who did not (Mann-Whitney tests) 
  Heart Not heart     
  mdn IQR mdn IQR U p  
Total patient delay 3.47 9.77 3.25 4.35 1640.0   0.528 
Appraisal delay 3.00 9.75 1.50 2.60 1740.0   0.394 
Illness delay 0.73 0.90 1.07 1.83 1103.0 0.042* 
Delay reported during call 1.50 5.30 1.80 2.95 718.0   0.876 
 
 
Person who made call  
Demographic  
No significant correlations were identified between PWMC report of total 
delay and the age of the patient (rs =-0.055, p=.561) or the PWMC (rs =-
0.095, p=.310). Nor were there significant differences in total delay relating to 
the gender of the patient (U=1536.5, p=0.424) or the PWMC (U=1598.5, 
p=0.696).  
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When the people who made the call within 2 hours of the onset of symptoms 
were compared with those who made the call >2 hours, there were no 
significant differences relating to either the age of the patient (U=1470.5, 
p=0.856) or the PWMC (U=1337.5, p=0.471), or to the gender of the patient 
(χ2 (df=1) = 0.966, p=0.326) or PWMC (χ2 (df=1)=0.104, p=0.747).  
Illness representations 
Participants who reported high emotion reported significantly shorter total 
delay, no other significant correlations relating to illness representations were 
identified (see Table 22 , below).  
Table 22: Spearman’s correlation between IPQ-R subscales and total patient delay – (PWMC) 
  
N rs p 
PWMC report patient identity 111 0.039 0.682 
PWMC report patient timeline- acute/chronic 111 -0.061 0.526 
PWMC report patient timeline - cyclical 109 0.032 0.740 
PWMC report patient consequences 111 -0.104 0.279 
PWMC report patient personal control 110 0.039 0.686 
PWMC report patient treatment control 112 0.055 0.567 
PWMC report patient coherence 112 0.028 0.773 
PWMC report patient emotion 113 -0.148 0.117 
PWMC's personal control 110 0.075 0.438 
PWMC's coherence 112 0.038 0.690 
PWMC's emotion 113 -0.215   0.022* 
When those with a total delay <2 hours were compared with those of >2 
hours there were not significant differences in the IPQ subscales (see Table 
23, below).  
Those who identified the most important likely cause of the patient’s 
symptoms to be relating to the heart did not have significantly different total 
delay time than those who identified other causes as most important 
(U=1145.5, p= .372).
  
 
 
Table 23: Total patient delay, person who made call: Comparison of delayers with non-delayers (Mann-Whitney tests) 
  Delay < 2 hours   Delay > 2 hours     
  mdn IQR   mdn IQR U p  
PWMC report patient identity 4.00 3.00  5.00 3.25 1241.0 0.492 
PWMC report patient timeline- acute/chronic 15.00 6.50  14.00 6.25 1342.0 0.781 
PWMC report patient timeline - cyclical 11.00 6.00  12.00 5.25 1036.5 0.072 
PWMC report patient consequences 20.00 5.50  20.00 6.00 1380.5 0.969 
PWMC report patient personal control 14.00 5.50  13.00 5.00 1334.0 0.916 
PWMC report patient treatment control 15.00 4.00  14.33 4.00 1349.5 0.813 
PWMC report patient coherence 12.00 8.00  10.00 7.00 1393.5 0.939 
PWMC report patient emotion 21.00 6.00  22.00 5.25 1253.5 0.297 
PWMC's personal control 12.00 5.00  12.00 5.00 1306.0 0.779 
PWMC's coherence 12.00 8.00  11.50 8.00 1279.0 0.433 
PWMC's emotion 21.00 6.00   21.00 5.00 1172.5 0.124 
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7.7.2 Appraisal delay 
Median appraisal delay reported by patients was  2 hours, range 0 minutes to 
90 weeks, IQR = 9.5 hours. Median total delay reported by callers was 2 
hours 15 minutes, range 0 minutes to 90 weeks, IQR = 8.5 hours. 
Callers’ reports of appraisal delay were highly correlated with those of the 
corresponding patient (rs =0.634, p<.001) and there were no significant 
differences between the two reports (z=-0.769, p=.442). 
When the total delay time reported by the PWMC (whether that be a caller or 
patient) was calculated for each call, median appraisal delay was 2 hours 22 
minutes, range 0 minutes – 90 weeks, IQR = 9.69 hours. 
Relationship between study variables and appraisal delay 
Patient 
Demographic and clinical factors 
No significant relationships were observed between appraisal time and the 
age of the patient (rs =.002, p=.981). However, appraisal delay was found to 
be significantly shorter for men (Mdn= 82 mins) than for women (Mdn=180 
mins; U= 2077.5, p= .029). As can be seen in Table 42, page 234, men 
tended to report significantly more serious consequences relating to their 
symptoms than women (t= -2.20, p=.029). 
Significant differences in appraisal delay were not found between DEPCAT 
classifications (H (6) = 5.515, p=.480, see Table 17, page 206). 
Patients who reported pain did not report significantly different appraisal 
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delay times than those who did not (U= 691.5, p= .849). Appraisal times for 
those with a documented history of CHD (Mdn = 150 mins) were not 
significantly different from those without (135 mins.), (U= 2000, p= .950).  Nor 
were there significant differences in appraisal time between patients with 
diabetes and those without (U=324.5, p=0.885). There was no significant 
correlation between the number of previous calls to NHS 24 and appraisal 
time (rs =-.092, p=.273) and those who were calling for the first time did not 
differ significantly from those who had called before (U= 2323, p= .362). 
Patients who received an ambulance as a result of their call had significantly 
shorter appraisal times (Mdn=2 hours) than those who did not (Mdn=6.5 
hours; U= 701, p= .017), see Table 45, page 239. 
Similarly, when those with appraisal time of < 2 hours (non-delayers) were 
compared with those >2 hours (delayers), there were no significant 
differences between the two groups in terms of age (U=2614.5, p=0.848). 
However, there were a significantly larger proportion of women than men in 
the delay group (see Table 24, below).  There were no significant differences 
between the two groups as to whether they had high or low DEPCAT 
classification.   
Neither were there differences between the two groups regarding experience 
of pain, previous history of CHD, presence of diabetes or whether or not it 
was the patient’s first call to NHS 24. A significantly higher proportion of 
patients with appraisal delay of <2 hours (96%) received an emergency 
response as a result of their call than those with appraisal delay >2 hours 
(81%; p=0.047) (see Table 24).  
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No significant differences relating to whether a caller was involved in the call 
were identified.  
Table 24: Appraisal delay:  χ2 test comparing delayers and non-delayers 
  
No delay  
(< 2 hours) 
(n=74) 
Delay  
(> 2 hours) 
(n=72) χ2 df p 
Male 59% 43% 3.93 1 0.047* 
High deprivation 32% 41% 1.33 1 0.248 
Reported pain 87% 88% 0.03 1 0.865 
Documented history CHD 26% 26% 0.00 1 0.961 
First call 42% 40% 0.04 1 0.843 
Emergency response 96% 81% 8.40 1 0.004* 
Caller 44% 46% 0.10 1 0.750 
Diabetes 6% 2% 2.00 1 0.270 
 
Illness representations 
No significant correlations were found between appraisal time and patients 
scores on the identity, timeline- acute/chronic, timeline-cyclical, 
consequences, personal control, treatment control or coherence subscales. 
However, a significant negative correlation was found between patients 
scores on the emotion subscale and appraisal time (rs =-.205, p=.016). 
Patients with stronger emotional representations tended to report shorter 
appraisal times (see Table 25, below).  
Table 25. Spearman’s correlations between IPQ-R subscales and appraisal time - patients 
 
N rs p 
Identity 140 0.10 0.238 
Timeline- acute/chronic 133 -0.03 0.705 
Timeline - cyclical 134 0.06 0.507 
Consequences 135 -0.12 0.179 
Personal Control 134 0.02 0.863 
Treatment control 134 -0.10 0.255 
Coherence 137 0.05 0.567 
Emotion 137 -0.21 0.016* 
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When those with appraisal times of <2hours and >2 hours were compared, 
no significant differences in scores for identity, timeline–acute/chronic or 
timeline cyclical were observed. Non-delayers tended to report higher identity 
and consequences than delayers but both results were just short of statistical 
significance (p=.081, p=.068, respectively).  Significant differences in 
personal control, treatment control or coherence scores were not observed 
between the two delay categories. However, non-delayers reported 
significantly higher scores on the emotion subscale than those with appraisal 
delays of >2 hours (U=1672, p=0.002), see Table 26, below.  
Participants who identified the most important likely cause of their symptoms 
as relating to the heart did not have significantly different appraisal time than 
those who identified other causes as most important (U= 1740, p= .394, see 
Table 21). 
 
Table 26: Appraisal delay: Comparison of delayers with non-delayers (Mann-Whitney tests) 
  Delay < 2 hours   Delay > 2 hours     
  mdn IQR   mdn IQR U p  
Age 53.50 22.00  53.00 24.00 2614.5 0.846 
Previous calls to NHS 24 2.00 3.00  2.00 2.00 2646.5 0.944 
Identity 4.00 2.00  5.00 4.00 2065.0 0.081 
Timeline- acute/chronic 15.00 7.50  14.00 6.00 2196.0 0.845 
Timeline - cyclical 12.00 4.00  12.00 5.25 2215.0 0.782 
Consequences 20.00 6.00  18.00 8.00 1891.5 0.068 
Personal Control 13.00 5.00  12.50 5.00 2200.5 0.733 
Treatment control 16.00 2.00  15.00 2.00 1960.0 0.152 
Coherence 10.68 6.50  9.50 6.00 2310.5 0.770 
Emotion 22.00 5.00  20.50 5.25 1672.0   0.002*   
 
A logistic regression analysis was performed with appraisal delay categories 
(<2 or>2 hours) as the dependent variable and gender, identity score, 
emotion score and consequences score as predictor variables. A total of 131 
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cases were analysed and the full model predicted appraisal delay category 
(omnibus chi-square=19.907, df=4, p=0.001). The model accounted for 
between 14% and 19% of variance in delay category, with 68% of non-
delayers and 57% of delayers successfully predicted. Overall 62% of 
predictions were accurate.  
Table 27 gives coefficients and the Wald statistic for each of the predictor 
variables. This shows that identity score and emotion score reliably predicted 
appraisal delay.  
 
Table 27: Logistic regression analysis: appraisal delay categories 
  
B SE Wald df p 
Identity 0.215  0.077 7.747 1  0.005* 
Consequences -0.036 0.046 0.586 1   0.444 
Emotion -0.173 0.062 7.793 1  0.005* 
Gender 0.374 0.385 0.942 1   0.332 
Constant 3.121 1.348 5.361 1   0.021 
 
Person who made call  
Demographic  
No significant correlations were identified between appraisal delay and the 
age of the patient (rs =0.003, p=.975) or the PWMC (rs =-0.048, p=.591). Nor 
were there significant differences in appraisal times relating to the gender of 
either the patient (U=1739.5, p=.147) or the PWMC (U=1807, p=.276).  
When participants with appraisal times < 2 hours were compared with those 
> 2 hours, there were no significant differences relating to either the age of 
the patient (U=1970.5, p=0.721) or the PWMC (U=1882, p=0.436). Nor were 
significant differences identified between the 2 groups relating to the gender 
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of the patient (χ2 (df=1) = 0.755, p = .385) or the PWMC (χ2 (df=1) = 0.314, p 
= .576).   
Illness representations 
No significant correlations were identified between appraisal time and any of 
the subscales of the IPQ-R with the exception of emotion.  Appraisal time 
was significantly shorter where the person who made the call reported high 
emotional representations themselves or high patient emotion (see Table 28, 
below). 
Those who identified the most important likely cause of the patient’s 
symptoms to be relating to the heart did not have significantly different 
appraisal delay than those who identified other causes as most important (U= 
1557, p= 971). 
Table 28: Spearman’s correlation between IPQ-R subscales and appraisal time – PWMC 
  
N rs p 
PWMC report patient identity 120 0.138  0.132 
PWMC report patient timeline- acute/chronic 119 -0.080  0.385 
PWMC report patient timeline - cyclical 118 -0.028  0.760 
PWMC report patient consequences 120 -0.149  0.105 
PWMC report patient personal control 118 0.039  0.677 
PWMC report patient treatment control 122 -0.029  0.749 
PWMC report patient coherence 120 0.024  0.797 
PWMC report patient emotion 121 -0.216   0.017* 
    
PWMC's personal control 119 -0.023  0.804 
PWMC's coherence 121 0.020  0.827 
PWMC's emotion 121 -0.267   0.003* 
 
Similarly, when participants with appraisal delay <2 hours were compared 
with those with appraisal time >2 hours, the only significant difference 
identified in IPQ subscales was emotion (see Table 29, below). Those 
reporting appraisal delay of < 2 hours reported higher patient emotion scores 
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and higher emotion themselves than those with appraisal delay of >2 hours.  
 
 
  
Table 29: Appraisal delay, PWMC: Comparison of delayers with non-delayers (Mann-Whitney tests) 
  Delay < 2 hours   Delay > 2 hours     
  mdn IQR   mdn IQR U p  
PWMC report patient identity 4.00 2.00  5.00 4.00 1499.0 0.121 
PWMC report patient timeline acute/chronic 15.00 6.00  14.00 6.00 1752.5 0.940 
PWMC report patient timeline - cyclical 12.00 4.00  12.00 6.00 1685.0 0.784 
PWMC report patient consequences 20.00 7.00  19.00 6.00 1549.0 0.191 
PWMC report patient personal control 13.00 5.00  12.00 5.00 1695.0 0.826 
PWMC report patient treatment control 15.00 4.00  14.00 4.00 1621.0 0.217 
PWMC report patient coherence 11.00 7.00  10.00 8.00 1676.0 0.517 
PWMC report patient emotion 22.00 5.00  21.00 6.00 1341.0  0.011* 
PWMC's personal control 13.00 5.00  12.00 4.00 1623.5 0.445 
PWMC's coherence 12.00 8.00  10.00 8.00 1774.0 0.775 
PWMC's emotion 22.00 6.00  20.00 5.00 1275.5  0.004* 
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7.7.3 Illness Delay  
Median illness delay reported by patients was 75 minutes, Range 0 minutes -
104 weeks, IQR =3.01 hours. 
 Median total delay reported by callers was 62 minutes, Range 0 – 112 
hours, IQR= 1.05 hours. 
Callers’ reports of illness delay were highly correlated with those of the 
corresponding patient (rs =0.660, p=.001) and there were no significant 
differences between the two reports (z=-1.452, p=.147). 
When the total delay time reported by the PWMC (whether that be a caller or 
patient) was calculated for each call, median illness delay was 75 minutes, 
Range 0 minutes – 104 weeks, IQR = 2.97 hours.  
Relationship between study variables and illness delay 
Patient 
Demographic and clinical factors 
No significant relationships were identified between illness delay and 
patients’ ages (rs =-.023, p=.803). Nor were significant differences identified 
between male (Mdn = 79 mins.) and female (Mdn = 69 mins.) patients (U= 
1678, p= .431); between DEPCAT classifications (H (6) = 10.604, p=.101, 
see Table 17, page 206). 
Patients who reported pain did not report significantly different illness delay 
times than those who did not (U= 394, p= .627). No significant differences in 
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illness delay were identified between patients with a history of CHD (Mdn = 
56 mins) and those without (Mdn = 79 mins.; U= 1267, p= .456). Nor were 
there significant differences in illness delay between patients with diabetes 
and those without (U=203, p=0.098). There was no significant relationship 
identified between the number of previous calls to NHS 24 and illness delay 
(rs =-.161, p=.078). However, those who were calling NHS 24 for the first 
time had significantly longer illness delay (Mdn=93 mins.) than those who 
had called before (Mdn=57mins.; U= 1381.5, p= .05). Those who received an 
ambulance as a result of the call did not differ significantly from those who 
did not (U= 634.5, p= .207). 
When those with an illness delay <2 hours and >2 hours were compared, 
there were no significant differences with regards to age (U=2072, p=0.693), 
gender (χ2 (df=1)=0.022, p=0.881), DEPCAT classification, ethnic group, 
presence of pain, history of CHD, presence of diabetes or whether it was 
their first call to NHS 24. However, a greater proportion of those who delayed 
<2 hours had a caller involved in the original call (χ2 (df=1) =3.82, p=0.051) 
and received an emergency response as a result of their call than those who 
delayed > 2 hours (χ2 (df=1) =4.42, p=0.036), see Table 30, below. 
Table 30: Illness delay:  χ2 test comparing delayers and non-delayers 
 
No delay  
(< 2 hours) 
(n=103) 
Delay  
(> 2 hours) 
(n=42) χ2 df p 
Male 50% 55% 0.22 1  0.640 
High deprivation 37% 36% 0.02 1  0.894 
Reported pain 89% 89% 0.01 1 1.000 
Documented history CHD 26% 24% 0.07 1  0.797 
First call 39% 50% 1.53 1 0.217 
Emergency response 91% 79% 4.42 1   0.036* 
Caller 48% 30% 3.82 1   0.051* 
Diabetes 6% 16% 3.04 1 0.124 
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Illness representations 
No significant correlations were identified between illness delay and any of 
the subscales of the IPQ-R (see Table 31, below). Nor were any significant 
differences found in subscale scores between those with an illness delay <2 
hours and >2 hours (see Table 32, below).  
Participants who identified the most important likely cause of their symptoms 
as relating to the heart had significantly shorter illness delay (Mdn=44 mins.) 
than those who identified other causes as most important (Mdn=64 mins.; U= 
1103, p= .042, see Table 21, page 208). 
Table 31: Spearman’s correlations between IPQ-R subscales and illness delay – patient 
  
N rs p 
Identity 118 0.06 0.515 
Timeline- acute/chronic 112 0.15 0.104 
Timeline - cyclical 112 0.06 0.567 
Consequences 113 0.06 0.558 
Personal Control 111 0.01 0.875 
Treatment control 113 0.06 0.500 
Coherence 114 -0.08 0.423 
Emotion 115 0.05 0.577 
 
Table 32: Illness delay: Comparison of delayers with non-delayers (Mann-Whitney tests) 
  Delay < 2 hours   Delay > 2 hours     
  mdn IQR   mdn IQR U p  
Age 54.00 22.00  51.50 23.00 2072.0 0.693 
Previous calls to NHS 24 2.00 3.00  1.50 2.00 1925.0 0.280 
Identity 4.00 3.00  5.00 4.50 1990.0 0.688 
Timeline- acute/chronic 14.00 7.00  14.00 6.00 1522.0 0.135 
Timeline - cyclical 12.00 4.00  12.00 6.50 1771.0 0.596 
Consequences 20.00 6.00  19.50 7.00 1769.0 0.618 
Personal Control 13.00 5.00  13.00 5.63 1771.5 0.692 
Treatment control 16.00 2.00  16.00 2.00 1806.5 0.644 
Coherence 10.00 6.00  8.00 5.00 1790.5 0.474 
Emotion 22.00 4.00  22.00 5.50 1786.0 0.392 
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Person who made call IPQ-R 
Demographic  
No significant relationship was identified between the age of the patient (rs =-
0.075, p=.454) or the person who made the call and illness delay (rs =-0.071, 
p=.475). Nor were there significant differences in illness delay relating to the 
gender of either the patient (U=1254, p=.637) or person who made the call 
(U=1209.5, p=.468).  
Similarly, when those with illness delay times of <2 hours were compared to 
those of >2 hours, no significant differences related to either the age of the 
patient (U=1140, p=0.651) or the PWMC (U=1161.5, p=0.761) or the gender 
of the patient (χ2 (df=1) =0.005, p=0.942) or PWMC (χ2 (df=1) =0.104, 
p=0.748) were identified.   
Illness representations 
A positive correlation was identified between treatment control and the 
PWMC report of illness delay (rs =0.234, p=.020). No other significant 
correlations were identified between the illness representations of the person 
who made the call and illness delay (see Table 33, page below). Similarly, 
the only significant difference in IPQ subscales when those reporting illness 
delay of <2 hours were compared with those >2 hours was treatment control 
(see Table 34, below) 
Those who identified the most important likely cause of the patient’s 
symptoms to be relating to the heart did not have significantly different illness 
delay than those who identified other causes as most important (U= 924.5, 
p= .237). 
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Table 33: Spearman’s correlation between IPQ-R subscales and illness delay – PWMC 
  
N rs p 
PWMC report patient identity 98 0.094 0.356 
PWMC report patient timeline- acute/chronic 98 0.046 0.651 
PWMC report patient timeline - cyclical 96 0.133 0.195 
PWMC report patient consequences 98 -0.046 0.655 
PWMC report patient personal control 97 -0.001 0.989 
PWMC report patient treatment control 99 0.234  0.020* 
PWMC report patient coherence 99 -0.023 0.818 
PWMC report patient emotion 103 0.032 0.754 
 
   
PWMC's personal control 97 0.097 0.354 
PWMC's coherence 99 0.049 0.633 
PWMC's emotion 100 0.055 0.586 
  
 
 
 
 
 
Table 34: Illness delay, PWMC: Comparison of delayers with non-delayers (Mann-Whitney) 
  Delay < 2 hours Delay > 2 hours     
  mdn IQR mdn IQR U p  
PWMC report patient identity 4.00 3.00 4.00 3.75 1065.5 0.784 
PWMC report patient timeline- acute/chronic 14.00 5.25 14.50 6.00 933.0 0.295 
PWMC report patient timeline - cyclical 12.00 6.00 12.50 5.75 812.5 0.062 
PWMC report patient consequences 19.50 6.00 18.60 5.75 1028.5 0.743 
PWMC report patient personal control 13.00 4.25 13.00 4.75 1003.5 0.691 
PWMC report patient treatment control 14.00 4.00 15.50 2.00 815.5  0.023* 
PWMC report patient coherence 11.50 8.00 10.50 6.25 1103.5 0.993 
PWMC report patient emotion 21.00 5.00 22.00 5.50 1097.5 0.774 
PWMC's personal control 12.00 4.00 13.00 5.00 824.5 0.077 
PWMC's coherence 12.00 8.00 10.50 7.00 1055.0 0.712 
PWMC's emotion 21.00 5.00 21.00 6.00 1091.0 0.738 
  225 
7.7.4 Decision time reported during the call to NHS 24 
Timing of symptoms was referred to in 156 of 162 calls reviewed. However 
an actual measurable time was only available in 101. The remaining 
statements (e.g. ‘since this morning’) were adequate for the clinician’s 
purposes and not explored further during the call. However, they were not 
precise enough to be included in the analysis where differences between 
comparison groups were being measured in minutes.  Two negative values 
were also excluded from the analysis (these occurred when patient reported 
contacting another health professional earlier than when they stated 
symptoms started during call).  
The median decision time reported during the call to NHS 24 was 90 minutes 
(IQR= 3 hours 22 minutes), Range 5 mins. -30.87 hours.  
The relationship between decision times reported during the call to NHS 24 
and the other measures of delay are reported on page 244. 
Patient 
Demographic and clinical factors 
No significant relationships were identified between decision time reported 
during NHS 24 call and patients ages (rs =-.167, p=.115).  Nor were 
significant differences identified between male and female patients (U= 
979.5, p= .696) or between DEPCAT classifications (see Table 17, page 
206).  
Patients who reported pain did not report significantly different total delay 
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times than those who did not (U= 229, p= .209). No difference in call-reported 
decision time was found between patients with a history of CHD (Mdn = 86 
mins) and those without (Mdn = 106 mins.; U= 809, p=.840). Nor were there 
significant differences in the decision time reported during the call between 
patients with diabetes and those without (U=177, p=0.593). There was no 
significant relationship between the number of previous calls to NHS 24 and 
call-reported decision time (rs =-.144, p=.174). No significant difference was 
found between the call-reported decision times of those calling NHS 24 for 
the first time and those who had called before (U= 838.5, p=.194), between 
those who received an ambulance as a result of the call and those who did 
not (U= 307, p=.726) or relating to whether a caller was involved (U =970, p = 
0.815). 
Those who reported decision times of <2hours during the call to NHS 24 
were not significantly different from those who reported decision times 
>2hours in terms of age (U=900.5, p=0.235), patient gender, high or low 
DEPCAT classification (χ2 (df=1) =0.07, p=0.791), white / non-white ethnic 
group, presence of pain, history of CHD or diabetes (see Table 35, below). A 
significantly larger proportion of those calling NHS 24 for the first time 
reported a delay of >2 hours (54%) than <2 hours (32%, χ2 (df=1) =4.71, 
p=.030).  There were no significant differences between the two groups 
regarding whether the participant received an ambulance as a result of the 
call or whether there was a caller involved in the call. 
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Table 35: Decision time reported during the call to NHS 24:  Comparisons between delayers 
and non-delayers (χ2 tests) 
 
  
Delay < 2 
hours 
(n=57) 
Delay > 2 
hours 
(n=37) χ2 df p 
Male 54% 54% 0.01 1 0.975 
High deprivation 35% 32% 0.07 1 0.791 
Reported pain 90% 85% 0.36 1 0.734 
Documented history CHD 34% 22% 1.64 1 0.201 
First call 32% 54% 4.71 1 0.030* 
Emergency response 89% 95% 0.76 1 0.385 
Caller 39% 46% 0.50 1 0.480 
Diabetes 10% 11% 0.05 1 1.000 
 
Illness representations 
No significant correlations were identified between decision time obtained 
from the call and any of the subscales of the IPQ-R (see Table 36, below).  
Table 36: Spearman’s correlations between IPQ-R and decision times obtained from the call – 
patient 
   
N Rs p 
Identity 87 -0.055 0.614 
Timeline- acute/chronic 80 0.077 0.497 
Timeline - cyclical 83 0.037 0.741 
Consequences 82 0.096 0.393 
Personal Control 83 0.148 0.182 
Treatment control 84 0.008 0.940 
Coherence 84 -0.088 0.426 
Emotion 84 0.073 0.507 
 
Similarly, when those who reported a decision time of <2 hours were 
compared with those reporting decision times >2 hours, no significant 
differences were identified (see Table 37 below).  
Patients who identified the most important likely cause of their symptoms as 
relating to the heart did not report significantly different delay times during the 
call to NHS 24 than those who identified other causes as most important (U= 
718, p= .876, see Table 21, page 208). 
  
 
 
 
 
 
 
Table 37: Decision time obtained during call to NHS 24: Comparison of delayers with non-delayers (Mann-Whitney tests) 
 Delay < 2 hours   Delay > 2 hours     
  mdn IQR   mdn IQR U p  
Identity 4.00 2.75  4.00 6.00 873.0 0.458 
Timeline- acute/chronic 14.00 6.00  14.00 4.50 748.5 0.530 
Timeline - cyclical 12.00 5.00  12.00 4.50 810.0 0.567 
Consequences 19.00 6.85  20.00 6.25 737.0 0.363 
Personal Control 12.00 4.75  14.00 4.25 676.5 0.092 
Treatment control 16.00 3.00  16.00 2.00 854.5 0.746 
Coherence 10.50 6.75  8.50 5.00 766.5 0.310 
Emotion 22.00 5.00   22.00 4.25 757.5 0.243 
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Person who made the call 
Demographic  
No relationship was found between the age of the PWMC and the decision 
time reported during the call (rs =.130, p=.261). Nor were significant 
differences in call-reported decision time identified in relation to the gender of 
the PWMC (U=701, p=0.731).  
Illness representations 
No significant correlations were identified between decision time obtained 
from the call and any of the subscales of the IPQ-R (see Table 38).  
Those who identified the most important likely cause of the patient’s 
symptoms to be relating to the heart (on the questionnaire) did not report 
significantly different decision times during the call to NHS 24 than those who 
identified other causes as most important (U= 512, p= .576). 
Table 38: Spearman’s correlations between IPQ-R and decision times obtained from call – 
PWMC 
  
N rs p 
PWMC report patient identity 74 -0.02 0.872 
PWMC report patient timeline- acute/chronic 71 0.12 0.305 
PWMC report patient timeline - cyclical 71 0.06 0.626 
PWMC report patient consequences 71 0.12 0.335 
PWMC report patient personal control 71 -0.01 0.936 
PWMC report patient treatment control 73 -0.04 0.749 
PWMC report patient coherence 72 -0.17 0.146 
PWMC report patient emotion 73 -0.01 0.913 
PWMC's personal control 71 -0.06 0.596 
PWMC's coherence 72 -0.18 0.123 
PWMC's emotion 72 -0.01 0.899 
When participants who reported a decision time < 2 hours during the call to 
NHS 24 were compared to those who reported > 2 hours, there were no 
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significant differences relating to age (U=661, p=0.408) or gender (χ2 (df=1) = 
0.003, p=0.953).  
Nor were there significant differences in the IPQ subscales (see Table 39, 
below).  
  
 
 
 
 
 
Table 39: Decision time reported during call to NHS 24, PWMC: Comparison of delayers with non-delayers (Mann-Whitney tests) 
  Delay < 2 hours Delay > 2 hours     
  mdn IQR mdn IQR U p  
PWMC report patient identity 4.00 3.00 4.00 5.25 657.5 0.731 
PWMC report patient timeline- acute/chronic 14.00 6.25 15.00 5.40 534.5 0.280 
PWMC report patient timeline - cyclical 12.00 6.00 12.50 5.50 546.0 0.341 
PWMC report patient consequences 19.00 8.00 20.50 5.50 547.5 0.352 
PWMC report patient personal control 13.00 6.00 13.50 5.25 578.0 0.557 
PWMC report patient treatment control 14.67 4.00 14.00 4.00 573.5 0.302 
PWMC report patient coherence 11.00 7.00 9.00 5.25 537.0 0.227 
PWMC report patient emotion 22.00 5.00 22.00 4.25 654.0 0.890 
PWMC's personal control 12.00 4.00 12.00 5.00 619.0 0.903 
PWMC's coherence 12.00 8.00 9.50 6.25 530.0 0.202 
PWMC's emotion 21.00 5.00 22.00 4.50 660.5 0.946 
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7.8 Other patterns in illness representations 
In order to improve understanding of the results obtained in relation to 
decision time, additional analyses of the relationship between key 
demographic factors and illness representations was performed. Differences 
relating to age, gender, social deprivation, previous history of CHD and to the 
outcome of the call are reported below. 
7.8.1 Age 
As can be seen in Table 40 below, there were no significant differences in 
the illness representations of younger and older patients. However, when the 
illness representations of the person who made the call were examined 
younger participants reported significantly higher identity scores than older 
participants (see Table 41, below). 
Table 40: Differences in illness representations relating to age 
  
Younger 
(age < mean=53yrs) 
Older  
(age>mean=53yrs)     
  n mean SD n mean SD t p  
Identity† 84 5.00 4.00 77 4.00 3.00 2890 0.242 
Timeline- acute/chronic 82 14.01 4.21 72 13.51 3.83 0.763 0.446 
Timeline - cyclical 82 12.49 3.45 74 12.04 3.38 0.823 0.412 
Consequences 83 18.57 4.67 74 18.78 4.18 -0.298 0.766 
Personal Control 81 13.21 3.45 74 13.00 3.21 0.408 0.684 
Treatment control † 84 16.00 2.17 72 16.00 2.00 2922 0.710 
Coherence 84 10.53 4.21 75 11.24 4.03 -1.08 0.279 
Emotion 86 21.79 3.73 74 21.33 3.81 0.759 0.449 
 
  
Table 41 : Differences in illness representations relating to age of person who made call 
  
Younger 
(age < mean=53yrs) 
Older  
(age>mean=53yrs)     
  n mean SD n mean SD t p  
PWMC report patient identity† 82 5.00 3.75 63 4.00 3.00 2102.5 0.053 
PWMC report patient timeline- acute/chronic 81 14.04 4.03 62 14.76 3.79 -1.089 0.278 
PWMC report patient timeline - cyclical 81 12.35 3.73 62 12.00 3.27 0.586 0.559 
PWMC report patient consequences 82 18.58 4.78 63 19.41 4.23 -1.078 0.283 
PWMC report patient personal control 80 13.07 3.66 62 13.41 3.14 -0.582 0.561 
PWMC report patient treatment control† 83 14.33 4.00 64 14.00 4.00 2232.0 0.092 
PWMC report patient coherence 83 10.76 4.14 62 11.18 3.80 -0.617 0.538 
PWMC report patient emotion 85 21.95 3.76 62 21.51 3.62 0.714 0.477 
PWMC's personal control 80 12.35 3.42 64 11.63 3.78 1.204 0.231 
PWMC's coherence 83 11.38 4.56 63 11.84 4.20 -0.630 0.530 
PWMC's emotion 85 21.45 4.07 63 21.03 3.68 0.639 0.524 
 
 
 
 
 
                                               
†
 Non-parametric test, Median and  IQR reported.  
  
 
 
Table 42: Differences in illness representations by gender (t-tests) 
 Male Female   Difference     
   mean SD  mean SD t (95% C.I) p  
Identity †  4.0 3.50  5.00 4.00       0.233 
Timeline- acute/chronic  13.99 4.38  13.58 3.68 -0.64 (-1.71, 0.88)    0.525 
Timeline - cyclical  12.17 3.26  12.38 3.57 0.39 (-0.87, 1.30)    0.695 
Consequences  19.45 4.46  17.92 4.29 -2.20 (-2.91, -0.15)      0.029* 
Personal Control  13.48 3.40  12.75 3.24 -1.38 (-1.79, 0.32)     0.171 
Treatment control † 
 16.00 2.00  16.00 2.00         0.546 
Coherence  11.15 4.26  10.58 4.01 -0.87 (-1.86, 0.72)     0.387 
Emotion  21.19 3.97  21.97 3.51 -1.31 (-1.95, 0.39)     0.193 
                                               
†
 Non-parametric test, Median and  IQR reported.  
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7.8.2 Gender 
As already discussed, there were significant differences in illness 
representations relating to gender (see Table 42, above). Men reported 
significantly more serious consequences than women. 
7.8.3 Social deprivation 
The results of analysis exploring the relationship between illness 
representations and social deprivation are summarised in Table 43, below. 
Patients from areas of high social deprivation (i.e. DEPCAT classification 5-7) 
reported significantly higher identity scores than patients from areas of low 
deprivation (U=2279, p=0.005). 
Patients from areas of high deprivation also tended to report a more chronic 
timeline and more serious consequences in relation to their symptoms than 
those from areas of low deprivation although this did not reach statistical 
significance (p=0.074, p=0.082 respectively). Significant differences in the 
remaining illness representation subscales were not identified between the 
two groups. 
 
  
 
 
 
 
 
Table 43: Differences in illness representations by DEPCAT 
  
Low deprivation 
(DEPCAT 1-4) 
High deprivation 
(DEPCAT 5-7)     
  n mean SD n mean SD t p  
Identity† 90 4.00 3.00 59 5.00 3.00 2279 0.005* 
Timeline- acute/chronic 96 13.33 4.01 58 14.52 4.02 -1.798  0.074 
Timeline - cyclical 97 12.20 3.42 59 12.40 3.44 -0.351  0.726 
Consequences 99 18.20 4.54 58 19.47 4.15 -1.751  0.082 
Personal Control 97 13.24 3.26 58 12.91 3.46 0.591  0.555 
Treatment control † 90 16.00 2.00 59 16.00 2.00 2750.5  0.629 
Coherence 100 10.86 3.94 59 10.87 4.46 -0.015  0.988 
Emotion 100 21.58 3.88 60 21.56 3.61 0.034  0.973 
 
 
 
 
 
 
 
 
 
                                               
†
 Non-parametric test, Median and  IQR reported.  
  
 
 
 
 
 
 
Table 44: Illness representations and previous history of CHD 
  No history CHD History CHD   Difference     
  n mean SD n mean SD t (95% C.I) p  
Identity † 118 4.00 4.00 41 5.00 3.00  2419   1.000 
Timeline- 
acute/chronic 113 13.72 4.06 39 14.05 4.08 0.44 (-1.16, 1.82) 0.658 
Timeline - cyclical 114 12.05 3.48 40 13.09 3.14 1.67 (-1.19, 2.27) 0.097 
Consequences 114 18.18 4.70 41 20.04 3.39 2.69 (0.48, 3.22) 0.008 
Personal Control 112 13.03 3.19 41 13.20 3.64 0.28 (-1.03, 1.37) 0.779 
Treatment control † 115 16.00 2.00 39 16.00 2.00 2240    0.991 
Coherence 116 10.09 3.90 41 13.01 4.16 4.04 (1.49 - 4.33) <0.001 
Emotion 118 21.65 3.75 40 21.53 3.82 -0.19 (-1.49, 1.23) 0.852 
                                               
†
 Non-parametric test, Median and  IQR reported.  
  238 
7.8.4 Previous history of CHD 
The illness representations of those with a previous history of CHD differed 
significantly from those without (see Table 44, above). Participants with a 
history of CHD reported significantly more serious consequences (p=.008), 
greater coherence (p<0.001) and also tended to report symptoms of a more 
cyclical nature (p=.097) than those without a previous history of CHD. 
Patients (χ2 (df=1) = 4.458, p=0.035) and the PWMC (χ2 (df=1) = 4.623, 
p=0.032) were also significantly more likely to identify the heart as the most 
likely cause of the symptoms when the patient had a previous history of 
CHD. 
7.8.5 Outcome of call to NHS 24 
Significant differences were identified between the illness representations of 
patients who received an emergency response to their call and those who did 
not. These are summarised in Table 45, below and show that patients who 
received an emergency response reported significantly more serious 
consequences than those who did not (t=2.67, p=0.008).  
 
  
 
 
 
 
 
Table 45: Differences in illness representations by outcome of call to NHS 24 (t-tests) 
  Emergency outcome   
Non-emergency 
outcome   Difference     
  n mean SD   n mean SD t (95% C.I) p  
Identity† 136 4.00 4.00  25 5.0 3.8      0.783   
Timeline- acute/chronic 131 13.77 4.13  39 13.8 3.5 -0.06 (-1.16, 1.82)    0.952 
Timeline - cyclical 133 12.18 3.28  40 12.9 4.1 -0.90 (-1.19, 2.27)   0.370 
Consequences 134 19.05 4.36  41 16.4 4.3 2.67 (0.48, 3.22) 0.008* 
Personal Control 132 13.21 3.41  41 12.6 2.8 0.87 (-1.03, 1.37)   0.384 
Treatment control † 133 16.00 2.00  23 15.0 3.0       0.188 
Coherence 135 10.90 4.10  41 10.7 4.4 0.24 (1.49, 4.33)   0.814 
Emotion 136 21.73 3.74   40 20.7 3.9 1.26 (-1.49, 1.23)   0.209 
                                               
†
 Non-parametric test, Median and  IQR reported.  
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7.9 Comparison of patients’ and callers’ illness 
representations 
Where both the patient and the person who called on their behalf completed 
the IPQ-R (n=45) there was an opportunity to compare the two 
representations of the same illness episode. Spearman’s correlations were 
used to explore the relationship between patients’ and callers’ illness 
representations. Paired t-tests (and where appropriate the Wilcoxon signed 
ranks test) were used to explore differences between patient and caller 
scores for each subscale of the IPQ-R.  
Dissimilarity scores were created by subtracting callers’ scores from patients’ 
scores and Spearman’s correlations used to explore the relationship between 
dissimilarity scores and the various measures of decision time. 
7.9.1 Correlations 
Callers’ reports of patients’ illness representations were highly correlated with 
patients’ own on all IPQ-R subscales with the exception of treatment control, 
(see Table 47, below). Similarly, callers’ reports of their own personal control, 
coherence and emotion relating to the patient’s illness were highly correlated 
with the patients’ own.
  
 
 
Table 46: Spearman correlations between patient and caller IPQ-R scores. 
  Patient  
   Identity Timeline-a/c Timeline-cyc. Consequences Personal Ctrl Treatment Ctrl Coherence Emotion p 
Identity 0.845        0.000* 
Timeline- 
acute/chronic  0.602       0.000* 
Timeline - cyclical   0.568      0.000* 
Consequences    0.660     0.000* 
Personal Control     0.616    0.000* 
Treatment control      0.122   0.430 
Coherence       0.618  0.000* 
Emotion        0.560 0.000* 
Caller's personal 
control     0.508    0.000* 
Caller's coherence       0.703  0.000* 
C
a
l
l
e
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Caller's emotion               0.319 0.037* 
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7.9.2 Differences 
As can be seen in Table 47, below, no significant differences were found 
between patient and caller reports of the number of symptoms which related to 
the call (identity score). Caller’s timeline-acute/chronic scores were found to be 
significantly higher (Mean=15.0, SD=4.2) than patients (Mean=13.47, SD= 
4.32) (high timeline scores reflect beliefs that symptoms will last a long time 
and low scores that symptoms will be short-lived). However, no significant 
differences were found between patient and caller timeline-cyclic scores.  
Callers tended to report higher consequence scores (Mean=19.7, SD=4.8) 
than patients (Mean=18.51, SD=4.7) but this did not reach statistical 
significance (t (43) =-1.933, p=.06). 
Callers’ reports of patients’ level of personal control were not significantly 
different from the patient’s own report. However, callers’ treatment control 
scores were significantly lower (Median=12.0, IQR=1.5) than patients’ 
(Median=15.0, IQR=2.0), t =2, p=<.001). 
Callers’ reports of patients’ levels of coherence and emotion were not 
significantly different from the patient’s own report. 
However, callers’ reports of their own level of personal control were 
significantly lower (Mean=9.61, SD=3.0) than patients’ own (Mean=12.54, 
SD=3.82) (t (43) =-5.618, p=<.01). Callers’ ratings of their own level of 
coherence were significantly higher (Mean=13.1. SD=4.6) than patients’ 
(Mean=11.23, SD=4.13) (t (42) =-3.5, p=<.01).  Callers’ and patients’ reports of 
their own emotion did not differ significantly.
  
.  
Table 47: Comparison of patient and caller illness representations: paired t-tests 
    
Patient Caller 
    Difference     
    mean SD mean  SD t df (95% C.I) p  
Identity† n=37 4.00 3.75 4.0 3.0 -1.27    0.206 
Timeline-acute/chronic n=41 13.5 4.32 15.0 4.2 -2.56 40 (-2.72, -0.32) 0.014* 
Timeline - cyclic n=43 11.7 3.07 11.5 3.5 0.56 42 (-0.73, 1.17)  0.647 
Consequences n=44 18.5 4.70 19.7 4.8 -1.93 43 (-2.34, 0.49)  0.060 
Personal Control n=43 12.7 3.78 12.6 4.1 0.02 42 (-1.05, 1.07)  0.982 
Treatment control† n=44 15.0 2.00 12.0 0.0 -5.14   <0.001* 
Coherence n=43 11.2 4.13 11.6 3.7 -0.62 42 (-1.38, 0.73)  0.538 
Emotion n=43 21.5 3.97 22.1 3.5 -1.00 42 (-1.60, 0.55)  0.328 
 
         
Callers personal control n=44 12.5 3.82 9.61 3.0 5.62 43 (1.88, 3.98) <0.001* 
Callers coherence n=43 11.2 4.13 13.1 4.6 -3.50 42 (-2.88, -0.79) 0.001* 
Callers emotion n=43 21.5 3.97 21.0 3.9 0.87 42 (-0.87, 1.95)  0.445 
        † Mann-Whitney U, Median and IQR 
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7.9.3 Dissimilarity 
A measure of the dissimilarity between callers’ and patients’ illness 
representations was created by subtracting callers’ scores from patients’. 
Thus for each construct, positive dissimilarity scores reflected higher scores 
by the patient and negative dissimilarity scores reflected higher caller scores. 
Correlations between dissimilarity scores and the various measures of 
decision time were then performed, results are summarised in the tables   
below.  
Table 48: Correlations between dissimilarity scores and total patient delay 
 
N rs p 
Identity 30 .125 .511 
Timeline- acute/chronic 34 .174 .324 
Timeline - cyclical 35 .146 .403 
Consequences 36 -.091 .598 
Personal Control 36 .110 .522 
Treatment control 36 .107 .535 
Coherence 36 .039 .823 
Emotion 36 -.208 .224 
Caller personal control 36 -.032 .854 
Caller coherence 36 .183 .286 
Caller emotion 36 .008 .965 
 
 
Table 49: Correlations between dissimilarity scores and appraisal delay 
 
N rs p 
Identity 32 .251 .166 
Timeline- acute/chronic 36 .036 .836 
Timeline - cyclical 37 .275 .099 
Consequences 38 -.140 .401 
Personal Control 37 .155 .361 
Treatment control 38 -.014 .932 
Coherence 37 .074 .662 
Emotion 37 -.300 .071 
Caller personal control 38 -.015 .928 
Caller coherence 37 .302 .070 
Caller emotion 37 -.141 .406 
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Table 50: Correlations between dissimilarity scores and illness delay 
 
N rs p 
Identity 25 -.090 .670 
Timeline- acute/chronic 27 .061 .761 
Timeline - cyclical 27 .142 .479 
Consequences 28 .088 .657 
Personal Control 28 .119 .548 
Treatment control 28 -.073 .712 
Coherence 28 -.208 .289 
Emotion 28 .223 .255 
Caller personal control 28 -.144 .466 
Caller coherence 28 .119 .546 
Caller emotion 28 .210 .284 
 
 
Table 51: Correlations between dissimilarity scores and decision time obtained from call 
 
N rs p 
Identity 19 .199    .413   
Timeline- acute/chronic 21 -.124    .593 
Timeline - cyclical 21 .123    .596 
Consequences 22 -.241    .280 
Personal Control 22 .226    .312 
Treatment control 23 -.073    .741 
Coherence 22 .266    .231 
Emotion 22 .141    .532 
Caller personal control 22 .441 .040* 
Caller coherence 22 .166    .461 
Caller emotion 22 .068    .763 
 
No significant correlations were identified between dissimilarity scores for any 
of the subscales of the IPQ-R and either total patient delay or illness delay. 
However, a negative correlation approaching significance was identified 
between dissimilarities in scores relating to the patient’s emotion and 
appraisal time. In other words there tended to be shorter appraisal time 
where callers reported higher patient emotion than did the patient. There was 
also a positive correlation approaching significance between dissimilarity 
scores in relation to patients’ and callers’ level of coherence. In other words 
appraisal time was longer where callers reported a higher level of coherence 
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than patients.  
With regard to the delay reported during the call to NHS 24, a significant 
positive correlation (p=.040) was identified between dissimilarity scores in 
relation to patients’ and callers’ reported level of personal control. Longer 
decision times were reported during the call where callers reported more 
personal control than patients.  
 
7.10 Comparison of data derived from call-recording with 
questionnaire. 
Where the patient gave permission for their original call-recording to be 
analysed, their was also an opportunity to compare what people presented 
regarding symptoms and timings at the time of the call with what they later 
reported on the IPQ. 
Overall, 167 patients gave consent for their call to be analysed. Technical 
difficulties meant that access to 2 calls was not achieved. Thus data 
regarding the symptoms mentioned during the call was available for 165 
patients.  
References within the call to the symptoms listed on the IPQ-R were 
identified and an identity score derived from the call calculated. Hereafter, 
this is referred to as call-identity. Call-identity scores ranged between 1 and 
9, Mdn= 3, IQR=3.   
However, participants also mentioned within the call, symptoms which did not 
relate to those listed on the IPQ-R. Therefore an additional identity score 
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referring to the total number of symptoms mentioned during the call was 
calculated and referred to as total call-identity. Total call-identity scores 
ranged between 2 and13, (Mdn=6, IQR=3). Call identity and the number of 
additional symptoms were significantly correlated (rs=0.205, p=0.008).   
No significant correlation was found between call-identity and the IPQ-R 
identity scores of the person who made the call (i.e. the same person who 
was describing the symptoms during the call) (rs=-0.001, p=0.992). However, 
total call-identity and the IPQ-R identity score of the person who made the 
call were significantly but weakly correlated (rs=0.173, p=0.031). 
Wilcoxon’s signed ranks test was used compare the various scores of identity 
for the person who made the call. Call-identity scores were found to be 
significantly lower (Mdn=3.0) than IPQ-R identity scores (Mdn=4.0) (z=-
4.530, p=<0.001) which in turn were significantly lower than total call-identity 
scores (Mdn=6.0) (z=5.598, p=<0.001). 
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Figure 22: Comparison of IPQ-R identity with scores obtained from call recording 
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As discussed previously, data regarding the timings of symptoms, mentioned 
during the call were available for 156 patients. However, this was precise 
enough to be compared with questionnaire data for only 101 patients. 
Delay times reported during the call were significantly correlated with 
questionnaire reports of total patient delay (rs=0.475, p=<0.001); appraisal 
time (rs =0.608, p=<0.001) and illness delay (rs =0.362, p=0.001).  
Wilcoxon’s signed ranks test was used compare call decision time with total 
patient delay and illness delay as measured on the questionnaire. Illness 
delay (Mdn=1.25 hours) was significantly less than call-decision time 
(Mdn=1.5 hours) (z=-2.941, p=0.003) which in turn was significantly less than 
total patient delay (Mdn=4.4 hours) (z=-4.854, p=<0.001). 
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7.11 Illness representations and clinical outcome at 3 
months.  
Permission to obtain outcome data from GPs, 3 months after the call was 
provided by 159 of the 182 patients. Figure 23, below provides a summary of 
the collection of this data. 
The GPs of 133 patients responded (73%) and the requested data was 
available for 119. Thus outcome data was available for 75% of the patients 
who had consented to it being collected. 
Reasons for the data not being available included GPs’ requirement for 
written consent (which was not available as consent was obtained verbally 
and audio-recorded) prior to release of patient information (n=8); the patient 
no longer being registered at the practice (n=5) and a requirement for 
financial reimbursement from 1 practice. 
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Figure 23: Collection of outcome data from GPs 
A total of 78 patients received a diagnosis regarding their symptoms. Those 
who did received a wide variety of diagnoses (e.g. ACS, musculoskeletal, 
gastro-intestinal, Chronic Obstructive Pulmonary Disease). Those relating to 
ACS were identified (i.e. a diagnoses of angina, MI or ACS, n=24). 
t-tests and where appropriate Mann-Whitney tests were used to explore 
whether the illness representations of patients who received a diagnosis of 
ACS differed from those who did not (or where appropriate the illness 
representations of the person who made the call).  
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7.11.1 Patient 
Demographic and clinical 
Patients who received a diagnosis of ACS were significantly older (mean age 
=62 years) than those who did not (mean age =51 years) (t=4.149, p<.001). 
There were no significant differences in the proportions of men and women 
who received a diagnosis of ACS (χ2 (df=1) =2.125, p=0.145) or in those from 
areas of high and low deprivation (χ2 (df=1) = 0.059, p=0.809). 
A greater proportion of those with a previous history of CHD received a 
diagnosis of ACS than those with no previous history (χ2 (df=1) =12.054, 
p=0.001). However, there were no significant differences between those with 
diabetes and those without (χ2 (df=1) =0.003, p=1.00). Those who received a 
diagnosis of ACS had made significantly fewer previous calls to NHS 24 than 
those who did not receive a diagnosis of ACS (U=815.5, p=0.041).  
Illness representations 
As can be seen in Table 52 below, there were no significant differences in 
patients’ illness representations between the two groups except for 
coherence. Patients who received an ACS diagnosis reported significantly 
higher coherence scores (Mean=13.39, SD=3.23) than those who did not 
(Mean=10.35, SD=4.17) (t=3.24 (95% CI: 1.18, 4.90) p=0.002). 
  
 
 
Table 52: Differences in IPQ-R scores by diagnosis of ACS - patients 
  ACS Not ACS       
 (n=24) (n=116)  Difference    
  mean (SD) t (95% C.I) p  
Identity† 4.00 (4.00) 5.00 (4.00) 887  0.594 
Timeline- acute/chronic 12.71 (4.22) 14.04 (3.90) -1.374 (-3.24, 0.59) 0.172 
Timeline - cyclic 12.40 (2.83) 12.26 (3.47) 0.185 (-1.39, 1.67) 0.853 
Consequences 19.76 (4.38) 18.41 (4.53) 1.271 (-0.75, 3.44) 0.206 
Personal Control 13.68 (2.60) 13.24 (3.14) 0.602 (-0.99, 1.85) 0.549 
Treatment control† 16.00 (1.50) 16.00 (2.83) 868  0.355 
Coherence 13.39 (3.23) 10.35 (4.17) 3.239 (1.18, 4.90)   0.002* 
Emotion 20.79 (3.89) 21.50 (3.77) -0.807 (-2.43, 1.03) 0.421 
† Mann-Whitney U, Median and IQR
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However, patients who reported the heart as the most important likely cause 
of their symptoms tended to be more likely than those who identified other 
causes to receive a cardiac diagnosis although this did not quite reach 
statistical significance (χ2 (df=1) = 3.469, p=0.063). 
A logistic regression analysis was performed with ACS diagnosis as the 
dependent variable and age, history of CHD, number of previous calls to 
NHS 24, cardiac cause and coherence score as predictor variables. A total of 
108 cases were analysed and the full model predicted ACS diagnosis 
(omnibus chi-square = 30.652, df=5, p<0.001). The model accounted for 
between 25% and 38% of variance in ACS diagnosis, successfully predicting 
95% of patients who did not receive a diagnosis and 52% of those who did. 
Overall, 86% of predictions were accurate. Table 53 gives coefficients and 
the Wald statistic for each of the predictor variables. This shows that age and 
coherence score reliably predicted ACS diagnosis. 
 
Table 53: Logistic regression analysis: ACS diagnosis 
  
B SE Wald df p 
Age 0.055 0.028 3.889 1 0.049* 
Previous history CHD 0.806 0.670 1.449 1  0.229 
No. of previous calls NHS 24 0.194 0.120 2.619 1  0.106 
Cardiac cause 0.762 0.626 1.481 1  0.224 
Coherence score 0.167 0.074 5.048 1 0.025* 
Constant -6.327 1.953 10.50 1 0.001* 
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7.11.2 Person who made call IPQ-R 
Demographics 
Illness representations 
The PWMC reported significantly higher consequences and coherence (both 
their own and that of the patient) where the patient received a diagnosis of 
ACS than where they did not, see Table 54, below. There were no significant 
differences relating to identity, timeline-acute/chronic or timeline-cyclical 
scores, and personal or treatment control.   
The proportion of patients receiving a cardiac diagnosis for their symptoms 
was not significantly different where the person who made the call had 
reported the heart as the most important likely cause of their symptoms and 
where they had identified other likely causes on the IPQ-R (χ2 (df=1) = 2.99, 
p=0.083). 
  
 
 
 
 
 
Table 54: Differences in IPQ-R scores by diagnosis of ACS – person who made call 
  ACS No ACS       
 (n=24) (n=92)  Difference    
  mean (SD) t (95% C.I) p  
PWMC report patient identity† 5.00 (4.50) 4.00 (3.00) 711.0   0.820 
PWMC report patient timeline- acu/chr 14.09 (3.77) 14.15 (3.86) -.067 (-1.96, 1.83)  0.947 
PWMC report patient timeline - cyclical 12.74 (2.95) 12.09 (3.69) 0.769 (-1.03, 2.34)  0.444 
PWMC report patient consequences 20.40 (4.00) 17.99 (4.84) 2.117 (0.15, 4.66) 0.037* 
PWMC report patient personal control 13.95 (2.16) 13.46 (3.40) 0.630 (-1.07, 2.06)  0.531 
PWMC report patient treatment control† 15.00 (4.00) 14.00 (4.00) 775.5   0.642 
PWMC report patient coherence 12.86 (3.51) 10.62 (3.94) 2.334 (0.33, 4.13) 0.022* 
PWMC report patient emotion 20.59 (3.81) 21.41 (3.80) -0.885 (-2.66, 1.02)  0.379 
 
     
PWMC's personal control 12.09 (3.54) 12.50 (3.35) -0.497 (-2.06, 1.23)  0.620 
PWMC's coherence 13.62 (3.69) 11.00 (4.30) 2.520 (0.55, 4.67)  0.014* 
PWMC's emotion 20.00 (3.82) 21.20 (4.01) -1.242 (-3.12, 0.72)  0.452 
†Mann-Whitney U, Median and IQR
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7.12 Discussion 
The main aim of the study was to explore if illness representations explained 
variance in decision time additional to that explained by demographic and 
clinical factors. The relationship between these factors and 4 different 
measures of decision time was explored.  Different factors were identified as 
significant for various components of decision time. These are summarised in 
Table 55 and discussed further below.  
Firstly, the results regarding the length of decision time are discussed and 
compared with previous findings in comparable patient groups. The 
relationship between demographic factors, clinical factors and illness 
representations and the various measures of decision time are then 
discussed in turn. Finally the overall strengths and limitations of the study are 
examined.  
 
  
 
Table 55: Summary of factors associated with delay > 2 hours or diagnosis of ACS 
  Delay >2hours Diagnosis  
  
Total Appraisal Illness Call ACS  
Patient 
     
  
Age ~ ~ ~ ~ ↑ Age  
Gender ~ Female  ~ ~ ~  
DEPCAT ↑ Deprivation ~ ~ ~ ~  
Ethnic group ~ ~ ~ ~ ~   
      
  
History CHD ~ ~ ~ ~ Previous CHD  
Diabetes ~ ~ ~ ~ ~  
1st call to NHS 24 ~ ~ 1st call 1st call ↓ previous calls 
Emergency outcome ~ Non-emergency Non-emergency  ~  ~  
Caller  ~ ~ ~ ~  ~  
        
Identity ~ ↑ identity (p=.061) ~ ~ ~ 
Timeline acute/chronic ~ ~ ~ ~ ~ 
Timeline cyclic ~ ~ ~ ~ ~ 
Cause ~ ~ Non-cardiac cause ~ Non-cardiac (p=.063) 
Consequences ~ ↓ consequences (p=.076) ~ ~ ~ 
Personal control ~ ~ ~ ~ ~ 
Treatment control ~ ~ ~ ~ ~ 
Coherence ~ ~ ~ ~ ↑ Coherence 
Emotion ~ ↓ Emotion ~ ~ ~ 
 
      (table continued on next page) 
 
 
 
↑ - higher 
 
↓ - lower / less 
 
~ - ns. result 
 
  
 
 
 
 
 
 
 
  
Delay >2hours Diagnosis  
 
Total Appraisal Illness  Call ACS 
PWMC 
 
      
Age ~ ~ ~ ~   
Gender ~ ~ ~ ~   
Ethnic group ~ ~ ~ ~   
        
Identity ~ ~ ~ ~ ~ 
Timeline acute/chronic ~ ~ ~ ~ ~ 
Timeline cyclic ↑ cyclic (p=.07) ~ ~ ~ ~ 
Cause ~ ~ ~ ~ ~ 
Consequences ~ ~ ~ ~ ↑ Consequences 
personal control ~ ~ ~ ~ ~ 
Treatment control ~ ~ ↑ treatment control ~ ~ 
Coherence ~ ~ ~ ~ ↑ Coherence 
Emotion ~ ↓ Emotion ~ ~ ~ 
 
↑ - higher 
 
↓ - lower / less 
 
~ - ns. result 
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7.12.1 Decision times 
Total patient delay, the time between symptom onset and the first call to a 
health professional was on average 4 hours. This is similar to the pre-hospital 
time reported by Grossman et al (2003) amongst patients with possible 
symptoms of ACS. It is also comparable with previous reports of studies 
relating to MI (Canto et al.  2000; Dracup et al.  2003) and ACS (Goldberg et 
al.  2002b; Rasmussen et al.  2003).   
Thus this study provides contemporary evidence that average decision times 
remain significantly out-with what would be considered ideal (<1 hour). Only 
11% of participants in this study reported total delay times of less than 60 
minutes. That this remains true amongst callers to an apparently low threshold 
service like NHS 24 is of even more concern. It suggests that the introduction 
of a 24-hour helpline has done little to reduce delay in this group. Previous 
research suggests that people feel less concerned about contacting their GP 
than they would calling an ambulance (Birkhead, 1992; Leslie et al.  2000) and 
that much delay is related to concern about calling an ambulance (Finnegan et 
al.  2000; Pattenden et al.  2002). 
Appraisal delay, or the time taken by the patient to decide that symptoms are 
of concern, was on average 2 hours. Illness delay (the time taken from 
deciding that symptoms were concerning and actually contacting health 
services) was on average 75 minutes. These results suggest that appraisal 
time accounts for the majority of delay and should be a priority for intervention. 
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However, even after people decide that symptoms are a matter of concern the 
current study demonstrates that there is still significant delay before health 
services are contacted.   
Despite widespread reference to the work of Safer et al (1979), surprisingly few 
other studies have reported appraisal and illness delay. As discussed earlier in 
Chapter 2, most have measured total pre-hospital time which includes 
transportation to hospital. The remainder have measured patient decision time 
but have not differentiated appraisal and illness delay.  
Breakdown of the different components of patient decision time is an important 
area for future research in order to inform interventions aimed at reducing 
delay. The evidence suggests the key determinants of appraisal and illness 
delay might be different. Interventions could be developed that aim to reduce 
one or both aspects of delay. These might address illness representations and 
beliefs about use of health services as well as the nature of symptoms. Having 
an impact on both components of decision time could potentially be more 
effective in reducing delay.   
7.12.2 Relationship between demographic factors and decision 
time  
Age 
Previous studies have identified a link between patient delay in ACS and age 
(GISSI, 1995; Goff et al.  1999; Goldberg et al.  2000; Goldberg et al.  2002b). 
However, several others (Burnett et al.  1995; Horne et al.  2000; Ottesen et al.  
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2004) have found no such link. In common with these, the current study did not 
identify a relationship between the age of the patient or PWMC and any of the 
measures of decision time. Nor did younger and older participants in the 
current study differ significantly in their illness representations. 
Gender 
Appraisal time was found to differ significantly in relation to the gender of the 
patient being significantly shorter when the patient was male. These findings 
are consistent with previous research which has identified longer pre-hospital 
time for women with MI (Gibler et al.  2002) and other ACS (Goldberg et al.  
2002b). However, others have suggested that extended pre-hospital times are 
accounted for by physician and transport delays and that patient decision time 
does not differ between men and women (Ottesen et al.  2004). The results of 
this study do not support this and instead suggest that there are significant 
differences in how men and women come to be concerned about their 
symptoms. It has been suggested that the increased delay amongst women 
may be related to a gender bias regarding perceptions of susceptibility to CHD 
(van Tiel et al.  1998; McGee et al.  2000). Indeed, illness representation data 
from the current study support this hypothesis. Men reported significantly more 
serious consequences in relation to their symptoms than did women. In logistic 
regression analysis only illness representations emerged as significant 
predictors of delay category. Thus differences in illness representation appear 
to underlie the gender difference in decision time. 
It may be important for future interventions aimed at reducing delay to have an 
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element of the campaign specifically targeting the illness representations of 
women.  
Ethnic group 
Despite achieving representation of people from minority ethnic groups in 
approximate proportion to the overall population of Scotland, the numbers 
included in individual analysis were small. It was therefore not possible to 
perform statistical analysis and draw conclusions about the influence of ethnic 
group from this data. However, none of the 3 participants of non-white ethnic 
group reported total delay times of less than 2 hours.   
This pattern is consistent with previous studies which have reported longer pre-
hospital times amongst patients of non-white ethnic group (Goldberg et al.  
1999; Gibler et al.  2002). Others have concluded that delays to treatment for 
people of non-white ethnic group are due to barriers at the level of healthcare 
provision (Adamson et al.  2003). The results from the few cases presented 
here suggest that differences could be evident even before people enter the 
healthcare system. This is an important area for future research. Further 
studies, using methodologies which ensure adequate representation of people 
of non-white ethnic group would be helpful in improving understanding of this 
issue. This might help to reduce inequalities associated with particular ethnic 
groups.  
Social deprivation 
When total patient delay was examined, a higher proportion of patients from 
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deprived areas were found to delay> 2 hours than <2hours. Previous work has 
identified a similar pattern (i.e. high deprivation associated with longer delay) 
(Sheifer et al.  2000) although a study using the same measures of socio-
economic status and decision time as the current study could not be identified 
for direct comparison.  
The results of the current study show that there are important differences in 
illness representations between people from areas of high and low social 
deprivation. Patients from areas of high social deprivation reported significantly 
higher identity scores than patients from areas of low deprivation and also 
tended to report a more chronic timeline and more serious consequences in 
relation to their symptoms than those from areas of low deprivation.  
Previous work has suggested that higher prevalence of CHD in more deprived 
areas may lead to normalisation of symptoms such as chest pain and a 
tendency not to present to health services (Richards et al.  2002).  Leventhal et 
al (2007) have recently identified both symptom novelty and social comparison 
amongst 13 heuristics or ‘rules of thumb’ which they suggest people use to 
translate somatic change into the illness representations which then 
subsequently guide coping (Leventhal et al.  2007). Thus, the presence of a 
number of symptoms, expected to be chronic in nature may not be novel 
enough amongst people in areas of deprivation to prompt people to seek help, 
despite recognition that they could have serious consequences.  
This is an important area for further research. It is important to improve our 
understanding of the underlying mechanisms that link decision time and social 
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deprivation.  It may be beneficial for an intervention aimed at reducing delay to 
be targeted specifically toward areas of deprivation. Reducing delay could help 
improve outcomes for people living in these areas who experience the poorest 
outcomes from CHD (Scottish Executive, 2004). It is also important to further 
our understanding of the processes that underlie the development of illness 
representations as this is likely to be of key importance in the development of 
interventions aimed at influencing representations or coping.   
7.12.3 Relationship between clinical factors and decision time  
Past medical history of CHD 
Consistent with the findings of Dracup & Moser (1997) and others (see page 
30), patients with a known history of CHD did not differ significantly from 
patients without such a history on any of the measures of decision time. Data 
were not available regarding the precise nature of patients’ previous CHD 
diagnosis and so comparisons with the differing results of studies pertaining to 
particular diagnostic groups were not possible.  
Those with a previous history of CHD are at greatest risk of further acute 
events and should have been informed by healthcare professionals of the need 
for prompt action in the event of symptoms suggestive of ACS (Lewin, 1997).  
However, the data in this study confirm the important finding that people with a 
history of CHD do not seek medical help for symptoms more quickly than 
others and suggests more effective interventions to reduce delay are required. 
There are a number of possible explanations.   
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Despite having a history of CHD the symptoms patients experience may 
nevertheless be ambiguous and difficult to attribute to the heart (Burnett et al.  
1995; O'Carroll et al.  2001; Carney et al.  2002). Indeed, only 36% of the 
patients with a history of CHD identified the heart as the most important likely 
cause of the symptoms they were contacting NHS 24 about (symptoms which 
were subsequently classified as possible symptoms of ACS by the 
investigator). Patients suspicions tended to be confirmed as a larger proportion 
of patients who suspected a cardiac cause received a diagnosis of ACS than 
those who did not although this did not reach statistical significance (p=0.063). 
Patients with a previous history of CHD may have medications such as 
glyceryl-trinitrate spray at their disposal. Attempts to self-manage symptoms 
using such medications may contribute to prolonged decision time 
(Schoenberg et al.  2004). No significant differences in either treatment control 
or personal control were identified between those with and without a history of 
CHD (see Table 44, page 237) in the current study but PWMC with longer 
illness delay tended to report high treatment control suggesting that attempts to 
self-manage symptoms may contribute to delay.  
In addition, patients with a history of angina may experience heart-related 
symptoms fairly frequently and it may be difficult to distinguish a new acute 
event or worsening, unstable symptoms against such a background of chronic 
symptoms. Indeed, within the current study, patients with a history of CHD did 
tend to report symptoms of a more cyclical nature than those without such a 
history (p=.097).   
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A limitation of the current study was that data regarding the history of CHD was 
obtained from NHS 24 files which obtained the data from the patient. Thus 
there is a possibility that the data was inaccurate or out-of-date. It is therefore 
possible that patients who did in fact have CHD were included in the group 
who did not have a history and vice-versa. However, given the nature of the 
symptoms the selected sample presented to NHS 24 it is considered highly 
unlikely that the nurse would not have enquired specifically about a CHD 
history at the time of the call and thus likely that the data were reliable and 
current. 
This study provides important evidence that the illness representations of those 
with a previous history of CHD differed significantly from those without (see 
Table 44, page 237). Participants with a history of CHD reported significantly 
more serious consequences (p=.008), greater coherence (p<0.001) whilst 
tending to report symptoms of a more cyclical nature (p=.097). Nevertheless, 
delay times were not significantly different amongst this group than amongst 
those with no history of CHD. Thus the relationship between illness 
representations and the decision to seek medical help requires further 
exploration. In particular more attention to coping procedures may be 
warranted. 
Diabetes 
Contrary to much of the published evidence (see page 29), the current study 
did not identify significant differences in decision time between people with 
diabetes and those without. It is considered that this is most probably due to 
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differences in the population being studied. Within the current study, patients 
seeking help with symptoms which were possibly those of ACS were identified. 
This ensured that the sample was not restricted only to those with chest pain 
but included those reporting other presentations (e.g. breathlessness). 
Explanations that have been proposed to explain extended decision times 
amongst people with diabetes are that they are more likely to experience 
atypical symptoms (i.e. no chest pain) (Canto et al.  2000) or that due to 
neuropathy their perception of chest pain, if it occurs, differs from those without 
diabetes (Ambepityia et al.  1990; Umachandran et al.  1991). Thus, it would 
follow that when other presentations are considered there are no significant 
differences between people with diabetes and those without. Within, the 
current sample the proportion of participants presenting with and without pain 
were not significantly different between those with diabetes and those without 
(χ2 (df=1) = 0.815, p = 0.685).  
People with diabetes are at increased risk of CHD and in regular contact with 
health services. It might therefore be expected that they would have increased 
awareness of the need to seek help promptly in the event of possible 
symptoms of ACS. These results would suggest the behaviour of people with 
diabetes is no different from the general population and thus would suggest 
that this group might also benefit from targeted intervention.   
Previous use of NHS 24 
An interesting result was found in relation to people’s previous use of NHS 24. 
Those who were calling NHS 24 for the first time had significantly longer illness 
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delay (on average >30 minutes greater) than those who had called before. This 
meant that after deciding that symptoms were of concern, people who had not 
contacted NHS 24 previously took on average 30 minutes longer to make the 
call. This significant additional delay could have important implications in the 
context of symptoms of ACS and other serious conditions. The increased delay 
may be due to unfamiliarity with the correct telephone number or the 
appropriate procedure for accessing medical care out of hours.  Fear of using 
services inappropriately or being unfamiliar with correct procedure have 
previously been cited as reasons for delay (Pattenden et al.  2002).  People 
who have not called NHS 24 before might be concerned about appropriate use 
of the service and thus hesitate before calling. This may have important 
implications for how people are informed about how to access the service. 
Current campaigns emphasise the importance of contacting the service only 
with symptoms which cannot wait until morning, explaining that this allows the 
busy service to respond better to people with very serious symptoms (see 
Appendix 46). This may have the unintended consequence of making even 
those with serious symptoms hesitate about calling.  
These findings suggest it would be beneficial for patients at high risk of CHD 
(and indeed the public in general) to be informed about how to contact their 
doctor at times when the surgery is closed. It may also be useful for people, 
particularly those at increased risk of ACS, to make initial contact with NHS 24 
at a time they are not experiencing serious symptoms in order to familiarise 
themselves with the process and thus reduce delay at a time when their 
symptoms are urgent. There is evidence that people tend to contact their GP 
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more readily than they would call for an ambulance (Birkhead, 1992; Leslie et 
al.  2000) and yet the results of the current study suggest there are still 
significant delays. It is also possible that adverse publicity about the quality of 
care delivered by NHS 24 (see Appendix 2) may also have contributed to delay 
amongst people contacting the service for the first time. 
It would be interesting to compare illness delay amongst those contacting the 
various emergency services available to explore how patients’ thresholds for 
contact differ and to establish more precisely the effect of previous use of 
emergency services on illness delay. Such an investigation might also usefully 
inform interventions aimed at reducing delay. If people’s thresholds for 
contacting the ambulance service are higher than for other services and thus 
contributing to delay, a campaign which encouraged people to seek help via a 
lower-threshold service (e.g. NHS 24)  in the first instance, could result in 
shorter overall delays (despite the additional time required to assess and 
transfer the patient).  
Outcome of call to NHS 24 
Patients who received an ambulance in response to their call to NHS 24 
reported significantly shorter appraisal times than did those who did not. 
Similarly, a significantly greater proportion of those with illness delay of <2 
hours received an emergency response as a result of their call than those who 
delayed > 2 hours. A possible explanation is that people experiencing very 
serious symptoms of the nature that necessitates an emergency response 
become concerned about their symptoms quickly and then seek help quickly. 
  270 
Indeed, patients with appraisal times < 2 hours tended to report more serious 
consequences than those with longer appraisal times although this was not 
statistically significant.  However, if this were universally the case then there 
would not be a problem with delay in the context of ACS.  Another possible 
explanation is that NHS 24 nurses responded to patients’ level of concern, 
rather than the seriousness of their symptoms and were more likely to provide 
an emergency response to patients who became concerned very soon after 
the onset of their symptoms or who sought help quickly. Those who received 
an emergency response did have higher mean emotion scores than patients 
who did not although the difference between the two was not statistically 
significant. This is worthy of further exploration as it is not clear if responding to 
the emotional response of patients/callers would lead to more or less 
appropriate clinical decisions. If nurses tend to provide less urgent responses 
to patients who have already delayed it is possible that they may compound 
further pre-hospital delay by adding to utilisation delay. In this study, no 
relationship was found between the emotion scores of patients or callers and 
whether or not a diagnosis of ACS was made.  
Involvement of a caller 
No difference in any of the measures of decision time was found between 
patients who made the call themselves and those where someone else made 
the call on behalf of the patient.  Nor was the proportion of calls involving a 
third party different when delayers and non-delayers were compared. These 
results would suggest that a third party has little influence on decision time. 
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This appears inconsistent with the conclusions of other authors who have 
reported that for many patients (44%) the decision to seek medical help was 
made by someone else (Horne et al.  2000) and that the presence of a third 
party is associated with reduced delay (GISSI, 1995; Dracup and Moser, 
1997). However, it is important to be clear that whether or not a caller was 
involved in the original call to NHS 24 is not a comprehensive measure of the 
influence of others. It is possible that even where the patient made the call 
themselves that this was actually prompted by a third party. Similarly, the caller 
making the call on behalf of the patient may have been prompted by an 
additional individual or by the patient themselves.  
Furthermore, it has been suggested in previous studies that spouses or 
relatives may be less influential in reducing delay than friends or strangers 
(GISSI, 1995). In the current study only 9 of the 58 callers who provided details 
of their relationship with the patient were not spouses or relatives. This may 
explain why the presence or absence of a caller was not associated with 
differences in decision time. Other authors have found no relationship between 
decision time and the presence of others (Dracup et al.  1997; Mumford et al.  
1999).  
However, it is considered likely that it is more than the mere presence of a third 
party which has an influence on delay. Rather, the CS-SRM would hypothesise 
that the third party also has representations of the patients illness (Leventhal et 
al.  1980; Leventhal et al.  1984; Figueiras and Weinman, 2003) and that these 
representations guide their subsequent actions in a similar manner as is 
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proposed for patients. Within the current study callers’ reports of patients’ 
illness representations were highly correlated with patients’ own on all IPQ-R 
subscales with the exception of treatment control .Furthermore, callers’ reports 
of their own personal control, coherence and emotion relating to the patient’s 
illness were highly correlated with the patients’ own.  
However, some important differences were also identified. Callers reported 
significantly higher timeline-acute/chronic scores and significantly lower 
treatment control than patients. They also tended to report higher 
consequences. Callers’ reports of their own level of personal control were 
significantly lower than patients’ own and callers’ ratings of their own level of 
coherence were significantly higher than patients’. 
Previous work had suggested that the degree to which patients and callers 
differ in their illness representations can be an important factor in adjustment to 
illness (Heijmans et al.  1999; Figueiras and Weinman, 2003). Thus it was 
possible that dissimilarities in illness representations might be related to 
decision time, in particular appraisal time (Leventhal et al.  1984; Figueiras and 
Weinman, 2003). Results confirmed that appraisal time did tend to be shorter 
where callers reported higher patient emotion than did the patient and longer 
where callers reported a higher level of coherence than patients. This suggests 
that time may be spent negotiating a shared understanding of the situation 
between patient and caller.  Furthermore, in relation to the delay reported 
during the call to NHS 24, significantly longer decision times were reported 
during the call where callers reported more personal control than patients. This 
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suggests that callers with higher personal control than the patient may spend 
time attempting to control the symptoms, rather than seeking medical help.  
These results have important implications for how relatives of patients with 
CHD and the public in general are informed about what to do in the event of 
witnessing a person experiencing possible symptoms of ACS. It may be 
important to emphasise that where a third party has a clear understanding of 
the situation that they should take action, even in a situation where the patient 
is unsure. It should also be emphasised that any attempts people make to try 
to control patients’ symptoms should not result in additional delay. For 
example, it might be helpful to explain that attempts to self-care should be 
attempted for a maximum of 15 minutes, after which medical help should be 
sought (Mumford et al.  1999). 
Total patient delay and illness delay were not related to dissimilarity in any of 
the subscales. Thus, once symptoms have been recognised as concerning, 
dissimilarity in illness representations between patients and others is not 
related to subsequent delay in obtaining medical help. 
This is consistent with the findings related to the direct relationship between 
patient and caller illness representations and decision times. Significant 
relationships between illness representations and delay were strongest in 
relation to appraisal delay. This is important as appraisal delay was found to 
constitute the largest component of patient decision time. Interventions 
targeting illness representations might be successful in reducing patient 
decision time.  
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These results are also consistent with those of Heijmans et al (1999) who 
found that the degree to which there was dissimilarity between patients and 
spouse’ illness representations impacted on coping and adaptation to chronic 
illness (Heijmans et al.  1999).  Furthermore, another study demonstrated that 
the degree of congruence between the illness representations of couples was 
associated with recovery following MI (Figueiras and Weinman, 2003).  
Thus this study suggests that the illness representations of significant others 
and, in particular, their relationship to those of patients are an important area 
for future research. Relatives, family members and others may affect a wide 
variety of factors relating to patient illness e.g. adherence to medication; health 
behaviours; emotional well-being and quality of life as well as having an 
important role in seeking medical care (Leventhal et al.  1985).   
7.12.4 Relationship between illness representations and decision time 
The relationship between IPQ-R subscales and decision time varied between 
the different measures. Illness representations appeared most significant in 
relation to appraisal time whilst fewer constructs were associated with illness 
and total delay.  Results relating to the constructs of the CS-SRM measured by 
the IPQ-R are discussed below. 
Identity 
Identity scores in those with appraisal times < 2 hours were higher on average 
than those with appraisal delay > 2 hours and emerged as significant in logistic 
regression successfully predicting delay category (<2 or >2 hours). It might be 
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anticipated that people experiencing a large number of symptoms would 
become concerned more quickly than people experiencing fewer.  This might 
be an important consideration in the development of interventions aimed at 
reducing delay – the likelihood of ACS is not necessarily associated with the 
number of symptoms. In the current study those who ultimately received a 
diagnosis of ACS reported an average of 4 symptoms as being related to the 
reason for their call and there were no significant differences in identity scores 
between those who received a diagnosis of ACS and those who did not. 
Interventions should emphasise that it is important to seek help with any 
symptoms of ACS and not necessary to wait for a large number of symptoms. 
Timeline 
No relationship was found between timeline-acute/chronic scores and any of 
the measures of decision time. Nor were there significant differences in 
timeline-acute/chronic scores between delayers and non-delayers across these 
measures. However, those with a total delay of more than 2 hours reported 
symptoms of a significantly more cyclical nature than those who delayed < 2 
hours.  This is consistent with the findings of  previous studies which suggest 
that symptoms which come and go may be more difficult for people to interpret 
and thus contribute to longer decision time (Scherk, 1997; Dracup and Moser, 
1997). However, the same result was not found in relation to appraisal time or 
illness delay. Furthermore, the picture may have been complicated by some 
participants reporting symptoms of a cyclical nature relating to existing chronic 
conditions other than CHD (see page 143). 
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However, increasing awareness that the symptoms of ACS can come and go 
might be an important goal of future interventions aimed at reducing delay.  
Cause 
Patients who identified the most important likely cause of their symptoms as 
relating to the heart delayed seeking medical help on average 20 minutes less 
than those who identified other causes as most important. This suggests that 
many people are aware of the need to seek prompt medical attention where a 
problem with the heart is suspected. This is consistent with the results of 
previous authors who have highlighted that recognition of symptoms as relating 
to the heart is a key determinant of pre-hospital delay (Burnett et al.  1995; 
Dracup and Moser, 1997; O'Carroll et al.  2001; Carney et al.  2002). However, 
as has been discussed previously, many people do not readily recognise their 
symptoms as relating to the heart (see page 36). Indeed, in this sample, only 9 
out of 24 who received a diagnosis of ACS (37%) reported that they believed 
the most likely cause of their symptoms to be their heart at the time of the 
symptoms. Amongst those who received a diagnosis of ACS, those who did 
not consider a cardiac cause as most likely were significantly more likely to 
identify pins and needles (χ2 (df=1) =5.00, p=0.044) as related to their illness 
than those who did identify the heart as the most likely cause of their 
symptoms. Otherwise there were no significant differences in symptoms or 
identity scores (U=34, p=.210) between patients who did and did not identify 
the heart as the most likely cause of their symptoms. These results suggest 
interventions aimed at reducing delay need to communicate the range of 
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possible symptoms of ACS, particularly pins and needles in order to help 
people more readily identify a cardiac cause. 
Consequences 
Patients’ beliefs about the consequences of their symptoms were not related to 
any of the measures of decision time.  However, patients with shorter appraisal 
times did tend to have higher consequence scores.  Although this was not 
statistically significant, the trend is in the direction that would be predicted by 
the CS-SRM and is consistent with the findings of Walsh et al (2004) who, in a 
study utilising the original IPQ amongst patients with MI found consequences 
to be significantly related to delay.  
Amongst patients who received a diagnosis of ACS, the PWMC reported 
significantly higher consequences than where the patient did not receive a 
diagnosis of ACS. This could suggest that the PWMC was frequently able to 
recognise the serious nature of the symptoms. However, it is important to note 
that the assessments of consequences were obtained retrospectively. 
Participants’ responses relating to their perception of consequences may have 
been influenced by the diagnosis of ACS having been made in the intervening 
period.  
Personal control 
No relationship was found between personal control scores for either the 
patient or the person who made the call and any of the measures of decision 
time. Nor were there significant differences in personal control scores between 
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delayers and non-delayers across the same measures. Thus actual levels of 
personal control may not be related to decision time. However, due to the poor 
internal reliability of the personal control measure in the current study it is 
difficult to draw firm conclusions. Higher personal control amongst callers 
(where they were involved) than patients contributed to longer delays being 
reported during the NHS 24 call and suggests that it might be useful to include 
guidance about how long it is appropriate to try and control symptoms of this 
nature within interventions aimed at bystanders or relatives of people with 
CHD. 
Treatment control 
Amongst PWMC, those with appraisal times of < 2 hours tended to report 
increased patient treatment control than those with longer appraisal times. This 
suggests that attempts to self-manage symptoms may contribute to delay 
which is consistent with the findings of previous research (Rasmussen et al.  
2003; Schoenberg et al.  2004). It may be important within an intervention 
aimed at reducing delay to specify a time limit highlight that attempts to self-
manage should be time limited.  
Coherence 
No relationship was found between coherence scores for either the patient or 
the person who made the call and any of the measures of decision time. Nor 
were there significant differences in coherence scores between delayers and 
non-delayers across the same measures. It may be that,  for some, having a 
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clear understanding of their symptoms (e.g. that they are having a heart attack) 
leads them to seek help quickly whereas others may be more inclined to seek 
help quickly when their symptoms do not make sense to them. 
However, coherence was found to be a significant predictor of whether or not 
participants received a diagnosis of ACS. Patients who received an ACS 
diagnosis reported significantly higher coherence scores than those who did 
not. In addition, the person who made the call reported higher coherence 
amongst patients and themselves where the patient received a diagnosis of 
ACS than where they did not. This suggests that where people have a clear 
understanding of what is happening, they are more likely to receive a diagnosis 
of ACS. However it is also possible that people who receive a diagnosis of 
ACS may be biased in how they subsequently report their coherence, i.e. that 
they be more likely to report retrospectively that their symptoms made sense 
because they have since received an explanation that makes sense. However, 
if this were the case for a diagnosis of ACS, it would also be expected to be 
true for patients who received other diagnoses. When those who received a 
diagnosis were compared with those who did not receive any diagnosis relating 
to their symptoms, there were no significant differences in coherence scores 
(t=-0.186, p=.853). This suggests the retrospective reports of coherence are 
not unduly biased by subsequent diagnoses. The finding that coherence is 
linked with diagnosis of ACS may be a useful additional clue for clinicians in 
the difficult position of assessing these types of symptoms. 
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Emotion 
A significant negative correlation was found between appraisal time and 
patients’ level of emotion. Thus patients who had a strong emotional reaction 
to their symptoms had shorter appraisal time. Furthermore, appraisal time also 
tended to be shorter where the person who made the call reported strong 
emotions related to the symptoms. This is consistent with the findings of 
previous evaluation of the CS-SRM in relation to decision times amongst 
people with MI (Walsh J C et al.  2004) .  These authors found that responses 
to emotional response items (developed for the study because the original IPQ 
did not include measures of emotional representations) were significantly 
associated with patient delay. The only demographic variable they identified as 
associated with delay was gender, with women having significantly longer 
delay times than men. Only the consequences subscale of the original IPQ 
(Weinman et al.  1996) was found to be related to delay.   
These are interesting findings and highlight the possible importance of emotion 
in how people evaluate their symptoms. However it is difficult to envisage how 
this might usefully contribute to an intervention aimed at reducing delay.  It may 
be beneficial within an intervention to prepare people to cope with the likely 
emotional response to symptoms. However, this would clearly require careful 
evaluation as the emotional representation appears to be associated with the 
desired situation of shorter appraisal time. Interventions which address the 
appropriate cognitive representations (e.g. beliefs about consequences, 
discussed above) may offer the most promise in generating the emotional 
representations associated with prompt help-seeking.  
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Interestingly the same pattern of results relating to age, emotion and to a 
lesser degree, consequences were identified in the current study in relation to 
appraisal time. It is possible that appraisal time constituted the majority of total 
pre-hospital time in the study by Walsh et al (2004) (as in this study) and thus 
that variables having most effect on that phase of delay emerged as significant 
in relation to total delay. However, that was not observed in the current study.  
Furthermore, the model that Walsh et al reported, which explained variance 
additional to that explained by demographic and clinical factors included 
measures of coping. These were not measured in the current study which may 
account for why the model was less successful in accounting for decision time.  
7.12.5 NHS 24 as environment for research 
NHS 24 provided the setting for the research described. This clearly provided a 
number of novel opportunities. The service receives on average 30,000 calls 
per week from people from all across Scotland. Thus, it was possible to sample 
from a geographically and demographically diverse population. All calls are 
recorded and stored within the organisation, which provided the opportunity to 
study what was said at the time of seeking help without impact on the clinical 
situation. This would have been especially difficult to achieve amongst patients 
with serious symptoms such as those of ACS, in other environments. 
Furthermore, it was possible to identify people early in their illness episode and 
thus to explore illness representations before diagnostic labels were applied 
and then subsequent to diagnosis.  
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These were compelling reasons to choose NHS 24 as a setting for this 
research but inevitably there also were a number of difficulties associated with 
the setting. 
Participation 
Most importantly, significant problems in achieving participation were 
experienced. Response rates via the various methods attempted were low 
(27% at best), raising concerns about possible bias in the sample. Checks for 
non-responder bias were carried out across a number of key variables and 
demonstrated few differences between participants and non-participants but it 
cannot be exclude that participants differed from non-participants in important 
ways which could not be assessed. The importance of this issue may vary 
depending upon the research design and clinical population being approached. 
The low response rate also has practical implications in that larger numbers of 
potential participants require to be contacted to achieve the desired sample. 
This takes longer, increases costs and thus may make larger projects 
unfeasible.  
The nature of the clinical population who were the subject of the current study 
is likely to have been a factor in the low participation rates. It is possible that 
people who have experienced possible symptoms of ACS may be very unwell 
or still in hospital. Indeed, these were common reasons given for non-
participation (see Figure 14, page 186).  Furthermore, they are a population 
who tend to be older; this may have reduced participation due to physical and 
cognitive problems. In addition, the requirement to achieve participation with 14 
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days is likely to have also limited the potential to achieve high participations 
rates. It was not considered ethical to contact people any earlier than 5 days 
after the call and so the window to achieve participations was very narrow. 
Alternative designs which could rely upon recruitment later after the original 
call might achieve higher participation.  
The lack of personal relationship between patients and either the clinicians at 
NHS 24 or the researcher may also have been a contributing factor. People 
may feel less inclined to contribute to research in the relatively anonymous, 
virtual environment of NHS 24 than they would do in a hospital, clinic or 
primary care environment. Research designs where recruitment of participants 
could occur in person, within clinical settings but where access to the original 
call to NHS 24 was included might overcome this difficulty.   
Such designs might also overcome the difficulties encountered in relation to 
postal invitations to take part. Inaccurate, ambiguous or missing contact details 
were a problem. As people often call NHS 24 from places other than their 
home address, the location of the patient is recorded within the record. This 
ensures that if necessary an ambulance is despatched to the location of the 
patient, rather than their home. However, inconsistencies in how the various 
addresses were documented meant it was not always possible to readily 
identify the current home address. It is recognised that the main purpose of the 
clinical record is to ensure appropriate clinical care and that research 
considerations are a secondary consideration. However, if further research is 
to be conducted using these details, some attention to these issues might be 
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required. Unexpected issues in relation to the postal service were also 
encountered. A surprising number of participants reported not receiving their 
letter of invitation even where details were accurate.  
Ethical issues 
There were also a number of ethical issues associated with the setting of NHS 
24. Audio-recordings form part of the clinical record which pertains to the 
patient at NHS 24 and thus clearly permission from patients was required for 
their recordings to be used in research. However, callers and NHS 24 staff are 
also involved in those consultations. Furthermore, calls relating to patients who 
are no longer alive may also be of particular value in research. In these 
circumstances the appropriate means of obtaining consent were unclear. The 
decision was initially made within the current study to obtain the explicit 
consent of all parties involved in each call. However, this proved impractical 
and meant that only a tiny proportion of relevant calls would be accessed. 
Instead an alternative process by which staff were informed about the project 
and asked to participate in general was undertaken and then only patients 
involved in calls which had been dealt with by those staff were invited to take 
part. This was more successful but the response rate from staff was still less 
than ideal. Furthermore, if such a process were to be repeated for each project 
it is likely that participation would reduce further. Instead it is suggested that 
process should be developed where the express position of staff members 
regarding the use of their consultations in research is recorded. This would 
negate the need to approach staff regarding each project and increase the 
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representativeness of the calls identified. Alternatively, the possibility of an opt-
out strategy might also be worthy of consideration. This would assume that 
unless otherwise stated, staff are willing for their consultations to be used in 
research. However, if they would rather not participate in a particular (or all) 
projects, easy mechanisms to opt-out would be provided. This might help to 
ensure increased participation and promote the view of research as ‘business 
as usual’ rather than an isolated and separate process from clinical practice.  
The same might be suggested in regard to users of the service. All callers to 
NHS 24 are currently played a message which informs them that call is being 
recorded. An opportunity to listen to additional information about how data is 
used within the organisation is provided. As a result of efforts made at the 
outset of the current project, this now includes reference to research. People 
are offered the opportunity to decline for their information to be shared with 
others or used for particular purposes but this is only recorded in relation to 
particular call. Thus, a readily-available indication of patients’ views regarding 
the use of their data is not available. It is considered that the existing process 
should be extended, so that the wishes of patients with regard to research (and 
other uses of their data) are permanently recorded. These could be reviewed 
each time they call (if clinically appropriate) and would thus provide a 
contemporaneous record of patient views. This might allow some research to 
be undertaken without the need for further consent. This would also ensure 
that people who feel strongly that they do not wish to be involved in research 
are not inadvertently contacted. 
  286 
However, this relates to another issue encountered in relation to consent. 
Within the study relating to decision time, consent (for the original call to be 
accessed and for information to be obtained from their GP) was provided 
verbally by patients and audio-recorded. This ensured there was a permanent 
record of consent for each participant. The process appeared acceptable to 
patients and where the investigator had any doubt about the validity of the 
consent, consent was assumed to be absent.  
However, when GP’s were contacted and the required information requested, 
many stated they required a copy of written consent. This problem was 
overcome in the current study by a clinical colleague reviewing the consent of 
all participants and providing a letter confirming the consent was valid and 
some GP’s contacted patients directly to obtain written consent. Clearly, this 
was not ideal. It is therefore considered that where clinical information relating 
to patients is required from other services that written consent be obtained. 
This would avoid any ambiguity and ensure the data relevant to the project can 
be collected.  
NHS 24 provided a fruitful environment for research. Difficulties relating to 
achieving the participation of patients were offset by the wealth of data 
obtained regarding initial presentations. Access to the illness representations 
of people in the midst of a health threat would have been very difficult to obtain 
in other settings.  
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7.12.6 Strengths and limitations 
The study had a number of important strengths. Participants were randomly 
selected from the entire overall population of people seeking help from primary 
care services out-of-hours in Scotland and are thus considered representative. 
Comparisons between retrospective and real-time reports of decision time and 
some components of illness representation were performed, strengthening the 
validity of results. Furthermore, participants were identified early in an illness 
episode and before diagnostic labels were applied. This ensured that the 
sample was not solely restricted to patients with confirmed ACS but reflected 
the larger population experiencing possible symptoms of ACS, the population 
who are the target of interventions aimed at reducing delay. A strong 
theoretical framework has enhanced the rigour of the research and ensured 
results can readily inform intervention. 
The main limitation of the study is that despite substantial efforts to achieve 
high participation, actual participation rates were low (28%). A considerable 
proportion of non-participation owed to not being able to make contact with 
eligible individuals due to problems with inaccurate contact details or technical 
problems e.g. with their telephone. However, a substantial proportion of 
identified patients were still in hospital or too unwell to take part at the time of 
contact (6-14 days after the call to NHS 24). Whilst there was little could be 
done to avoid this problem, given the nature of the symptoms people had 
experienced, it almost certainly resulted in less participation by the most unwell 
and is thus likely to have introduced a degree of bias to the sample. This is 
also likely to be the case for other studies that endeavour to recruit patients 
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during an acute illness episode and thus probably applies to most studies of 
pre-hospital delay.  
However, the sample is considered representative in other important ways. A 
variety of information about potential participants was available which allowed 
an assessment of non-responder bias to be made. Participants did not differ 
from non-participants with regard to gender, DEPCAT classification, number of 
previous calls to NHS 24, previous history of CHD or whether or not they made 
the call to NHS 24 themselves. The only significant difference identified was 
that participants were slightly younger than non-participants. Nevertheless, 
participation from a wide distribution of ages was achieved 18-91 years (see 
page 188). Another strong feature of the sample is that it included people from 
all regions of Scotland and so is considered more representative of the overall 
population than a regional sample.  Furthermore people from minority ethnic 
groups were represented in approximately similar proportions (2%) to Census 
reports of the overall population of Scotland (Office of the Chief Statistician. 
Scottish Executive, 2004). However, it is recognised that the proportion of 
people from minority ethnic groups in Scotland is lower than for other parts of 
the UK and beyond. Therefore, there may be limits to the generalisability of 
findings to populations outside of Scotland. 
Furthermore, although the sample was randomly selected from the entire total 
of people trying to reach their GP in out-of-hours period, people with possible 
symptoms of ACS who chose to request an ambulance, attend A&E directly or 
who did not present their symptoms to medical services at all were not 
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included in this study. The characteristics of these groups may differ in 
important ways and are important groups to study in the future utilising 
alternative methodologies.  
A second possible limitation of the study is that in contrast to what was 
planned, most participants elected to self-complete the IPQ-R rather than 
complete it during telephone interview. The main disadvantage of this was that 
probing around decision time reports was not possible. However, no significant 
differences in decision time were identified between the 2 methods. Nor were 
there are a greater proportion of negative decision times in the self-report 
group. Whilst not ideal in terms of methodology, the option of two methods of 
administration was necessary to make participation possible for as many who 
of those who wished to take part. Some participants found filling in forms off-
putting or had difficulty with reading/writing whilst others preferred to complete 
the questionnaire in their own time. Checks for systematic bias relating to the 
mode of administration were performed. Those who participated in telephone 
interview were significantly less likely to have had a caller involved in the 
original call. It may have been that as the participation of the caller would also 
have been requested in this context that the additional burden of achieving two 
20 minute interviews was a deterring factor. Alternatively, it is possible that 
patients who did not make the call themselves were in fact more ill and unable 
to complete an interview. Those who participated in a telephone interview also 
had significantly higher scores for personal control than those who self-
completed. Although unintended it cannot be excluded that explanations 
provided by the investigator in relation to these items during telephone 
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interview may have led to different responses. In particular, the issue of 
whether or not simply making the call to NHS 24 constituted ‘doing something 
to control the symptoms’ was discussed with more than a few participants. 
Whether or not such a discussion took place may also have contributed to the 
poorer internal reliability of personal control items when administered by 
telephone interview. 
It is also possible that there is a cognitive style or trait effect where people who 
tend to report high personal control in relation to a health threat may also wish 
to exert control during a telephone interview in preference to passive 
completion of a questionnaire. No other significant differences between the two 
groups in relation to demographic, clinical or IPQ-R factors were identified. The 
differences relating to the presence of a caller and personal control were 
considered unlikely to significantly affect the overall pattern of results and so it 
was considered appropriate to combine the analysis of data obtained by both 
methods. 
Thirdly, in common with other studies of this nature, retrospective reports of 
decision time and illness representation were used. The possibility that 
people’s experiences subsequent to their call influenced their reporting of 
decision times and beliefs about their symptoms cannot be excluded.  
However, realistic alternatives to retrospective reports in the investigation of 
this phenomenon are not available.  Importantly and unusually within this study 
there was an opportunity to compare retrospective reports of some variables 
with data obtained from the original call to NHS 24. All measures of decision 
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times were found to be significantly correlated with what was reported during 
the call. Furthermore, results from the first stage of the investigation suggested 
that IPQ-R measures of illness representation collected within 2 weeks of the 
original call were found to be consistent with the representations presented by 
participants during their initial presentations. 
The modified IPQ-R was found to be a reliable measure of illness perceptions 
within this group. Internal reliability of subscales was good apart from the 
telephone-administered personal control items which were discussed above. 
The strong correlations between patient and caller scores for each subscale 
except treatment control provide support for the existence of the phenomenon 
of illness representation shared between the two parties. Furthermore, identity 
scores were significantly correlated with the total number of symptoms 
reported during the call. This provided some support for the validity of the 
construct as measured by the IPQ-R. However, there were a number of issues 
identified in relation to the IPQ-R. 
Firstly, it was apparent that the IPQ-R measure of identity did not capture all 
the symptoms considered important by patients. Two participants scored 0 for 
identity, presumably because the reason for their call was not included on the 
list. Furthermore, when identity scores were compared with the total number of 
symptoms identified during the call to NHS 24 they were significantly lower 
(p<.001). That participants cannot identify symptoms that they see as related to 
their illness is considered an important limitation of a measure designed to 
elicit participants’ representations of illness. From a methodological point of 
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view, this issue may have limited the potential of studies using the IPQ-R to 
identify important relationships between decision time and identity. In the study 
relating to the content of presentations, references to identity were made by all 
participants within their relatively brief responses to an open question about the 
reason for their call. Thus, the inclusion of a similarly open question within the 
IPQ-R might be an alternative means of eliciting information relating to identity 
that is participant-derived rather than suggested by the researcher. 
Furthermore, it is not considered that a measure which relies solely upon the 
number of symptoms adequately represents the relative importance of 
particular symptoms for participants. Someone may have only one symptom 
(e.g. chest pain) but believe strongly that it relates to a heart attack.  
In hindsight, within the context of ACS, the symptoms listed on the IPQ-R 
(Appendix 39) were probably too imprecise to meaningfully distinguish 
particular patterns between participants. For example many patients may have 
reported ‘pain’ but the location of that pain (e.g. foot or chest) and the nature of 
the pain (e.g. sharp or heavy) were not differentiated. More detailed 
descriptions would have been useful. However, it is recognised that such a 
history would be burdensome to complete and might be difficult include in a 
self-complete questionnaire. In the context of the current study restricting the 
mode of completion to only telephone-interview would have resulted in even 
lower rates of participation. Future studies of this nature are likely to need to 
balance the depth of detail required regarding symptoms against a possibly 
lower participation rate.  
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The burden of the questionnaire was an issue and participants commented that 
they found it difficult, repetitive or not very meaningful (see Appendix 27). This 
may have contributed to the low response rate achieved, particularly as the 
questionnaire had to be presented by post in this context. The questionnaire 
took approximately 20 minutes to administer by telephone. It would be difficult 
to include additional measures (e.g. coping measures) without impacting on 
participation or encountering ethical difficulties relating to the burden placed 
upon participants (especially those who might be seriously ill). The Brief IPQ 
recently developed by Broadbent et al (2006) might be a more manageable 
measure for people completing the questionnaire in this type of situation or 
where administration of additional measures is required.  
Finally, a relatively large number of statistical tests were performed during the 
analysis of this data, increasing the risk of Type I errors. If a more cautionary 
significance level of p<0.02 were applied fewer factors would emerge as 
significantly related to the various measures of decision time, these are 
summarised below. 
In relation to total delay, higher emotion scores of the PWMC were associated 
with reduced delay. Receipt of an emergency response and high patient 
emotion were associated with reduced appraisal time and identity and emotion 
scores remained significant in logistic regression of appraisal delay category. 
Similarly emotion scores of the PWMC remained significantly associated with 
appraisal delay.The PWMC report of treatment control was significantly 
associated with illness delay. 
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7.12.7 Summary 
Importantly the study has highlighted that delay is a significant problem 
amongst those with possible symptoms of ACS. Appraisal time constitutes the 
largest proportion of this time but illness delay is not insignificant. A number of 
demographic, clinical and IPQ-R factors were found to be associated with 
different components of patient decision time. This suggests that particular 
groups, such as those who live in deprived areas or those with a history of 
CHD or diabetes, might benefit from targeted intervention. Any intervention 
should address both appraisal and illness delay. The factors associated with 
each component of delay appear to be different. Particular relationships 
between specific illness representations and both total and appraisal delay 
were identified which may be useful to consider within a future intervention 
aimed at reducing patient decision time. This is discussed in detail in the 
following, concluding chapter. 
  295 
Chapter 8. Conclusions and implications 
Within this final chapter, the main conclusions of the study are summarised. 
The implications related to theory and measurement, clinical practice and 
future research identified.  
8.1 Theory 
8.1.1 Existence of components of illness representations 
This study has provided strong additional evidence for the existence of the 
components of illness representations (Leventhal et al.  1980; Lau and 
Hartman, 1983; Bishop et al.  1987; Lau et al.  1989). To date, components 
have been identified from hypothetical patient scenarios or through special 
interview techniques. The current study has demonstrated that the components 
of illness representation are spontaneously volunteered during clinical 
consultations, in the real-time context of significant health threat.  
In addition, the study suggests that although there is evidence that patients’ 
models of illness are frequently neglected within clinical encounters (Helman, 
1985; Cohen et al.  1994; Heijmans et al.  2001), this is unlikely to occur as a 
consequence of information not being provided by the patient. Thus, neglect of 
patients’ representations of illness may be more likely due to a lack of 
awareness or attention on the part of clinician. Increased awareness of the 
importance of illness representations could have benefits in relation to many 
areas of clinical practice. These are discussed further under ‘Clinical Practice’ 
below. 
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In common with previous work (Lau et al.  1989), some components of illness 
representation were mentioned more frequently than others. Importantly, the 
components least commonly volunteered during initial presentations (i.e. 
cause, consequences, emotion and coherence) were those found to be most 
significantly related to decision time or outcome.  Thus it is possible that the 
most influential components of illness representation are those that people are 
least likely to express. It is possible that where certain components of illness 
representations tend not to be discussed with others, beliefs related to these 
components become more deeply held and thus more likely to predict 
behaviour. These are hypotheses that could not be tested further within the 
current study but may be useful to explore in future.  
8.1.2 Context 
Many of the statements unaccounted for by the components of illness 
representation related to the context in which the participants’ symptoms 
occurred. It is considered important to further elaborate the effect of context on 
illness representation.   
8.1.3 Description versus prediction 
Whilst the components of illness representation successfully explained the 
content of initial presentations, the results relating to the prediction of decision 
time were less convincing. Previous investigations have yielded, at best, 
modest results in predicting various outcome measures (Petrie et al. 1996; 
Orbell et al. 2006).  It is important to consider why this might be the case.  
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It is possible that too much emphasis has been placed upon illness 
representations which constitute only one aspect of the model (see Figure 1). 
Tools such as the IPQ-R may be failing to measure other important aspects of 
the model such as coping procedures, appraisals and the heuristics that are 
hypothesised to influence representations. Including measurement of such 
components may add to the predictive ability of the IPQ-R. However it is 
recognised that to do so would add to the burden of the questionnaire, possibly 
limiting its acceptability. Furthermore, the relationships between the numerous 
constructs may be complex and difficult to disentangle. 
Similarly, measurement using the IPQ-R may fail to consider higher level 
contextual factors such as personality and socio-cultural roles which may 
influence both representations and coping procedures (Martin and Leventhal, 
2004; Leventhal et al. 2005) 
Furthermore it may be that research has applied the model to inappropriate 
outcome measures. Whilst the behaviour of contacting a health professional is 
of particular interest to health professionals it may only one of a range of 
coping behaviours undertaken by patients. Thus the model may poorly predict 
a single pre-defined coping behaviour (such as decision time to call the doctor) 
but might perform better in relation to a patient-identified behaviour. Future 
studies might wish to address these issues. 
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8.1.4 Illness representations of significant others  
The study also explored the illness representations of significant others who 
were involved in dealing with a patient’s health threat and provided evidence of 
shared representations of illness.  
Results suggest that the degree of concordance or dissimilarity between 
individuals’ illness representations to be significantly related to appraisal time 
and thus an important issue which is worthy of further investigation. Knowledge 
of what happens when people with different representations of illness become 
mutually engaged in a health threat may help us understand how illness 
representations are shared culturally and of the processes by which they might 
be changed.  
8.2 Measurement 
8.2.1 Coding 
Good reliability was achieved in the coding of transcriptions confirming the 
components of illness representation can be reliably identified. The method 
might be usefully applied to other contexts and clinical problems.  
Reliability of coding for coherence was less than optimal and thus further 
elaboration of coding rules is recommended. The level of reliability was 
achieved between 2 coders familiar with the CS-SRM and additional research 
is required to establish if similar reliability can be achieved by naïve 
participants.  
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8.2.2 IPQ-R 
The IPQ-R was readily adapted for use with both the patients and callers within 
the current study. Items with ‘my illness’ were replaced with ‘my symptoms’. 
For example, ‘My symptoms will last a long time’ (see Appendix 12). However, 
for a number of the components of illness representation relating to callers it 
was less straightforward. It was not clear within personal control, coherence 
and emotion whether callers’ perceptions of the patient’s representations or 
their own representations were most relevant. In the absence of a precedent, 
the decision was made to assess both (see Appendix 13).  Most significant 
differences were identified between the patients’ and callers’ own 
representations.  Callers’ reports of their own level of personal control were 
significantly lower than patients’ own and their ratings of their own level of 
coherence were significantly higher than patients’. Appraisal time was shorter 
where callers reported higher coherence than the patient did. Longer decision 
times were reported during the call to NHS 24 where callers reported more 
personal control than patients. However, appraisal time was also shorter where 
callers perceived higher patient emotion than the patient reported, 
demonstrating that differences relating to the callers perception of the patient 
were also important.  
These results suggest that examination of the illness representations of 
significant others and their perception of the illness representations of the 
participant have the potential to provide important insights into behaviour 
during health threats. It is important to include these in future studies 
examining the role of significant others. It is also plausible that significant 
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others might have representations relating to consequences for themselves. 
These were not measured within the current study but might be useful to 
include in future studies.  
Pilot work informed the content of the versions of the IPQ-R used in the second 
stage of the investigation. The validity and reliability of the measures 
developed are discussed below.  
Reliability 
The subscales of the IPQ-R were found to have acceptable internal reliability 
(α > 0.7)  with the exception of the personal control items which had good 
internal reliability when the IPQ-R was self-completed but was lower when 
telephone administered. Most subscales of the C-IPQ were also found to be 
internally reliable with the exception of the emotion subscale. The reliability of 
the treatment control subscale alpha was improved with the removal of item 
CIP23 “There was nothing which could help their condition”.  
During pilot work, and subsequent telephone administration, negatively 
phrased statements were generally problematic for participants (see Appendix 
27). This an important issue for future work using the IPQ-R. The psychometric 
rationale for inclusion of these items may be negated if the complexity of the 
questionnaire deters people from taking part. The recently developed Brief IPQ 
might offer a less demanding, alternative method of eliciting the illness 
representations and might be better suited to postal survey administration 
(Broadbent et al.  2006). 
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Validity 
The face validity of the adapted IPQ-R was established. However, in addition 
the research design allowed the relationship between participants’ illness 
representations expressed at the time of seeking help to be compared with 
those subsequently reported on the IPQ-R and thus to evaluate convergent 
validity (Bowling, 2002).  Conclusions regarding the validity of the IPQ-R 
measure of each construct are discussed below. 
Identity 
Most (65%) symptoms mentioned by participants during their initial 
presentations to NHS 24 were captured by the IPQ-R. However, the measure 
failed to capture some symptoms and for 2 participants this meant that the 
IPQ-R did not capture any of the symptoms these participants reported during 
their call. This may limit the ability of the IPQ-R to identify significant 
relationships between identity and other variables. However, there were also 
instances where participants did not identify specific symptoms during their 
initial presentations and yet were subsequently able to identify symptoms on 
the IPQ-R.  
Together, these data suggest that the checklist format may be a useful means 
of helping some individuals to articulate their illness representations but may 
not reflect precisely the identity expressed previously. Furthermore, 
components of identity other than symptoms such as labels and visible signs 
were frequently expressed. These components are specified by the CS-SRM 
but not assessed by the IPQ-R. Thus additional information relating to identity 
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may not be captured by the IPQ-R.  In particular, visible signs such as pallor, 
cyanosis and sweating may be important in the context of ACS, particularly 
amongst significant others (Pattenden et al.  2002).   
Timeline 
IPQ-R reports of timeline-acute/chronic were generally consistent with those 
expressed by participants during initial consultations although those reporting 
acute timelines were less likely to refer to time during their presentations. The 
data available generally supported the validity of the timeline measure but also 
demonstrated that some caution is required in interpreting the results of a 
retrospective IPQ-R measure of timeline – retrospective patient reports did not 
always accurately reflect the content of the original presentation. 
Cause, consequences, personal control and treatment control 
Of the small number of cases available, most participants were consistent 
between the two reports of cause, consequences, personal control and 
treatment control providing limited support for the validity of the IPQ-R 
measure of these constructs.  
Coherence 
The finding that none of the 20 participants with above-average coherence 
scores discussed their understanding of their symptoms at the time of 
presentation and that most statements made by participants with below-
average coherence scores suggested a poor understanding of their symptoms 
suggest the IPQ-R measure of coherence is valid measure.  
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Emotion 
None of the 16 participants with below-average emotion scores made 
statements relating to emotion during their presentation of symptoms. 
However, 6 of the 17 with higher than average scores did. Participants with 
above-average emotion scores on the IPQ-R were significantly more likely to 
express emotion during their initial presentation. This suggests that the IPQ-R 
is sensitive to emotional representations and provides support for the validity of 
the IPQ-R measure of emotion. 
Coping 
A previous study which utilised the IPQ found that the CS-SRM  explained a 
significant amount of variance in pre-hospital delay amongst people with MI 
(Walsh J C et al.  2004). The current study did not find such convincing results 
in relation to the continuous measure of decision time although illness 
representations did emerge as significant in predicting delay category. This 
may be due to differences in method, context and population. However, 
another important difference is that Walsh et al (2004) included data related to 
coping in multivariate analysis. Coping was assessed using the Coping 
Response Inventory which samples 5 categories of coping styles i.e. problem-
focused; emotion-focused; active-cognitive; active-behavioural and avoidant 
(Billings and Moos, 1981). Coping style was found to explain an additional 16% 
of variance in pre-hospital time additional to that explained by demographic 
and IPQ factors. An assessment of coping procedures may have been a useful 
addition to the IPQ-R in the context of the current study although Leventhal 
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argues that checklist type measures of coping are too simplistic and 
inadequate to assess the wide range of procedures in which individuals may 
engage (Martin and Leventhal, 2004).  
8.2.3 Decision times 
Questions regarding symptom onset were added to the IPQ-R. The questions 
were based on the stages of patient delay described by Safer et al (1979). 
Timings were obtained to allow the calculation both of appraisal and illness 
delay. Previous studies of pre-hospital delay have relied on similar methods. 
Importantly, within the current study, where the participant gave consent for 
their original call to be reviewed, there was an opportunity for the timings 
provided within that call to be compared with those on the questionnaire. Delay 
times reported during the call were significantly correlated with questionnaire 
reports of total, appraisal and illness delay suggesting the measures were a 
satisfactory measure of decision time.  Reported illness delay was significantly 
less than the decision time reported during the call which in turn was 
significantly less than total patient delay.  
This might be expected as people would tend to talk during the call about how 
long they had been concerned about their symptoms but some may also have 
referred to when they started. Due to limits of time, data was gathered in a 
manner which did not easily facilitate the distinction. Thus the measure of 
decision time obtained from the calls may represent a combination of both total 
and illness delay. Given that different factors are associated with each of these 
components of delay; this may explain why fewer relationships were identified 
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between key variables and call-reported decision time.  
8.3 Clinical practice 
8.3.1 Clinical consultations 
Results from the study have a number of important implications for practice 
within clinical consultations.  
Importantly, a large proportion of participants who later reported that they 
believed their symptoms to have severe consequences did not share those 
beliefs with NHS 24 staff when presenting their symptoms.  This is a significant 
issue, particularly in the context of a telephone triage situation. Information that 
an individual believes their symptoms to have serious consequences might be 
valuable information for clinicians, alerting them to potentially urgent clinical 
situations. This finding suggests that it may be important for clinicians to ask 
questions relating to potential consequences as it appears unlikely to be 
volunteered. Furthermore, irrespective of the actual urgency of the clinical 
situation, knowledge that an individual believes their symptoms to have serious 
consequences would be helpful information for clinicians in all settings in their 
negotiation of an appropriate outcome with an individual. This might help to 
ensure that any advice and/or treatment provided to patients is adhered to 
(Leventhal et al.  1992; Petrie et al.  1996; Horne and Weinman, 2002b) and 
improve patient satisfaction with the consultation (Lang et al.  2002). Failure to 
attend to patients’ concerns about potential consequences could lead to 
anxiety and repeated presentation (Johnston, 1987; Coia and Morely, 1998).   
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Where people made reference to attempts to control symptoms they referred 
only to treatment and in particular to using medicines. Research would suggest 
that other responses such as resting or increasing activity might be attempted 
(Meischke et al.  1995) and yet were not mentioned by any of the participants 
in this study. This suggests that people might consider non-medical attempts to 
control symptoms un-important or not valid to discuss in these types of clinical 
consultations. Again, this has implications for clinicians who should ensure 
they ask appropriate questions in order to elicit important information about the 
self-care measures people have tried. For example,  the information that 
increased activity was associated with worsening chest pain would be 
important clinical information. Furthermore, clinicians should be aware of how 
the content of their communication may perpetuate a medicine-orientated 
discussion of self-care.  
Finally, 1 of the 24 participants, who ultimately received a diagnosis of ACS in 
relation to their symptoms, did not receive an emergency response as a result 
of their call to NHS 24. This represents a significant clinical risk and suggests 
there is potential to improve practice in relation to this area. 
8.3.2 Reducing patient decision time 
Decision time a significant problem 
Within the current study, participants reported an average total patient delay of 
4 hours. This is similar to previous findings in relation to similar patient groups 
(Canto et al.  2000; Goldberg et al.  2002b; Rasmussen et al.  2003; Grossman 
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et al.  2003; Dracup et al.  2003) and demonstrates that average decision times 
amongst a representative group of patients with possible symptoms of ACS 
remain significantly out-with the ideal. Only 11% of participants reported total 
delay times of less than 60 minutes. Appraisal delay constituted the majority of 
the delay (average 2 hours) whilst illness delay was on average 75 minutes.  
Appraisal delay 
Appraisal delay was found to be shorter amongst men (who also reported more 
serious consequences), those with few symptoms and strong emotional 
representations. Thus interventions aimed at reducing delay may need to 
emphasise the potential serious consequences of delay in the context of ACS, 
particularly for women. 
It may also be beneficial within a public health or individual patient intervention 
to prepare people to cope with the likely emotional response to symptoms. 
Participants with longer delay times tended to report more symptoms than 
those with shorter delay suggesting that people experience particular 
difficulties in evaluating many symptoms. Given that there may be a number of 
symptoms associated with ACS, it might be useful to highlight this within 
interventions aimed at reducing appraisal time.   
Illness delay 
Those who identified the most important likely cause of their symptoms as 
relating to the heart delayed seeking medical help an average of 20 minutes 
less than those who identified other causes as most important, suggesting that 
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many people are aware of the need to seek prompt medical attention where a 
problem with the heart is suspected. However, the symptoms of ACS may be 
ambiguous and in common with previous work (Burnett et al.  1995), this study 
demonstrated that many people do not readily recognise their symptoms as 
being related to the heart. This suggests that interventions aimed at reducing 
delay should aim to help people recognise a range of possible presentations.  
However, it is recognised that this would likely result in an increase in 
presentations from people with less urgent symptoms and thus the health 
economics would require evaluation. The most recent campaign by the British 
Heart Foundation portrayed a stereotypical image of a middle aged man with a 
constricting belt around his chest (see Appendix 45). Such images, although 
well-intended may actually serve to reinforce gender and symptom stereotypes 
which could actually contribute to longer delays amongst some patients. 
Those calling NHS 24 for the first time had significantly longer illness delay 
than those who had called before. This has important implications for how 
people are informed about how to access out-of-hours care. Current media 
campaigns by NHS Scotland (see Appendix 46) emphasise the importance of 
contacting the service only with symptoms which cannot wait until morning, 
explaining that this allows busy services to respond better to people with very 
serious symptoms. This may have the unintended consequence of making 
even those with serious symptoms hesitate about calling.  
It may be useful for people, particularly those at increased risk of ACS, to make 
initial contact with NHS 24 at a time they are not experiencing serious 
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symptoms in order to familiarise themselves with the process and thus reduce 
delay at a time when their symptoms are urgent. At the very least it would be 
well-advised for people at high risk of ACS to become familiar with the process 
for seeking medical help, particularly out-of-hours. Advice in this regard could 
be incorporated into CHD review clinics relatively easily.  
Furthermore, it is important that all clinical staff who respond to people seeking 
help with possible symptoms of ACS reinforce the message that seeking help 
is appropriate, even where there are ‘false alarms’. Fear of embarrassment 
about wasting resources and false alarms have been associated with longer 
delay in the context of ACS (Finnegan et al.  2000; Pattenden et al.  2002).  
Role of significant others  
To date, inconsistent results have been reported regarding the role of 
significant others in relation to decision time in the context of ACS.   
Results from the current study suggest that illness representations may be an 
important mediating factor relating to the impact of significant others on 
decision time. The degree to which patients and significant others differed in 
their illness representations was significantly related to decision time.  
These results suggest that the content of interventions aimed at potential 
bystanders may need to be different from those targeting the people 
experiencing symptoms. Relatives of patients with CHD and the public in 
general should be informed about what to do in the event of witnessing a 
person experiencing possible symptoms of ACS. It may be important to 
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emphasise that where they have a clear understanding of the situation or 
perceive the patient to be very emotional that they should take action, even in 
situations where the patient is unsure.  Furthermore, it is necessary to make it 
clear that if attempts to control the patient’s symptoms have not been 
successful within 15 minutes that medical help should be sought. 
 
8.4 Research 
8.4.1 NHS 24 as an environment for research 
NHS 24 provided novel opportunities for research. Access to a geographically 
and demographically diverse population of people seeking help with possible 
symptoms of ACS was achieved. All calls are recorded providing an 
opportunity to study what is said at the time of seeking help without impact on 
the clinical situation. This might be useful in relation to other clinical conditions.  
The significant difficulties encountered achieving participation of patients and 
staff may have been largely due to the study design and the nature of the 
particular clinical population.  Alternative study designs and clinical populations 
may prove less problematic. Alterations to some procedures within NHS 24 
might help to overcome difficulties relating to participation and thus enhance 
the potential of the organisation to facilitate further innovative research. 
8.4.2 Consultations 
The study has shown that the CS-SRM accounts for a large proportion of 
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participants’ initial presentations. Whilst this data is particularly valuable as it is 
largely uncontaminated by either the researcher’s or professionals’ questions, 
it represents a small proportion of the overall clinical presentation.  
Participants may reveal additional components of illness representation later 
within the consultation. Staff members at NHS 24, although likely naïve to the 
CS-SRM may ask questions which elicit further components of illness 
representation. Examination of the illness representations within the entire 
consultation would provide additional data about which representations are 
discussed. Furthermore, the important role of clinicians in either elaborating or 
restricting the range of representations shared could be explored. The 
relationship between the number and type of illness representations discussed 
within consultations and the outcome of the call (e.g. patient satisfaction or 
clinically appropriate decisions) would be useful to examine. The CS-SRM 
might usefully inform the pattern of consultations.  
Furthermore, the CS-SRM guided content analysis utilised within the current 
study has been shown to be a feasible and reliable method of eliciting illness 
representations. However, as already discussed, interpreting what people said 
during consultations was not unproblematic. It is proposed that a methodology 
where the participant is involved in reviewing the consultation might be useful 
both in verifying the interpretation of data but also in elaborating further the 
relationships between the various components. 
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8.4.3 Pre-hospital delay 
The results of this study have demonstrated that different factors are 
associated with appraisal and illness delay. This has important implications for 
future research into patient decision time. Breakdown of the different 
components of patient decision time is important in order to inform 
interventions aimed at reducing delay. These might address illness 
representations and beliefs about use of health services as well as the nature 
of symptoms. Having an impact on both components of decision time could 
potentially be more effective in reducing delay.   
Data from this study and previous research (Johnson and King, 1995; Dracup 
et al.  2003; Walsh J C et al.  2004) suggest that the CS-SRM is a useful 
theoretical framework in which to investigate patient decision time. Illness 
representations emerged as the only significant variables predicting appraisal 
delay category and may also account for differences relating to demographic 
factors (e.g. gender). However, it is likely that the relationships between the 
various components as well as between demographic, clinical and contextual 
factors are complex. Further detailed exploration of the illness representations 
revealed during initial presentation of particular participants might be useful in 
elaborating some of these complexities. For example, the illness 
representations of those who reported serious consequences but nevertheless 
delayed may be interesting to examine, perhaps using the cued recall method 
already described. Similarly, the initial presentations of those who received a 
diagnosis of ACS might be useful to compare with those who did not. 
Furthermore, there were participants within the study who had made in excess 
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of 100 calls to NHS 24 in the preceding 3 years. A detailed analysis of the 
illness representations of participants who seek help frequently might be useful 
to contrast with those who delay.   
Additionally, the data relating to the initial presentations of participants from the 
current study could be applied to the issue of utilisation delay (the delay 
between patients seeking help and actually receiving it). Clinical staff within 
NHS 24 and in primary care regularly evaluate patients with possible 
symptoms of ACS. Chest discomfort, and indeed other symptoms of ACS, are 
common reasons for presentation to healthcare (Fox, 2005) and may be 
caused by many other conditions ranging from the benign to the  immediately 
life-threatening (Nilsson et al.  2003).  A significant challenge exists for 
clinicians to consistently identify all potential cases of ACS whilst minimising 
‘false alarms’.  
Nurses in the context of NHS 24 face the additional challenge of making these 
judgements based entirely on patients or relatives verbal accounts of their 
symptoms. Powerful cues such as pallor, sweating or cyanosis that would be 
immediately apparent to an experienced clinician in a face to face consultation 
may be more difficult to assess in this situation. Serious adverse incidents 
have occurred within NHS 24 where patients with ACS have been 
inappropriately referred to GP out-of-hours centres. 
The exercise within Pilot Study 1, where clinicians were asked to evaluate 
whether the symptoms presented in transcriptions of consultations represented 
possible symptoms of ACS, further illustrated the problem. The raters were 
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rarely unanimous in their assessments and even when the 4-point scale was 
collapsed into a yes/no dichotomy there remained some disagreements.  
A better understanding of how judgements vary in relation to identical cases 
and of which cues are most powerful in predicting decisions would be helpful in 
identifying a clear focus for improving clinical decision making. The 
presentations of participants from the current study, for whom the outcome is 
known (i.e. ACS or not), could be used as the basis for a study based on signal 
detection theory. Data from such a study would be useful in identifying the 
cues most helpful in successfully identifying potential cases of ACS and those 
factors that lead to less appropriate decisions.  
8.5 Conclusion 
The CS-SRM provided a useful framework to explore both the content and 
timing of people’s initial presentations with symptoms of ACS. The study has 
shown that patients and significant others present the components of illness 
representations within their initial presentations of symptoms. The components 
of illness representations which most influence behaviour and outcome may be 
least likely to be volunteered. Clinicians may need to enquire specifically about 
cause, consequences, cure/control and coherence.  
Decision time for most people with possible symptoms of ACS remains well 
out-with the ideal with appraisal time accounting for the majority of the delay. 
Appraisal delay was found to be shorter for men, those with few symptoms and 
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high emotion. This suggests that interventions aimed at reducing appraisal 
delay may need to target women and highlight the possibility of a range of 
symptoms and possible emotional reaction. 
Illness delay was shorter where people recognised the heart as the most likely 
cause of their symptoms. Interventions should aim to help people recognise a 
range of possible presentations. Illness delay was also longer amongst people 
calling NHS 24 for the first time suggesting that people at high risk of ACS 
should be informed about how to access healthcare out-of-hours. 
The degree to which patients and significant others differed in their illness 
representations was significantly related to appraisal time, suggesting that the 
content of interventions aimed at potential bystanders may need to be different 
from those targeting the people experiencing symptoms.  
NHS 24 provided a fruitful environment for research into patient presentations 
and there are many other related research questions which could be explored 
within the setting. Such research could contribute to knowledge in a number of 
fields including illness representations, clinical presentation and decision-
making and thus be of considerable benefit to both staff and patients. 
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GP
NHS24
Greeting Message
Creates patient record within database
Establishes and records reason for call
Records patient details
Is Call immediately life 
threatening ?
999 -
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Performs assessment
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Negotiates clinically appropriate outcome with patient
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See GP 
next day
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Attend 
A&E
GP Home 
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threatening ?
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Call handler
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List of unique ID’s created
RQ1
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patients noted
Age
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on own behalf
Patient invited to participate
Patient 
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Call excluded
Call handler and nurse advisor 
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Staff consent 
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no
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yes
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these elements of the call 
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Simplified NHS 24 call process Research process
 
  333 
Appendix 2 
Negative NHS 24 publicity 
 
  334 
 
  335 
 
 
 
  336 
 
Appendix 3 
Dear {patients name}, 
 
My name is Barbara Farquharson, I am a nurse working with 
NHS 24. I am currently undertaking a research project which 
aims to better understand how people seek medical help with 
symptoms. 
 
I am writing to invite you to take part in this study. You are one 
of 150 patients who have been selected after recently being in 
contact with NHS 24. You have been selected using a method 
that ensures everyone has an equal chance of being chosen. 
 
I am aware that it is possible that I may be contacting you at a 
difficult time and I do not wish to cause you any concern. If you 
feel unable to deal with this request at this time, please simply 
return all the enclosed information in the envelope provided and 
accept my apologies for troubling you. 
 
However, if you feel able to consider participating please read 
the enclosed Patient Information Sheet carefully. It explains 
clearly what the study involves and should answer any questions 
you might have.  If you require any additional information please 
contact me on the number below. Thank you for your assistance. 
 
Yours sincerely 
 
 
 
 
Barbara Farquharson  MSc; BSc; RGN 
Tel: 01786 466287 
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Appendix 4 
Patient Information Sheet 
 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms? 
 
You are being invited to take part in a research study. Before you 
decide it is important for you to understand why the research is being 
done and what it will involve. Please take time to read the following 
information carefully. Please discuss it with others if you wish. Feel 
free to ask us if there is anything that is not clear or if you would like 
more information. It is important that you take time to decide 
whether or not you wish to take part. Thank you for reading this 
information. 
 
What is the purpose of the study? 
 
The aim of this study is to learn how people’s personal circumstances 
and thoughts about their symptoms influence how and when they 
contact health services. It is hoped this information will help us to 
adapt services to make sure that people get the help they need, as 
quickly as possible. 
 
Why have I been chosen? 
 
150 people who have been in contact with NHS 24 recently have 
been invited to take part. You were selected using a process that 
ensures everyone who called NHS 24 recently has an equal chance of 
being chosen. 
 
As some people who call NHS 24 are very unwell, there is a small 
possibility that you have opened this letter on behalf of someone who 
has recently died. If this is the case, we apologise for troubling you 
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and offer you our deepest sympathies. If you wish to simply ignore 
this request we completely understand. However, if you do feel able 
to consider taking part we believe you could help us gain a better 
insight into how people get help for serious symptoms. Whilst, 
unfortunately, this will not benefit the person we wrote to, it may 
help us to improve things for others in the future.  
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide 
to take part you may keep this information sheet and you will be 
asked to sign the enclosed consent form. If you decide to take part 
you are still free to withdraw at any time and without giving a reason. 
A decision to withdraw at any time, or a decision not to take part, 
will not affect the standard of care you receive. If you are deciding to 
take part on behalf of someone who has recently died, please only 
initial and sign the statements on page 2 of the consent form. 
 
If you decide not to take part please simply return the enclosed 
material using the stamped addressed envelope included and you will 
not be contacted about this study again. If you would like to provide 
the reason why you feel unable to take part, we would find that very 
helpful. 
 
 
What will happen to me if I take part? 
 
By agreeing to take part in the study and signing the consent form, 
you will be giving permission for us to use the recording of the 
original call you made to NHS 24 for the purposes of this study.  
 
You will also be asked to complete the enclosed questionnaire and 
return it by post, if possible, within a week. The questionnaire asks 
about the symptoms you experienced before contacting NHS 24, and 
your thoughts and feelings about those symptoms. The questionnaire 
usually takes less than 15 minutes to complete.  
This letter is the only contact we will make with you. You will not be 
contacted in relation to this study again. 
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What are the possible risks/ disadvantages of taking part? 
 
Some people may find being asked to recall the events which led 
them to contact health services distressing. Others may find it helpful 
to do so. 
 
 
What are the possible benefits of taking part? 
 
There is no direct benefit for you in taking part. However, the 
information gained from this study may help us to better understand 
how people seek help with symptoms.  This may inform how services 
are developed to better meet the needs of the public. 
 
 
What if something goes wrong? 
 
It is unlikely you will be harmed by taking part in this study. 
However, if you wish to complain or have any concerns about any 
aspect of the way you have been approached or treated during the 
course of this study, please contact Gill Stillie, Associate Director of 
Nursing, NHS 24, Norseman House, South Queensferry, EH30 9QZ.  
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the 
research will be kept strictly confidential. It will not be possible to 
identify you from any information which leaves NHS premises.  
 
If you decide to take part in this study we would like to inform your 
GP that you are doing so. If you do not wish your GP to be informed 
please do not initial that section of the consent form. 
 
What will happen to the results of the research study? 
 
The results of the study will be reported in a PhD thesis which will be 
available in the University of Stirling. The results will also be 
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submitted to healthcare journals for publication. You will not be 
identified in any report or publication. If you would like the results to 
be sent to you on completion of the study please initial the 
appropriate box on the consent form. 
 
 
Who is organising and funding the research? 
 
This study is being organised jointly between NHS 24 and the 
Universities of Stirling and Aberdeen. It has been funded by the 
Nursing, Midwifery and Allied Health Professionals (NMAHP) 
Research Training Scheme which was developed in association with 
NHS Education for Scotland (NES), The Scottish Executive and The 
Health Foundation. No-one will receive payment as a result of your 
participation. 
 
Who has reviewed the study? 
 
The study has been reviewed by the Departmental Research Ethics 
Committee, University of Stirling and by a Main NHS Research 
Ethics Committee. 
 
Who should I contact for further information? 
 
Should you have any questions or require further information please 
do not hesitate to contact 
 
Barbara Farquharson          or Dr Carol Bugge 
NHS 24     Senior Lecturer 
Norseman House    Dept of Nursing & Midwifery 
2 Ferrymuir    University of Stirling 
South Queensferry   Stirling 
Tel: 01786 466287   Tel: 01786 466109 
 
Thank-you for reading this information. Please keep this leaflet and a 
signed consent form for your own records. 
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Appendix 5 
 
PATIENT CONSENT FORM 
 
Title:  What factors influence patient’s behaviour when seeking help with 
symptoms? 
 
Name of researcher: Barbara Farquharson 
 
Please initial box if you agree with the following statements. 
 
 
1. I have read and understand the information sheet dated October 
2004, version 1 for the above study. 
 
2. I have had the opportunity to ask questions. 
 
 
3.  I understand that my participation is voluntary and that I am  
 free to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected. 
 
4. I understand that the record of my call to NHS 24 will be accessed 
and listened to by the research team. 
 
5. I would like the results from this study to be sent to me when 
available. 
 
6.  I give permission for my GP to be informed that I am taking part in 
this research. 
 
7.  I agree to take part in the above study. 
 
 
 
  
Name of Patient  Date Signature 
 
 
 
 
 
Researcher   Date                          Signature 
1 for patient;  1 for researcher;  1 to be stored at NHS 24 
 
 
 
 
 
 
 
 
 
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Please only complete this section of the consent form if you are providing 
consent on behalf of someone who has died. 
 
 
 CONSENT FORM 
 
 
Title:  What factors influence patient’s behaviour when seeking help with 
symptoms? 
 
Name of researcher: Barbara Farquharson 
 
 
Please initial box if you agree with the following statements. 
 
 
1. I have read and understand the information sheet dated October 
2004, version 1 for the above study. 
 
2. I have had the opportunity to ask questions. 
 
 
3.  I understand that my participation is voluntary and that I am  
 free to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected. 
 
4. I understand that the record of the call to NHS 24, about the person 
named overleaf, will be accessed and listened to by the research 
team. 
 
 
 
 
 
Name……………………………….        Signature………………………………… 
 
 
 
Relationship to patient…………………..Date……………………......................... 
 
 
 
 
_________________________ ________________         ___________ 
Researcher   Date                          Signature 
1 for person giving consent; 1 for researcher;  1 to be stored at NHS 24 
 
 
 
 
 
 
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Appendix 6 
 
Dear {staff members name}, 
 
My name is Barbara Farquharson, I am a Team Leader with NHS 
24 based in the East Contact Centre. I am currently undertaking a 
research project which aims to better understand how people 
seek medical help with possible cardiac symptoms. 
 
I am writing to invite your participation in this study. 150 calls to 
our service have been selected at random. I hope to analyse the 
voice recordings of these consultations. As you were involved in 
one or more of these consultations I am writing to request your 
consent to analyse these calls for the purposes of this study. The 
patient has given their consent. 
 
I enclose a Staff Information Sheet which I ask you to read 
carefully. It explains clearly what the study involves and should 
answer any questions you might have. However, if you require 
any additional information please do not hesitate to contact me 
on the number below. Thank you for your assistance. 
 
Yours sincerely 
 
 
 
 
 
 
Barbara Farquharson  MSc; BSc; RGN 
Tel: 01786 466287 
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Appendix 7 
Staff Information Sheet 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms which may be cardiac? 
 
You are being invited to take part in a research study. Before you decide it 
is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. Ask us if there is anything 
that is not clear or if you would like more information. It is important to 
take time to decide whether or not you wish to take part. Thank you for 
reading this information. 
 
What is the purpose of the study? 
A number of treatments are of proven benefit to people having a heart 
attack if administered soon after the onset of symptoms. However, 
previous research has shown that many people wait for lengthy periods 
before seeking help and thus do not receive maximum benefit from 
treatment. The aim of this study is to learn how people’s personal 
circumstances, symptoms and particularly their own perceptions of their 
symptoms influence how and when they present to healthcare services.  
 
Why have I been chosen? 
150 patients have been selected randomly after contacting our service 
seeking help with symptoms. These patients have given permission for 
their voice-recordings to be used for the purposes of this study. As you 
were involved in one or more of these calls you are being asked to give 
your consent for the voice recording to be used. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to 
take part you may keep this information sheet and you will be asked to 
sign the enclosed consent form. If you decide to take part you are still free 
to withdraw at any time and without giving a reason. A decision to 
withdraw at any time, or a decision not to take part, will not affect your 
employment at NHS 24 in any way. 
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If you decide not to take part please simply return the enclosed material 
using the envelope provided and you will not be contacted about this study 
again.  
 
What will happen to me if I take part? 
The voice-recording of the consultation between you and the participant 
identified for the study will be accessed and transcribed. The 
transcriptions will be analysed to see whether elements of a theoretical 
model (Leventhal's self-regulation model) are evident within the 
consultation. It is necessary to include analysis of call-handlers and nurses 
words to establish which elements were expressed spontaneously by 
callers and which in response to questions asked. 
 
What are the possible risks/ disadvantages of taking part? 
The recordings of your consultation will only be accessed for the purposes 
of this study as outlined in this document. There is no intention to evaluate 
the performance of staff members. However in the unlikely event that 
serious misconduct was identified during the course of the study, the 
researcher would be professionally obliged to take action and would bring 
the matter to the attention of your Team Leader. 
 
What are the possible benefits of taking part? 
There is no direct benefit for you in taking part. However, the information 
gained from this study may help us to better understand how people seek 
help with symptoms and may inform how services are developed to better 
meet the needs of the public. 
 
What if something goes wrong? 
It is unlikely you will be harmed by taking part in this study. However, if 
you wish to complain or have any concerns about any aspect of the way 
you have been approached or treated during the course of this study, 
please contact Gill Stillie, Associate Director of Nursing, Norseman 
House or your staff representative. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the 
research will be kept strictly confidential. You will not be personally 
identified within the transcripts or in any publication thereafter. 
 
 
 
  346 
What will happen to the results of the research study? 
The results of the study will be reported in a PhD thesis which will be 
available in Stirling University. The results will also be submitted to 
healthcare journals for publication. You will not be identified in any report 
or publication. Reports will also be made available within NHS 24. 
 
Who is organising and funding the research? 
This study is being organised jointly between NHS 24 and the Universities 
of Stirling and Aberdeen. It has been funded by the Nursing, Midwifery 
and Allied Health Professionals (NMAHP) Research Training Scheme 
which was developed in association with NHS Education for Scotland 
(NES), The Scottish Executive and The Health Foundation. No-one will 
receive payment as a result of your participation. 
 
Who has reviewed the study? 
The study has been reviewed by the Departmental Research Ethics 
Committee, University of Stirling and by a Main NHS Research Ethics 
Committee. 
 
Who should I contact for further information? 
Should you have any questions or require further information please do 
not hesitate to contact 
 
Barbara Farquharson          or Dr Carol Bugge 
NHS 24     Senior Lecturer 
Norseman House    Dept of Nursing & Midwifery 
2 Ferrymuir     University of Stirling 
South Queensferry    Stirling 
 
Tel: 01786 466287    Tel: 01786 466109 
Thank-you for reading this information. Please keep this leaflet and a 
signed consent form for your own records. 
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Appendix 8 
 
STAFF CONSENT FORM 
 
Title:  What factors influence patient’s behaviour when seeking help with 
symptoms? 
 
Name of researcher: Barbara Farquharson 
 
Please initial box if you agree with the following statements. 
 
                            
1. I confirm that I have read and understand the information sheet 
dated October 2004, version 3 for the above study and have had the 
opportunity to ask questions. 
 
2.  I understand that my participation is voluntary and that I am  
 free to withdraw at any time, without giving any reason, without my 
employment, medical care or legal rights being affected. 
 
3. I understand that sections of medical notes (including voice 
recordings) relating to patients selected for the study will be 
examined by responsible individuals from Stirling University or NHS 
24 where it is relevant to my taking part in research. I give 
permission for these individuals to have access to such records.  
 
 
4. I would like the results from this study to be sent to me when 
available. 
  
 
5.  I agree to take part in the above study 
 
 
 
 
Name of staff member Date Signature 
 
 
 
 
Researcher   Date                          Signature 
1 for staff member;  1 for researcher;  1 to be stored at NHS 24 
 
 
 
 
 
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Appendix 9 
 
Dear {patients name}, 
 
My name is Barbara Farquharson, I am a nurse working with 
NHS 24. I am currently undertaking a research project which 
aims to better understand how people seek medical help with 
symptoms. 
 
I am writing to invite you to take part in this study. You are one 
of 150 patients who have been selected after recently being in 
contact with NHS 24. You have been selected using a method 
that ensures everyone has an equal chance of being chosen. 
 
I am aware that it is possible that I may be contacting you at a 
difficult time and I do not wish to cause you any concern. If you 
feel unable to deal with this request at this time, please simply 
return all the enclosed information in the envelope provided and 
accept my apologies for troubling you. 
 
However, if you feel able to consider participating please read 
the enclosed Patient Information Sheet carefully. It explains 
clearly what the study involves and should answer any questions 
you might have.  
 
I understand that, in your case, the telephone call to NHS 24 was 
made by someone other than yourself. Where possible, I would 
be very interested in hearing their views too. Therefore, if you 
could pass the ‘Caller Information’ on to the person who called 
on your behalf, it would be very helpful.  
 
If you wish to take part but are unable to pass this information 
onto the person who made the call, please do not worry. Please 
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still complete the ‘Patient Information’ and return it using the 
enclosed stamped addressed envelope.  
 
 
 If you require any additional information please contact me on 
the number below. Thank you for your assistance. 
 
Yours sincerely 
 
 
 
 
 
Barbara Farquharson  MSc; BSc; RGN 
Tel: 01786 466287 
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Appendix 10 
 
Dear {callers name}, 
 
My name is Barbara Farquharson; I am a nurse working with 
NHS 24. I am currently undertaking a research project which 
aims to better understand how people seek medical help with 
symptoms. 
 
I am writing to invite you to take part in this study. 150 patients 
have been selected after recently being in contact with NHS 24. 
You are being approached as you were involved in making a call 
on behalf of one of the patients selected. I have asked them to 
pass this information to you. 
 
I am aware that it is possible that I may be contacting you at a 
difficult time and do not wish to cause you any concern. If you 
feel unable to deal with this request at this time, please simply 
return all the enclosed information in the envelope provided and 
accept my apologies for troubling you. 
 
However, if you feel able to consider taking part please read the 
enclosed Caller Information Sheet carefully. It explains clearly 
what the study involves and should answer any questions you 
might have. If you require any additional information please 
contact me on the number below. Thank you for your assistance. 
 
Yours sincerely 
 
 
 
Barbara Farquharson  MSc; BSc; RGN 
Tel: 01786 466112 
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Appendix 11 
Caller Information Sheet 
 
Study Title: What factors influence people’s behaviour 
when seeking help with symptoms? 
 
You are being invited to take part in a research study. Before you 
decide it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the 
following information carefully. Please discuss it with others if 
you wish. Feel free to ask us if there is anything that is not clear 
or if you would like more information. It is important to take 
time to decide whether or not you wish to take part. Thank you 
for reading this information. 
 
What is the purpose of the study? 
 
The aim of this study is to learn how people’s personal 
circumstances and thoughts about their symptoms influence how 
and when they contact health services. We are also interested in 
the views of other people who were present when the telephone 
call to NHS 24 was made. It is hoped this information will help 
us to adapt services to make sure that people get the help they 
need, as quickly as possible. 
 
Why have I been chosen? 
 
150 telephone calls to NHS 24 have been selected using a 
process that ensures that everyone who called NHS 24 recently 
has an equal chance of being chosen. The patients have been 
invited to participate in this study. Where someone else made the 
telephone call on their behalf we have asked them to pass this 
information to that person. You are being approached as you 
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were involved in making the telephone call to NHS 24 on behalf 
of one of the patients selected. We are interested in exploring 
your thoughts about the patient’s symptoms. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do 
decide to take part you may keep this information sheet and you 
will be asked to sign the enclosed consent form. If you decide to 
take part you are still free to withdraw at any time and without 
giving a reason. A decision to withdraw at any time, or a 
decision not to take part, will not affect the standard of care you 
or the patient receives. 
 
If you decide not to take part please simply return the enclosed 
material using the stamped addressed envelope included and you 
will not be contacted about this study again. If you want to 
provide the reason why you feel unable to take part that would be 
very helpful. 
 
What will happen to me if I take part? 
By agreeing to take part in the study and signing the consent 
form you will be giving permission for us to use the recording of 
the call you made to NHS 24, for the purposes of this study.  
 
You will also be asked to complete the enclosed questionnaire 
and return it in the envelope provided, if possible, within a week. 
The questionnaire usually takes less than 15 minutes to complete. 
 
This letter is the only contact we will make with you. You will 
not be contacted in relation to this study again. 
 
What are the possible risks/ disadvantages of taking part? 
Some people may find being asked to recall the events which led 
them to contact health services distressing. Others may find it 
helpful to do so. 
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What are the possible benefits of taking part? 
There is no direct benefit for you in taking part. However, the 
information gained from this study may help us to better 
understand how people seek help with symptoms. This may 
inform how services are developed to better meet the needs of 
the public. 
 
What if something goes wrong? 
It is unlikely you will be harmed by taking part in this study. 
However, if you wish to complain or have any concerns about 
any aspect of the way you have been approached or treated 
during the course of this study, please contact Gill Stillie, 
Associate Director of Nursing, NHS 24, Norseman House, South 
Queensferry, EH30 9QZ. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of 
the research will be kept strictly confidential. It will not be 
possible to identify you from any information which leaves NHS 
premises.  
 
If you decide to take part in this study we would like to inform 
your GP that you are doing so. If you do not wish your GP to be 
informed please do not initial that section of the consent form. 
 
 
What will happen to the results of the research study? 
The results of the study will be reported in a PhD thesis which 
will be available in Stirling University. The results will also be 
submitted to healthcare journals for publication. You will not be 
identified in any report or publication. If you would like the 
results to be sent to you on completion of the study please tick 
the appropriate box on the consent form. 
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Who is organising and funding the research? 
This study is being organised jointly between NHS 24 and the 
Universities of Stirling and Aberdeen. It has been funded by the 
Nursing, Midwifery and Allied Health Professionals (NMAHP) 
Research Training Scheme which was developed in association 
with NHS Education for Scotland (NES), The Scottish Executive 
and The Health Foundation. No-one will receive payment as a 
result of your participation. 
 
Who has reviewed the study? 
The study has been reviewed by the Departmental Research 
Ethics Committee, University of Stirling and by a Main NHS 
Research Ethics Committee. 
 
Who should I contact for further information? 
 
Should you have any questions or require further information 
please do not hesitate to contact 
 
Barbara Farquharson          or Dr Carol Bugge 
NHS 24     Senior Lecturer 
Norseman House   Dept of Nursing & Midwifery 
2 Ferrymuir    University of Stirling 
South Queensferry   Stirling 
 
Tel: 01786 466287   Tel: 01786 466109 
 
 
Thank-you for reading this information. Please keep this leaflet 
and a signed consent form for your own records. 
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Appendix 12 
ILLNESS PERCEPTION QUESTIONNAIRE (IPQ-R) 
Study ID No………………………………    Date………………………………… 
 
YOUR VIEWS ABOUT YOUR ILLNESS 
Listed below are a number of symptoms that you may or may not have experienced 
when you contacted NHS 24. Please indicate by circling Yes or No, whether you  have 
experienced any of these symptoms recently and whether these symptoms relate to 
why you were in contact with NHS 24. 
 
I have experienced this  
symptom recently 
 (within last 2 weeks) 
This symptom is 
related to why I was in 
contact with NHS 24 
 
 
Pain     Yes  No ________________Yes     No 
Discomfort    Yes  No ________________Yes  No 
Sore Throat   Yes  No ________________Yes  No 
Nausea    Yes  No ________________Yes  No 
Breathlessness   Yes  No ________________Yes  No 
Weight Loss   Yes  No ________________Yes  No 
Tiredness    Yes  No ________________Yes  No 
Stiff Joints    Yes  No ________________Yes  No 
Sore Eyes    Yes  No ________________Yes  No 
Wheeziness    Yes  No ________________Yes  No 
Headaches    Yes  No ________________Yes  No 
Upset Stomach   Yes  No ________________Yes  No 
Sleep Difficulties   Yes  No ________________Yes  No 
Dizziness    Yes  No ________________Yes  No 
Loss of Strength   Yes  No ________________Yes  No 
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We are interested in your own personal views of how you now see your current illness. 
 
Please indicate how much you agree or disagree with the following statements about 
your symptoms by ticking the appropriate box. 
 
 VIEWS ABOUT THEIR ILLNESS STRONGLY DISAGREE   DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP1*
 My symptoms will last a short time      
IP2
 My symptoms are likely to be permanent 
rather than temporary 
     
IP3
 My symptoms will last for a long time      
IP4*
 My symptoms will pass quickly      
IP5
 I expect I will have these symptoms for the 
rest of my life 
     
IP6
 My illness is a serious condition      
IP7
 My symptoms have major consequences 
on my life 
     
IP8*
 My symptoms do not have much effect on 
my life 
     
IP9
 My symptoms strongly affect the way 
others see me 
     
IP10
 My symptoms have serious financial 
consequences 
     
IP11
 My symptoms cause difficulties for those 
who are close to me 
     
IP12
 There is a lot which I can do to control my 
symptoms 
     
IP13
 What I do can determine whether my 
symptoms get better or worse 
     
IP14
 The course of my illness depends on me      
IP15*
 Nothing i do will affect my symptoms      
IP16
 I have the power to influence my 
symptoms 
     
IP17*
 My actions will have no affect on the 
outcome of my illness 
     
IP18*
 My symptoms will improve in time      
IP19*
 There is very little that can be done to 
improve my symptoms 
     
IP20
 My treatment will be effective in curing 
my illness 
     
IP21
 The negative effects of my illness can be 
prevented (avoided) by my treatment 
     
IP22
 My treatment can control my symptoms      
IP23*
 There is nothing which can help my 
condition 
     
IP24
 The symptoms of my condition are 
puzzling to me 
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STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP25
 My symptoms are a mystery to me      
IP26
 I don’t understand my symptoms      
IP27
 My symptoms don’t make any sense to me      
IP28*
 I have a clear picture or understanding of 
my condition 
     
IP29
 My symptoms change a great deal from 
day to day 
     
IP30
 My symptoms come and go in cycles      
IP31
 My symptoms are very unpredictable      
IP32
 I go through cycles in which my symptoms 
get better and worse. 
     
IP33
 I get depressed when I think about my 
symptoms 
     
IP34
 When I think about my symptoms I get 
upset 
     
!P35
 My symptoms make me feel angry      
IP36*
 My symptoms do not worry me      
IP37
 Having these symptoms makes me feel 
anxious 
     
IP38
 My symptoms make me feel afraid      
CAUSES OF MY ILLNESS  
 
We are interested in what you consider may have been the cause of your symptoms.  
As people are very different, there is no correct answer for this question.  We are most 
interested in your own views about the factors that caused your symptoms rather than 
what others including doctors or family may have suggested to you.  Below is a list of 
possible causes for your symptoms.  Please indicate how much you agree or disagree 
that they were causes for you by ticking the appropriate box. 
 
 POSSIBLE CAUSES STRONGLY DISAGREE  DISAGREE NEITHER AGREE 
NOR 
DISAGREE 
AGREE  STRONGLY AGREE
C1
 Stress or worry      
C2
 Hereditary - it runs in my family      
C3
 A Germ or virus      
C4
 Diet or eating habits      
C5
 Chance or bad luck      
C6
 Poor medical care in my past      
C7
 Pollution in the environment      
C8
 My own behaviour      
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STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE  
C9
 My mental attitude e.g. thinking about 
life negatively 
     
C10
 Family problems or worries caused my 
illness 
     
C11
 Overwork      
C12
 My emotional state e.g. feeling down, 
lonely, anxious, empty 
     
C13
 Ageing      
C14
 Alcohol      
 C15
 Smoking      
C16
 Accident or injury      
C17
 My personality      
C18
 Being ‘rundown’      
 
In the table below, please list in rank-order the three most important factors that you 
believed might be causing YOUR symptoms at the time you called NHS 24.   You 
may use any of the items from the box above, or you may have additional ideas of 
your own. 
 
The most important causes for me:- 
1.  ______________________________________  
2. _______________________________________ 
3. _______________________________________ 
 
 
ADDITIONAL INFORMATION 
 
In order to help us understand the information you have provided better, it would be 
very helpful if you could tell us a little about yourself. 
 
 
1. What is your age?  ___________  
 
2. Are you male or female? ___________ 
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3. What is your ethnic group?  Choose one section from A to E,  tick box if 
appropriate or add your own description. 
A. White 
Scottish 
British 
Irish 
 
Other White background? 
 
B. Asian, Asian Scottish or Asian 
British 
Indian 
Pakistani 
Bangladeshi 
Chinese 
Other Asian background? 
 
 
C. Black 
Caribbean 
African 
 
 
Other Black background? 
D. Mixed 
 
 
E. Any other ethnic background  
 
HOW DID YOU FIND THIS QUESTIONNAIRE? 
We are also interested in hearing your views about how reasonable the 
questionnaire was to complete 
 
 
 
STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
 
 The questionnaire was easy to complete      
 I was contacted at an appropriate time      
 The questions were relevant to me      
 I remember the reason I was in contact 
with NHS 24 
     
 
Please feel free to make any additional comments below or overleaf: 
 
 
 
Once completed please put this questionnaire and a signed consent form in the 
stamped, addressed envelope provided. Please post it within a week if possible. 
Thank you very much for taking part in this study.  
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Appendix 13 
CALLER ILLNESS PERCEPTION QUESTIONNAIRE 
(IPQ-R) 
 
Study ID No………………………………   Date………………………………… 
 
YOUR VIEWS ABOUT THE PATIENTS ILLNESS 
Listed below are a number of symptoms that the patient (the person you called 
NHS 24 about) may or may not have experienced.  Please indicate by circling Yes 
or No, whether you believe they have experienced any of these symptoms and 
whether these symptoms relate to why you were in contact with NHS 24. 
They have experienced this  
symptom recently 
 (within last 2 weeks) 
This symptom is 
related to why I 
contacted NHS 24 on 
their behalf 
   
Pain    Yes No Don’t know________________Yes     No 
Discomfort   Yes No Don’t know________________Yes  No 
Sore Throat  Yes No Don’t know________________Yes  No 
Nausea   Yes No Don’t know________________Yes  No 
Breathlessness  Yes No Don’t know________________Yes  No 
Weight Loss  Yes No Don’t know________________Yes  No 
Tiredness   Yes No Don’t know________________Yes  No 
Stiff Joints   Yes No Don’t know________________Yes  No 
Sore Eyes   Yes No Don’t know________________Yes  No 
Wheeziness   Yes No Don’t know________________Yes  No 
Headaches   Yes No Don’t know________________Yes  No 
Upset Stomach  Yes No Don’t know________________Yes  No 
Sleep Difficulties  Yes No Don’t know________________Yes  No 
Dizziness   Yes No Don’t know________________Yes  No 
Loss of Strength  Yes No Don’t know________________Yes  No 
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We are interested in YOUR own personal views about the patient’s symptoms. 
 
Please indicate how much you agree or disagree with the following statements about 
the patients symptoms by ticking the appropriate box. 
 
 VIEWS ABOUT THEIR ILLNESS STRONGLY DISAGREE   DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP1*
 Their symptoms will last a short time      
IP2
 Their symptoms are likely to be 
permanent rather than temporary 
     
IP3
 Their symptoms will last for a long time      
IP4*
 Their symptoms will pass quickly      
IP5
 I expect they will have these symptoms for 
the rest of their life 
     
IP6
 Their illness is a serious condition      
IP7
 Their symptoms have major consequences 
on their life 
     
IP8*
 Their symptoms do not have much effect 
on their life 
     
IP9
 Their symptoms strongly affect the way 
others see them 
     
IP10
 Their symptoms have serious financial 
consequences 
     
IP11
 Their symptoms cause difficulties for 
those who are close to them 
     
IP12
 There is a lot which they can do to control 
their symptoms 
     
IP13
 What they do can determine whether their 
symptoms get better or worse 
     
IP14
 The course of their illness depends on 
them 
     
IP15*
 Nothing they do will affect their symptoms      
IP16
 They have the power to influence their 
symptoms 
     
IP17*
 Their actions will have no affect on the 
outcome of their illness 
     
IP18*
 Their symptoms will improve in time      
IP19*
 There is very little that can be done to 
improve their symptoms 
     
IP20
 Their treatment will be effective in curing 
their illness 
     
IP21
 The negative effects of their illness can be 
prevented (avoided) by treatment 
     
IP22
 Their treatment can control their 
symptoms 
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STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP23*
 There is nothing which can help their 
condition 
     
IP24
 The symptoms of their condition are 
puzzling to them 
     
IP25
 Their symptoms are a mystery to them      
IP26
 They don’t understand their symptoms      
IP27
 Their symptoms don’t make any sense to 
them 
     
IP28*
 They have a clear picture or 
understanding of their condition 
     
IP29
 Their symptoms change a great deal from 
day to day 
     
IP30
 Their symptoms come and go in cycles      
IP31
 Their symptoms are very unpredictable      
IP32
 They go through cycles in which their 
symptoms get better and worse. 
     
IP33
 They get depressed when they think about 
their symptoms 
     
IP34
 When they think about their symptoms 
they get upset 
     
!P35
 Their symptoms make them feel angry      
IP36*
 Their symptoms do not worry them      
IP37
 Having these symptoms makes them feel 
anxious 
     
IP38
 Their symptoms make them feel afraid      
 
We are also interested in exploring how the patient’s illness affects you. 
Please indicate how much you agree or disagree with the following statements about 
the patients symptoms by ticking the appropriate box. 
 
 
 
STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP39
 There is a lot which I can do to control the 
patient’s symptoms 
     
IP40
 What I do can determine whether their 
symptoms get better or worse 
     
IP41
 The course of their illness depends on me      
IP42*
 Nothing I do will affect their symptoms      
IP43
 I have the power to influence the patient’s 
symptoms 
     
IP44*
 My actions will have no affect on the 
outcome of their illness 
     
IP45 The symptoms of their condition are 
puzzling to me 
     
IP46 Their symptoms are a mystery to me      
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STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP47 I don’t understand their symptoms      
IP48 Their symptoms don’t make any sense to 
me 
     
IP49* I have a clear picture or understanding of 
their condition 
     
IP50 I get depressed when I think about their 
symptoms 
     
IP51 When I think about their symptoms I get 
upset 
     
IP52 Their symptoms make me feel angry      
IP53* Their symptoms do not worry me      
IP54 The patient having these symptoms makes 
me feel anxious 
     
IP55 Their symptoms make me feel afraid      
 
CAUSES OF THEIR ILLNESS  
 
We are interested in what you consider may have been the cause of the patient’s 
symptoms.  As people are very different, there is no correct answer for this question.  
We are most interested in your own views about the factors that caused the patient’s 
symptoms rather than what others including doctors or family may have suggested to 
you.  Below is a list of possible causes for their symptoms.  Please indicate how much 
you agree or disagree that they were causes for them by ticking the appropriate box. 
 
 POSSIBLE CAUSES STRONGLY DISAGREE  DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
C1
 Stress or worry      
C2
 Hereditary - it runs in their family      
C3
 A Germ or virus      
C4
 Diet or eating habits      
C5
 Chance or bad luck      
C6
 Poor medical care in the past      
C7
 Pollution in the environment      
C8
 Their own behaviour      
C9
 Their mental attitude e.g. thinking about 
life negatively 
     
C10
 Family problems or worries caused their 
illness 
     
C11
 Overwork      
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STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
C12
 Their emotional state e.g. feeling down, 
lonely, anxious, empty 
     
C13
 Ageing      
C14
 Alcohol      
 C15
 Smoking      
C16
 Accident or injury      
C17
 Their personality      
C18
 Being ‘rundown’      
 
 
 
In the table below, please list in rank-order the three most important factors that you 
believed might be causing the patients symptoms at the time you called NHS 24.   
You may use any of the items from the box above, or you may have additional ideas 
of your own. 
 
The most important causes for me:- 
1.  ______________________________________  
2. _______________________________________ 
3. _______________________________________ 
 
 
ADDITIONAL INFORMATION 
In order to help us understand the information you have provided better, it would be 
very helpful if you could tell us a little about yourself. 
 
1. What is your age?  ___________  
 
2. Are you male or female? ___________ 
 
3. What is your relationship to the patient? ___________ 
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4. What is your ethnic group?  Choose one section from A to E,  tick box if appropriate 
or add your own description. 
E. White 
Scottish 
British 
Irish 
 
Other white background? 
 
F. Asian, Asian Scottish or Asian 
British 
Indian 
Pakistani 
Bangladeshi 
Chinese 
Other asian background? 
 
 
G. Black 
Caribbean 
African 
 
 
Other black background? 
H. Mixed 
 
 
E. Any other ethnic background  
 
HOW DID YOU FIND THIS QUESTIONNAIRE? 
We are also interested in hearing your views about how reasonable the questionnaire 
was to complete 
 
 
 
STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
 
 The questionnaire was easy to complete      
 I was contacted at an appropriate time      
 The questions were relevant to me      
 I remember the reason I was in contact 
with NHS 24 
     
 
Please feel free to make any additional comments below or overleaf: 
 
 
 
 
 
 
Once completed please put this questionnaire and a signed consent form in the 
stamped, addressed envelope provided. Please post it within a week if possible. 
Thank you very much for taking part in this study.  
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Appendix 14 
 
Dear Colleague 
 
I am writing to let you know about a research project I am developing 
within NHS 24 and which you are being asked to get involved in. 
 
The research is funded by a new scheme in Scotland designed to improve 
the research capacity amongst nurses, midwives and allied health 
professionals within the NHS. I have been seconded from my post at 
NHS 24 to one of 6 studentships with the NMAHP training scheme. 
 
The research is concerned with developing a better understanding of how 
people seek help with possible cardiac symptoms. It will include analysis 
of calls to NHS 24 from patients with these types of symptoms. The 
recordings of our consultations provide an ideal opportunity to observe 
actual behaviour at the time of seeking help without interfering in the 
patients journey of care. It is planned that permission will be obtained 
from 100 patients to use the recording of their call for this purpose. 
 
It will be useful to examine what types of information people volunteer 
and what they provide in response to the questions call handlers and 
nurses ask. Thus I am writing to request permission from you (and each 
of your colleagues) to use the recordings of your consultations for the 
purposes of this research (should you happen to be involved in one of the 
100 calls randomly selected). The participation of yourself and your 
colleagues is vital - without the consent of all parties involved in a call I 
am unable to access it for analysis.  
 
I’d like to reassure you that my analysis is solely concerned with 
evaluating a theoretical model about how people interpret illness and 
NOT with evaluating your performance. Your participation is confidential 
and no-one will be informed about who is or is not taking part. 
 
A small number of you may have received previous correspondence from 
me in connection with this study. Thank you to those who have already 
agreed to take part. I am aware that some information contained within 
that correspondence has caused some of you concern and prevented you 
from feeling safe to take part. This was not my intention and I apologise. 
The protocol has been reviewed in light of this feedback and I now 
promise you complete confidentiality. I can assure you that there will be 
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no negative consequences associated with giving your permission for 
your calls to be used in this way. This also applies to those who have 
already given their consent. 
 
Please take time to read the enclosed revised information carefully. 
Contact me on the number provided (or by email) if there is anything 
which is unclear or if you would like more information. I will also be 
available in your centre on [specific dates] if you would like to discuss 
any queries with me in person. 
 
If you decide to take part please ensure you sign and return the consent 
form in the envelope provided. A reminder will be sent to those who have 
not responded within 2 weeks. If you do not wish to take part, please feel 
free to ignore this correspondence although if you could respond, giving 
your reasons that would be very helpful.  
 
Thank you in anticipation of your help and I look forward to meeting 
many of you over the next few weeks. 
 
 
 
Yours sincerely 
 
 
 
 
 
 
 
 
 
Barbara Farquharson 
Team Leader / PhD student 
 
Tel: 01786 466112 
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Appendix 15 
Staff Information Sheet 
 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms which may be cardiac? 
 
You are being invited to contribute to a research study. Before you decide it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and 
discuss it with others if you wish. Ask me if there is anything that is not clear 
or if you would like more information. It is important to take time to decide 
whether or not you wish to take part. Thank you for reading this information. 
 
What is the purpose of the study? 
 
A number of treatments are of proven benefit to people having a heart attack if 
administered soon after the onset of symptoms. However, previous research has 
shown that many people wait for lengthy periods before seeking help and thus 
do not receive maximum benefit from treatment. The aim of this study is to 
learn how people’s personal circumstances, symptoms and particularly their 
own perceptions of their symptoms influence how and when they present to 
healthcare services.  
 
Why have I been chosen? 
 
All NHS 24 nurses and call handlers are being asked to participate. From calls 
involving staff who consent, 100 calls will be chosen AT RANDOM. The 
patients involved in these calls will then be approached for their consent.   
This is to ensure that we only trouble patients for consent when we know that 
the staff involved are happy to take part.  
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide to take 
part you may keep this information sheet and you will be asked to sign the 
enclosed consent form. If you decide to take part you are still free to withdraw 
at any time and without giving a reason. A decision to withdraw at any time, or 
a decision not to take part, will not affect your employment at NHS 24 in any 
way. 
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If you decide not to take part please return the enclosed material using the 
envelope provided. If you feel able to provide a brief reason that would be 
helpful. You will not be contacted about this study again.  
 
If we do not receive a reply from you, we will send you a reminder after 2 
weeks. If you choose not to respond at this point we will assume you do not 
wish to take part and will not contact you about the study again. 
 
What will happen to me if I take part? 
 
If you agree to participate, and a patient you have spoken with is randomly 
selected and gives their consent, then the voice-recording of the consultation 
between you and the participant identified for the study will be accessed and 
transcribed. The transcriptions will be analysed to see whether elements of a 
theoretical model (Leventhal's self-regulation model) are evident within the 
consultation. It is necessary to include analysis of call-handlers and nurses 
words to establish which elements were expressed spontaneously by callers and 
which in response to questions asked. 
 
What are the possible risks/ disadvantages of taking part? 
 
None are anticipated. The recordings of your consultation will only be accessed 
for the purposes of this study as outlined in this document. There is no intention 
to evaluate the performance of staff members. The content of the consultation 
will not be discussed with anyone outside the research team. Your participation 
is completely confidential. No-one else will be aware of whether or not you 
took part. 
 
What are the possible benefits of taking part? 
 
There is no direct benefit for you in taking part. However, the information 
gained from this study may help us to better understand how people seek help 
with symptoms and may inform how services are developed to better meet the 
needs of the public. 
 
What if something goes wrong? 
 
It is unlikely you will be harmed by taking part in this study. However, if you 
wish to complain or have any concerns about any aspect of the way you have 
been approached or treated during the course of this study, please contact Gill 
Stillie, Associate Director of Nursing, Norseman House or your staff 
representative. 
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Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the research 
will be kept strictly confidential. You will not be personally identified within 
the transcripts or in any publication thereafter. 
 
 
What will happen to the results of the research study? 
 
The results of the study will be reported in a PhD thesis which will be available 
in Stirling University. The results will also be submitted to healthcare journals 
for publication. You will not be identified in any report or publication. Reports 
will also be made available within NHS 24. 
 
Who is organising and funding the research? 
 
This study is being organised jointly between NHS 24 and the Universities of 
Stirling and Aberdeen. It has been funded by the Nursing, Midwifery and 
Allied Health Professionals (NMAHP) Research Training Scheme which was 
developed in association with NHS Education for Scotland (NES), The Scottish 
Executive and The Health Foundation. No-one will receive payment as a result 
of your participation. 
 
Who has reviewed the study? 
The study has been reviewed by the Departmental Research Ethics Committee, 
University of Stirling and by Fife & Forth Valley NHS Research Ethics 
Committee. 
 
Who should I contact for further information? 
 
Should you have any questions or require further information please do not 
hesitate to contact 
 
Barbara Farquharson     
NHS 24      
Norseman House     
2 Ferrymuir      
South Queensferry   
 
Tel: 01786 466112              
 
 
 
Thank-you for reading this information. Please keep this leaflet and a consent 
form for your own records. 
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Appendix 16 
 
STAFF CONSENT FORM 
 
Title:  What factors influence patient’s behaviour when seeking help with 
symptoms? 
 
Name of researcher: Barbara Farquharson 
 
Please initial box if you agree with the following statements. 
 
   
1. I confirm that I have read and understand the information sheet 
dated August 2005, version 1 for the above study and have had the 
opportunity to ask questions. 
 
2.  I understand that my participation is voluntary and that I am  
 free to withdraw at any time, without giving any reason, without my 
employment, medical care or legal rights being affected. 
 
3. I understand that sections of medical notes (including voice 
recordings) relating to patients selected for the study will be 
examined by responsible individuals from Stirling University or NHS 
24 where it is relevant to my taking part in research. I give 
permission for these individuals to have access to such records.  
 
 
4. I would like the results from this study to be sent to me when 
available. 
  
 
5.  I agree to take part in the above study 
 
 
 
Name of staff member Date Signature 
 
 
 
 
Researcher Date  Signature                      
(1 for staff member;  1 for researcher) 
 
 
 
 
 
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Appendix 17 
Patient Information Sheet 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms? 
 
You are being invited to take part in a research study. Before you 
decide it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the 
following information carefully. Please discuss it with others if you 
wish. Feel free to ask us if there is anything that is not clear or if you 
would like more information. It is important that you take time to 
decide whether or not you wish to take part. Thank you for reading 
this information. 
 
 
What is the purpose of the study? 
 
The aim of this study is to learn how people’s personal 
circumstances and thoughts about their symptoms influence how and 
when they contact health services. It is hoped this information will 
help us to adapt services to make sure that people get the help they 
need, as quickly as possible. 
 
 
Why have I been chosen? 
 
150 people who have been in contact with NHS 24 recently have 
been invited to take part. You were selected using a process that 
ensures everyone who called NHS 24 recently has an equal chance 
of being chosen. 
 
As some people who call NHS 24 are very unwell, there is a small 
possibility that you have opened this letter on behalf of someone 
who has recently died. If this is the case, we apologise for troubling 
you and offer you our deepest sympathies. . If you wish to simply 
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ignore this request we completely understand – please just let us 
know. However, if you do feel able to consider taking part we 
believe you could help us gain a better insight into how people get 
help for serious symptoms. Whilst, unfortunately, this will not 
benefit the person we wrote to, it may help us to improve things for 
others in the future.  
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide 
to take part you do not need to take any action. The researcher will 
contact you over the next few days to confirm that you wish to take 
part and to make further arrangements with you. 
 
If you do not wish to take part, please respond to the researcher as 
soon as possible. Please either return the enclosed ‘I decline’ card in 
the pre-paid envelope or telephone 01786 466112 and leave a 
message including this study number -[study number]. You will not 
be contacted about this study again. If you would like to provide the 
reason why you feel unable to take part, we would find that very 
helpful. 
 
If you do not respond within 3 days the researcher will telephone 
you. If you receive this call, you are still under no obligation to take 
part. You are free to withdraw at any time and without giving a 
reason. A decision to withdraw at any time, or a decision not to take 
part, will not affect the standard of care you receive. 
 
You may keep this information sheet.  
 
What will happen to me if I take part? 
 
By agreeing to take part in the study you will be giving permission 
for us to use the recording of the original call you made to NHS 24 
for the purposes of this study.  
 
You will also be asked to complete the enclosed questionnaire and 
return it by post, if possible, within a week. The questionnaire asks 
about the symptoms you experienced before contacting NHS 24, and 
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your thoughts and feelings about those symptoms. The questionnaire 
usually takes less than 15 minutes to complete.  
 
What are the possible risks/ disadvantages of taking part? 
 
Some people may find being asked to recall the events which led 
them to contact health services distressing. Others may find it 
helpful to do so. 
 
What are the possible benefits of taking part? 
 
There is no direct benefit for you in taking part. However, the 
information gained from this study may help us to better understand 
how people seek help with symptoms.  This may inform how 
services are developed to better meet the needs of the public. 
 
What if something goes wrong? 
 
It is unlikely you will be harmed by taking part in this study. 
However, if you wish to complain or have any concerns about any 
aspect of the way you have been approached or treated during the 
course of this study, please contact Gill Stillie, Associate Director of 
Nursing, NHS 24, Norseman House, South Queensferry, EH30 9QZ.  
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the 
research will be kept strictly confidential. It will not be possible to 
identify you from any information which leaves NHS premises.  
 
If you decide to take part in this study we would like to inform your 
GP that you are doing so. You will be given the opportunity to 
advise us if you do not wish for that to happen. 
 
What will happen to the results of the research study? 
 
The results of the study will be reported in a PhD thesis which will 
be available in the University of Stirling. The results will also be 
submitted to healthcare journals for publication. You will not be 
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identified in any report or publication. You will be given an 
opportunity to request a summary of the results. 
 
Who is organising and funding the research? 
 
This study is being organised jointly between NHS 24 and the 
Universities of Stirling and Aberdeen. It has been funded by the 
Nursing, Midwifery and Allied Health Professionals (NMAHP) 
Research Training Scheme which was developed in association with 
NHS Education for Scotland (NES), The Scottish Executive and The 
Health Foundation. No-one will receive payment as a result of your 
participation. 
 
Who has reviewed the study? 
 
The study has been reviewed by the Departmental Research Ethics 
Committee, University of Stirling and by a Main NHS Research 
Ethics Committee. 
 
Who should I contact for further information? 
 
Should you have any questions or require further information please 
do not hesitate to contact 
 
Barbara Farquharson  
NHS 24 
Norseman House     
2 Ferrymuir 
South Queensferry    
Tel: 01786 466112    
 
Thank-you for reading this information. Please keep this leaflet 
and a signed consent form for your own records. 
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Appendix 18 
Patient Information Sheet 
 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms? 
 
You are being invited to take part in a research study. Before you 
decide it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the 
following information carefully. Please discuss it with others if you 
wish. Feel free to ask us if there is anything that is not clear or if you 
would like more information. It is important that you take time to 
decide whether or not you wish to take part. Thank you for reading 
this information. 
 
 
What is the purpose of the study? 
 
The aim of this study is to learn how people’s personal 
circumstances and thoughts about their symptoms influence how and 
when they contact health services. It is hoped this information will 
help us to adapt services to make sure that people get the help they 
need, as quickly as possible. 
 
 
Why have I been chosen? 
 
150 people who have been in contact with NHS 24 recently have 
been invited to take part. You were selected using a process that 
ensures everyone who called NHS 24 recently has an equal chance 
of being chosen. 
 
As some people who call NHS 24 are very unwell, there is a small 
possibility that you have opened this letter on behalf of someone 
who has recently died. If this is the case, we apologise for troubling 
you and offer you our deepest sympathies. If you wish to simply 
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ignore this request we completely understand – please just let us 
know. However, if you do feel able to consider taking part we 
believe you could help us gain a better insight into how people get 
help for serious symptoms. Whilst, unfortunately, this will not 
benefit the person we wrote to, it may help us to improve things for 
others in the future.  
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide 
to take part you do not need to take any action. The researcher will 
contact you over the next few days to confirm that you wish to take 
part and to make further arrangements with you. 
 
If you do not wish to take part, please respond to the researcher as 
soon as possible. Please either return the enclosed ‘I decline’ card in 
the pre-paid envelope or telephone 01786 466112 and leave a 
message including this study number -[study number]. You will not 
be contacted about this study again. If you would like to provide the 
reason why you feel unable to take part, we would find that very 
helpful. 
 
If you do not respond within 3 days the researcher will telephone 
you. If you receive this call, you are still under no obligation to take 
part. You are free to withdraw at any time and without giving a 
reason. A decision to withdraw at any time, or a decision not to take 
part, will not affect the standard of care you receive. 
 
You may keep this information sheet.  
 
What will happen to me if I take part? 
 
By agreeing to take part in the study you will be giving permission 
for us to use the recording of the original call you made to NHS 24 
for the purposes of this study.  
 
You will also be asked to take part in an interview by telephone. The 
researcher who contacts you will confirm you wish to take part and 
make arrangements to interview you at a convenient time. The 
interview will be carried out by telephone and will last up to 30 
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minutes. The questions will about the symptoms you experienced 
before contacting NHS 24, and your thoughts and feelings about 
those symptoms. The enclosed Illness Perception Questionnaire 
contains similar questions to those you will be asked.  
 
What are the possible risks/ disadvantages of taking part? 
 
Some people may find being asked to recall the events which led 
them to contact health services distressing. Others may find it 
helpful to do so. 
 
What are the possible benefits of taking part? 
 
There is no direct benefit for you in taking part. However, the 
information gained from this study may help us to better understand 
how people seek help with symptoms.  This may inform how 
services are developed to better meet the needs of the public. 
 
What if something goes wrong? 
 
It is unlikely you will be harmed by taking part in this study. 
However, if you wish to complain or have any concerns about any 
aspect of the way you have been approached or treated during the 
course of this study, please contact Gill Stillie, Associate Director of 
Nursing, NHS 24, Norseman House, South Queensferry, EH30 9QZ.  
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the 
research will be kept strictly confidential. It will not be possible to 
identify you from any information which leaves NHS premises.  
 
If you decide to take part in this study we would like to inform your 
GP that you are doing so. You will be given the opportunity to 
advise us if you do not wish for that to happen. 
 
What will happen to the results of the research study? 
 
The results of the study will be reported in a PhD thesis which will 
be available in the University of Stirling. The results will also be 
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submitted to healthcare journals for publication. You will not be 
identified in any report or publication. You will be given the 
opportunity to request a summary of the results. 
 
Who is organising and funding the research? 
 
This study is being organised jointly between NHS 24 and the 
Universities of Stirling and Aberdeen. It has been funded by the 
Nursing, Midwifery and Allied Health Professionals (NMAHP) 
Research Training Scheme which was developed in association with 
NHS Education for Scotland (NES), The Scottish Executive and The 
Health Foundation. No-one will receive payment as a result of your 
participation. 
 
Who has reviewed the study? 
 
The study has been reviewed by the Departmental Research Ethics 
Committee, University of Stirling and by a Main NHS Research 
Ethics Committee. 
 
Who should I contact for further information? 
 
Should you have any questions or require further information please 
do not hesitate to contact 
 
Barbara Farquharson           
NHS 24      
Norseman House     
2 Ferrymuir     
South Queensferry    
 
Tel: 01786 466112    
 
 
Thank-you for reading this information. Please keep this leaflet 
and a signed consent form for your own records. 
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Appendix 19 
 
I decline 
 
To take part in 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms? 
 
Study Number: 0001 
 
My reasons are: 
 
 
 
 
 
 
Please return in enclosed stamped addressed envelope 
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Appendix 20 
 
Schedule for invitation by telephone 
 
Ask for patient, introduce self  
 
Explain call being recorded 
 
Check received and read study information 
 
Check understanding 
 
Request consent – analyse call / take part interview/ questionnaire as appropriate 
 
NO YES 
Consider asking for a reason Thank you for taking part 
Thank you for your time Clarify can withdraw at any time 
End call Make arrangements for interview/ completion of 
questionnaire as appropriate.  
 If appropriate enquire if they have details of 3rd party 
 Request consent to contact 3rd party 
 Request consent to notify GP 
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Appendix 21 
 
Dear {patients name}, 
 
My name is Barbara Farquharson, I am currently undertaking a 
research project which aims to better understand how people 
seek medical help with symptoms. 
 
I am writing to invite you to take part in this study. You are one 
of 150 patients who have been selected after recently being in 
contact with NHS 24. You have been selected using a method 
that ensures everyone has an equal chance of being chosen. 
 
I am aware that it is possible that I may be contacting you at a 
difficult time and I do not wish to cause you any concern. If you 
feel unable to deal with this request at this time, please simply 
return all the enclosed information in the envelope provided and 
accept my apologies for troubling you. 
 
However, if you feel able to consider participating please read 
the enclosed Patient Information Sheet carefully. It explains 
clearly what the study involves and should answer any questions 
you might have.  
 
I understand that, in your case, the telephone call to NHS 24 was 
made by someone other than yourself. Where possible, I would 
be very interested in hearing their views too. Therefore, if you 
could pass the ‘Caller Information’ on to the person who called 
on your behalf, it would be very helpful.  
 
If you wish to take part but are unable to pass this information 
onto the person who made the call, do not worry. Please simply 
follow the instructions contained in the ‘Patient Information 
Sheet’. 
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 If you require any additional information please contact me on 
the number below. Thank you for your assistance. 
 
Yours sincerely 
 
 
 
 
 
 
 
Barbara Farquharson  MSc; BSc; RGN 
Tel: 01786 466112 
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Appendix 22 
Caller Information Sheet 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms? 
 
You are being invited to take part in a research study. Before you 
decide it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the 
following information carefully. Please discuss it with others if you 
wish. Feel free to ask us if there is anything that is not clear or if you 
would like more information. It is important that you take time to 
decide whether or not you wish to take part. Thank you for reading 
this information. 
 
What is the purpose of the study? 
 
The aim of this study is to learn how people’s personal 
circumstances and thoughts about their symptoms influence how and 
when they contact health services. It is hoped this information will 
help us to adapt services to make sure that people get the help they 
need, as quickly as possible. 
 
 
Why have I been chosen? 
 
150 people who have been in contact with NHS 24 recently have 
been invited to take part. You were selected using a process that 
ensures everyone who called NHS 24 recently has an equal chance 
of being chosen. 
 
As some people who call NHS 24 are very unwell, there is a small 
possibility that you have opened this letter on behalf of someone 
who has recently died. If this is the case, we apologise for troubling 
you and offer you our deepest sympathies. If you wish to simply 
ignore this request we completely understand. However, if you do 
feel able to consider taking part we believe you could help us gain a 
  385 
better insight into how people get help for serious symptoms. Whilst, 
unfortunately, this will not benefit the person we wrote to, it may 
help us to improve things for others in the future.  
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide 
to take part you do not need to take any action. The researcher will 
contact you over the next few days to confirm that you wish to take 
part and to make further arrangements with you. 
 
If you do not wish to take part, please respond to the researcher as 
soon as possible. Please either return the enclosed ‘I decline’ card in 
the pre-paid envelope or telephone 01786 466112 and leave a 
message including this study number -[study number]. You will not 
be contacted about this study again. If you would like to provide the 
reason why you feel unable to take part, we would find that very 
helpful. 
 
If you do not respond within 3 days the researcher will telephone 
you. If you receive this call, you are still under no obligation to take 
part. You are free to withdraw at any time and without giving a 
reason. A decision to withdraw at any time, or a decision not to take 
part, will not affect the standard of care you receive. 
 
You may keep this information sheet.  
 
 
What will happen to me if I take part? 
 
By agreeing to take part in the study you will be giving permission 
for us to use the recording of the original call you made to NHS 24 
for the purposes of this study.  
 
You will also be asked to complete the enclosed questionnaire and 
return it by post, if possible, within a week. The questionnaire asks 
about the symptoms you experienced before contacting NHS 24, and 
your thoughts and feelings about those symptoms. The questionnaire 
usually takes less than 15 minutes to complete.  
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What are the possible risks/ disadvantages of taking part? 
 
Some people may find being asked to recall the events which led 
them to contact health services distressing. Others may find it 
helpful to do so. 
 
 
What are the possible benefits of taking part? 
 
There is no direct benefit for you in taking part. However, the 
information gained from this study may help us to better understand 
how people seek help with symptoms.  This may inform how 
services are developed to better meet the needs of the public. 
 
 
What if something goes wrong? 
 
It is unlikely you will be harmed by taking part in this study. 
However, if you wish to complain or have any concerns about any 
aspect of the way you have been approached or treated during the 
course of this study, please contact Gill Stillie, Associate Director of 
Nursing, NHS 24, Norseman House, South Queensferry, EH30 9QZ.  
 
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the 
research will be kept strictly confidential. It will not be possible to 
identify you from any information which leaves NHS premises.  
 
If you decide to take part in this study we would like to inform your 
GP that you are doing so. You will be given an opportunity to let us 
know if you would prefer we did not do this. 
 
 
What will happen to the results of the research study? 
 
The results of the study will be reported in a PhD thesis which will 
be available in the University of Stirling. The results will also be 
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submitted to healthcare journals for publication. You will not be 
identified in any report or publication. If you would like the results 
to be sent to you on completion of the study please initial the 
appropriate box on the consent form. 
 
 
Who is organising and funding the research? 
 
This study is being organised jointly between NHS 24 and the 
Universities of Stirling and Aberdeen. It has been funded by the 
Nursing, Midwifery and Allied Health Professionals (NMAHP) 
Research Training Scheme which was developed in association with 
NHS Education for Scotland (NES), The Scottish Executive and The 
Health Foundation. No-one will receive payment as a result of your 
participation. 
 
 
Who has reviewed the study? 
 
The study has been reviewed by the Departmental Research Ethics 
Committee, University of Stirling and by a Main NHS Research 
Ethics Committee. 
 
Who should I contact for further information? 
 
Should you have any questions or require further information please 
do not hesitate to contact 
 
Barbara Farquharson  
NHS 24 
Norseman House     
2 Ferrymuir 
South Queensferry    
Tel: 01786 466112    
 
Thank-you for reading this information. Please keep this leaflet 
and a signed consent form for your own records. 
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Appendix 23 
Caller Information Sheet 
 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms? 
 
You are being invited to take part in a research study. Before you 
decide it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the 
following information carefully. Please discuss it with others if you 
wish. Feel free to ask us if there is anything that is not clear or if you 
would like more information. It is important that you take time to 
decide whether or not you wish to take part. Thank you for reading 
this information. 
 
 
What is the purpose of the study? 
 
The aim of this study is to learn how people’s personal 
circumstances and thoughts about their symptoms influence how 
and when they contact health services. We are also interested in 
the views of other people who were present when the telephone 
call to NHS 24 was made. It is hoped this information will help 
us to adapt services to make sure that people get the help they 
need, as quickly as possible. 
 
Why have I been chosen? 
 
150 telephone calls to NHS 24 have been selected using a 
process that ensures that everyone who called NHS 24 recently 
has an equal chance of being chosen. The patients have been 
invited to participate in this study. Where someone else made 
the telephone call on their behalf we have asked them to pass 
this information to that person. You are being approached as you 
were involved in making the telephone call to NHS 24 on behalf 
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of one of the patients selected. We are interested in exploring 
your thoughts about the patient’s symptoms. 
 
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide 
to take part you do not need to take any action. The researcher will 
contact you over the next few days to confirm that you wish to take 
part and to make further arrangements with you. 
 
If you do not wish to take part, please respond to the researcher as 
soon as possible. Please either return the enclosed ‘I decline’ card in 
the pre-paid envelope or telephone 01786 466112 and leave a 
message including this study number -[study number]. You will not 
be contacted about this study again. If you would like to provide the 
reason why you feel unable to take part, we would find that very 
helpful. 
 
If you do not respond within 3 days the researcher will telephone 
you. If you receive this call, you are still under no obligation to take 
part. You are free to withdraw at any time and without giving a 
reason. A decision to withdraw at any time, or a decision not to take 
part, will not affect the standard of care you receive. 
 
You may keep this information sheet.  
 
What will happen to me if I take part? 
 
By agreeing to take part in the study you will be giving permission 
for us to use the recording of the original call you made to NHS 24 
for the purposes of this study.  
 
You will also be asked to take part in an interview by telephone. The 
researcher who contacts you will confirm you wish to take part and 
make arrangements to interview you at a convenient time. The 
interview will be carried out by telephone and will last up to 30 
minutes. The questions will about the symptoms the patient 
experienced prior to you contacting NHS 24, and your thoughts and 
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feelings about those symptoms. The enclosed Illness Perception 
Questionnaire contains similar questions to those you will be asked.  
 
 
What are the possible risks/ disadvantages of taking part? 
 
Some people may find being asked to recall the events which led 
them to contact health services distressing. Others may find it 
helpful to do so. 
 
 
What are the possible benefits of taking part? 
 
There is no direct benefit for you in taking part. However, the 
information gained from this study may help us to better understand 
how people seek help with symptoms.  This may inform how 
services are developed to better meet the needs of the public. 
 
 
What if something goes wrong? 
 
It is unlikely you will be harmed by taking part in this study. 
However, if you wish to complain or have any concerns about any 
aspect of the way you have been approached or treated during the 
course of this study, please contact Gill Stillie, Associate Director of 
Nursing, NHS 24, Norseman House, South Queensferry, EH30 9QZ.  
 
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the 
research will be kept strictly confidential. It will not be possible to 
identify you from any information which leaves NHS premises.  
 
 
 
What will happen to the results of the research study? 
 
The results of the study will be reported in a PhD thesis which will 
be available in the University of Stirling. The results will also be 
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submitted to healthcare journals for publication. You will not be 
identified in any report or publication. You will be given the 
opportunity to request a summary of the results. 
 
 
Who is organising and funding the research? 
 
This study is being organised jointly between NHS 24 and the 
Universities of Stirling and Aberdeen. It has been funded by the 
Nursing, Midwifery and Allied Health Professionals (NMAHP) 
Research Training Scheme which was developed in association with 
NHS Education for Scotland (NES), The Scottish Executive and The 
Health Foundation. No-one will receive payment as a result of your 
participation. 
 
 
Who has reviewed the study? 
 
The study has been reviewed by the Departmental Research Ethics 
Committee, University of Stirling and by a Main NHS Research 
Ethics Committee. 
 
Who should I contact for further information? 
 
Should you have any questions or require further information please 
do not hesitate to contact 
 
Barbara Farquharson           
NHS 24      
Norseman House     
2 Ferrymuir     
South Queensferry    
 
Tel: 01786 466112    
 
 
Thank-you for reading this information. Please keep this leaflet 
and a signed consent form for your own records. 
 
 
  
Appendix 24 
Dear Colleague 
 
Please read the transcripts that you have been given one at a time. Enter the ID number in the column on the left and then tick one box which 
best describes how likely the symptoms described in the transcript are to be ‘possibly cardiac’ (i.e. Would you consider the possibility of a 
cardiac cause for the symptoms described at any point during the call?)  
 
Then, please indicate how confident you feel about your rating on the table on the right. 
 
 
Study 
Number 
Definitely Probably Probably 
Not 
Definitely 
Not 
Very 
confident 
Fairly 
confident 
Not very 
confident 
Not at all 
confident 
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Appendix 25 
Gender split of calls to NHS 24 on a randomly selected day 
 
 
 
Adhoc Report 
 
Requested by   Barbara Farquharson 
 
Information Requested Gender split of previously supplied raw data. 
 
Period    *18th August 2006 – 22nd August 2006 
 
 
 
 
 
 
Total records   14681 
 
 
 
Gender Split 
• Female  8792 
• Male   5884 
• Blank               4 
• Unknown                    1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Same date range as previous raw data sent 
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Appendix 26 
 
Interview schedule 
 
• Introduction and thanks 
 
• Re-check consent 
 
• Explanation of what interview will involve, expected duration 
 
• Opportunity for participant to ask questions 
 
• Instructions read from IPQ-R 
 
• Check understanding 
 
• Read questions from IPQ-R 
 
• Note areas of ambiguity, questions asked, areas of confusion or which cause 
anxiety in answering. Time how long it takes to complete 
 
• Additional questions 
 
• How did you find the questionnaire? 
• How could we improve it? 
• Could the instructions be made clearer? If so, how? 
• Could we make it any easier for you? If so, how? 
• How long would be acceptable for it to take? 
• If you received this in the post, would you complete it? 
• If not, why not? Would anything make you more likely to complete it? 
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Appendix 27 
 Issues Respondents comments Modifications 
Symptoms 5 respondents required 
clarification about 
which symptoms were 
being referred to 
(either which call or 
which illness) 
 
3 respondents 
identified 
psychological 
symptoms which were 
not accounted for in Q 
 
Other symptoms were 
identified as reasons 
for calling but were 
not listed 
 
 
 
 
 
Anxiety (2) 
Hallucinating 
 
 
Vomiting  
Shaking 
Pins and needles 
(expanded yes to 
‘discomfort’) 
Diarrhoea 
Sweating (missing from 
caller Q) 
Collapse 
Consider adding these to 
the list 
IP1 2 respondents required 
clarification about 
which symptoms were 
being asked about 
 
2 respondents issues 
with the time point of 
measurement 
 
 
2 respondents required 
reminding about scale 
“what symptoms? 
 
 
 
“at the time you cant say 
how long it is going to 
last” 
“do you mean will last or 
would last” 
Reinforce instructions 
about which symptoms are 
being asked about 
 
 
Make clear within the 
instructions the time point 
we are referring to (I’m not 
clear myself!) 
 
 
See section entitled ‘scale’ 
IP2 2 respondents required 
clarification before 
answering 
“I’m not understanding 
where you are leading 
from. When you say 
permanent - do you mean 
is it going to happen again” 
Clarity about time point 
referring to may lessen this 
confusion 
IP3 4 respondents found it 
difficult to answer 
Time point referred to 
ambiguous. In these 
two examples one 
answered about the 
symptoms at the time, 
the other ‘from now’ 
“nobody knows how long 
its going to last.” 
 
“maybe it something i’ll 
have for the rest of my 
days but how can you 
tell?” 
Clarity about time point 
referring to may lessen this 
confusion 
IP4 2 respondents required 
clarification of the 
time point being 
referred to. 
2 respondents found it 
difficult to answer as 
they did not know 
what was happening 
at the time 
“Is this referring to just this 
time or in general?” 
 
“Can’t answer because I 
didn’t know what was 
happening” 
Clarity about time point 
IP7 1 respondent 
identified that this 
ip7 - consequences are they 
positive / negative - he felt 
Consider stating ‘negative 
consequences’ 
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could include positive 
consequences 
positive 
IP8 2 respondents required 
to reread question 
before answering 
A respondent answered 
then realised there was 
negative within the 
question, re-read and 
changed answer 
Consider rephrasing 
without negative 
IP9 4 respondents 
identified difficulties 
with this question 
People don’t know about 
his symptoms 
 
I don’t know how others 
see me 
 
What do you mean by that? 
 
I don’t see many people 
 
IP14 2 respondents required 
the question to be 
reworded before could 
answer 
 
2 responded “I don’t 
know” 
 
1 respondent qualified 
their answer with “to 
an extent” 
“i wasnt quite sure about 
that one. Em, does that 
mean from a psychological 
point of view or that I 
actually wore the hand 
brace or...or what?” 
 
IP15 A number of 
respondents appeared 
to experience 
difficulty in making 
sense of this question 
– 
2 respondents 
hesitated before 
answering 
A further 2 required 
the question to be re-
read 
A further 2 required 
the question to be 
rephrased 
 
2 respondents queried 
what time period the 
question related to.  
 
 
 
 
 
 
 
 
 
 
 
 
Qualifies answer with ‘that 
night?’ 
Reword statement. 
Consider “There is nothing 
I can do to effect my 
symptoms” or “there was 
nothing I could do to effect 
my symptoms” depending 
on time point. 
IP17 4 respondents required 
this question to be 
reread before 
answering. 
1 respondent 
answered and then 
immediately changed 
their mind 
 Reword statement. 
Consider “Any action I 
take (took) will  (would) 
not effect the outcome of 
my illness 
IP20 2 respondents required 
the question to be re-
read before answering 
1 explained they did 
not receive treatment 
 Reword statement. 
Consider “My treatment is 
(was) effective in easing 
my symptoms” 
IP21 1 respondent required  Reword statement. 
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the question to be re-
read before answering 
A further 5 
respondents required 
the question to be re-
phrased 
2 explained they did 
not receive treatment 
 
 
 
Consider “Treatment 
reduces the unpleasantness 
of my symptoms”  
IP24 4 respondents required 
clarification of the 
time period being 
referred to 
1 respondent 
explained that the 
symptoms themselves 
were not puzzling but 
why she got them was 
“at the time yes, but now 
less so” 
“they were…” 
Clarify timepoint for 
coherence items. Consider 
e.g. “My symptoms were 
puzzling” 
IP25 As above  See IP24 
IP27 3 respondents 
hesitated or were 
unsure about this 
question 
“some did and some 
didn’t” 
 
IP28 3 respondents 
explained that it 
required clarification 
what time period was 
being referred to 
“Are you talking about at 
the time? Different now.” 
See IP24 
IP29 4 respondents 
identified that this 
depends on the nature 
of the illness 
“type of thing its not all the 
time” 
 
“leave blank because it was 
a one-off” 
Consider excluding calls 
which relate to accidents. 
 
Consider removing 
‘cyclic’ items – If all other 
questions being asked of a 
particular timepoint i.e. 
time of call, it does not 
make sense to ask if 
change from day-to-day if 
wasa one-off 
IP30 2 respondents 
indicated that this 
question was not 
relevant if the episode 
of symptoms were a 
one-off 
“only applicable to 
something that is ongoing, 
this was a one-off” 
See IP29 
IP31 2 respondents 
explained that it 
required clarification 
what time period was 
being referred to 
 See IP29 
IP35 2 respondents 
indicated that angry 
was too strong a word 
“would say frustrated” 
“angry too strong a word” 
Consider rewording to 
“My symptoms made me 
feel annoyed” 
IP36 2 respondents required 
clarification due to the 
negative question 
“I agree” - I check “They 
don’t worry you?” - “Oh 
no I disagree, they do 
worry me” 
Another respondent 
checked “do not?”  before 
answering 
Consider emboldening 
“not” and emphasising 
during telephone 
administration 
IP37 3 respondents reported “I’d like to qualify that. I  
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being anxious about 
issues related to the 
symptoms e.g. what 
caused them or the 
consequences of them, 
but not about the 
actual symptom 
 
 3 respondents 
required clarification 
what time period was 
being referred to 
was flying out to Milan the 
following day and that is 
why I was anxious, not just 
because of the symptoms. 
If that hadn’t been 
happening I would not 
have been anxious” 
 
“Having them or having 
had them?” 
 
“Every now and again or 
every day?” 
 
 
 
 
 
 
Clarify timepoint for 
emotion items. Consider 
e.g.  “My symptoms did 
not worry me” 
IP38 2 respondents 
indicated that afraid 
might be putting it too 
strongly 
“to a degree” 
“afraid too strong a word” 
Consider rewording to 
“My symptoms frightened 
me” 
IP41 (Caller 
only) 
2/?? Found this one 
difficult to answer 
“Thats a hard one, can you 
repeat it?” 
“Not entirely” 
Clarity about time point 
referring to may lessen this 
confusion. Consider 
rewording “There was a lot 
I could do to control the 
patients symptoms” 
IP42 (Caller 
only) 
1 “Again its a hard one, 
tempted to agree but 
disagree, too direct” 
Clarity about time point 
referring to may lessen this 
confusion 
IP44 (Caller 
only) 
2 “my actions?” 
“again its difficult because 
sometimes yes and 
sometimes no” 
Consider “Any action I 
take (took) will  (did) not 
effect the outcome of the 
patients illness 
IP45 (Caller 
only) 
1 “at the time they were, less 
so now” 
Clarity about time point 
referring to may lessen this 
confusion. Consider 
rewording “Their 
symptoms were puzzling 
to me” 
IP46 (Caller 
only) 
1 “At the time they were, I 
thought it was something 
but it was something 
totally different” 
Clarity about time point 
referring to may lessen this 
confusion. Consider 
rewording “Their 
symptoms were a mystery 
to me” 
IP47 (Caller 
only) 
3 “I understood his 
symptoms but not what 
was causing them” 
“I’m not a doctor. If I was 
getting paid for it well 
then…” 
“I understand in a way” 
Clarity about time point 
referring to may lessen this 
confusion. Consider 
rewording “I didn’t 
understand their 
symptoms” 
IP48 (Caller 
only) 
2 “I understand that he is like 
that but I don’t understand 
why” 
“I understand in a way” 
 
Cause 1 
 
1 participant could not 
answer 
 
Another wanted to 
differentiate between 
the cause of the 
“I haven’t got a clue” 
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physical symptoms he 
had experienced and 
those of anxiety 
Cause 3 
 
2 participants reported 
what the doctor had 
said and required 
prompting to provide 
their own views. 
“Well that’s what the 
doctors thought?” 
“The doctor never said so”. 
 
Adjust instructions to 
make clear they do not 
have to be certain / correct 
cause. 
Cause 8 
 
3 participants 
described it as “their 
fault” at least to a 
degree but were 
hesitant to agree with 
this statement 
 
  
Cause 9 2 participants required 
clarification 
  
Cause 10 
 
3 participants 
commented on how 
past personal worries 
may have contributed 
but explained that 
these were not recent 
  
The most 
important causes 
for me 
6 respondents were 
able to articulate 3 
causes easily 
 
A further 3 
respondents identified 
2 causes 
 
A further 4 
respondents identified 
1 cause 
 
4 respondents had 
difficulty identifying 
any causes at all 
 
 
 
 
 
 
 
 
 
“I havent a clue” 
 
How did you find 
the 
questionnaire? 
15 respondents 
indicated that they 
found it easy to 
respond 
 
 
 
6 respondents reported 
finding it difficult to 
understand, confusing, 
too complex  
 
 
 
 
 
 
 
 
 
 
 
“I found questions straight 
forward” 
 
“no problem at all to 
answer questions” 
 
 
“Found it all right. Some of 
them were easy to answer, 
some were not. I couldn’t 
understand some of them  - 
the wording “what does it 
mean”. It was alright you 
know, I hope I was of 
help” 
 
I found it complex and 
have to say if XXXX 
hadn’t been so bad at 
responding he would have 
declined. It all looked 
complex. 
 
 
 
 
 
Issues with individual 
questions will be addressed 
as above 
 
 
 
 
Consider improving the 
‘look’ of the questionnaire. 
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4 respondents 
indicated that not all 
the questions were 
relevant to that 
particular call (e.g. 
accident) although a 
number also 
commented that they 
could see how it 
would be relevant in 
different 
circumstances 
 
 
 
3 respondents found it 
difficult to answer as 
requested  
 
 
 
 
2 respondents 
commented that 
repetition of the 
questions was 
problematic 
 
I found it total rubbish. 
What has it got to do with 
my wife getting ill. I don’t 
think it will help you learn 
anything. Won’t do 
anything for National 
Health, they need to get 
their house in order first” - 
explains was back in A&E 
and waited for hours. 
Explains how he is paying 
our wages and that is what 
we should be doing rather 
than asking stupid 
questions about illness.  
 
“When I looked at it I 
thought a lot of this does 
not apply to me” 
 
 
“Didn’t seem that relevant 
but could see how a lot of 
it could relate to a previous 
call when I thought I had 
bronchitis”  
 
 
 
 
 
 
“Had a read of it and found 
it hard to just say yes/ no” 
 
“answering so direct, its 
very hard to just answer as 
agree/diasagree” 
 
“questions repeat 
themselves, ridiculousy so, 
you start to question 
yourself” 
 
 
 
 
 
 
 
Consider excluding those 
who have had an accident. 
 
 
 
 
 
 
 
Consider reducing no of 
options for answering to 3. 
Would this affect the 
reliability of the 
questionnaire and/or limit 
the ability of the 
questionnaire to detect 
differences in IP – advice 
please 
Scale 5 respondents do not 
use ‘strongly’ options 
at all 
 
2 respondents only 
use after being 
prompted  
 
A number of  
respondents answer 
yes/ no even after 
scale being described 
 
3 respondents 
commented that scale 
was too complex 
 
 
 
e.g. you sound very 
definite do you strongly 
disagree? 
 
 
 
 
Makes life complicated 
 
Might be daunting (5 
options for responding) 
 
Its very hard to answer 
Consider reducing no of 
options for answering to 3. 
Would this affect the 
reliability of the 
questionnaire and/or limit 
the ability of the 
questionnaire to detect 
differences in IP – advice 
please  
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agree/disagree 
Were you 
contacted at an 
appropriate time? 
17 agreed they were 
contacted at an 
appropriate time 
 
 
 
 
 
 
2 were unsure, feeling 
taken aback at being 
called or expressing 
concern about how 
would feel if 
circumstances were 
different. 
 
 
 
 
 
 
 
1 participant felt they 
were contacted too 
late and it was too late 
to remember 
 
“2 weeks after the call, if 
was really ill could not be 
bothered but 3 weeks 
might forget important 
details so I think 2 weeks is 
perfect” 
 
Feel timing was right - 
close to condition 
 
 
 
I was taken aback, not 
sure. Good to phone back 
another time. Caught me 
on the hop. I got agitated 
thinking about what had 
happened and how was I 
going to put it into words. 
If you’d phoned earlier I 
wouldn’t have been able to 
answer, still confused 
 
It was OK but if it had 
been a heart attack and 
XXXX was in hospital  I 
would have resented it. 
And if the person had died 
that would be almost 
unbearable. 
 
 
 
Timing would seem to be 
OK. 
Do you 
remember the 
reason you were 
in contact with 
NHS 24? 
15 respondents agreed 
they remembered the 
reason they were in 
contact with NHS 24 
 
2 required prompting 
as to which call 
 
1 respondent had 
trouble remembering 
 People appear to remember 
their call to NHS 24. 
Consider including the 
date of the call to 
invitation letter to assist 
those with more than one 
call. 
 
It is not considered 
possible to include the call 
reason for reasons of 
confidentiality. 
Were the 
questions 
relevant to you? 
8 respondents agree 
the questions were 
relevant to them 
 
4 respondents found 
some were not 
relevant 
 
 
4 respondents did not 
find the questions 
relevant 
 
2 further respondents 
“questions were relevant” 
 
 
“some not relevant, 
because it was never found 
out what the cause was, no 
treatment either” 
 
 
 
 
 
Didn’t seem that relevant 
but could see how a lot of 
Some of this is 
understandable e.g. Q’s 
about treatment where no 
treatment was offered. 
 
People who had 
experienced accidents 
found questions relating to 
‘illness’ or ‘condition’ not 
relevant – excluding these 
people may help to 
improve relevance.  
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stated that they did not 
find the questions 
particularly relevant to 
their particular 
symptoms on this 
occasion but could see 
relevance to others 
it could relate to a previous 
call about when she 
thought she had bronchitis 
 
 
How long is it 
acceptable to 
take? 
4 respondents 
indicated that they 
would be happy to 
take as long as it takes 
 
9 respondents 
indicated that up to 30 
mins would be 
acceptable 
 
9 respondents 
indicated that up to 20 
mins would be 
acceptable 
 
1 respondent indicated 
that 12 mins (actual 
time taken) was 
acceptable.  
 Most respondents actually 
completed questionnaire in 
less than 20 mins. This 
was considered acceptable 
by almost all respondents. 
 
Useful to explain to 
participants that they can 
stop at any time. 
Could the 
instructions be 
any clearer? 
19 participants 
identified that the 
instructions were clear 
 
1 commented that 
they could be clearer 
 
“Instructions perfectly 
clear, fine.” 
 
 
“Could possibly be made 
clearer” (make clearer 
timepoint being referred 
to) 
 
If we had posted 
the questionnaire 
would you have 
responded? 
9 respondents 
indicated it was 
unlikely 
 
 
 
 
 
 
8 respondents 
indicated they would 
definitely have 
responded 
 
4 respondents 
indicated that they had 
intended to respond 
but now were unaware 
of where the 
documents were! 
 
8 respondents 
expressed a preference 
for doing it over the 
phone, this included 
respondents who 
“To be honest I forgot all 
about it, she has been ill 
too. Questionnaire last 
thing on your mind.” 
 
Would not have completed 
questionnaire , was going 
to write back and say sorry. 
The way to answer isn’t 
my way of doing it. 
 
“Would have filled it in” 
 
 
 
 
 
 
“Would have filled it in but 
good to talk to somebody 
instead of just writing on 
the paper” 
 
“May have got around to it, 
there is a chance it 
would’ve been overlooked. 
Telephone approach seems 
to allow some people to 
participate who otherwise 
would not. 
 
Simplifying and improving 
the relevance of the 
questionnaire may improve 
response by post. 
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indicated they would 
respond to a 
questionnaire and 
those who indicated 
they would not. 
 
 
Depends on when you 
catch me, good intentions, 
more chance over the 
phone 
How might we 
improve the 
questionnaire? 
Avoid the tick-boxes 
and let people answer 
in their own way 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Make sure the 
questions are relevant 
to the call 
 
 
Reduce the repetition 
of the questions 
 
 
Make it clearer the 
time frame we are 
talking about 
“Sounds like a recipe, tick 
boxes, not bring out the 
emotion of what might be 
affecting the person” 
 
“Just ask a question and let 
people answer in their own 
way, not degrees etc. Most 
people don’t like 
answering these sort of 
questions. 
 
“A simpler approach may 
make people more likely to 
respond” 
 
“It’s very hard to just 
answer as agree/disagree” 
 
 
 
 
“Fine tuning actual calls 
chosen. Lots of questions 
were fundamental but not 
in relation to that call” 
 
“Some questions repeat 
themselves” 
 
 
“Are we speaking past or 
present –confusing” 
 
“Main issue is about time 
frame” 
Consider beginning with 
an open question. E.g. 
“Please tell us in your own 
words what led to you 
being in contact with NHS 
24 on (date)”  
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider excluding calls 
for which questions may 
not seem relevant e.g. 
medicine-related enquiries; 
accidents 
 
 
 
 
Clarity about timepoint as 
discussed elsewhere. 
Caller IPQ 
 
1 caller participant 
checked responses 
with the patient (his 
wife).  
 
The labels are missing 
from the top of that 
sheet which makes it 
difficult to identify the 
correct column to tick. 
 Might be useful to include 
an instruction not to do this 
 
Insert the labels 
Learning points 
for me in 
administering 
over the 
questionnaire by 
phone 
Addressing people by 
first name  
 
 
Forgetting to explain 
that call being 
recorded 
Should ask what people 
would like me to call them 
 
Useful to explain being 
recorded so can keep a 
note of what they have said 
 
Added to interview 
schedule as a aide-memoir 
 
 
Added to interview 
schedule 
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Apologised on a 
couple of occasions 
for the questionnaire  
 
Stated that I had a 
note of the 
participants age 
 
 
People state ‘not 
relevant’ or similar 
 
 
 
 
 
 
 
 
Should avoid this 
 
Might be better to ask their 
age than to state already 
know. Might cause anxiety 
about what other personal 
information we have 
recorded. 
 
Would be helpful to ask 
‘why not?’ 
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Appendix 28 
ILLNESS PERCEPTION QUESTIONNAIRE (IPQ-R) 
Study ID No………………………………    Date………………………………… 
 
YOUR VIEWS ABOUT YOUR ILLNESS 
We are interested in  what leads people to seek medical help for their symptoms. Please 
describe in your own words what led you to be in contact with NHS 24. 
 
 
 
 
 
 
 
 
 
 
Listed below are a number of symptoms that you may or may not have experienced 
recently. 
1) Please underline any symptoms you have experienced within the last 2 weeks 
2) Please circle any that relate to why you were in contact with NHS 24.  
 
If you experienced additional symptoms that are not on the list please feel free to 
add them and underline or circle as appropriate. 
  
 
Pain   Discomfort   Numbness   Sore throat  
 
 
Nausea  Breathlessness  Weight loss   Collapse  
 
 
Tiredness  Sweating   Stiff joints   Sore Eyes  
 
 
Wheeziness  Headache   Upset stomach  Sleep difficulties 
 
 
Vomiting  Dizziness   Loss of strength  Pins and needles 
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We are interested in your own personal views of how you now see your current illness. 
Please indicate by ticking the appropriate box how much you agree or disagree with the following 
statements about your symptoms AT THE TIME YOU CONTACTED NHS 24. 
 I thought….. STRONGLY DISAGREE   DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP1*
 My symptoms would last a short time      
IP2
 My symptoms were likely to be permanent 
rather than temporary 
     
IP3
 My symptoms would last for a long time      
IP4*
 My symptoms would  pass quickly      
IP5
 I would have these symptoms for the rest 
of my life 
     
IP6
 My illness was a serious condition      
IP7
 My symptoms would have major negative 
consequences on my life 
     
IP8*
 My symptoms would not have much effect 
on my life 
     
IP9
 My symptoms would strongly effect the 
way others see me 
     
IP10
 My symptoms would have serious 
financial consequences 
     
IP11
 My symptoms would cause difficulties for 
those who are close to me 
     
IP12
 There was a lot I could do to control my 
symptoms 
     
IP13
 What I did could determine whether my 
symptoms got better or worse 
     
IP14
 The course of my illness depended on me      
IP15*
 There was nothing I could do to effect my 
symptoms 
     
IP16
 I had the power to influence my symptoms      
IP17*
 Any action I took would not affect the 
outcome of my illness 
     
IP18*
 My symptoms would improve in time      
IP19*
 There was very little that could be done to 
improve my symptoms 
     
IP20
 My treatment would be effective in easing 
my symptoms 
     
IP21
 Treatment would reduce the 
unpleasantness of my symptoms 
     
IP22
 My treatment could control my symptoms      
IP23*
 There was nothing which could help my 
condition 
     
IP24
 The symptoms of my condition were 
puzzling to me 
     
     
    
    
    
407 
 
  
STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP25
 My symptoms were a mystery to me      
IP26
 I did not understand my symptoms      
IP27
 My symptoms didn’t make any sense to 
me 
     
IP28*
 I had a clear picture or understanding of 
my condition 
     
IP33
 I felt depressed about my symptoms      
IP34
 I was upset about my symptoms      
IP35
 My symptoms made me feel annoyed      
IP36*
 My symptoms did NOT worry me      
IP37
 Having these symptoms made me feel 
anxious 
     
IP38
 My symptoms frightened me      
 
CAUSES OF MY ILLNESS  
We are interested in what you considered may have been causing your symptoms at the 
time you were in contact with NHS 24.  As people are very different, there is no correct 
answer for this question.  We are most interested in your own views about the factors 
that may have caused your symptoms rather than what others including doctors or 
family may have suggested to you.  Below is a list of possible causes for your symptoms.  
Please indicate how much you agree or disagree that they may have been causes for you 
by ticking the appropriate box. 
 
 POSSIBLE CAUSES STRONGLY DISAGREE  DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
C1
 Stress or worry      
C2
 Hereditary - it runs in my family      
C3
 A Germ or virus      
C4
 Diet or eating habits      
C5
 Chance or bad luck      
C6
 Poor medical care in my past      
C7
 Pollution in the environment      
C8
 My own behaviour      
C9
 My mental attitude e.g. thinking about 
life negatively 
     
C10
 Family problems or worries caused my 
illness 
     
C11
 Overwork      
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STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
C12
 My emotional state e.g. feeling down, 
lonely, anxious, empty 
     
C13
 Ageing      
C14
 Alcohol      
 C15
 Smoking      
C16
 Accident or injury      
C17
 My personality      
C18
 Being ‘rundown’      
 
 
 
Below, please list in rank-order the three most important factors that you believed 
might be causing YOUR symptoms at the time you called NHS 24.   You may use any of 
the items from the box above, or you may have additional ideas of your own. 
 
The most important causes for me:- 
1.  ______________________________________  
2. _______________________________________ 
3. _______________________________________ 
 
 
ADDITIONAL INFORMATION 
 
In order to help us understand the information you have provided better, it would be 
very helpful if you could tell us a little about yourself. 
 
 
1. What is your age?  ___________  
 
2. Are you male or female? ___________ 
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3. What is your ethnic group?  Choose one section from A to E,  tick box if appropriate or 
add your own description. 
I. White 
Scottish 
British 
Irish 
 
 
Other white background? (please 
state) 
J. Asian, Asian Scottish or Asian 
British 
Indian 
Pakistani 
Bangladeshi 
Chinese 
 
Other asian background? (please 
state) 
 
 
K. Black 
Caribbean 
African 
 
 
 
Other black background? (please 
state) 
L. Mixed 
 
 
E. Any other ethnic background (please state) 
 
HOW DID YOU FIND THIS QUESTIONNAIRE? 
We are interested in hearing your views about completing the questionnaire. Please 
indicate how much you agree or disagree with the following statements by ticking the 
appropriate box. 
 
 
 
STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
 
 The questionnaire was easy to complete      
 I was contacted at an appropriate time      
 The questions were relevant to me      
 I remember the reason I was in contact 
with NHS 24 
     
Please feel free to make any additional comments below or overleaf: 
 
 
Once completed please put this questionnaire and a signed consent form in the 
stamped, addressed envelope provided. Please post it within a week if possible. Thank 
you very much for taking part in this study.  
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Appendix 29 
CALLER ILLNESS PERCEPTION QUESTIONNAIRE  
Study ID No………………………………    Date………………………………… 
 
YOUR VIEWS ABOUT THE PATIENT’S SYMPTOMS 
We are interested in  what leads people to seek medical help for others. Please describe 
in your own words what led you to be in contact with NHS 24. 
 
 
 
 
 
 
 
 
 
 
Listed below are a number of symptoms that the patient may or may not have 
experienced recently. 
3) Please underline any symptoms they have experienced within the last 2 weeks 
4) Please circle any that relate to why you were in contact with NHS 24.  
 
If they have experienced additional symptoms that are not on the list please feel free 
to add them and underline or circle as appropriate. If you do not know about a 
particular symptom, please just write “don’t know” beside it.  
  
 
Pain   Discomfort   Numbness   Sore throat  
 
 
Nausea  Breathlessness  Weight loss   Collapse  
 
 
Tiredness  Sweating   Stiff joints   Sore Eyes  
 
 
Wheeziness  Headache   Upset stomach  Sleep difficulties 
 
 
Vomiting  Dizziness   Loss of strength  Pins and needles  
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We are interested in YOUR own personal views about the patient’s symptoms. 
Please indicate how much you agree or disagree with the following statements about the 
patient’s symptoms by ticking the appropriate box. 
 
 I thought… STRONGLY DISAGREE   DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP1*
 Their symptoms would last a short time      
IP2
 Their symptoms were likely to be 
permanent rather than temporary 
     
IP3
 Their symptoms would last for a long time      
IP4*
 Their symptoms would pass quickly      
IP5
 They would have these symptoms for the 
rest of their life 
     
IP6
 Their illness was a serious condition      
IP7
 Their symptoms would have major 
negative consequences on their life 
     
IP8*
 Their symptoms would not have much 
effect on their life 
     
IP9
 Their symptoms would strongly effect the 
way others see them 
     
IP10
 Their symptoms would have serious 
financial consequences 
     
IP11
 Their symptoms would cause difficulties 
for those who are close to them 
     
IP12
 There was a lot they could do to control 
their symptoms 
     
IP13
 What they did could determine whether 
their symptoms got better or worse 
     
IP14
 The course of their illness depended on 
them 
     
IP15*
 There was nothing they could do to effect 
their symptoms 
     
IP16
 They had the power to influence their 
symptoms 
     
IP17*
 Any action they took would not effect the 
outcome of their illness 
     
IP18*
 Their symptoms would improve in time      
IP19*
 There was very little that could be done to 
improve their symptoms 
     
IP20
 Their treatment would be effective in 
easing their symptoms 
     
IP21
 Treatment would reduce the 
unpleasantness of their symptoms 
     
IP22
 Their treatment can control their 
symptoms 
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STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP23*
 There was nothing which could help their 
condition 
     
IP24
 The symptoms of their condition were 
puzzling to them 
     
IP25
 Their symptoms were a mystery to them      
IP26
 They did not understand their symptoms      
IP27
 Their symptoms didn’t make any sense to 
them 
     
IP28*
 They had a clear picture or understanding 
of their condition 
     
IP33
 They felt depressed about their symptoms      
IP34
 They were upset about their symptoms      
IP35
 Their symptoms made them feel annoyed      
IP36*
 Their symptoms did NOT worry them      
IP37
 Having these symptoms made them feel 
anxious 
     
IP38
 Their symptoms frightened them      
 
 
We are also interested in exploring how the patient’s illness affected you. 
Please indicate how much you agree or disagree with the following statements about the 
patient’s symptoms by ticking the appropriate box. 
 
 
 
STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP39
 There was a lot that  I could do to control 
the patient’s symptoms 
     
IP40
 What I did  could determine whether their 
symptoms got better or worse 
     
IP41
 The course of their illness depended on me      
IP42*
 There was nothing I could do to effect 
their symptoms 
     
IP43
 I had the power to influence the patient’s 
symptoms 
     
IP44*
 Any action I took would not effect the 
outcome of their illness 
     
IP45 The symptoms of their condition were 
puzzling to me 
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STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP46 Their symptoms were a mystery to me      
IP47 I did not understand their symptoms      
IP48 Their symptoms didn’t make any sense to 
me 
     
IP49* I had a clear picture or understanding of 
their condition 
     
IP50 I felt depressed about their symptoms      
IP51 I was upset about their symptoms      
IP52 Their symptoms made me feel annoyed      
IP53* Their symptoms did NOT worry me      
IP54 The patient having these symptoms made 
me feel anxious 
     
IP55 Their symptoms frightened me      
 
CAUSES OF THEIR ILLNESS  
We are interested in what you consider may have been the causing the patient’s 
symptoms at the time you were in contact with NHS 24.  As people are very different, 
there is no correct answer for this question.  We are most interested in your own views 
about the factors that may have caused the patient’s symptoms rather than what others 
including doctors or family may have suggested to you.  Below is a list of possible causes 
for their symptoms.  Please indicate how much you agree or disagree that they may 
have been causes for them by ticking the appropriate box. 
 
 POSSIBLE CAUSES STRONGLY DISAGREE  DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
C1
 Stress or worry      
C2
 Hereditary - it runs in their family      
C3
 A Germ or virus      
C4
 Diet or eating habits      
C5
 Chance or bad luck      
C6
 Poor medical care in the past      
C7
 Pollution in the environment      
C8
 Their own behaviour      
C9
 Their mental attitude e.g. thinking about 
life negatively 
     
C10
 Family problems or worries       
C11
 Overwork      
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STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
C12
 Their emotional state e.g. feeling down, 
lonely, anxious, empty 
     
C13
 Ageing      
C14
 Alcohol      
 C15
 Smoking      
C16
 Accident or injury      
C17
 Their personality      
C18
 Being ‘rundown’      
 
 
In the table below, please list in rank-order the three most important factors that you 
believed might be causing the patients symptoms at the time you called NHS 24.   You 
may use any of the items from the box above, or you may have additional ideas of your 
own. 
 
The most important causes for me:- 
1.  ______________________________________  
2. _______________________________________ 
3. _______________________________________ 
 
 
ADDITIONAL INFORMATION 
In order to help us understand the information you have provided better, it would be 
very helpful if you could tell us a little about yourself. 
 
1. What is your age?  ___________  
 
2. Are you male or female? ___________ 
 
3. What is your relationship to the patient? ___________ 
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4. What is your ethnic group?  Choose one section from A to E,  tick box if appropriate or 
add your own description. 
M. White 
Scottish 
British 
Irish 
 
 
Other white background? (please 
state) 
N. Asian, Asian Scottish or Asian 
British 
Indian 
Pakistani 
Bangladeshi 
Chinese 
 
Other asian background? (please 
state) 
 
 
O. Black 
Caribbean 
African 
 
 
 
Other black background? (please 
state) 
P. Mixed 
 
 
E. Any other ethnic background (please state) 
 
HOW DID YOU FIND THIS QUESTIONNAIRE? 
We are interested in hearing your views about completing the questionnaire. Please 
indicate how much you agree or disagree with the following statements by ticking the 
appropriate box. 
 
 
 
STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
 PF1
 The questionnaire was easy to complete      
PF2
 I was contacted at an appropriate time      
PF3
 The questions were relevant to me      
PF4
 I remember the reason I was in contact 
with NHS 24 
     
 
Please feel free to make any additional comments below or overleaf: 
 
 
Once completed please put this questionnaire and a signed consent form in the 
stamped, addressed envelope provided. Please post it within a week if possible. Thank 
you very much for taking part in this study.  
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Appendix 30 
 
Dear {patients name}, 
 
My name is Barbara Farquharson, I am a nurse working with 
NHS 24. I am currently undertaking a research project which aims 
to better understand how people seek medical help with particular 
medical symptoms. 
 
I am writing to invite you to take part in this study. You have 
been selected after recently being in contact with NHS 24. You 
have been selected using a method that ensures everyone with 
these types of symptoms has an equal chance of being chosen. 
 
I am aware that it is possible that I may be contacting you at a 
difficult time and I do not wish to cause you any concern. If you 
feel unable to deal with this request at this time, please simply 
return all the enclosed information in the envelope provided and 
accept my apologies for troubling you. 
 
However, if you feel able to consider participating please read the 
enclosed Patient Information Sheet carefully. It explains clearly 
what the study involves and should answer any questions you 
might have.  If you require any additional information please 
contact me on the number below. Thank you for your assistance. 
 
Yours sincerely 
 
 
 
 
Barbara Farquharson  MSc; BSc; RGN 
Tel: 01786 466112 
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Appendix 31 
Participant Information Sheet 
 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms? 
 
You are being invited to take part in a research study. Before you 
decide it is important for you to understand why the research is being 
done and what it will involve. Please take time to read the following 
information carefully. Please discuss it with others if you wish. Feel 
free to ask us if there is anything that is not clear or if you would like 
more information. It is important that you take time to decide whether 
or not you wish to take part.  
 
What is the purpose of the study? 
 
The study is part of a PhD studentship. The aim is to learn how 
people’s personal circumstances and thoughts about their symptoms 
influence how and when they contact health services. It is hoped this 
information will help us to adapt services to make sure that people get 
the help they need, as quickly as possible. 
 
Why have I been chosen? 
 
A number of people who have been in contact with NHS 24 recently 
have been invited to take part. You were selected using a process that 
ensures everyone who called NHS 24 recently with particular medical 
symptoms has an equal chance of being chosen. 
 
As some people who call NHS 24 are very unwell, there is a small 
possibility that you have opened this letter on behalf of someone who 
has recently died. If this is the case, we apologise for troubling you 
and offer you our deepest sympathies. If you wish to simply ignore 
this request we completely understand – please just return all the 
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information in the reply paid envelope. However, if you do feel able to 
consider taking part we believe you could help us gain a better insight 
into how people get help for serious symptoms. Whilst, unfortunately, 
this will not benefit the person we wrote to, it may help us to improve 
things for others in the future.  
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide to 
take part you do not need to take any action. The researcher will 
contact you over the next few days to confirm that you wish to take 
part and to make further arrangements with you. 
 
If you do not wish to take part, please respond to the researcher as 
soon as possible. Please either return the enclosed ‘I decline’ card in 
the pre-paid envelope or telephone [mobile number] and leave a 
message including this study number -[study number]. You will not 
need to talk to anyone and will not be contacted about this study 
again. If you would like to provide the reason why you feel unable to 
take part, we would find that very helpful. 
 
If you do not respond within 3 days the researcher will telephone you. 
You should be aware that this call will be recorded. If you receive this 
call, you are still under no obligation to take part. You are free to 
withdraw at any time and without giving a reason. A decision to 
withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive.  
 
If you do decide to take part we will send you a written record of the 
consent you have given. You may also keep this information sheet.  
 
 
What will happen to me if I take part? 
 
You will be asked to take part in an interview by telephone. The 
researcher who contacts you will confirm you wish to take part and 
make arrangements to interview you at a convenient time. The 
interview will be carried out by telephone and will last up to 30 
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minutes. The questions will be about the symptoms you experienced 
before contacting NHS 24, and your thoughts and feelings about those 
symptoms. The enclosed Illness Perception Questionnaire contains 
similar questions to those you will be asked.  
You will also be asked to give your permission for the researcher to 
access your general practice records in approximately 3 months time 
to obtain additional information –  
• what (if any) diagnosis did you receive at the time of your 
symptoms 
• what (if any) diagnoses have you received in the following 3 
months 
• if you have ever been diagnosed with diabetes 
 
We will ask permission to access the original voice-recording at NHS 
24 to obtain details of the symptoms you described at the time you 
called. 
It may be that you could help us with other research in the future. We 
will check whether you would be happy to be contacted again should 
this be the case.  
 
What are the possible risks/ disadvantages of taking part? 
 
Some people may find being asked to recall the events which led them 
to contact health services distressing. Others may find it helpful to do 
so. 
 
What are the possible benefits of taking part? 
 
There is no direct benefit for you in taking part. However, the 
information gained from this study may help us to better understand 
how people seek help with symptoms.  This may inform how services 
are developed to better meet the needs of the public. 
 
What if something goes wrong? 
 
It is unlikely you will be harmed by taking part in this study. 
However, if you wish to complain or have any concerns about any 
aspect of the way you have been approached or treated during the 
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course of this study, please contact Gill Stillie, Associate Director of 
Nursing, NHS 24, Norseman House, South Queensferry, EH30 9QZ.  
 
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the 
research will be kept strictly confidential. It will not be possible to 
identify you from any information which leaves NHS premises.  
 
If you decide to take part in this study we would like to inform your 
GP that you are doing so. You will be given the opportunity to advise 
us if you do not wish for that to happen. 
 
What will happen to the results of the research study? 
 
The results of the study will be reported in a PhD thesis which will be 
available in the University of Stirling. The results will also be 
submitted to healthcare journals for publication. You will not be 
identified in any report or publication. You will be given the 
opportunity to request a summary of the results. 
 
Who is organising and funding the research? 
 
This study is being organised jointly between NHS 24 and the 
Universities of Stirling and Aberdeen. It has been funded by the 
Nursing, Midwifery and Allied Health Professionals (NMAHP) 
Research Training Scheme which was developed in association with 
NHS Education for Scotland (NES), The Scottish Executive and The 
Health Foundation. No-one will receive payment as a result of your 
participation. 
 
Who has reviewed the study? 
 
The study has been reviewed by Fife and Forth Valley NHS Research 
Ethics Committee and by the Department of Nursing and Midwifery 
Research Ethics Committee. 
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Who should I contact for further information? 
 
Should you have any questions or require further information please 
do not hesitate to contact 
 
Barbara Farquharson           
NHS 24      
Norseman House     
2 Ferrymuir     
South Queensferry    
 
Tel: 01786 466112    
 
 
Thank-you for reading this information. Please keep this leaflet 
for your own records. 
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Appendix 32 
 
I decline 
 
To take part in 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms? 
 
Study Number: XXXX 
 
If you would like to give a reason please write it here: 
 
 
 
 
 
 
Please return in enclosed stamped addressed envelope 
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Appendix 33 
 
Invitation schedule 
 
Ask for patient, introduce self  
 
Explain call being recorded 
 
Check received and read study information 
 
Check understanding 
 
Request consent  
 
• to take part interview/ questionnaire as appropriate 
• to access recording of call 
• to obtain details of outcome of this call and any diagnosis at 3 
months from GP 
• to contact you again in the future if necessary 
 
 
 
NO YES 
Consider asking for a 
reason 
Thank you for taking part 
Thank you for your 
time 
Clarify can withdraw at any time 
End call Make arrangements for interview/ 
completion of questionnaire as 
appropriate.  
 If appropriate enquire if they have 
details of 3rd party 
 Request consent to contact 3rd party 
 Would you like to receive a summary 
of the results of the research? 
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Appendix 34 
 
 [Date} 
 
[Patient Name and Address] 
 
 
 
Dear [patient name] 
 
Re: What factors influence people’s behaviour when seeking help with symptoms? 
 
Thank you very much for agreeing to take part in the above research study. This is to 
confirm that on [date]  
 
1. you confirmed to me you had read and understood the study information 
 
2. you had the opportunity to ask questions 
 
3. you gave your consent for me to access the recording of your call to NHS 24 
made on [date] 
 
4. you gave consent for me to obtain details of the outcome of this call and any 
diagnosis at 3 months from your GP 
 
5. you agreed it would be acceptable for someone from the research team to 
contact you again regarding this study if necessary. 
 
I hope this accurately reflects our discussion. If not please let me know as soon as 
possible. You are free to withdraw from the study at any time  - please just call me on 
the number below and leave a message stating your study number.  
 
If anything is unclear or you would like further information please just call me on the 
number below. 
 
Thank you once again for your help, your participation is very much appreciated.  
 
Yours sincerely, 
 
 
 
 
Barbara Farquharson 
Tel: 01786 466112 
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Appendix 35 
 
Interview schedule 
 
• Introduction and thanks 
 
• Re-check consent 
 
• Explanation of what interview will involve, expected duration 
 
• Opportunity for participant to ask questions 
 
• Instructions read from IPQ-R 
 
• Check understanding 
 
• Read questions from IPQ-R 
 
• Confirm contact details for any future correspondence 
 
• Thank you and goodbye 
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Appendix 36 
Dear {patients name}, 
 
My name is Barbara Farquharson, I am currently undertaking a 
research project which aims to better understand how people seek 
medical help with particular medical symptoms. 
 
I am writing to invite you to take part in this study. You have 
been selected after recently being in contact with NHS 24. You 
have been selected using a method that ensures everyone with 
these types of symptoms has an equal chance of being chosen. 
 
I am aware that it is possible that I may be contacting you at a 
difficult time and I do not wish to cause you any concern. If you 
feel unable to deal with this request at this time, please simply 
return all the enclosed information in the envelope provided and 
accept my apologies for troubling you. 
 
However, if you feel able to consider participating please read the 
enclosed Patient Information Sheet carefully. It explains clearly 
what the study involves and should answer any questions you 
might have.  
 
I understand that, in your case, the telephone call to NHS 24 was 
made by someone other than yourself. Where possible, I would 
be very interested in hearing their views too. Therefore, if you 
could pass the ‘Caller Information’ on to the person who called 
on your behalf, it would be very helpful.  
 
If you wish to take part but are unable to pass this information 
onto the person who made the call, do not worry. Please simply 
follow the instructions contained in the ‘Patient Information 
Sheet’. 
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If you require any additional information please contact me on 
the number below. Thank you for your assistance. 
 
Yours sincerely 
 
 
Barbara Farquharson  MSc; BSc; RGN 
Tel: 01786 466112 
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Appendix 37 
 
Dear caller 
 
My name is Barbara Farquharson; I am a nurse working with 
NHS 24. I am currently undertaking a research project which 
aims to better understand how people seek medical help with 
particular symptoms. 
 
I am writing to invite you to take part in this study. Patients have 
been selected after recently being in contact with NHS 24. You 
are being approached as you were involved in making a call on 
behalf of one of the patients selected. I have asked them to pass 
this information to you. 
 
I am aware that it is possible that I may be contacting you at a 
difficult time and do not wish to cause you any concern. If you 
feel unable to deal with this request at this time, please simply 
return all the enclosed information in the envelope provided and 
accept my apologies for troubling you. 
 
However, if you feel able to consider taking part please read the 
enclosed Caller Information Sheet carefully. It explains clearly 
what the study involves and should answer any questions you 
might have. If you require any additional information please 
contact me on the number below. Thank you for your assistance. 
 
Yours sincerely 
 
 
 
Barbara Farquharson  MSc; BSc; RGN 
Tel: 01786 466112 
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Appendix 38 
Caller Information Sheet 
 
Study Title: What factors influence people’s behaviour when 
seeking help with symptoms? 
 
You are being invited to take part in a research study. Before you 
decide it is important for you to understand why the research is being 
done and what it will involve. Please take time to read the following 
information carefully. Please discuss it with others if you wish. Feel 
free to ask us if there is anything that is not clear or if you would like 
more information. It is important that you take time to decide whether 
or not you wish to take part. Thank you for reading this information. 
 
What is the purpose of the study? 
 
The study is part of a PhD studentship. The aim is to learn how 
people’s personal circumstances and thoughts about their symptoms 
influence how and when they contact health services. We are also 
interested in the views of other people who were present when the 
telephone call to NHS 24 was made. It is hoped this information will 
help us to adapt services to make sure that people get the help they 
need, as quickly as possible. 
 
Why have I been chosen? 
 
A number of telephone calls to NHS 24 have been selected using a 
process that ensures that everyone who called NHS 24 recently with 
particular medical symptoms has an equal chance of being chosen. 
The patients have been invited to participate in this study. Where 
someone else made the telephone call on their behalf we have asked 
them to pass this information to that person. You are being 
approached as you were involved in making the telephone call to 
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NHS 24 on behalf of one of the patients selected. We are interested in 
exploring your thoughts about the patient’s symptoms. 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide 
to take part you do not need to take any action. The researcher will 
contact you over the next few days to confirm that you wish to take 
part and to make further arrangements with you. 
 
If you do not wish to take part, please respond to the researcher as 
soon as possible. Please either return the enclosed ‘I decline’ card in 
the pre-paid envelope or telephone [mobile number] and leave a 
message including this study number -[study number]. You will not 
need to talk to anyone and will not be contacted about this study 
again. If you would like to provide the reason why you feel unable to 
take part, we would find that very helpful. 
 
If you do not respond within 3 days the researcher will telephone you. 
You should be aware that this call will be recorded. If you receive this 
call, you are still under no obligation to take part. You are free to 
withdraw at any time and without giving a reason. A decision to 
withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive.  
 
If you do decide to take part we will send you a written record of the 
consent you have given. You may also keep this information sheet.  
 
What will happen to me if I take part? 
 
You will also be asked to take part in an interview by telephone. The 
researcher who contacts you will confirm you wish to take part and 
make arrangements to interview you at a convenient time. The 
interview will be carried out by telephone and will last up to 30 
minutes. The questions will be about the symptoms the patient 
experienced prior to you contacting NHS 24, and your thoughts and 
feelings about those symptoms. The enclosed Illness Perception 
Questionnaire contains similar questions to those you will be asked.  
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What are the possible risks/ disadvantages of taking part? 
 
Some people may find being asked to recall the events which led 
them to contact health services distressing. Others may find it helpful 
to do so. 
 
 
What are the possible benefits of taking part? 
 
There is no direct benefit for you in taking part. However, the 
information gained from this study may help us to better understand 
how people seek help with symptoms.  This may inform how services 
are developed to better meet the needs of the public. 
 
 
What if something goes wrong? 
 
It is unlikely you will be harmed by taking part in this study. 
However, if you wish to complain or have any concerns about any 
aspect of the way you have been approached or treated during the 
course of this study, please contact Gill Stillie, Associate Director of 
Nursing, NHS 24, Norseman House, South Queensferry, EH30 9QZ.  
 
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the 
research will be kept strictly confidential. It will not be possible to 
identify you from any information which leaves NHS premises.  
 
 
What will happen to the results of the research study? 
 
The results of the study will be reported in a PhD thesis which will be 
available in the University of Stirling. The results will also be 
submitted to healthcare journals for publication. You will not be 
identified in any report or publication. You will be given the 
opportunity to request a summary of the results. 
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Who is organising and funding the research? 
 
This study is being organised jointly between NHS 24 and the 
Universities of Stirling and Aberdeen. It has been funded by the 
Nursing, Midwifery and Allied Health Professionals (NMAHP) 
Research Training Scheme which was developed in association with 
NHS Education for Scotland (NES), The Scottish Executive and The 
Health Foundation. No-one will receive payment as a result of your 
participation. 
 
 
Who has reviewed the study? 
 
The study has been reviewed by the Departmental Research Ethics 
Committee, University of Stirling and by Fife and Forth Valley NHS 
Research Ethics Committee. 
 
Who should I contact for further information? 
 
Should you have any questions or require further information please 
do not hesitate to contact 
 
Barbara Farquharson           
NHS 24      
Norseman House     
2 Ferrymuir     
South Queensferry    
 
Tel: 01786 466112    
 
 
Thank-you for reading this information. Please keep this leaflet for 
your own records. 
 
    
  
   
   
   
   
  
433 
 
Appendix 39 
 
ILLNESS PERCEPTION QUESTIONNAIRE  
 
Study ID No………………………………    
 
YOUR VIEWS ABOUT YOUR SYMPTOMS 
We are interested in what leads people to seek medical help for their symptoms. Please 
describe in your own words what led you to be in contact with NHS 24. 
 
 
 
 
 
 
 
 
 
THE TIMING OF YOUR SYMPTOMS 
We are interested in how long you experienced your symptoms before you decided to 
contact health services. It is really important that this is as accurate as possible,  so we 
ask that you think carefully and double-check your dates and times.   
 
T1: When did you first notice the symptoms you spoke to NHS 24 about?   
 
Day:                Month:    Year:   
 
Time:    am/pm (please circle as appropriate) 
 
 
T1: When did you your symptoms begin to cause you real concern?   
 
Day:                Month:    Year:   
 
Time:    am/pm (please circle as appropriate) 
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T3: Did you contact any other health professional before you spoke to  
NHS 24?  (please circle as appropriate) 
 
No    Yes  - if yes  Who? 
        At what time? 
      
 
VIEWS ABOUT YOUR ILLNESS 
Listed below are a number of symptoms that you may or may not have experienced 
when you contacted NHS 24. Please indicate by circling Yes or No, whether you  
have experienced any of these symptoms recently and whether these symptoms 
relate to why you were in contact with NHS 24. 
I have experienced this  
symptom recently 
 (within last 2 weeks) 
This symptom is 
related to why I was in 
contact with NHS 24 
Pain     Yes  No ________________Yes     No 
Discomfort    Yes  No ________________Yes  No 
Numbness    Yes  No ________________Yes  No 
Sore Throat   Yes  No ________________Yes  No 
Nausea    Yes  No ________________Yes  No 
Breathlessness   Yes  No ________________Yes  No 
Weight Loss   Yes  No ________________Yes  No 
Tiredness    Yes  No ________________Yes  No 
Stiff Joints    Yes  No ________________Yes  No 
Collapse    Yes  No ________________Yes  No 
Wheeziness    Yes  No ________________Yes  No 
Headaches    Yes  No ________________Yes  No 
Upset Stomach   Yes  No ________________Yes  No 
Sleep Difficulties   Yes  No ________________Yes  No 
Dizziness    Yes  No ________________Yes  No 
Loss of Strength   Yes  No ________________Yes  No 
Pins and needles   Yes  No ________________Yes  No 
  
We are interested in your own personal views of how you now see your current 
illness. 
Please indicate by ticking the appropriate box how much you agree or disagree with 
the following statements about your symptoms AT THE TIME YOU CONTACTED 
NHS 24. 
 
 I thought….. STRONGLY DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP1*
 My symptoms would last a short time      
IP2
 My symptoms were likely to be permanent 
rather than temporary 
     
IP3
 My symptoms would last for a long time      
IP4*
 My symptoms would  pass quickly      
IP5
 I would have these symptoms for the rest 
of my life 
     
IP6
 My illness was a serious condition      
IP7
 My symptoms would have major negative 
consequences on my life 
     
IP8*
 My symptoms would not have much effect 
on my life 
     
IP9
 My symptoms would strongly effect the 
way others see me 
     
IP10
 My symptoms would have serious 
financial consequences 
     
IP11
 My symptoms would cause difficulties for 
those who are close to me 
     
IP12
 There was a lot I could do to control my 
symptoms 
     
IP13
 What I did could determine whether my 
symptoms got better or worse 
     
IP14
 The course of my illness depended on me      
IP15*
 There was nothing I could do to effect my 
symptoms 
     
IP16
 I had the power to influence my symptoms      
IP20
 My treatment would be effective in easing 
my symptoms 
     
IP21
 Treatment would reduce the 
unpleasantness of my symptoms 
     
IP22
 My treatment could control my symptoms      
IP23*
 There was nothing which could help my 
condition 
     
IP24
 The symptoms of my condition were 
puzzling to me 
     
IP25
 My symptoms were a mystery to me      
IP26
 I did not understand my symptoms      
IP27
 My symptoms didn’t make any sense to 
me 
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STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
IP29
 My symptoms change a great deal from 
day to day 
     
IP30
 My symptoms come and go in cycles      
IP31
 My symptoms are very unpredictable      
IP32
 I go through cycles in which my symptoms 
get better and worse. 
     
IP33
 I felt depressed about my symptoms      
IP34
 I was upset about my symptoms      
IP35
 My symptoms made me feel annoyed      
IP36*
 My symptoms did NOT worry me      
IP37
 Having these symptoms made me feel 
anxious 
     
IP38
 My symptoms frightened me      
 
CAUSES OF MY ILLNESS  
 
We are interested in what you considered may have been causing your symptoms at 
the time you were in contact with NHS 24.  As people are very different, there is no 
correct answer for this question.  We are most interested in your own views about the 
factors that may have caused your symptoms rather than what others including 
doctors or family may have suggested to you.  Below is a list of possible causes for 
your symptoms.  Please indicate how much you agree or disagree that they may have 
been causes for you by ticking the appropriate box. 
 
 POSSIBLE CAUSES STRONGLY DISAGREE  DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
C1
 Stress or worry      
C2
 Hereditary - it runs in my family      
C3
 A Germ or virus      
C4
 Diet or eating habits      
C5
 Chance or bad luck      
C6
 Poor medical care in my past      
C7
 Pollution in the environment      
C8
 My own behaviour      
C9
 My mental attitude e.g. thinking about 
life negatively 
     
C10
 Family problems or worries caused my 
illness 
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STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
C11
 Overwork      
C12
 My emotional state e.g. feeling down, 
lonely, anxious, empty 
     
C13
 Ageing      
C14
 Alcohol      
 C15
 Smoking      
C16
 Accident or injury      
C17
 My personality      
C18
 Being ‘rundown’      
 
 
 
Below, please list in rank-order the three most important factors that you believed 
might be causing YOUR symptoms at the time you called NHS 24.   You may use any 
of the items from the box above, or you may have additional ideas of your own. 
 
The most important causes for me:- 
1.  ______________________________________  
2. _______________________________________ 
3. _______________________________________ 
 
 
ADDITIONAL INFORMATION 
 
In order to help us understand the information you have provided better, it would be 
very helpful if you could tell us a little about yourself. 
 
 
1. What is your age?  ___________  
 
2. Are you male or female? ___________ 
 
3. On what date did you complete this questionnaire?___________ 
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4. What is your ethnic group?  Choose one section from A to E,  tick box if appropriate 
or add your own description. 
Q. White 
Scottish 
British 
Irish 
 
 
Other white background? (please 
state) 
R. Asian, Asian Scottish or Asian 
British 
Indian 
Pakistani 
Bangladeshi 
Chinese 
 
Other asian background? (please 
state) 
 
 
S. Black 
Caribbean 
African 
 
 
 
Other black background? (please 
state) 
T. Mixed 
 
 
E. Any other ethnic background (please state) 
 
HOW DID YOU FIND THIS QUESTIONNAIRE? 
We are interested in hearing your views about completing the questionnaire. Please 
indicate how much you agree or disagree with the following statements by ticking the 
appropriate box. 
 
 
 
STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
 
 The questionnaire was easy to complete      
 I was contacted at an appropriate time      
 The questions were relevant to me      
 I remember the reason I was in contact 
with NHS 24 
     
 
Please feel free to make any additional comments below or on an additional sheet: 
 
 
Once completed please in the stamped, addressed envelope provided. Please post it 
within a week if possible. Thank you very much for taking part in this study.  
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Appendix 40 
CALLER ILLNESS PERCEPTION QUESTIONNAIRE  
Study ID No………………………………    
 
YOUR VIEWS ABOUT THE PATIENT’S SYMPTOMS 
We are interested in what leads people to seek medical help for others. Please describe 
in your own words what led you to be in contact with NHS 24. 
 
 
 
 
 
 
 
 
 
 
THE TIMING OF THE PATIENTS SYMPTOMS 
We are interested in how long the patient (the person you spoke to NHS 24 about) 
experienced symptoms before you decided to contact health services. It is really 
important that this is as accurate as possible,  so we ask that you think carefully and 
double-check your dates and times.   
 
T1: When did the patient first notice the symptoms you spoke to NHS 24 
about?   
 
Day:                Month:    Year:   
 
Time:    am/pm (please circle as appropriate) 
 
 
T1: When did the patients symptoms begin to cause you real concern?   
 
Day:                Month:    Year:   
 
Time:    am/pm (please circle as appropriate) 
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T3: Did you contact any other health professional before you spoke to  
NHS 24?  (please circle as appropriate) 
 
No    Yes  - if yes  Who? 
        At what time? 
      
VIEWS ABOUT THE PATIENT’S ILLNESS 
 
Listed below are a number of symptoms that the patient may or may not have 
experienced when you contacted NHS 24.  Please indicate by circling Yes or No, 
whether you believe they have experienced any of these symptoms recently (within 
last 2 weeks) and whether these symptoms relate to why you were in contact with 
NHS 24. 
 
They have experienced this  
symptom recently 
 (within last 2 weeks) 
This symptom is 
related to why I 
contacted NHS 24 on 
their behalf 
   
Pain    Yes No Don’t know________________Yes     No 
Discomfort   Yes No Don’t know________________Yes  No 
Numbness      Yes No Don’t know________________Yes  No 
Sore Throat  Yes No Don’t know________________Yes  No 
Nausea   Yes No Don’t know________________Yes  No 
Breathlessness  Yes No Don’t know________________Yes  No 
Weight Loss  Yes No Don’t know________________Yes  No 
Tiredness   Yes No Don’t know________________Yes  No 
Stiff Joints   Yes No Don’t know________________Yes  No 
Collapse        Yes No Don’t know________________Yes  No 
Wheeziness   Yes No Don’t know________________Yes  No 
Headaches   Yes No Don’t know________________Yes  No 
Upset Stomach  Yes No Don’t know________________Yes  No 
Sleep Difficulties  Yes No Don’t know________________Yes  No 
Dizziness   Yes No Don’t know________________Yes  No 
Loss of Strength  Yes No Don’t know________________Yes  No 
Pins and needles  Yes No Don’t know________________Yes  No 
  
We are interested in YOUR own personal views about the patient’s symptoms. 
 
Please indicate how much you agree or disagree with the following statements about 
the patient’s symptoms by ticking the appropriate box. 
 
 I thought… STRONGLY DISAGREE   DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
CIP1*
 Their symptoms would last a short time      
CIP2
 Their symptoms were likely to be 
permanent rather than temporary 
     
CIP3
 Their symptoms would last for a long time      
CIP4*
 Their symptoms would pass quickly      
CIP5
 They would have these symptoms for the 
rest of their life 
     
CIP6
 Their illness was a serious condition      
CIP7
 Their symptoms would have major 
negative consequences on their life 
     
CIP8*
 Their symptoms would not have much 
effect on their life 
     
CIP9
 Their symptoms would strongly effect the 
way others see them 
     
CIP10
 Their symptoms would have serious 
financial consequences 
     
CIP11
 Their symptoms would cause difficulties 
for those who are close to them 
     
CIP12
 There was a lot they could do to control 
their symptoms 
     
CIP13
 What they did could determine whether 
their symptoms got better or worse 
     
CIP14
 The course of their illness depended on 
them 
     
CIP15
*
 
There was nothing they could do to effect 
their symptoms 
     
CIP16
 They had the power to influence their 
symptoms 
     
CIP19
*
 
There was very little that could be done to 
improve their symptoms 
     
CIP20
 Their treatment would be effective in 
easing their symptoms 
     
CIP21
 Treatment would reduce the 
unpleasantness of their symptoms 
     
CIP22
 Their treatment would control their 
symptoms 
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STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
CIP23
*
 
There was nothing which could help their 
condition 
     
CIP24
 The symptoms of their condition were 
puzzling to them 
     
CIP25
 Their symptoms were a mystery to them      
CIP26
 They did not understand their symptoms      
CIP27
 Their symptoms didn’t make any sense to 
them 
     
CIP29
 Their symptoms changed a great deal 
from day to day 
     
CIP30
 Their symptoms came and went in cycles      
CIP31
 Their symptoms were very unpredictable      
CIP32
 They went through cycles in which their 
symptoms got better and worse. 
     
CIP33
 They felt depressed about their symptoms      
CIP34
 They were upset about their symptoms      
CIP35
 Their symptoms made them feel annoyed      
CIP36
*
 
Their symptoms did NOT worry them      
CIP37
 Having these symptoms made them feel 
anxious 
     
CIP38
 Their symptoms frightened them      
 
We are also interested in exploring how the patient’s illness affected you. 
Please indicate how much you agree or disagree with the following statements about 
the patient’s symptoms by ticking the appropriate box. 
 
 
 
STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
CIP39
 There was a lot that  I could do to control 
the patient’s symptoms 
     
CIP40
 What I did  could determine whether their 
symptoms got better or worse 
     
CIP41
 The course of their illness depended on me      
CIP42
*
 
There was nothing I could do to effect 
their symptoms 
     
CIP43
 I had the power to influence the patient’s 
symptoms 
     
CIP44
*
 
Any action I took would not effect the 
outcome of their illness 
     
CIP45 The symptoms of their condition were 
puzzling to me 
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STRONGLY 
DISAGREE  
 DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
CIP46 Their symptoms were a mystery to me      
CIP47 I did not understand their symptoms      
CIP48 Their symptoms didn’t make any sense to 
me 
     
CIP49
* 
I had a clear picture or understanding of 
their condition 
     
CIP50 I felt depressed about their symptoms      
CIP51 I was upset about their symptoms      
CIP52 Their symptoms made me feel annoyed      
CIP53
* 
Their symptoms did NOT worry me      
CIP54 The patient having these symptoms made 
me feel anxious 
     
CIP55 Their symptoms frightened me      
 
CAUSES OF THEIR ILLNESS  
We are interested in what you consider may have been the causing the patient’s 
symptoms at the time you were in contact with NHS 24.  As people are very different, 
there is no correct answer for this question.  We are most interested in your own 
views about the factors that may have caused the patient’s symptoms rather than 
what others including doctors or family may have suggested to you.  Below is a list of 
possible causes for their symptoms.  Please indicate how much you agree or disagree 
that they may have been causes for them by ticking the appropriate box. 
 
 POSSIBLE CAUSES STRONGLY DISAGREE  DISAGREE NEITHER AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
CC1
 Stress or worry      
CC2
 Hereditary - it runs in their family      
CC3
 A Germ or virus      
CC4
 Diet or eating habits      
CC5
 Chance or bad luck      
CC6
 Poor medical care in the past      
CC7
 Pollution in the environment      
CC8
 Their own behaviour      
CC9
 Their mental attitude e.g. thinking about 
life negatively 
     
  
 
 
STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
CC10
 Family problems or worries caused their 
illness 
     
CC11
 Overwork      
CC12
 Their emotional state e.g. feeling down, 
lonely, anxious, empty 
     
CC13
 Ageing      
CC14
 Alcohol      
 CC15
 Smoking      
CC16
 Accident or injury      
CC17
 Their personality      
CC18
 Being ‘rundown’      
 
 
In the table below, please list in rank-order the three most important factors that you 
believed might be causing the patients symptoms at the time you called NHS 24.   
You may use any of the items from the box above, or you may have additional ideas 
of your own. 
 
The most important causes for me:- 
1.  ______________________________________  
2. _______________________________________ 
3. _______________________________________ 
 
 
ADDITIONAL INFORMATION 
In order to help us understand the information you have provided better, it would be 
very helpful if you could tell us a little about yourself. 
 
1. What is your age?  ___________  
 
2. Are you male or female? ___________ 
 
3. What is your relationship to the patient? ___________ 
 
4. On what date did you complete this questionnaire? ___________ 
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5. What is your ethnic group?  Choose one section from A to E,  tick box if appropriate 
or add your own description. 
A. White 
Scottish 
British 
Irish 
 
 
Other white background? (please 
state) 
B. Asian, Asian Scottish or Asian 
British 
Indian 
Pakistani 
Bangladeshi 
Chinese 
 
Other asian background? (please 
state) 
 
 
C. Black 
Caribbean 
African 
 
 
 
Other black background? (please 
state) 
D. Mixed 
 
 
E. Any other ethnic background (please state) 
 
HOW DID YOU FIND THIS QUESTIONNAIRE? 
We are interested in hearing your views about completing the questionnaire. Please 
indicate how much you agree or disagree with the following statements by ticking the 
appropriate box. 
 
 
 
STRONGLY 
DISAGREE  
DISAGREE NEITHER 
AGREE NOR 
DISAGREE 
AGREE  STRONGLY 
AGREE 
 
CPF1
 
The questionnaire was easy to complete      
CPF2
 I was contacted at an appropriate time      
CPF3
 The questions were relevant to me      
CPF4
 I remember the reason I was in contact 
with NHS 24 
     
 
Please feel free to make any additional comments below or overleaf: 
 
Once completed please put this questionnaire in the stamped, addressed envelope 
provided. Please post it within a week if possible. Thank you very much for taking 
part in this study.  
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Appendix 41 
Interview schedule 
 
• Introduction and thanks 
 
• Re-check consent 
 
• Explanation of what interview will involve, expected duration 
 
• Opportunity for participant to ask questions 
 
• Instructions read from IPQ-R 
 
• Check understanding 
 
• Read questions from IPQ-R 
 
• Confirm contact details for any future correspondence 
 
• Thank you and goodbye 
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Appendix 42 
 
Dear Dr {patients GP}, 
 
Re: {patient/caller details} 
 
My name is Barbara Farquharson, I am a Team Leader with NHS 24 based 
in the East Contact Centre. I am currently undertaking a research project 
which aims to better understand how people seek medical help with 
symptoms. 
 
I am writing to inform you that the person named above has consented to 
take part in this study. Their participation involves completing a 
questionnaire designed to assess illness perception. 
 
They have also given their consent for me to obtain some clinical data from 
their medical notes in 3 months time. Their consent was obtained verbally 
and is recorded within NHS 24. Please feel free to confirm this with the 
patient in the meantime.  
 
I will contact you nearer the time for this very brief information. If you 
would prefer that I contact someone else in the practice please just let me 
know. To avoid over-burdening practices, the number of cases from each 
practice will be collated and each practice approached only once regarding 
data for all participating patients. 
 
I enclose a copy of the information sheet and questionnaire which have 
been provided to the patient. If you would like any further detail about the 
study or have any concerns or questions please do not hesitate to contact 
me on the number below. 
 
Yours sincerely 
 
 
 
Barbara Farquharson MSc; BSc; RGN 
Tel: 01786 466112 
email: barbara.farquharson@stir.ac.uk 
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Appendix 43 
 
Dear Dr {patients GP}, 
 
Re: {patient/caller details} 
 
I wrote to you recently to inform you of the above patients participation in the research 
study I am conducting.  
 
They have given their consent for me to obtain some clinical data from their medical 
notes. This was given verbally and is recorded within NHS 24. If possible I would be 
grateful if you could provide the information requested below and return a copy to me 
using the reply-paid envelope. 
Alternatively you may wish to email this to me at the address below. 
 
If, for any reason,  I do not receive a reply I will contact your practice in 2 weeks time to 
discuss how best I might obtain this information with minimal inconvenience to you and 
your staff.  
 
 If you would like any further detail about the study or have any concerns or questions 
please do not hesitate to contact me on the number below. 
 
Yours sincerely 
 
 
 
 
 
 
Barbara Farquharson MSc; BSc; RGN 
Tel: 01786 466112 
email: barbara.farquharson@stir.ac.uk 
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GP:  
 
Patient Name 
Address 
 
 
1. What (if any) diagnosis did the patient receive regarding their symptoms of the [date 
of call]. 
 
 
2. On what date was this diagnosis made? 
 
 
3. What other diagnoses (if any) has the patient received between [date of call] and 
[date 3 mths later]? 
 
 
4. Is the patient alive as of  [date 3 mths post-call]? If not on what date did they die? 
 
5. Is the patient diabetic? 
 
 
 
 
 
 
Thank you very much for your help. 
 
Please return (SAE enclosed) to: 
 
Barbara Farquharson 
NHS 24 
Norseman House 
2 Ferrymuir 
South Queensferry 
EH30 9QZ
  
 
 
Appendix 44 
Distribution of subscale scores 
 Mean (SD) Skewness SE z-skewness Kurtosis SE z-kurtosis Normal  
Identity 4.969 2.990 1.100 .191 5.76 1.753 .380 4.61 no 
Caller-identity 4.4800 2.476 .949 .337 2.81 1.774 .662 2.67 no 
Timeline 13.779 4.035 .131 .195 .067 -.546 .389 -1.4 yes 
Caller- timeline 14.957 4.046 .056 .327 .171 -.224 .644 -.34 yes 
Timeline-cyclic 12.278 3.415 -.323 .194 -1.66 -.204 .386 -0.52 yes 
Caller-timeline cyclic 11.387 3.236 .048 .325 .148 -.177 .639 -.277 yes 
Consequences 18.671 4.430 -.424 .194 -2.1 .107 .385 .27 yes 
Caller-consequences 19.578 4.634 -.390 .322 -1.21 .540 .634 .851 yes 
Personal control 13.114 3.332 .214 .195 1.09 .135 .387 .34 yes 
Caller report patient’s personal control 12.625 3.936 .449 .325 1.38 .978 .639 1.53 yes 
Caller’s own personal control 9.590 2.971 .123 .319 .385 0 .628 0 yes 
Treatment control 15.077 2.403 -.844 .194 4.32 2.198 .386 5.69 no 
Caller treatment control 11.964 1.878 -1.792 .319 -5.62 8.740 .628 13.91 no 
Coherence 10.864 4.131 .309 .192 1.6 -.785 .383 2.04 yes 
Caller report patient’s coherence 11.333 3.619 .28 .325 .86 -1.130 .639 -1.76 yes 
Caller’s own coherence 13.018 4.382 -.263 .322 -.081 -.975 .634 1.53 yes 
Emotion 21.576 3.765 -.096 .192 -.05 -.69 .381 -1.81 yes 
Caller report patient’s emotion 22.118 3.298 -.241 .325 .74 .167 .639 0.26 yes 
Caller’s own emotion 20.789 3.867 .051 .322 .158 .169 .634 .26 yes 
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